data_2lfk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lfk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.81 166.99 27.17 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.525 2.817 . . . . 0.0 112.235 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.92 -28.15 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.427 1.091 . . . . 0.0 113.4 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.39 2.01 86.06 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.158 1.361 . . . . 0.0 115.393 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.15 156.43 31.72 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.404 1.602 . . . . 0.0 112.217 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -77.15 99.83 5.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.971 1.309 . . . . 0.0 111.483 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.0 155.72 36.23 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.406 1.482 . . . . 0.0 113.263 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.78 165.54 29.95 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.234 2.623 . . . . 0.0 112.475 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.23 138.05 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.803 1.241 . . . . 0.0 111.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -68.61 146.36 53.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.367 1.067 . . . . 0.0 110.604 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.42 -11.07 69.66 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mp 47.33 34.27 3.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.102 2.161 . . . . 0.0 114.737 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -97.37 178.68 5.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 1.75 14.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.544 1.938 . . . . 0.0 114.506 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.76 158.4 31.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.111 1.764 . . . . 0.0 112.778 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -134.7 83.75 2.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.932 1.693 . . . . 0.0 112.354 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.03 171.8 12.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.737 1.215 . . . . 0.0 111.663 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.6 m -122.05 112.75 18.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.355 1.462 . . . . 0.0 109.726 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -119.8 167.38 12.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.788 1.635 . . . . 0.0 110.849 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -133.41 140.14 47.16 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.182 0.993 . . . . 0.0 110.239 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -133.37 165.95 23.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 109.548 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.3 t -112.65 138.8 48.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.55 -0.719 . . . . 0.0 111.293 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.4 mtp -125.67 86.25 2.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.912 1.685 . . . . 0.0 109.255 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.37 -77.3 0.89 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.025 1.774 . . . . 0.0 112.68 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -131.57 -4.41 3.73 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.015 1.326 . . . . 0.0 114.135 -174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.3 m -123.83 139.37 54.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.179 1.392 . . . . 0.0 111.536 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.09 147.52 32.74 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.942 0.897 . . . . 0.0 111.824 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -147.02 127.02 13.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.554 1.942 . . . . 0.0 110.565 -171.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.44 145.17 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.421 1.089 . . . . 0.0 112.372 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -131.72 137.06 48.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.344 1.857 . . . . 0.0 110.595 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.54 117.46 12.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.381 1.472 . . . . 0.0 110.666 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.62 65.69 0.04 OUTLIER Glycine 0 N--CA 1.477 1.409 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.88 28.74 15.02 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -72.45 -46.43 54.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.152 . . . . 0.0 113.588 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.3 p 50.75 -10.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 131.224 3.81 . . . . 0.0 118.405 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.61 -171.39 47.71 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.656 2.074 . . . . 0.0 113.168 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.06 -168.76 23.82 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.751 -0.852 . . . . 0.0 113.759 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -67.31 146.83 53.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.429 1.492 . . . . 0.0 111.932 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.8 p -75.43 -32.82 60.82 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -136.76 163.05 31.51 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.144 1.777 . . . . 0.0 112.071 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.3 tpp -56.53 -38.53 71.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.749 0.82 . . . . 0.0 111.725 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.06 -17.39 75.61 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.19 0.9 . . . . 0.0 115.07 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -82.85 -33.63 27.03 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.908 1.354 . . . . 0.0 111.798 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.2 t -69.33 -53.4 19.77 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.474 -0.766 . . . . 0.0 112.016 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.31 -17.87 64.94 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -78.94 -18.36 53.93 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -106.91 -51.69 2.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.196 1.398 . . . . 0.0 112.352 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.551 0.987 0 CA-C-N 118.713 0.688 . . . . 0.0 112.251 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.98 161.59 43.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.81 2.34 . . . . 0.0 112.5 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 tp -58.27 -28.12 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.833 1.253 . . . . 0.0 113.262 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.13 4.46 83.26 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.179 1.371 . . . . 0.0 115.506 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -63.6 157.34 24.09 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.479 1.639 . . . . 0.0 112.379 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -76.36 70.35 2.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.368 1.467 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.19 157.05 88.85 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.399 1.479 . . . . 0.0 112.901 171.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.76 176.72 9.01 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.848 3.032 . . . . 0.0 113.263 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.47 135.48 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.728 1.611 . . . . 0.0 111.52 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -77.28 141.95 39.71 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.969 1.308 . . . . 0.0 110.752 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.4 -4.42 90.0 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 56.15 21.16 4.96 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.822 2.049 . . . . 0.0 114.255 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.0 m -70.16 168.84 14.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.167 1.387 . . . . 0.0 113.29 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.17 -0.44 14.23 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.96 164.44 22.32 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.933 1.693 . . . . 0.0 112.766 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -129.47 93.09 3.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.247 1.819 . . . . 0.0 110.905 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.15 174.04 11.97 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.472 1.109 . . . . 0.0 111.455 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.1 m -128.01 110.84 12.9 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.001 1.32 . . . . 0.0 109.744 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -116.42 165.91 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.871 1.668 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.07 85.05 2.18 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.263 1.025 . . . . 0.0 111.135 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -82.35 156.19 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.844 0.858 . . . . 0.0 111.091 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 t -90.48 140.38 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 111.442 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.2 mtp -133.77 111.17 10.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.604 1.962 . . . . 0.0 109.663 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.69 -95.57 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.94 1.257 . . . . 0.0 112.186 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -116.0 -8.98 11.81 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.342 1.457 . . . . 0.0 113.932 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.3 p -120.51 156.58 31.23 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.733 1.151 . . . . 0.0 113.14 -171.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.24 124.53 35.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.687 1.195 . . . . 0.0 110.378 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -121.43 135.16 55.08 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.454 1.902 . . . . 0.0 110.704 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -67.22 145.99 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.318 0.647 . . . . 0.0 112.006 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -127.14 135.79 51.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.732 2.013 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.07 107.97 11.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.519 . . . . 0.0 110.423 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.01 -169.01 31.34 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.911 0.767 . . . . 0.0 113.095 -172.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.45 86.51 3.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.949 -0.736 . . . . 0.0 110.675 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.55 133.62 48.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.845 1.658 . . . . 0.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.2 p -136.79 -3.42 2.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.197 1.399 . . . . 0.0 114.389 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.1 0.83 58.98 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.189 1.376 . . . . 0.0 115.842 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.79 176.58 17.64 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.02 1.771 . . . . 0.0 113.606 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -60.01 136.37 57.99 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.204 1.002 . . . . 0.0 112.522 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.5 m -76.41 -17.16 59.49 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -131.92 146.99 52.44 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.081 1.753 . . . . 0.0 110.951 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 tpp -55.82 -37.84 69.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.241 1.016 . . . . 0.0 111.504 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.02 -47.8 85.68 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.225 0.917 . . . . 0.0 112.646 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.23 -37.9 81.75 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.091 0.946 . . . . 0.0 112.688 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.931 0.492 . . . . 0.0 111.887 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -19.01 65.65 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -66.46 -25.04 66.53 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.676 -1.265 . . . . 0.0 113.116 169.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -109.49 -55.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.807 1.643 . . . . 0.0 112.231 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 0.987 0 C-N-CA 123.709 0.804 . . . . 0.0 112.911 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.385 -0.341 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 160.12 50.44 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.848 2.366 . . . . 0.0 112.346 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 tt -58.85 -26.71 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.94 1.296 . . . . 0.0 113.712 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.83 2.02 88.0 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.886 1.232 . . . . 0.0 115.497 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -66.91 157.39 33.32 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.286 1.543 . . . . 0.0 112.617 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.3 m -75.37 57.7 0.93 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.974 . . . . 0.0 113.425 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.22 155.98 89.24 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.131 1.373 . . . . 0.0 113.912 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -75.39 178.46 7.3 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 124.003 3.135 . . . . 0.0 112.734 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.08 139.68 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.342 1.457 . . . . 0.0 112.213 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -68.18 142.44 55.7 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.026 1.33 . . . . 0.0 110.879 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.09 -11.63 75.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 46.17 69.82 0.44 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.313 2.245 . . . . 0.0 112.671 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.6 m -120.55 175.12 6.15 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.652 1.581 . . . . 0.0 111.874 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -84.64 4.5 32.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.156 1.382 . . . . 0.0 114.475 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.13 163.53 24.44 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.338 1.855 . . . . 0.0 112.808 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -130.33 87.12 2.47 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.156 1.783 . . . . 0.0 111.677 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.06 175.46 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.508 1.123 . . . . 0.0 112.152 171.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -128.04 115.36 18.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.221 1.408 . . . . 0.0 110.256 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -119.98 165.71 14.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.11 1.764 . . . . 0.0 111.037 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -129.04 134.44 48.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 109.945 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.62 139.6 47.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.708 1.203 . . . . 0.0 110.436 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.6 t -81.3 111.19 17.46 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.604 -0.685 . . . . 0.0 111.589 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.8 mmm -92.68 71.61 4.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.109 0.963 . . . . 0.0 109.33 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.25 -75.0 2.39 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.99 1.757 . . . . 0.0 113.804 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -133.65 5.96 3.72 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.843 1.657 . . . . 0.0 113.745 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 93.4 m -135.65 117.18 14.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.188 1.795 . . . . 0.0 110.399 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.61 133.29 49.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.896 0.878 . . . . 0.0 111.165 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -131.21 141.45 50.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.119 1.768 . . . . 0.0 110.983 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.64 145.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 112.19 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -134.39 141.57 46.88 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.113 2.165 . . . . 0.0 110.552 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.97 117.67 10.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.426 1.49 . . . . 0.0 110.759 -172.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.02 58.85 0.02 OUTLIER Glycine 0 N--CA 1.478 1.456 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 56.52 30.92 18.05 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -71.23 -53.24 15.05 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.658 1.183 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.5 p 50.74 3.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 129.618 3.167 . . . . 0.0 118.23 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.97 -6.31 52.21 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.342 1.449 . . . . 0.0 116.082 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.12 -177.97 39.0 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.165 1.364 . . . . 0.0 114.112 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.4 146.76 47.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.167 1.387 . . . . 0.0 111.535 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.8 t -69.39 -36.39 76.73 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -136.26 162.58 32.58 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.259 1.824 . . . . 0.0 111.123 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 35.7 tpp -58.03 -37.56 74.57 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 112.014 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.8 -44.15 98.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.64 1.114 . . . . 0.0 113.792 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.26 -40.25 96.87 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.451 1.126 . . . . 0.0 112.22 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.8 t -57.8 -47.76 81.67 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.378 1.071 . . . . 0.0 111.348 170.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.18 62.71 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -73.08 -40.76 64.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.069 1.304 . . . . 0.0 112.06 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -84.4 -51.5 6.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.45 1.5 . . . . 0.0 112.006 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.549 0.935 0 C-N-CA 123.802 0.841 . . . . 0.0 112.995 174.335 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.81 162.57 41.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.71 2.273 . . . . 0.0 112.67 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.11 -27.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.96 1.304 . . . . 0.0 113.509 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.44 3.98 86.36 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.068 1.318 . . . . 0.0 115.298 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -64.46 157.81 25.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.438 1.619 . . . . 0.0 112.317 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 m -72.92 58.23 0.46 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.926 2.09 . . . . 0.0 113.376 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.55 155.54 80.91 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.873 1.269 . . . . 0.0 113.25 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.12 176.43 9.55 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.478 2.785 . . . . 0.0 113.382 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.46 140.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.651 1.58 . . . . 0.0 111.206 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -81.91 145.73 30.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.047 1.339 . . . . 0.0 111.107 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.08 -7.3 80.65 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 124.99 1.281 . . . . 0.0 115.823 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mp 53.98 26.61 6.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.01 2.124 . . . . 0.0 114.435 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -68.12 171.1 7.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.116 1.766 . . . . 0.0 113.233 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -76.0 -1.82 27.59 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.562 1.545 . . . . 0.0 114.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.85 167.48 18.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.212 1.805 . . . . 0.0 112.859 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -127.57 102.72 6.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.388 1.875 . . . . 0.0 110.988 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.21 175.77 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.803 1.241 . . . . 0.0 111.271 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.7 m -128.75 117.1 20.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.141 1.377 . . . . 0.0 109.518 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -123.91 167.06 14.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.491 1.516 . . . . 0.0 110.463 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.32 105.18 5.87 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.353 1.461 . . . . 0.0 109.993 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -103.57 132.03 50.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 111.117 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.05 91.99 2.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.291 0.567 . . . . 0.0 111.7 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -86.76 83.76 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.54 1.136 . . . . 0.0 109.936 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.67 -73.47 2.26 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.602 1.572 . . . . 0.0 112.837 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -136.1 0.69 2.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 114.058 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -136.22 151.96 50.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.008 0.923 . . . . 0.0 112.992 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.8 m -89.05 81.16 6.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.491 1.516 . . . . 0.0 111.42 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -64.84 124.2 21.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.245 0.618 . . . . 0.0 110.142 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.77 142.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.082 0.553 . . . . 0.0 111.347 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -125.91 125.7 43.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.456 1.902 . . . . 0.0 109.717 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.21 106.18 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.876 1.67 . . . . 0.0 110.237 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.94 -169.55 32.5 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.809 1.195 . . . . 0.0 112.078 -170.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.4 t -77.14 88.6 3.62 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.471 -1.017 . . . . 0.0 111.177 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -129.48 134.68 47.93 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.005 1.722 . . . . 0.0 110.321 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.0 p -138.77 -7.98 1.42 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.983 1.313 . . . . 0.0 114.519 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.91 -2.99 88.24 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.932 1.254 . . . . 0.0 115.982 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.82 178.03 22.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.819 1.676 . . . . 0.0 112.993 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -55.21 134.0 49.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.763 1.625 . . . . 0.0 114.033 -165.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 t -81.04 -10.87 59.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -132.7 146.92 52.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.566 1.546 . . . . 0.0 111.643 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.5 tpp -52.96 -39.1 62.71 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.03 1.332 . . . . 0.0 111.849 168.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.03 -45.16 63.62 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.897 0.761 . . . . 0.0 113.325 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.66 -34.51 77.23 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.123 0.969 . . . . 0.0 112.36 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 t -66.17 -53.58 35.74 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.791 -0.568 . . . . 0.0 112.249 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.23 75.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -63.36 -22.49 66.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -104.53 -23.63 13.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.558 1.543 . . . . 0.0 114.1 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.8 m . . . . . 0 CA--C 1.551 0.988 0 CA-C-N 118.847 0.749 . . . . 0.0 112.697 164.822 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.06 148.81 63.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.451 2.101 . . . . 0.0 111.772 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.8 -21.98 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.416 1.087 . . . . 0.0 113.342 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.31 83.86 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 114.957 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -68.51 139.37 55.65 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.408 1.604 . . . . 0.0 110.829 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 t -72.43 94.18 1.62 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.41 159.07 50.97 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.379 1.471 . . . . 0.0 112.647 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.71 175.59 11.09 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.08 2.52 . . . . 0.0 113.711 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.76 138.28 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.696 1.598 . . . . 0.0 111.632 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -82.9 138.95 33.68 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.0 1.32 . . . . 0.0 111.191 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.68 2.62 82.34 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.544 2.021 . . . . 0.0 115.756 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.9 mt 57.19 17.89 3.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.015 2.526 . . . . 0.0 115.776 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.9 p -78.62 173.63 12.22 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 2.43 6.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.732 2.013 . . . . 0.0 115.252 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.61 162.43 17.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.572 1.549 . . . . 0.0 112.889 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -130.93 87.15 2.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.575 1.95 . . . . 0.0 111.545 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.39 174.88 11.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.976 1.311 . . . . 0.0 111.482 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -128.47 131.89 48.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.289 1.436 . . . . 0.0 109.377 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -130.42 158.29 40.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.833 1.253 . . . . 0.0 111.12 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -123.61 81.36 1.89 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.531 1.158 . . . . 0.0 111.374 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -77.37 170.91 15.72 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -126.45 136.4 52.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.552 1.141 . . . . 0.0 110.549 169.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.4 mmm -121.35 10.59 10.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.694 1.198 . . . . 0.0 112.814 -172.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.87 -91.07 0.12 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.656 1.598 . . . . 0.0 111.914 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.09 8.75 18.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.849 1.66 . . . . 0.0 113.411 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -146.2 132.75 19.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.302 1.841 . . . . 0.0 110.815 -172.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.2 m -81.01 86.68 6.08 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.604 0.761 . . . . 0.0 111.958 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -62.61 114.07 3.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.65 144.09 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.117 0.967 . . . . 0.0 111.165 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -124.93 148.23 48.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.276 1.43 . . . . 0.0 110.528 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -131.36 127.69 38.11 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.044 1.738 . . . . 0.0 110.575 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.62 -168.02 25.68 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.096 0.855 . . . . 0.0 112.652 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.73 71.19 0.34 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.602 -0.94 . . . . 0.0 111.861 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.5 136.15 53.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.699 1.6 . . . . 0.0 110.651 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.5 p -129.75 -8.39 4.52 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.301 1.441 . . . . 0.0 114.117 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.6 -174.06 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.325 1.44 . . . . 0.0 113.444 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.09 -172.95 8.47 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.123 0.868 . . . . 0.0 114.216 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -69.73 137.15 51.77 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.783 0.802 . . . . 0.0 112.05 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -80.82 -13.0 59.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -130.1 144.72 51.5 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.658 1.983 . . . . 0.0 110.875 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.2 ttt -65.3 -15.49 62.57 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.112 1.365 . . . . 0.0 113.895 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.11 -32.15 15.12 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.591 1.091 . . . . 0.0 114.275 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.27 -28.42 67.19 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.537 1.135 . . . . 0.0 113.049 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.7 p -73.98 -44.16 55.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.357 0.663 . . . . 0.0 112.171 168.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.87 -24.3 61.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.264 1.426 . . . . 0.0 114.564 -171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -65.89 -30.1 70.64 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 167.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.68 -49.15 5.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.665 1.186 . . . . 0.0 112.006 -171.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.552 1.033 0 C-N-CA 124.419 1.088 . . . . 0.0 112.431 169.155 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.06 155.23 57.27 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.64 2.226 . . . . 0.0 112.473 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.91 -27.34 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.943 1.297 . . . . 0.0 113.484 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.09 83.05 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.221 1.391 . . . . 0.0 115.51 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -63.7 153.8 35.12 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.527 1.663 . . . . 0.0 112.414 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -78.06 74.87 4.6 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.805 1.242 . . . . 0.0 111.5 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.18 154.25 94.27 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.511 1.125 . . . . 0.0 111.584 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.88 162.53 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 113.203 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.28 132.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.882 1.273 . . . . 0.0 111.437 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.58 136.62 47.5 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.203 1.001 . . . . 0.0 110.733 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.13 -4.22 86.06 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.361 0.982 . . . . 0.0 115.259 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.4 mt 59.35 9.07 1.3 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.747 2.419 . . . . 0.0 115.697 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 p -89.72 173.21 8.41 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -171.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -0.31 15.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.768 2.027 . . . . 0.0 115.92 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.86 152.12 25.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.293 1.437 . . . . 0.0 112.849 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -121.49 78.77 1.47 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.275 1.83 . . . . 0.0 110.624 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -72.14 171.95 11.06 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.194 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -128.29 116.01 19.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.882 1.273 . . . . 0.0 109.573 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -120.46 159.14 25.74 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.848 1.659 . . . . 0.0 110.905 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -126.93 120.0 28.07 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.729 1.212 . . . . 0.0 109.958 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -120.5 124.66 45.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.149 0.979 . . . . 0.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.7 t -73.61 116.02 13.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.096 0.474 . . . . 0.0 110.488 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 mtp -93.83 67.32 3.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.705 1.602 . . . . 0.0 109.439 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.31 -64.92 3.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.605 1.574 . . . . 0.0 114.126 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -140.0 9.6 2.35 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.68 148.08 29.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.789 1.636 . . . . 0.0 109.988 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -102.76 129.66 49.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 112.597 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -119.27 136.96 53.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.858 1.663 . . . . 0.0 110.889 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.12 141.23 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.351 1.06 . . . . 0.0 111.106 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.43 128.45 48.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.351 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.48 97.98 3.83 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.588 1.555 . . . . 0.0 111.894 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.47 63.41 0.01 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.22 -0.925 . . . . 0.0 114.491 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.4 t 52.93 53.7 11.65 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.715 1.206 . . . . 0.0 112.917 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.43 140.8 41.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.5 p -130.2 -12.41 4.07 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.843 1.257 . . . . 0.0 114.341 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.83 -174.4 48.47 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.238 1.399 . . . . 0.0 113.106 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.06 -166.9 52.08 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.808 -0.819 . . . . 0.0 113.313 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -87.02 146.75 26.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 111.977 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.6 m -78.08 -13.2 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -137.73 148.2 45.41 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 112.072 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.01 -27.23 68.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 112.508 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.91 -28.56 45.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.42 -0.8 . . . . 0.0 114.155 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -72.16 -34.02 68.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.432 1.116 . . . . 0.0 112.579 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 p -68.78 -45.47 71.23 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.351 -0.843 . . . . 0.0 111.453 168.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -38.38 88.68 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.906 1.282 . . . . 0.0 114.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -84.77 -46.27 11.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.0 112.118 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 176.512 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.91 161.9 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.881 2.387 . . . . 0.0 112.205 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.4 tt -63.18 146.97 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.718 0.807 . . . . 0.0 111.068 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.49 0.84 89.38 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.527 1.06 . . . . 0.0 115.384 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -62.67 154.7 28.5 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.152 1.476 . . . . 0.0 111.523 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -77.05 68.69 3.23 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.945 1.298 . . . . 0.0 111.922 176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.01 155.65 91.43 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.298 1.439 . . . . 0.0 112.7 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.6 175.06 11.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.223 2.615 . . . . 0.0 112.935 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.55 139.64 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.33 1.452 . . . . 0.0 111.428 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -67.17 146.17 54.49 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.91 82.65 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.84 17.18 4.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.182 2.193 . . . . 0.0 114.662 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.21 168.49 19.03 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.442 1.097 . . . . 0.0 112.937 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -68.6 -42.78 77.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.353 1.061 . . . . 0.0 112.321 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.13 157.44 37.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.913 1.285 . . . . 0.0 113.078 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.09 90.95 2.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.067 1.747 . . . . 0.0 111.213 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.8 173.98 3.21 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.371 1.068 . . . . 0.0 111.656 170.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -125.14 115.02 19.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.877 1.271 . . . . 0.0 109.744 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -118.83 165.63 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.348 1.459 . . . . 0.0 110.929 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.29 136.44 50.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.337 1.455 . . . . 0.0 109.318 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -130.17 137.48 50.12 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.386 1.075 . . . . 0.0 109.457 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.9 t -72.88 131.19 41.93 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.98 -0.45 . . . . 0.0 110.695 169.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 97.2 mmm -123.14 6.42 9.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.625 1.57 . . . . 0.0 113.906 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.23 91.35 0.81 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.582 1.563 . . . . 0.0 111.99 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 58.44 9.32 1.03 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.829 2.052 . . . . 0.0 114.933 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 t -155.74 165.29 36.98 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.054 2.542 . . . . 0.0 108.961 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.5 m -117.29 159.99 21.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 112.792 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.39 142.1 49.98 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.767 2.027 . . . . 0.0 110.095 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.38 143.44 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.0 0.92 . . . . 0.0 111.004 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -132.16 126.82 34.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.312 1.845 . . . . 0.0 110.605 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.99 108.7 9.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.823 1.649 . . . . 0.0 110.562 -171.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.79 55.18 0.01 OUTLIER Glycine 0 N--CA 1.476 1.337 0 C-N-CA 123.599 0.618 . . . . 0.0 114.238 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.1 t 60.5 22.94 12.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.506 1.523 . . . . 0.0 114.887 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.55 135.24 53.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.197 1.399 . . . . 0.0 111.228 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.7 p -132.33 -13.74 3.02 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.37 -9.31 79.64 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.32 170.67 21.6 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.308 1.432 . . . . 0.0 114.198 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.33 144.48 57.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.8 1.64 . . . . 0.0 111.821 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -72.22 -22.69 61.21 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -140.48 152.58 45.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.705 1.602 . . . . 0.0 111.385 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.86 -30.56 71.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.25 70.11 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.316 -0.865 . . . . 0.0 114.208 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.87 -44.3 17.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.915 1.358 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.47 -35.92 78.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.831 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.91 -7.23 49.99 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.976 1.71 . . . . 0.0 115.264 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -76.51 -42.05 44.71 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.658 1.117 . . . . 0.0 111.948 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -81.57 -54.67 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.926 1.691 . . . . 0.0 111.945 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 124.047 0.939 . . . . 0.0 112.22 169.617 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.34 160.56 49.11 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.662 2.241 . . . . 0.0 112.245 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.51 -26.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.005 1.322 . . . . 0.0 113.713 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.03 6.01 84.02 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.165 1.365 . . . . 0.0 115.569 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.6 t-105 -63.54 153.26 36.23 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.482 1.641 . . . . 0.0 112.617 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.7 m -72.27 87.69 1.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.823 1.649 . . . . 0.0 112.086 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.87 157.27 35.08 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 125.991 1.716 . . . . 0.0 112.505 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.11 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.549 2.833 . . . . 0.0 113.945 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.92 136.3 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.125 1.37 . . . . 0.0 111.492 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.19 147.6 49.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.641 1.176 . . . . 0.0 110.732 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.17 -14.3 66.92 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.8 mp 46.51 50.54 12.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.906 2.082 . . . . 0.0 113.417 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 25.0 m -96.73 173.71 7.18 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.612 1.165 . . . . 0.0 112.467 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -69.07 -34.89 75.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.981 1.312 . . . . 0.0 112.79 173.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.93 165.19 13.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.762 1.625 . . . . 0.0 112.995 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -131.36 92.41 3.18 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.21 1.804 . . . . 0.0 111.252 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -68.48 175.66 3.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.64 1.176 . . . . 0.0 112.099 172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -125.19 113.0 17.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.097 1.359 . . . . 0.0 110.456 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -115.44 169.29 9.27 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.963 1.705 . . . . 0.0 110.867 173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -135.38 129.5 33.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.214 1.406 . . . . 0.0 109.677 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.82 129.12 41.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.692 1.197 . . . . 0.0 110.775 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.05 134.26 38.84 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.992 0.425 . . . . 0.0 111.497 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.3 mtp -122.5 56.92 1.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.289 1.836 . . . . 0.0 109.97 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.33 -79.7 0.3 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.018 1.77 . . . . 0.0 112.576 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -124.54 1.02 8.26 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 m -136.2 147.08 47.47 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.395 1.878 . . . . 0.0 110.249 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.25 132.85 51.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 111.185 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -126.28 141.7 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.346 1.859 . . . . 0.0 110.544 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.56 148.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.039 0.935 . . . . 0.0 111.776 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -136.1 133.18 37.03 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.792 2.037 . . . . 0.0 110.438 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.91 119.08 18.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.158 1.383 . . . . 0.0 110.956 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.54 51.98 0.02 OUTLIER Glycine 0 N--CA 1.476 1.333 0 N-CA-C 114.592 0.597 . . . . 0.0 114.592 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.36 32.68 20.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.314 1.446 . . . . 0.0 114.233 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.91 121.41 19.01 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.673 1.189 . . . . 0.0 110.602 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -108.36 -7.51 15.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.268 1.427 . . . . 0.0 113.678 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.11 -168.96 40.7 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.958 1.742 . . . . 0.0 113.122 172.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 -162.03 41.74 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.004 0.811 . . . . 0.0 113.989 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.43 138.12 31.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.795 0.838 . . . . 0.0 110.863 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.9 p -77.9 -16.8 57.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 -139.38 155.76 47.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.997 2.119 . . . . 0.0 111.913 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 52.6 tpp -61.77 -39.66 92.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.012 0.925 . . . . 0.0 111.853 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.97 -37.53 94.56 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.146 -0.972 . . . . 0.0 113.436 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -68.49 -29.95 68.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.1 p -81.13 -45.55 16.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.679 1.127 . . . . 0.0 112.499 166.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 -18.94 65.07 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -68.41 -24.69 64.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.928 -1.108 . . . . 0.0 113.156 169.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -106.28 -56.05 2.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.173 1.789 . . . . 0.0 111.481 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 124.139 0.976 . . . . 0.0 112.814 173.744 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.85 168.67 20.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.955 2.437 . . . . 0.0 112.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 tp -60.47 147.27 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.196 0.998 . . . . 0.0 111.532 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.77 9.72 86.49 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -61.62 157.1 18.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.918 1.359 . . . . 0.0 112.401 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -77.34 62.63 2.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.68 1.592 . . . . 0.0 112.485 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.76 157.85 85.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.368 1.467 . . . . 0.0 112.716 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.31 178.24 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.683 2.922 . . . . 0.0 113.87 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.11 137.45 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.752 1.621 . . . . 0.0 111.248 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -82.7 144.48 30.2 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.306 1.443 . . . . 0.0 111.059 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.54 -8.3 83.31 Favored Glycine 0 CA--C 1.542 1.736 0 C-N-CA 124.761 1.172 . . . . 0.0 115.93 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 mp 55.4 22.35 4.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.208 2.203 . . . . 0.0 114.694 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -67.7 168.83 10.55 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.171 1.789 . . . . 0.0 113.204 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -66.18 -28.93 69.14 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.76 166.72 12.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.567 1.547 . . . . 0.0 113.15 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -132.76 107.22 8.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.154 1.781 . . . . 0.0 111.203 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.3 178.0 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.466 1.506 . . . . 0.0 110.971 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 m -128.97 110.49 12.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 110.015 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -114.49 168.12 10.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.312 1.445 . . . . 0.0 110.856 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -133.69 139.71 46.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.738 1.215 . . . . 0.0 110.29 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.37 131.06 29.34 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.668 1.187 . . . . 0.0 110.492 -176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.7 m -73.45 94.38 2.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.724 0.81 . . . . 0.0 111.574 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.7 mmm -80.46 54.33 2.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.789 1.636 . . . . 0.0 109.944 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.56 -88.77 1.13 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.398 1.951 . . . . 0.0 112.19 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -86.83 -14.04 43.28 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.3 p -145.44 143.52 30.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.8 m -75.06 92.28 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.935 1.294 . . . . 0.0 110.761 169.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -75.53 126.08 30.29 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.89 147.06 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.136 0.574 . . . . 0.0 110.869 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -128.75 108.39 10.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.746 2.018 . . . . 0.0 109.756 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -98.78 110.37 22.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.134 1.774 . . . . 0.0 110.461 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.01 -169.34 33.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.453 1.025 . . . . 0.0 112.647 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.06 87.14 2.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.561 -0.964 . . . . 0.0 111.215 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.36 122.49 27.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.027 1.731 . . . . 0.0 110.644 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.3 p -115.03 -8.06 12.48 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.534 1.534 . . . . 0.0 113.789 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.96 -173.18 49.76 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.776 1.655 . . . . 0.0 113.625 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.94 -159.97 42.73 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.102 0.858 . . . . 0.0 114.61 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -82.53 128.85 34.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.131 0.973 . . . . 0.0 110.65 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.5 p -70.04 -26.9 64.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.645 1.178 . . . . 0.0 113.352 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -139.59 160.04 40.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.891 2.077 . . . . 0.0 111.048 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 50.2 ttm -63.11 -31.61 72.79 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.68 73.68 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 114.036 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -80.98 -29.05 35.37 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.055 0.927 . . . . 0.0 113.265 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.83 -34.35 39.52 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.103 -0.998 . . . . 0.0 112.432 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.88 -22.33 66.63 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -78.54 -5.18 51.98 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.166 1.386 . . . . 0.0 114.566 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -118.92 -43.81 2.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.171 1.788 . . . . 0.0 112.411 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 111.814 167.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.26 159.99 48.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.867 2.378 . . . . 0.0 112.675 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -58.82 -27.72 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.192 1.397 . . . . 0.0 113.635 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.88 -3.62 89.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.513 1.054 . . . . 0.0 115.23 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -68.76 141.4 55.23 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.42 1.61 . . . . 0.0 111.739 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -71.63 92.43 1.16 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.92 159.32 63.28 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.194 1.398 . . . . 0.0 112.532 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.03 161.39 38.75 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.748 2.299 . . . . 0.0 113.235 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.77 133.34 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.742 1.217 . . . . 0.0 111.886 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -72.16 144.71 48.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.314 1.046 . . . . 0.0 110.593 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.2 -6.9 80.91 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 57.01 20.02 5.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.974 2.11 . . . . 0.0 114.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 m -74.43 169.49 17.6 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.958 -1.089 . . . . 0.0 112.426 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.74 -39.96 80.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.938 0.895 . . . . 0.0 112.68 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 159.66 29.37 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.806 1.243 . . . . 0.0 113.115 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -131.39 90.18 2.83 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.938 1.695 . . . . 0.0 111.706 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -61.44 174.32 0.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 111.943 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -123.14 107.99 12.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.465 1.106 . . . . 0.0 110.341 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? -111.33 157.55 20.06 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.034 1.334 . . . . 0.0 111.039 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -120.99 138.96 53.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.95 120.71 18.46 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.843 1.257 . . . . 0.0 109.881 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.36 96.44 0.87 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.685 0.755 . . . . 0.0 110.581 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.6 mmm -78.95 81.88 5.19 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 0.0 108.734 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.96 -67.45 2.38 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.47 1.985 . . . . 0.0 114.536 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -132.64 -4.83 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.585 1.554 . . . . 0.0 114.068 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t -134.29 134.43 41.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.447 1.099 . . . . 0.0 112.007 -174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 52.5 m -81.87 95.41 7.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 111.321 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.44 156.44 24.12 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.787 0.835 . . . . 0.0 110.981 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.38 145.11 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.655 1.182 . . . . 0.0 110.46 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.36 131.14 33.85 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.88 1.672 . . . . 0.0 110.388 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.41 122.42 24.96 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 111.187 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.27 52.15 0.02 OUTLIER Glycine 0 N--CA 1.474 1.184 0 C-N-CA 123.753 0.692 . . . . 0.0 113.709 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.6 t 61.22 23.59 13.79 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 0.0 114.459 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -67.73 136.44 54.27 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.389 . . . . 0.0 111.599 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -130.02 -7.38 4.41 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.48 -10.24 59.45 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.411 1.005 . . . . 0.0 115.375 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.82 174.07 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.831 1.205 . . . . 0.0 114.089 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -71.5 149.56 45.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.903 1.281 . . . . 0.0 111.863 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m -70.6 -31.21 68.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.034 1.334 . . . . 0.0 113.752 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -140.23 160.25 40.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.534 1.934 . . . . 0.0 111.063 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.8 ttm -62.57 -36.95 84.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.624 0.77 . . . . 0.0 112.413 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.83 91.69 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.359 -0.838 . . . . 0.0 113.645 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.03 -38.52 82.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.143 0.977 . . . . 0.0 112.65 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.0 p -75.52 -40.76 56.56 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.806 0.73 . . . . 0.0 111.985 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.38 87.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -68.48 -27.21 65.94 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.36 -48.43 10.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.795 1.238 . . . . 0.0 112.165 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.93 163.71 34.89 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.108 2.539 . . . . 0.0 111.53 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.9 tp -56.79 -26.74 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.544 1.138 . . . . 0.0 113.422 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.83 -5.42 88.63 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.609 1.1 . . . . 0.0 115.274 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -71.51 160.22 33.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.605 1.703 . . . . 0.0 111.357 172.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 m -77.56 55.22 1.28 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.978 1.311 . . . . 0.0 112.233 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.39 156.29 88.82 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.032 1.333 . . . . 0.0 113.575 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.84 171.42 16.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.037 2.491 . . . . 0.0 112.776 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.84 132.74 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.159 1.384 . . . . 0.0 111.904 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -84.38 139.83 31.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.153 1.381 . . . . 0.0 110.53 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.14 -2.85 89.27 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.254 1.407 . . . . 0.0 116.156 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 54.11 27.3 7.46 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.89 2.076 . . . . 0.0 114.342 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 m -65.53 171.09 4.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.654 1.581 . . . . 0.0 112.96 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -75.0 -0.06 17.53 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.449 1.5 . . . . 0.0 114.841 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.28 163.35 19.82 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.156 1.782 . . . . 0.0 112.785 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -132.15 85.26 2.22 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.432 1.893 . . . . 0.0 111.934 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -72.63 172.61 10.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.022 0.929 . . . . 0.0 111.589 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 m -121.82 113.15 19.25 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.855 1.262 . . . . 0.0 109.256 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.49 164.63 14.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.212 1.405 . . . . 0.0 110.801 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.75 140.33 50.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.655 1.582 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -142.01 137.5 31.18 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.217 . . . . 0.0 111.001 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.67 97.16 8.95 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.648 -0.658 . . . . 0.0 111.455 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 88.8 mmm -81.67 71.48 8.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.165 1.386 . . . . 0.0 110.584 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.88 -79.59 1.67 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.505 1.526 . . . . 0.0 112.989 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.11 -10.3 9.04 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -133.07 136.64 46.03 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 110.386 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.56 144.39 47.94 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.362 -0.836 . . . . 0.0 110.884 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -132.68 132.55 42.52 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.019 1.727 . . . . 0.0 110.266 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.77 142.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.669 0.788 . . . . 0.0 110.65 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -129.56 103.35 6.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.694 1.998 . . . . 0.0 109.567 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -86.47 114.75 23.49 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.1 1.36 . . . . 0.0 110.453 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.69 -176.44 33.22 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.542 1.067 . . . . 0.0 113.547 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 9.2 t -79.22 59.71 2.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.724 1.21 . . . . 0.0 111.89 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -85.72 -36.64 20.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.952 0.901 . . . . 0.0 113.358 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p 54.2 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 130.993 3.717 . . . . 0.0 118.187 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.45 -160.29 35.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.91 2.195 . . . . 0.0 113.85 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.17 -136.57 48.1 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.967 1.27 . . . . 0.0 113.518 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -108.33 136.91 47.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.327 1.451 . . . . 0.0 110.599 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t -75.64 -22.83 56.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.228 1.011 . . . . 0.0 112.255 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 154.86 49.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.169 1.788 . . . . 0.0 112.776 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -58.97 -33.07 70.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.081 0.952 . . . . 0.0 112.516 173.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.56 -40.94 94.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.055 0.836 . . . . 0.0 113.652 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.56 -31.8 73.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 0.0 112.249 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -71.04 -51.13 27.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.294 1.038 . . . . 0.0 111.797 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.47 76.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.902 1.681 . . . . 0.0 114.17 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.57 -21.3 65.49 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -105.72 -34.61 7.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.061 1.344 . . . . 0.0 113.464 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.4 m . . . . . 0 CA--C 1.552 1.034 0 C-N-CA 124.096 0.959 . . . . 0.0 112.81 171.178 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 120.71 0.291 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.99 168.14 25.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.922 2.415 . . . . 0.0 112.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.56 -27.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.545 1.138 . . . . 0.0 113.418 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.21 90.1 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.803 1.192 . . . . 0.0 115.375 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -65.48 152.65 43.48 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.405 1.603 . . . . 0.0 111.984 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 p -75.54 72.17 2.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.375 1.47 . . . . 0.0 112.064 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.8 151.35 85.09 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.682 1.193 . . . . 0.0 112.542 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.6 171.11 17.86 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.018 2.479 . . . . 0.0 112.536 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.72 126.45 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.759 1.224 . . . . 0.0 112.179 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -69.69 141.84 53.47 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.394 1.078 . . . . 0.0 110.246 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.11 -6.67 89.07 Favored Glycine 0 CA--C 1.541 1.681 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.76 20.08 4.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.78 2.032 . . . . 0.0 113.985 -175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 m -77.18 172.03 13.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.643 1.177 . . . . 0.0 113.328 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -84.43 5.33 27.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.756 2.022 . . . . 0.0 115.305 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.01 165.07 20.14 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.302 1.841 . . . . 0.0 113.225 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -128.78 95.16 4.02 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.671 1.988 . . . . 0.0 112.571 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -83.19 177.34 8.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.762 0.825 . . . . 0.0 111.297 166.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -134.43 114.48 12.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.044 1.337 . . . . 0.0 111.227 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.4 mmp_? -116.05 166.14 12.34 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.965 1.706 . . . . 0.0 111.266 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.81 99.25 4.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.412 1.485 . . . . 0.0 110.496 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -97.13 137.15 36.62 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.48 0.712 . . . . 0.0 110.748 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -77.89 107.04 10.13 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.246 -0.909 . . . . 0.0 110.906 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.8 mmm -93.29 17.1 11.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.835 1.654 . . . . 0.0 113.529 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.44 90.04 2.14 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.473 1.511 . . . . 0.0 111.348 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 t30 59.23 14.05 3.39 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.34 1.856 . . . . 0.0 114.803 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.4 m -142.99 116.47 9.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.2 m -61.6 115.0 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.175 0.59 . . . . 0.0 110.55 157.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -113.49 132.18 55.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.63 1.572 . . . . 0.0 110.184 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.62 144.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.265 0.626 . . . . 0.0 111.608 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -133.73 137.93 45.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.881 1.672 . . . . 0.0 110.869 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -135.33 117.92 15.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.503 1.521 . . . . 0.0 110.776 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.41 59.22 0.01 OUTLIER Glycine 0 N--CA 1.475 1.273 0 C-N-CA 123.532 0.587 . . . . 0.0 114.292 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 59.0 25.18 13.52 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.03 113.16 6.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.985 1.314 . . . . 0.0 110.968 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -102.77 -8.26 20.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.944 1.298 . . . . 0.0 113.678 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.96 -174.14 42.46 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.523 1.535 . . . . 0.0 113.011 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 -171.53 26.76 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.206 0.908 . . . . 0.0 114.239 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.64 139.06 38.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.787 0.835 . . . . 0.0 110.746 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.6 p -84.76 -10.98 56.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -135.01 150.55 50.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.248 1.819 . . . . 0.0 112.037 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.3 tpp -59.37 -40.59 86.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.956 1.302 . . . . 0.0 111.575 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.55 93.44 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.558 -0.714 . . . . 0.0 113.471 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.18 -38.02 75.27 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.5 p -70.97 -41.75 70.63 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.602 1.092 . . . . 0.0 111.77 169.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.97 -29.5 68.55 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -69.54 -22.47 63.56 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -102.25 -50.79 3.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.988 1.315 . . . . 0.0 112.87 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.551 1.015 0 CA-C-N 118.697 0.68 . . . . 0.0 112.707 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 119.018 -0.515 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.72 161.75 44.7 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.042 . . . . 0.0 112.15 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -62.86 146.19 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.393 0.677 . . . . 0.0 110.653 170.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 15.81 81.27 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.031 0.772 . . . . 0.0 115.031 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -61.52 165.29 4.99 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.87 1.335 . . . . 0.0 111.74 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 t -72.2 93.94 1.51 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.094 -1.003 . . . . 0.0 111.538 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.61 156.73 34.92 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.514 1.525 . . . . 0.0 112.856 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.33 152.6 55.52 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.916 2.411 . . . . 0.0 112.461 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.91 128.62 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.871 0.868 . . . . 0.0 111.936 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -71.53 140.6 49.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.057 0.943 . . . . 0.0 110.664 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.08 -8.94 87.29 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.2 mt 61.67 16.55 7.88 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.222 2.209 . . . . 0.0 115.058 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.0 m -74.94 170.99 14.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.116 1.367 . . . . 0.0 113.551 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.57 -20.55 65.4 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.73 164.36 14.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.427 1.891 . . . . 0.0 112.361 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.55 99.78 4.76 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 112.184 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.34 176.63 1.02 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.349 1.06 . . . . 0.0 110.944 165.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.0 m -124.08 112.41 17.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -119.68 166.59 13.0 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.022 1.729 . . . . 0.0 110.856 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.49 137.75 44.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.356 1.063 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -141.99 126.75 18.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.859 1.264 . . . . 0.0 110.401 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -78.12 128.38 33.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.984 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtp -102.87 5.54 38.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.701 1.2 . . . . 0.0 113.371 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.89 -74.77 0.27 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.527 1.537 . . . . 0.0 111.978 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -120.35 13.69 11.93 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.711 1.605 . . . . 0.0 113.15 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.8 p -147.89 169.37 19.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.21 1.404 . . . . 0.0 111.597 169.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -117.01 111.93 20.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.27 1.828 . . . . 0.0 110.719 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -97.82 137.21 37.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.699 1.599 . . . . 0.0 110.899 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.52 146.79 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.831 0.852 . . . . 0.0 111.456 171.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.37 124.95 25.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.586 1.954 . . . . 0.0 110.555 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -127.44 110.7 13.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.234 1.414 . . . . 0.0 111.388 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.44 52.31 0.01 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 -168.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.0 t 60.51 22.32 12.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.679 1.592 . . . . 0.0 114.476 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.43 128.76 37.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.659 1.584 . . . . 0.0 111.082 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.0 p -105.36 -20.6 13.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.461 1.104 . . . . 0.0 113.769 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.24 -161.06 34.97 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.899 1.714 . . . . 0.0 114.052 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.54 -172.1 48.73 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.861 1.22 . . . . 0.0 114.427 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -73.29 138.12 45.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.525 0.73 . . . . 0.0 109.951 167.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.2 m -70.08 -32.2 70.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.614 0.766 . . . . 0.0 113.054 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -140.49 165.46 27.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.264 1.826 . . . . 0.0 112.17 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.4 ttt -68.91 -24.54 64.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.33 -35.78 69.64 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.259 -0.9 . . . . 0.0 112.809 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -44.07 69.71 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.326 1.45 . . . . 0.0 112.523 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -62.92 -42.56 99.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.777 0.717 . . . . 0.0 112.334 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -3.82 9.98 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.2 mtp-105 -67.22 -42.49 83.97 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.743 -1.223 . . . . 0.0 111.889 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -93.6 -53.08 4.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.248 1.819 . . . . 0.0 111.433 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.3 m . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 111.432 -177.212 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.27 166.0 29.78 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.015 175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.75 148.14 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.89 0.876 . . . . 0.0 111.229 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.72 6.64 89.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -65.66 159.69 24.33 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 119.029 1.414 . . . . 0.0 112.151 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.1 m -76.39 53.5 0.85 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.047 1.739 . . . . 0.0 112.781 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.43 156.11 86.53 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.029 1.332 . . . . 0.0 112.647 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.49 166.19 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.463 2.776 . . . . 0.0 113.604 176.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -97.34 132.52 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.974 1.31 . . . . 0.0 111.639 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -77.27 142.66 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 111.16 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.05 -9.16 77.61 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.478 1.513 . . . . 0.0 115.209 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mp 55.13 18.07 2.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.365 2.266 . . . . 0.0 114.687 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 p -70.9 173.05 7.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -75.65 2.52 11.71 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.204 1.801 . . . . 0.0 114.206 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.52 169.82 13.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.26 2.224 . . . . 0.0 111.431 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -136.55 105.1 5.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.401 1.48 . . . . 0.0 111.126 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -93.87 155.11 17.36 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.55 1.14 . . . . 0.0 111.667 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -102.95 105.11 15.39 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.712 1.205 . . . . 0.0 110.658 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.26 157.85 32.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.02 1.328 . . . . 0.0 110.814 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.43 92.43 3.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.276 1.83 . . . . 0.0 111.146 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.08 139.47 30.6 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.495 -0.753 . . . . 0.0 111.506 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.7 m -74.43 109.11 7.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.87 0.868 . . . . 0.0 112.151 172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.6 mtp -91.75 69.44 5.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.669 1.188 . . . . 0.0 109.804 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.06 -100.51 1.25 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.266 1.413 . . . . 0.0 112.733 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.33 -8.67 56.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.24 161.0 38.5 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.978 1.711 . . . . 0.0 111.49 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.9 m -90.24 152.49 21.05 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.658 -0.651 . . . . 0.0 111.602 165.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -133.34 132.65 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.253 1.821 . . . . 0.0 109.903 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -77.01 146.54 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.985 0.514 . . . . 0.0 111.126 171.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -109.44 -68.76 0.9 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 67.83 78.57 0.23 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.573 1.949 . . . . 0.0 112.91 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.92 14.84 0.03 OUTLIER Glycine 0 N--CA 1.474 1.181 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.6 t 77.07 91.98 0.07 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.436 2.294 . . . . 0.0 112.104 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.3 -56.94 0.8 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 0.0 113.664 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.9 p 54.84 -2.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 129.693 3.197 . . . . 0.0 118.473 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.53 -19.66 53.89 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 119.848 1.204 . . . . 0.0 115.375 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.87 179.04 27.46 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 126.002 1.763 . . . . 0.0 113.356 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -58.88 142.76 49.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.679 1.191 . . . . 0.0 112.871 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.0 p -83.4 -16.28 46.54 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.219 1.408 . . . . 0.0 114.458 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -137.79 154.71 49.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.324 1.85 . . . . 0.0 111.511 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 46.7 ttm -65.67 -29.42 69.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.508 0.723 . . . . 0.0 112.562 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.33 -37.59 94.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.992 -1.068 . . . . 0.0 113.452 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -71.46 -33.8 69.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.106 0.962 . . . . 0.0 113.098 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.2 p -74.9 -49.46 20.23 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.785 -0.572 . . . . 0.0 111.735 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.24 -16.92 62.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.75 -25.78 65.8 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.052 1.296 . . . . 0.0 113.438 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -100.55 -48.9 4.38 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.103 1.361 . . . . 0.0 111.555 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 127.443 2.297 . . . . 0.0 111.568 175.655 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.75 160.15 48.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.87 2.38 . . . . 0.0 111.682 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -61.62 141.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.306 0.574 . . . . 0.0 110.726 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.37 -3.92 85.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.387 0.994 . . . . 0.0 115.163 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.52 156.51 34.7 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.357 1.579 . . . . 0.0 110.956 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 t -77.52 97.81 5.14 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.52 1.128 . . . . 0.0 111.717 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 157.37 34.31 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.902 1.681 . . . . 0.0 113.181 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.4 161.58 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.043 2.495 . . . . 0.0 112.605 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.68 134.56 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.506 1.122 . . . . 0.0 111.85 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -66.84 141.73 57.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.148 0.979 . . . . 0.0 110.485 174.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -10.39 85.82 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.2 mt 62.78 13.24 6.3 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.466 2.306 . . . . 0.0 114.716 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -80.62 171.54 14.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.592 1.157 . . . . 0.0 113.3 -172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -62.55 -43.4 98.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.941 1.296 . . . . 0.0 113.412 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.52 126.53 35.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 113.238 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.33 89.48 5.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.272 1.429 . . . . 0.0 111.174 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -64.1 176.12 1.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.417 1.087 . . . . 0.0 111.625 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -123.0 105.83 10.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.403 1.081 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -112.42 168.14 9.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.197 1.799 . . . . 0.0 110.729 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -135.97 140.1 43.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.37 1.068 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.36 138.85 35.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.181 0.992 . . . . 0.0 112.277 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.38 91.48 1.35 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.929 1.292 . . . . 0.0 112.251 175.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 76.1 mmm -85.61 76.6 9.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.175 0.99 . . . . 0.0 109.331 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.34 -86.44 0.71 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.747 1.641 . . . . 0.0 112.257 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -122.1 3.63 9.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.659 1.583 . . . . 0.0 114.228 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.6 m -130.48 124.95 33.15 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.539 1.536 . . . . 0.0 111.846 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.3 m -73.34 85.98 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.035 1.334 . . . . 0.0 111.632 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -75.42 139.85 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.536 -0.728 . . . . 0.0 110.897 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.38 143.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.692 1.197 . . . . 0.0 111.366 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.98 133.25 45.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.138 1.775 . . . . 0.0 110.734 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -134.3 106.98 7.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.088 1.355 . . . . 0.0 111.293 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.55 0.01 OUTLIER Glycine 0 N--CA 1.475 1.246 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -171.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 t 55.07 29.48 12.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.002 1.321 . . . . 0.0 114.383 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.34 140.8 52.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.756 1.223 . . . . 0.0 110.764 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.8 p -139.06 -3.35 1.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.95 9.76 74.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.349 1.452 . . . . 0.0 116.019 -172.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.03 -172.1 24.78 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 118.861 1.33 . . . . 0.0 114.702 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -61.56 135.93 57.83 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 114.082 -165.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.1 t -72.23 -22.71 61.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 113.363 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -136.07 152.21 50.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.901 1.68 . . . . 0.0 112.518 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.6 tpp -55.04 -44.45 74.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.572 1.549 . . . . 0.0 111.049 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.84 -50.68 62.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.047 1.308 . . . . 0.0 113.306 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -62.15 -37.86 86.8 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.542 1.171 . . . . 0.0 112.991 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.4 t -60.13 -42.24 94.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 171.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.47 -14.69 44.0 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.22 -54.28 39.83 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.082 1.353 . . . . 0.0 111.838 171.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.05 -33.17 44.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 113.265 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.559 0.743 . . . . 0.0 112.306 172.572 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.14 159.05 54.5 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.387 2.058 . . . . 0.0 111.474 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.53 -28.37 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.291 1.037 . . . . 0.0 113.346 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.44 2.44 87.91 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.125 1.345 . . . . 0.0 115.514 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -64.25 158.45 23.24 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.411 1.605 . . . . 0.0 112.085 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -78.87 98.33 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.647 1.179 . . . . 0.0 111.615 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.01 157.23 37.52 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.874 1.67 . . . . 0.0 112.936 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.08 166.22 29.58 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.348 2.699 . . . . 0.0 112.975 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.53 133.35 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.77 1.228 . . . . 0.0 112.194 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -73.32 143.95 46.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.457 1.503 . . . . 0.0 110.705 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.82 -8.67 87.22 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.3 mp 49.72 35.86 9.75 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.63 1.972 . . . . 0.0 113.321 -173.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 m -78.57 168.35 19.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.35 1.46 . . . . 0.0 112.954 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -68.66 -35.06 76.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.253 1.021 . . . . 0.0 113.198 165.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.88 160.53 27.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.138 1.375 . . . . 0.0 112.6 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -132.87 77.51 1.74 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.007 1.723 . . . . 0.0 111.049 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.81 166.24 22.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.543 1.137 . . . . 0.0 111.389 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -128.82 120.93 27.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.635 1.574 . . . . 0.0 110.647 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -124.82 171.85 9.81 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.088 2.555 . . . . 0.0 110.343 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -134.72 137.62 43.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.681 1.192 . . . . 0.0 110.307 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -137.97 132.43 32.3 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.271 1.028 . . . . 0.0 111.544 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.91 121.56 15.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.009 0.923 . . . . 0.0 111.571 170.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.7 mmm -111.87 11.8 20.81 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.672 1.989 . . . . 0.0 113.082 -176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.27 104.04 1.2 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.694 1.14 . . . . 0.0 111.485 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 63.67 -1.27 0.63 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.148 2.179 . . . . 0.0 115.23 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -141.9 156.25 45.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.873 2.069 . . . . 0.0 110.294 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.42 107.93 14.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.949 1.3 . . . . 0.0 110.006 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -90.53 144.48 25.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.434 1.093 . . . . 0.0 110.874 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.28 146.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.691 0.796 . . . . 0.0 111.002 167.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.34 129.21 42.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.319 1.848 . . . . 0.0 109.012 172.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -133.17 149.91 52.03 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.679 0.792 . . . . 0.0 112.27 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.18 12.01 2.16 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 10.1 t 95.87 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 130.05 3.34 . . . . 0.0 110.504 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.05 130.6 33.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.242 1.817 . . . . 0.0 109.114 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -117.41 -4.36 11.32 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.871 1.268 . . . . 0.0 113.941 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.31 -167.97 31.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.198 1.856 . . . . 0.0 113.197 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.85 -164.47 43.0 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.232 0.92 . . . . 0.0 114.526 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -81.89 138.86 34.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.884 0.873 . . . . 0.0 110.392 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -69.14 -30.56 68.83 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -140.6 158.48 43.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.659 1.984 . . . . 0.0 112.087 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.2 ttm -61.75 -34.87 76.62 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.162 0.585 . . . . 0.0 112.084 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.5 -27.93 70.4 Favored Glycine 0 CA--C 1.536 1.377 0 O-C-N 121.471 -0.768 . . . . 0.0 114.059 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.26 -48.27 17.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.266 1.033 . . . . 0.0 112.072 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -65.13 -30.14 71.05 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.462 1.028 . . . . 0.0 113.058 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -6.52 7.23 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -78.32 -12.2 59.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.0 -1.062 . . . . 0.0 113.598 167.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -125.36 -52.77 1.61 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.567 1.947 . . . . 0.0 112.221 -177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 123.746 0.819 . . . . 0.0 111.513 164.512 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.88 158.88 56.1 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.713 2.275 . . . . 0.0 111.802 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.06 138.33 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.239 0.616 . . . . 0.0 111.092 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.69 -1.58 68.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.539 1.066 . . . . 0.0 115.312 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.2 t-105 -65.3 151.69 45.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.588 1.694 . . . . 0.0 111.187 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -78.08 72.14 4.59 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.108 1.363 . . . . 0.0 112.526 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.58 155.16 89.48 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.864 1.265 . . . . 0.0 114.082 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.4 174.38 12.93 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.908 3.072 . . . . 0.0 112.124 170.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.3 143.12 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.614 1.165 . . . . 0.0 112.62 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.35 146.27 54.7 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.434 1.493 . . . . 0.0 111.033 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.47 -7.07 79.85 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 56.05 22.77 6.18 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.267 2.227 . . . . 0.0 114.346 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 m -75.02 172.22 12.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.772 1.229 . . . . 0.0 112.723 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -76.57 -2.12 30.89 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.471 1.509 . . . . 0.0 114.819 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.88 160.74 28.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.9 1.68 . . . . 0.0 113.059 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -131.11 85.16 2.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.48 1.912 . . . . 0.0 112.407 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -66.24 172.0 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.233 1.013 . . . . 0.0 111.293 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -121.24 114.0 20.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.294 1.038 . . . . 0.0 110.518 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -118.37 168.13 10.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.955 1.702 . . . . 0.0 110.657 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -131.65 142.6 49.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.533 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.36 132.26 29.3 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.207 1.403 . . . . 0.0 109.987 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.5 t -71.47 140.62 50.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.808 166.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.31 24.99 11.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.488 1.515 . . . . 0.0 112.59 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.26 -40.35 1.68 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.188 2.328 . . . . 0.0 112.491 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -152.19 -48.46 0.11 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.687 1.595 . . . . 0.0 112.223 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.2 m -71.02 134.75 47.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.122 0.969 . . . . 0.0 111.841 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 95.9 m -73.58 134.86 43.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.006 0.922 . . . . 0.0 110.749 162.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.14 133.52 54.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.039 1.736 . . . . 0.0 109.679 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.78 146.45 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.401 0.681 . . . . 0.0 110.847 172.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.54 134.82 41.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.992 1.717 . . . . 0.0 110.747 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -136.67 113.42 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.208 1.403 . . . . 0.0 111.001 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.63 60.52 0.02 OUTLIER Glycine 0 N--CA 1.476 1.344 0 N-CA-C 115.166 0.827 . . . . 0.0 115.166 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 t 59.73 30.52 20.11 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -70.44 -45.78 65.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.786 1.234 . . . . 0.0 113.641 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.2 p 50.83 -8.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 131.112 3.765 . . . . 0.0 118.394 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.52 -161.35 37.36 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 127.265 2.364 . . . . 0.0 113.965 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.69 -122.99 31.94 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.541 1.067 . . . . 0.0 113.007 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.36 152.84 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.768 1.627 . . . . 0.0 111.944 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.2 p -82.2 -23.54 35.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.867 1.267 . . . . 0.0 114.219 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -137.34 156.11 48.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.152 1.381 . . . . 0.0 112.417 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 ttt -66.46 -19.8 65.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.849 1.26 . . . . 0.0 113.123 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.88 -38.58 26.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.904 0.764 . . . . 0.0 113.501 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -64.56 -45.62 86.3 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.767 1.284 . . . . 0.0 112.747 -174.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -59.69 -35.11 73.82 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.55 -0.719 . . . . 0.0 112.176 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -14.21 60.43 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -74.47 -21.03 59.78 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.819 -1.176 . . . . 0.0 112.762 166.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -103.66 -55.51 2.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.018 1.727 . . . . 0.0 111.649 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 113.237 173.271 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 119.146 -0.455 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.74 155.69 67.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.238 1.959 . . . . 0.0 112.316 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.62 -26.26 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.213 1.405 . . . . 0.0 113.587 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.98 2.43 86.82 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.996 1.284 . . . . 0.0 115.724 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -65.58 155.41 35.87 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.99 1.895 . . . . 0.0 111.555 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -73.53 75.24 1.46 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.906 1.283 . . . . 0.0 111.763 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -78.15 157.19 78.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.654 1.582 . . . . 0.0 113.287 176.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.0 174.81 11.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.21 2.607 . . . . 0.0 112.595 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.62 135.04 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.475 1.51 . . . . 0.0 111.006 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -86.41 138.75 31.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.51 1.124 . . . . 0.0 110.809 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.59 -2.21 88.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.215 1.388 . . . . 0.0 115.659 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 53.85 19.35 1.89 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.341 2.256 . . . . 0.0 114.866 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.4 p -71.85 170.05 14.49 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.014 -1.054 . . . . 0.0 113.472 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.97 3.15 7.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.85 1.66 . . . . 0.0 114.947 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.16 154.37 31.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.843 1.657 . . . . 0.0 112.257 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -124.47 90.42 3.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.308 1.843 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -75.92 171.77 13.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 111.544 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.9 m -125.59 113.71 17.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.186 1.394 . . . . 0.0 108.889 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -121.33 159.94 25.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.897 1.679 . . . . 0.0 110.723 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -119.52 142.64 48.13 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.069 0.948 . . . . 0.0 110.396 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.06 170.75 15.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.111 1.364 . . . . 0.0 110.195 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -136.95 144.92 43.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.539 1.136 . . . . 0.0 110.777 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.9 mtt -137.04 71.83 1.41 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.468 1.107 . . . . 0.0 110.231 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.87 -109.37 2.68 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.883 1.706 . . . . 0.0 112.73 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -113.12 34.01 4.72 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.868 1.667 . . . . 0.0 111.381 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.0 104.92 1.74 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.266 1.427 . . . . 0.0 112.742 -175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.04 157.13 31.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.605 1.162 . . . . 0.0 112.2 164.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -161.83 -178.98 6.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.125 2.17 . . . . 0.0 111.474 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.04 146.58 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.306 2.242 . . . . 0.0 110.767 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.93 138.12 49.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.004 2.122 . . . . 0.0 109.774 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.41 111.86 14.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.595 1.558 . . . . 0.0 110.377 -168.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.08 -170.95 33.3 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.984 0.802 . . . . 0.0 113.28 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.58 77.15 1.08 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 111.227 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.46 141.91 51.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.069 1.747 . . . . 0.0 111.803 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.3 p -134.51 -7.09 2.53 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -173.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.6 -2.4 65.32 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -172.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.62 174.45 25.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.826 1.203 . . . . 0.0 115.06 -170.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.32 156.86 38.1 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.842 1.657 . . . . 0.0 111.953 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -78.75 -29.83 45.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.707 1.203 . . . . 0.0 114.144 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mtm105 -141.34 159.47 42.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.67 1.988 . . . . 0.0 111.347 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 33.4 ttm -62.86 -32.0 73.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.7 0.8 . . . . 0.0 112.356 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.8 -28.8 72.34 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.834 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.59 -46.53 38.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.019 1.409 . . . . 0.0 112.878 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.4 p -62.3 -31.91 72.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.073 -1.017 . . . . 0.0 112.379 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 -10.47 49.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.177 1.391 . . . . 0.0 114.739 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -79.71 -36.22 37.82 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.281 0.946 . . . . 0.0 112.571 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -84.43 -50.85 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 111.928 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 171.537 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.82 159.33 53.76 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.359 2.706 . . . . 0.0 112.503 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 tt -61.4 143.06 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.009 0.924 . . . . 0.0 111.314 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.77 -0.83 83.0 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.604 1.097 . . . . 0.0 115.291 -178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -65.09 160.06 21.92 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.19 1.495 . . . . 0.0 111.204 167.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.7 m -74.88 64.96 1.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.694 1.598 . . . . 0.0 112.91 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 154.2 91.61 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.672 1.189 . . . . 0.0 113.805 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.91 153.39 42.23 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.092 2.528 . . . . 0.0 112.183 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.95 135.03 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.84 0.856 . . . . 0.0 111.93 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.6 144.06 54.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.311 1.045 . . . . 0.0 110.726 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 -10.61 86.13 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 115.219 0.847 . . . . 0.0 115.219 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.6 mt 61.84 14.37 6.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.495 2.318 . . . . 0.0 115.134 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 m -75.76 171.75 13.82 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.599 1.16 . . . . 0.0 113.617 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.76 -46.7 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 112.14 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.82 159.51 28.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.063 1.345 . . . . 0.0 113.195 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -131.1 90.68 2.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.471 1.909 . . . . 0.0 111.527 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -68.6 174.23 4.4 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.968 1.307 . . . . 0.0 111.763 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -126.48 112.07 15.15 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 110.172 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -117.53 168.89 9.99 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.24 1.816 . . . . 0.0 110.459 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -133.18 135.33 45.03 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.603 1.161 . . . . 0.0 109.953 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -132.93 147.59 52.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 0.0 111.205 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.0 t -85.93 127.43 34.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.152 0.581 . . . . 0.0 110.475 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.1 mmm -116.19 25.14 10.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.494 1.917 . . . . 0.0 112.933 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.42 93.43 1.82 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.124 1.345 . . . . 0.0 111.228 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.257 13.2 p30 47.09 28.05 0.87 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.755 2.022 . . . . 0.0 115.116 -173.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -151.24 154.12 36.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.776 2.03 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.74 138.23 54.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.612 1.165 . . . . 0.0 110.819 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -142.48 148.46 37.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.649 1.18 . . . . 0.0 112.011 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.97 150.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.58 1.152 . . . . 0.0 111.804 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -134.73 132.77 39.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.795 2.038 . . . . 0.0 110.467 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -132.74 115.46 15.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.576 1.55 . . . . 0.0 111.022 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.73 55.23 0.01 OUTLIER Glycine 0 N--CA 1.475 1.295 0 O-C-N 121.823 -0.548 . . . . 0.0 114.454 -170.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.2 t 57.07 28.26 14.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.167 1.387 . . . . 0.0 114.401 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.81 139.67 53.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.651 1.18 . . . . 0.0 110.538 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.2 p -125.89 -5.29 6.87 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.89 1.276 . . . . 0.0 113.915 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.13 -167.67 33.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.813 1.673 . . . . 0.0 112.637 173.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.6 49.49 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 122.245 0.914 . . . . 0.0 113.808 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -79.82 148.77 31.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 0.0 111.198 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -78.14 -19.87 53.18 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.38 159.19 42.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.727 2.011 . . . . 0.0 111.95 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.7 tpp -62.45 -40.59 97.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.0 0.92 . . . . 0.0 112.199 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.82 -38.77 93.24 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.721 0.676 . . . . 0.0 112.902 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -39.24 90.96 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.038 1.335 . . . . 0.0 111.676 173.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.03 -56.62 15.41 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.769 -0.582 . . . . 0.0 111.676 167.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.76 70.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -79.18 -18.94 52.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -98.04 -47.07 5.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.876 1.27 . . . . 0.0 112.535 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.557 1.212 0 C-N-CA 123.012 0.525 . . . . 0.0 111.604 167.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.74 146.45 54.14 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.37 2.047 . . . . 0.0 111.614 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.41 -27.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.64 1.176 . . . . 0.0 113.615 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.01 1.56 88.64 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.889 1.233 . . . . 0.0 115.491 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -65.02 155.63 34.04 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.567 1.683 . . . . 0.0 112.015 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 t -78.65 80.3 5.02 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.554 1.142 . . . . 0.0 111.725 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.81 153.84 89.16 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.851 1.26 . . . . 0.0 113.131 172.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.96 168.68 23.02 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.472 2.782 . . . . 0.0 112.897 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.12 134.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.13 1.372 . . . . 0.0 111.769 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -78.16 141.78 38.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.213 1.405 . . . . 0.0 110.93 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.21 -6.8 83.98 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.884 1.113 . . . . 0.0 115.884 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mp 57.5 17.92 4.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.266 2.226 . . . . 0.0 114.765 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.14 167.98 9.2 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.195 1.798 . . . . 0.0 113.706 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -66.34 -23.16 66.31 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.34 162.68 12.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.542 1.537 . . . . 0.0 112.894 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -131.61 95.85 3.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.012 1.725 . . . . 0.0 110.804 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -80.14 175.22 10.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 111.637 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -124.83 123.17 39.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.03 1.332 . . . . 0.0 109.887 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -126.71 162.72 25.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.426 1.89 . . . . 0.0 110.916 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -129.33 123.94 33.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.617 1.167 . . . . 0.0 110.327 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -130.26 126.01 36.23 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.521 1.128 . . . . 0.0 111.394 -172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.36 122.04 18.13 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.293 -0.879 . . . . 0.0 111.659 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mmm -102.72 11.34 37.78 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.812 1.245 . . . . 0.0 113.371 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.08 -76.0 0.31 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.623 2.059 . . . . 0.0 111.863 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -126.14 6.39 7.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.062 1.745 . . . . 0.0 113.379 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.7 m -136.79 117.96 14.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.982 2.113 . . . . 0.0 109.448 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 t -78.25 122.19 25.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.443 0.697 . . . . 0.0 110.764 172.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -111.01 136.44 50.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.569 1.947 . . . . 0.0 110.74 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.84 144.31 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.619 0.768 . . . . 0.0 111.378 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -123.2 133.56 54.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.219 1.807 . . . . 0.0 109.655 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -126.56 109.88 12.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.932 1.693 . . . . 0.0 110.358 -170.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 -168.79 30.84 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.463 1.03 . . . . 0.0 112.121 -171.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.06 84.74 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.47 -1.017 . . . . 0.0 111.201 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -129.43 138.97 51.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.565 1.946 . . . . 0.0 110.268 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -127.94 -9.5 5.45 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.01 1.324 . . . . 0.0 114.43 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 -169.77 43.8 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.577 1.56 . . . . 0.0 113.067 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.47 -171.08 51.93 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 121.921 0.734 . . . . 0.0 114.001 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -83.49 149.81 26.39 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.434 1.494 . . . . 0.0 111.64 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.9 m -84.6 -14.32 49.08 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -141.5 153.9 45.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.453 1.501 . . . . 0.0 111.944 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 45.5 tpp -61.73 -24.51 66.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.383 1.473 . . . . 0.0 113.359 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.11 -22.74 58.64 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.197 -0.94 . . . . 0.0 114.572 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -78.59 -39.11 38.41 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.882 1.341 . . . . 0.0 112.623 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 p -58.87 -39.34 81.07 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.38 -0.825 . . . . 0.0 112.277 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.51 53.39 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -67.7 -40.84 84.32 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.923 -1.111 . . . . 0.0 111.705 169.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.5 -52.92 4.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.761 1.624 . . . . 0.0 111.938 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.7 m . . . . . 0 CA--C 1.548 0.871 0 C-N-CA 123.983 0.913 . . . . 0.0 113.297 179.142 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.558 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.26 117.88 15.96 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.469 1.508 . . . . 0.0 111.559 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -137.77 171.74 13.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.982 2.113 . . . . 0.0 111.55 173.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -109.86 162.67 14.26 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.894 1.678 . . . . 0.0 111.48 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -75.06 164.69 26.27 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.372 1.069 . . . . 0.0 112.18 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.4 m -127.88 81.23 2.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.923 1.689 . . . . 0.0 110.495 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 p -71.06 109.46 5.16 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.924 1.69 . . . . 0.0 111.734 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.0 t -125.67 83.68 61.76 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.31 1.444 . . . . 0.0 110.041 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.81 166.99 27.17 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.525 2.817 . . . . 0.0 112.235 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.92 -28.15 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.427 1.091 . . . . 0.0 113.4 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.39 2.01 86.06 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.158 1.361 . . . . 0.0 115.393 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.15 156.43 31.72 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.404 1.602 . . . . 0.0 112.217 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -77.15 99.83 5.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.971 1.309 . . . . 0.0 111.483 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.0 155.72 36.23 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.406 1.482 . . . . 0.0 113.263 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.78 165.54 29.95 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.234 2.623 . . . . 0.0 112.475 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.23 138.05 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.803 1.241 . . . . 0.0 111.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -68.61 146.36 53.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.367 1.067 . . . . 0.0 110.604 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.42 -11.07 69.66 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mp 47.33 34.27 3.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.102 2.161 . . . . 0.0 114.737 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -97.37 178.68 5.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 1.75 14.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.544 1.938 . . . . 0.0 114.506 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.76 158.4 31.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.111 1.764 . . . . 0.0 112.778 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -134.7 83.75 2.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.932 1.693 . . . . 0.0 112.354 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.03 171.8 12.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.737 1.215 . . . . 0.0 111.663 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.6 m -122.05 112.75 18.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.355 1.462 . . . . 0.0 109.726 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -119.8 167.38 12.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.788 1.635 . . . . 0.0 110.849 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -133.41 140.14 47.16 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.182 0.993 . . . . 0.0 110.239 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -133.37 165.95 23.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 109.548 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.3 t -112.65 138.8 48.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.55 -0.719 . . . . 0.0 111.293 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.4 mtp -125.67 86.25 2.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.912 1.685 . . . . 0.0 109.255 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.37 -77.3 0.89 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.025 1.774 . . . . 0.0 112.68 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -131.57 -4.41 3.73 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.015 1.326 . . . . 0.0 114.135 -174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.3 m -123.83 139.37 54.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.179 1.392 . . . . 0.0 111.536 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.09 147.52 32.74 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.942 0.897 . . . . 0.0 111.824 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -147.02 127.02 13.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.554 1.942 . . . . 0.0 110.565 -171.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.44 145.17 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.421 1.089 . . . . 0.0 112.372 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -131.72 137.06 48.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.344 1.857 . . . . 0.0 110.595 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.54 117.46 12.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.381 1.472 . . . . 0.0 110.666 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.62 65.69 0.04 OUTLIER Glycine 0 N--CA 1.477 1.409 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.88 28.74 15.02 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -72.45 -46.43 54.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.152 . . . . 0.0 113.588 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.3 p 50.75 -10.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 131.224 3.81 . . . . 0.0 118.405 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.61 -171.39 47.71 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.656 2.074 . . . . 0.0 113.168 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.06 -168.76 23.82 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.751 -0.852 . . . . 0.0 113.759 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -67.31 146.83 53.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.429 1.492 . . . . 0.0 111.932 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.8 p -75.43 -32.82 60.82 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -136.76 163.05 31.51 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.144 1.777 . . . . 0.0 112.071 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.3 tpp -56.53 -38.53 71.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.749 0.82 . . . . 0.0 111.725 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.06 -17.39 75.61 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.19 0.9 . . . . 0.0 115.07 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -82.85 -33.63 27.03 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.908 1.354 . . . . 0.0 111.798 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.2 t -69.33 -53.4 19.77 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.474 -0.766 . . . . 0.0 112.016 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.31 -17.87 64.94 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -78.94 -18.36 53.93 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -106.91 -51.69 2.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.196 1.398 . . . . 0.0 112.352 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.8 159.0 85.34 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 118.713 0.688 . . . . 0.0 112.251 171.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.36 -12.94 15.39 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.178 2.585 . . . . 0.0 115.197 -170.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.207 0 C-N-CA 126.229 1.871 . . . . 0.0 112.972 -179.009 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.457 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -134.75 78.08 1.72 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.913 1.285 . . . . 0.0 110.698 -166.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -108.3 -52.64 2.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.09 1.356 . . . . 0.0 112.7 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -80.59 -19.56 45.27 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.556 1.143 . . . . 0.0 113.515 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -73.63 165.49 25.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.245 1.018 . . . . 0.0 113.118 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.7 p -84.72 155.75 21.75 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.027 0.931 . . . . 0.0 112.396 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.6 p -143.82 158.79 43.44 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.283 1.833 . . . . 0.0 110.842 171.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 m -140.89 155.84 68.85 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 126.15 1.78 . . . . 0.0 110.97 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.98 161.59 43.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.81 2.34 . . . . 0.0 112.5 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 tp -58.27 -28.12 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.833 1.253 . . . . 0.0 113.262 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.13 4.46 83.26 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.179 1.371 . . . . 0.0 115.506 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -63.6 157.34 24.09 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.479 1.639 . . . . 0.0 112.379 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -76.36 70.35 2.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.368 1.467 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.19 157.05 88.85 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.399 1.479 . . . . 0.0 112.901 171.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.76 176.72 9.01 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.848 3.032 . . . . 0.0 113.263 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.47 135.48 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.728 1.611 . . . . 0.0 111.52 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -77.28 141.95 39.71 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.969 1.308 . . . . 0.0 110.752 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.4 -4.42 90.0 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 56.15 21.16 4.96 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.822 2.049 . . . . 0.0 114.255 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.0 m -70.16 168.84 14.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.167 1.387 . . . . 0.0 113.29 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.17 -0.44 14.23 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.96 164.44 22.32 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.933 1.693 . . . . 0.0 112.766 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -129.47 93.09 3.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.247 1.819 . . . . 0.0 110.905 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.15 174.04 11.97 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.472 1.109 . . . . 0.0 111.455 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.1 m -128.01 110.84 12.9 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.001 1.32 . . . . 0.0 109.744 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -116.42 165.91 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.871 1.668 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.07 85.05 2.18 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.263 1.025 . . . . 0.0 111.135 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -82.35 156.19 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.844 0.858 . . . . 0.0 111.091 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 t -90.48 140.38 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 111.442 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.2 mtp -133.77 111.17 10.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.604 1.962 . . . . 0.0 109.663 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.69 -95.57 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.94 1.257 . . . . 0.0 112.186 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -116.0 -8.98 11.81 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.342 1.457 . . . . 0.0 113.932 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.3 p -120.51 156.58 31.23 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.733 1.151 . . . . 0.0 113.14 -171.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.24 124.53 35.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.687 1.195 . . . . 0.0 110.378 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -121.43 135.16 55.08 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.454 1.902 . . . . 0.0 110.704 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -67.22 145.99 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.318 0.647 . . . . 0.0 112.006 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -127.14 135.79 51.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.732 2.013 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.07 107.97 11.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.519 . . . . 0.0 110.423 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.01 -169.01 31.34 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.911 0.767 . . . . 0.0 113.095 -172.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.45 86.51 3.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.949 -0.736 . . . . 0.0 110.675 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.55 133.62 48.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.845 1.658 . . . . 0.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.2 p -136.79 -3.42 2.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.197 1.399 . . . . 0.0 114.389 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.1 0.83 58.98 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.189 1.376 . . . . 0.0 115.842 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.79 176.58 17.64 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.02 1.771 . . . . 0.0 113.606 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -60.01 136.37 57.99 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.204 1.002 . . . . 0.0 112.522 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.5 m -76.41 -17.16 59.49 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -131.92 146.99 52.44 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.081 1.753 . . . . 0.0 110.951 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 tpp -55.82 -37.84 69.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.241 1.016 . . . . 0.0 111.504 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.02 -47.8 85.68 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.225 0.917 . . . . 0.0 112.646 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.23 -37.9 81.75 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.091 0.946 . . . . 0.0 112.688 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.931 0.492 . . . . 0.0 111.887 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -19.01 65.65 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -66.46 -25.04 66.53 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.676 -1.265 . . . . 0.0 113.116 169.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -109.49 -55.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.807 1.643 . . . . 0.0 112.231 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.99 159.72 75.34 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.709 0.804 . . . . 0.0 112.911 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.62 -17.64 12.49 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.054 2.502 . . . . 0.0 115.125 -170.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.253 0 C-N-CA 125.916 1.722 . . . . 0.0 113.893 -179.391 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.441 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -64.98 133.58 52.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.111 0.964 . . . . 0.0 112.074 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -138.63 129.32 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.209 1.804 . . . . 0.0 110.215 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -144.05 165.5 27.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.092 1.357 . . . . 0.0 112.015 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.74 111.52 19.89 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.119 1.367 . . . . 0.0 111.13 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -89.63 99.0 12.09 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.478 0.711 . . . . 0.0 111.426 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.7 p -129.7 172.55 11.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.084 1.753 . . . . 0.0 111.342 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.05 156.04 79.78 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 125.904 1.682 . . . . 0.0 111.489 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 160.12 50.44 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.848 2.366 . . . . 0.0 112.346 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 tt -58.85 -26.71 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.94 1.296 . . . . 0.0 113.712 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.83 2.02 88.0 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.886 1.232 . . . . 0.0 115.497 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -66.91 157.39 33.32 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.286 1.543 . . . . 0.0 112.617 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.3 m -75.37 57.7 0.93 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.974 . . . . 0.0 113.425 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.22 155.98 89.24 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.131 1.373 . . . . 0.0 113.912 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -75.39 178.46 7.3 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 124.003 3.135 . . . . 0.0 112.734 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.08 139.68 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.342 1.457 . . . . 0.0 112.213 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -68.18 142.44 55.7 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.026 1.33 . . . . 0.0 110.879 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.09 -11.63 75.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 46.17 69.82 0.44 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.313 2.245 . . . . 0.0 112.671 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.6 m -120.55 175.12 6.15 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.652 1.581 . . . . 0.0 111.874 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -84.64 4.5 32.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.156 1.382 . . . . 0.0 114.475 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.13 163.53 24.44 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.338 1.855 . . . . 0.0 112.808 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -130.33 87.12 2.47 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.156 1.783 . . . . 0.0 111.677 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.06 175.46 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.508 1.123 . . . . 0.0 112.152 171.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -128.04 115.36 18.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.221 1.408 . . . . 0.0 110.256 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -119.98 165.71 14.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.11 1.764 . . . . 0.0 111.037 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -129.04 134.44 48.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 109.945 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.62 139.6 47.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.708 1.203 . . . . 0.0 110.436 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.6 t -81.3 111.19 17.46 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.604 -0.685 . . . . 0.0 111.589 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.8 mmm -92.68 71.61 4.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.109 0.963 . . . . 0.0 109.33 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.25 -75.0 2.39 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.99 1.757 . . . . 0.0 113.804 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -133.65 5.96 3.72 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.843 1.657 . . . . 0.0 113.745 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 93.4 m -135.65 117.18 14.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.188 1.795 . . . . 0.0 110.399 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.61 133.29 49.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.896 0.878 . . . . 0.0 111.165 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -131.21 141.45 50.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.119 1.768 . . . . 0.0 110.983 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.64 145.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 112.19 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -134.39 141.57 46.88 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.113 2.165 . . . . 0.0 110.552 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.97 117.67 10.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.426 1.49 . . . . 0.0 110.759 -172.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.02 58.85 0.02 OUTLIER Glycine 0 N--CA 1.478 1.456 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 56.52 30.92 18.05 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -71.23 -53.24 15.05 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.658 1.183 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.5 p 50.74 3.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 129.618 3.167 . . . . 0.0 118.23 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.97 -6.31 52.21 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.342 1.449 . . . . 0.0 116.082 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.12 -177.97 39.0 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.165 1.364 . . . . 0.0 114.112 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.4 146.76 47.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.167 1.387 . . . . 0.0 111.535 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.8 t -69.39 -36.39 76.73 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -136.26 162.58 32.58 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.259 1.824 . . . . 0.0 111.123 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 35.7 tpp -58.03 -37.56 74.57 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 112.014 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.8 -44.15 98.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.64 1.114 . . . . 0.0 113.792 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.26 -40.25 96.87 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.451 1.126 . . . . 0.0 112.22 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.8 t -57.8 -47.76 81.67 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.378 1.071 . . . . 0.0 111.348 170.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.18 62.71 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -73.08 -40.76 64.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.069 1.304 . . . . 0.0 112.06 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -84.4 -51.5 6.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.45 1.5 . . . . 0.0 112.006 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.2 163.93 61.8 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.802 0.841 . . . . 0.0 112.995 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.11 -9.35 20.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.418 2.745 . . . . 0.0 114.483 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 C-N-CA 127.197 2.332 . . . . 0.0 112.775 178.342 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.499 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -143.26 168.18 20.38 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.724 1.61 . . . . 0.0 112.546 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -148.62 169.13 21.04 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.981 1.712 . . . . 0.0 112.443 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.09 15.51 2.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.538 1.535 . . . . 0.0 113.991 -174.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -61.71 155.86 21.67 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -67.16 123.14 19.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.213 1.405 . . . . 0.0 111.723 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -139.98 164.15 30.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.311 1.444 . . . . 0.0 111.941 173.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 m -139.14 157.37 71.28 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 126.892 2.077 . . . . 0.0 110.527 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.81 162.57 41.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.71 2.273 . . . . 0.0 112.67 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.11 -27.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.96 1.304 . . . . 0.0 113.509 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.44 3.98 86.36 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.068 1.318 . . . . 0.0 115.298 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -64.46 157.81 25.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.438 1.619 . . . . 0.0 112.317 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 m -72.92 58.23 0.46 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.926 2.09 . . . . 0.0 113.376 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.55 155.54 80.91 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.873 1.269 . . . . 0.0 113.25 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.12 176.43 9.55 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.478 2.785 . . . . 0.0 113.382 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.46 140.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.651 1.58 . . . . 0.0 111.206 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -81.91 145.73 30.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.047 1.339 . . . . 0.0 111.107 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.08 -7.3 80.65 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 124.99 1.281 . . . . 0.0 115.823 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mp 53.98 26.61 6.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.01 2.124 . . . . 0.0 114.435 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -68.12 171.1 7.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.116 1.766 . . . . 0.0 113.233 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -76.0 -1.82 27.59 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.562 1.545 . . . . 0.0 114.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.85 167.48 18.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.212 1.805 . . . . 0.0 112.859 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -127.57 102.72 6.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.388 1.875 . . . . 0.0 110.988 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.21 175.77 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.803 1.241 . . . . 0.0 111.271 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.7 m -128.75 117.1 20.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.141 1.377 . . . . 0.0 109.518 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -123.91 167.06 14.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.491 1.516 . . . . 0.0 110.463 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.32 105.18 5.87 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.353 1.461 . . . . 0.0 109.993 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -103.57 132.03 50.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 111.117 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.05 91.99 2.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.291 0.567 . . . . 0.0 111.7 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -86.76 83.76 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.54 1.136 . . . . 0.0 109.936 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.67 -73.47 2.26 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.602 1.572 . . . . 0.0 112.837 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -136.1 0.69 2.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 114.058 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -136.22 151.96 50.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.008 0.923 . . . . 0.0 112.992 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.8 m -89.05 81.16 6.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.491 1.516 . . . . 0.0 111.42 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -64.84 124.2 21.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.245 0.618 . . . . 0.0 110.142 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.77 142.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.082 0.553 . . . . 0.0 111.347 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -125.91 125.7 43.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.456 1.902 . . . . 0.0 109.717 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.21 106.18 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.876 1.67 . . . . 0.0 110.237 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.94 -169.55 32.5 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.809 1.195 . . . . 0.0 112.078 -170.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.4 t -77.14 88.6 3.62 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.471 -1.017 . . . . 0.0 111.177 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -129.48 134.68 47.93 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.005 1.722 . . . . 0.0 110.321 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.0 p -138.77 -7.98 1.42 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.983 1.313 . . . . 0.0 114.519 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.91 -2.99 88.24 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.932 1.254 . . . . 0.0 115.982 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.82 178.03 22.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.819 1.676 . . . . 0.0 112.993 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -55.21 134.0 49.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.763 1.625 . . . . 0.0 114.033 -165.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 t -81.04 -10.87 59.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -132.7 146.92 52.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.566 1.546 . . . . 0.0 111.643 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.5 tpp -52.96 -39.1 62.71 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.03 1.332 . . . . 0.0 111.849 168.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.03 -45.16 63.62 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.897 0.761 . . . . 0.0 113.325 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.66 -34.51 77.23 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.123 0.969 . . . . 0.0 112.36 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 t -66.17 -53.58 35.74 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.791 -0.568 . . . . 0.0 112.249 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.23 75.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -63.36 -22.49 66.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -104.53 -23.63 13.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.558 1.543 . . . . 0.0 114.1 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.8 m -58.1 155.79 23.44 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 118.847 0.749 . . . . 0.0 112.697 164.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.61 -8.43 18.19 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 123.522 2.815 . . . . 0.0 114.336 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 126.99 2.233 . . . . 0.0 113.016 179.544 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -138.42 111.96 8.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.901 1.28 . . . . 0.0 111.67 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -122.82 -13.08 7.95 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.39 1.476 . . . . 0.0 114.372 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.35 75.53 4.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.863 1.265 . . . . 0.0 110.568 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -142.92 166.69 23.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.962 1.305 . . . . 0.0 112.898 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.6 m -119.09 59.38 0.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.701 1.6 . . . . 0.0 110.995 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 p -67.87 149.32 49.99 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.8 0.84 . . . . 0.0 110.99 163.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.44 156.1 63.9 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.589 1.556 . . . . 0.0 111.357 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.06 148.81 63.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.451 2.101 . . . . 0.0 111.772 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.8 -21.98 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.416 1.087 . . . . 0.0 113.342 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.31 83.86 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 114.957 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -68.51 139.37 55.65 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.408 1.604 . . . . 0.0 110.829 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 t -72.43 94.18 1.62 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.41 159.07 50.97 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.379 1.471 . . . . 0.0 112.647 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.71 175.59 11.09 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.08 2.52 . . . . 0.0 113.711 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.76 138.28 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.696 1.598 . . . . 0.0 111.632 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -82.9 138.95 33.68 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.0 1.32 . . . . 0.0 111.191 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.68 2.62 82.34 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.544 2.021 . . . . 0.0 115.756 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.9 mt 57.19 17.89 3.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.015 2.526 . . . . 0.0 115.776 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.9 p -78.62 173.63 12.22 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 2.43 6.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.732 2.013 . . . . 0.0 115.252 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.61 162.43 17.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.572 1.549 . . . . 0.0 112.889 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -130.93 87.15 2.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.575 1.95 . . . . 0.0 111.545 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.39 174.88 11.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.976 1.311 . . . . 0.0 111.482 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -128.47 131.89 48.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.289 1.436 . . . . 0.0 109.377 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -130.42 158.29 40.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.833 1.253 . . . . 0.0 111.12 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -123.61 81.36 1.89 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.531 1.158 . . . . 0.0 111.374 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -77.37 170.91 15.72 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -126.45 136.4 52.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.552 1.141 . . . . 0.0 110.549 169.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.4 mmm -121.35 10.59 10.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.694 1.198 . . . . 0.0 112.814 -172.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.87 -91.07 0.12 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.656 1.598 . . . . 0.0 111.914 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.09 8.75 18.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.849 1.66 . . . . 0.0 113.411 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -146.2 132.75 19.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.302 1.841 . . . . 0.0 110.815 -172.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.2 m -81.01 86.68 6.08 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.604 0.761 . . . . 0.0 111.958 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -62.61 114.07 3.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.65 144.09 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.117 0.967 . . . . 0.0 111.165 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -124.93 148.23 48.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.276 1.43 . . . . 0.0 110.528 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -131.36 127.69 38.11 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.044 1.738 . . . . 0.0 110.575 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.62 -168.02 25.68 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.096 0.855 . . . . 0.0 112.652 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.73 71.19 0.34 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.602 -0.94 . . . . 0.0 111.861 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.5 136.15 53.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.699 1.6 . . . . 0.0 110.651 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.5 p -129.75 -8.39 4.52 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.301 1.441 . . . . 0.0 114.117 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.6 -174.06 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.325 1.44 . . . . 0.0 113.444 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.09 -172.95 8.47 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.123 0.868 . . . . 0.0 114.216 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -69.73 137.15 51.77 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.783 0.802 . . . . 0.0 112.05 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -80.82 -13.0 59.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -130.1 144.72 51.5 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.658 1.983 . . . . 0.0 110.875 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.2 ttt -65.3 -15.49 62.57 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.112 1.365 . . . . 0.0 113.895 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.11 -32.15 15.12 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.591 1.091 . . . . 0.0 114.275 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.27 -28.42 67.19 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.537 1.135 . . . . 0.0 113.049 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.7 p -73.98 -44.16 55.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.357 0.663 . . . . 0.0 112.171 168.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.87 -24.3 61.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.264 1.426 . . . . 0.0 114.564 -171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -65.89 -30.1 70.64 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 167.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.68 -49.15 5.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.665 1.186 . . . . 0.0 112.006 -171.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.5 m -68.39 160.42 75.95 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.419 1.088 . . . . 0.0 112.431 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.42 -23.75 20.03 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.321 2.681 . . . . 0.0 114.275 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.279 0 C-N-CA 125.978 1.751 . . . . 0.0 114.55 -177.573 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.439 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -134.96 137.68 43.31 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.438 1.495 . . . . 0.0 111.006 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.74 154.63 36.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.487 1.115 . . . . 0.0 110.71 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -138.64 92.22 2.6 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.971 1.308 . . . . 0.0 111.04 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.84 164.88 12.59 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.011 1.725 . . . . 0.0 112.931 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.5 m -125.72 85.88 2.46 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.512 1.525 . . . . 0.0 111.248 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.3 p -71.09 122.49 20.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.573 1.149 . . . . 0.0 111.761 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.53 157.03 66.41 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 126.257 1.823 . . . . 0.0 111.701 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.06 155.23 57.27 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.64 2.226 . . . . 0.0 112.473 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.91 -27.34 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.943 1.297 . . . . 0.0 113.484 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.09 83.05 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.221 1.391 . . . . 0.0 115.51 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -63.7 153.8 35.12 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.527 1.663 . . . . 0.0 112.414 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -78.06 74.87 4.6 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.805 1.242 . . . . 0.0 111.5 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.18 154.25 94.27 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.511 1.125 . . . . 0.0 111.584 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.88 162.53 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 113.203 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.28 132.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.882 1.273 . . . . 0.0 111.437 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.58 136.62 47.5 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.203 1.001 . . . . 0.0 110.733 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.13 -4.22 86.06 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.361 0.982 . . . . 0.0 115.259 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.4 mt 59.35 9.07 1.3 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.747 2.419 . . . . 0.0 115.697 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 p -89.72 173.21 8.41 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -171.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -0.31 15.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.768 2.027 . . . . 0.0 115.92 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.86 152.12 25.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.293 1.437 . . . . 0.0 112.849 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -121.49 78.77 1.47 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.275 1.83 . . . . 0.0 110.624 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -72.14 171.95 11.06 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.194 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -128.29 116.01 19.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.882 1.273 . . . . 0.0 109.573 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -120.46 159.14 25.74 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.848 1.659 . . . . 0.0 110.905 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -126.93 120.0 28.07 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.729 1.212 . . . . 0.0 109.958 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -120.5 124.66 45.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.149 0.979 . . . . 0.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.7 t -73.61 116.02 13.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.096 0.474 . . . . 0.0 110.488 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 mtp -93.83 67.32 3.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.705 1.602 . . . . 0.0 109.439 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.31 -64.92 3.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.605 1.574 . . . . 0.0 114.126 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -140.0 9.6 2.35 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.68 148.08 29.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.789 1.636 . . . . 0.0 109.988 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -102.76 129.66 49.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 112.597 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -119.27 136.96 53.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.858 1.663 . . . . 0.0 110.889 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.12 141.23 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.351 1.06 . . . . 0.0 111.106 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.43 128.45 48.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.351 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.48 97.98 3.83 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.588 1.555 . . . . 0.0 111.894 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.47 63.41 0.01 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.22 -0.925 . . . . 0.0 114.491 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.4 t 52.93 53.7 11.65 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.715 1.206 . . . . 0.0 112.917 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.43 140.8 41.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.5 p -130.2 -12.41 4.07 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.843 1.257 . . . . 0.0 114.341 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.83 -174.4 48.47 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.238 1.399 . . . . 0.0 113.106 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.06 -166.9 52.08 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.808 -0.819 . . . . 0.0 113.313 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -87.02 146.75 26.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 111.977 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.6 m -78.08 -13.2 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -137.73 148.2 45.41 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 112.072 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.01 -27.23 68.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 112.508 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.91 -28.56 45.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.42 -0.8 . . . . 0.0 114.155 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -72.16 -34.02 68.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.432 1.116 . . . . 0.0 112.579 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 p -68.78 -45.47 71.23 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.351 -0.843 . . . . 0.0 111.453 168.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -38.38 88.68 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.906 1.282 . . . . 0.0 114.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -84.77 -46.27 11.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.0 112.118 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.05 166.15 43.55 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.01 -8.21 18.74 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.514 2.809 . . . . 0.0 114.347 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 127.322 2.391 . . . . 0.0 112.706 179.019 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.482 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.91 98.64 3.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.341 1.456 . . . . 0.0 110.178 -167.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -131.27 4.94 4.4 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.28 1.832 . . . . 0.0 114.028 -172.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -67.62 14.6 0.05 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.787 2.435 . . . . 0.0 115.27 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.89 152.56 31.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.837 1.655 . . . . 0.0 112.826 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.07 103.01 4.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.148 0.979 . . . . 0.0 111.714 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -143.22 155.33 44.49 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.013 1.325 . . . . 0.0 111.723 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t -141.17 91.13 8.93 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.968 1.707 . . . . 0.0 109.837 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.91 161.9 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.881 2.387 . . . . 0.0 112.205 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.4 tt -63.18 146.97 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.718 0.807 . . . . 0.0 111.068 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.49 0.84 89.38 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.527 1.06 . . . . 0.0 115.384 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -62.67 154.7 28.5 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.152 1.476 . . . . 0.0 111.523 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -77.05 68.69 3.23 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.945 1.298 . . . . 0.0 111.922 176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.01 155.65 91.43 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.298 1.439 . . . . 0.0 112.7 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.6 175.06 11.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.223 2.615 . . . . 0.0 112.935 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.55 139.64 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.33 1.452 . . . . 0.0 111.428 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -67.17 146.17 54.49 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.91 82.65 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.84 17.18 4.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.182 2.193 . . . . 0.0 114.662 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.21 168.49 19.03 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.442 1.097 . . . . 0.0 112.937 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -68.6 -42.78 77.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.353 1.061 . . . . 0.0 112.321 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.13 157.44 37.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.913 1.285 . . . . 0.0 113.078 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.09 90.95 2.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.067 1.747 . . . . 0.0 111.213 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.8 173.98 3.21 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.371 1.068 . . . . 0.0 111.656 170.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -125.14 115.02 19.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.877 1.271 . . . . 0.0 109.744 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -118.83 165.63 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.348 1.459 . . . . 0.0 110.929 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.29 136.44 50.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.337 1.455 . . . . 0.0 109.318 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -130.17 137.48 50.12 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.386 1.075 . . . . 0.0 109.457 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.9 t -72.88 131.19 41.93 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.98 -0.45 . . . . 0.0 110.695 169.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 97.2 mmm -123.14 6.42 9.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.625 1.57 . . . . 0.0 113.906 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.23 91.35 0.81 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.582 1.563 . . . . 0.0 111.99 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 58.44 9.32 1.03 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.829 2.052 . . . . 0.0 114.933 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 t -155.74 165.29 36.98 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.054 2.542 . . . . 0.0 108.961 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.5 m -117.29 159.99 21.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 112.792 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.39 142.1 49.98 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.767 2.027 . . . . 0.0 110.095 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.38 143.44 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.0 0.92 . . . . 0.0 111.004 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -132.16 126.82 34.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.312 1.845 . . . . 0.0 110.605 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.99 108.7 9.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.823 1.649 . . . . 0.0 110.562 -171.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.79 55.18 0.01 OUTLIER Glycine 0 N--CA 1.476 1.337 0 C-N-CA 123.599 0.618 . . . . 0.0 114.238 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.1 t 60.5 22.94 12.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.506 1.523 . . . . 0.0 114.887 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.55 135.24 53.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.197 1.399 . . . . 0.0 111.228 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.7 p -132.33 -13.74 3.02 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.37 -9.31 79.64 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.32 170.67 21.6 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.308 1.432 . . . . 0.0 114.198 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.33 144.48 57.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.8 1.64 . . . . 0.0 111.821 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -72.22 -22.69 61.21 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -140.48 152.58 45.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.705 1.602 . . . . 0.0 111.385 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.86 -30.56 71.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.25 70.11 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.316 -0.865 . . . . 0.0 114.208 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.87 -44.3 17.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.915 1.358 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.47 -35.92 78.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.831 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.91 -7.23 49.99 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.976 1.71 . . . . 0.0 115.264 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -76.51 -42.05 44.71 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.658 1.117 . . . . 0.0 111.948 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -81.57 -54.67 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.926 1.691 . . . . 0.0 111.945 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.28 160.87 74.65 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.047 0.939 . . . . 0.0 112.22 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.45 -7.76 18.01 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.304 2.669 . . . . 0.0 114.24 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 C-N-CA 127.714 2.578 . . . . 0.0 112.487 177.88 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.431 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -140.16 166.31 25.02 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.461 1.505 . . . . 0.0 110.982 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -79.5 -26.03 41.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.64 1.576 . . . . 0.0 113.118 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -135.82 111.0 8.95 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.045 1.738 . . . . 0.0 110.508 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.2 164.64 25.89 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.973 1.309 . . . . 0.0 113.488 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.92 94.02 4.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.851 1.66 . . . . 0.0 111.555 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.4 p -110.85 164.57 12.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.597 1.959 . . . . 0.0 112.183 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.55 159.07 58.87 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 126.741 2.017 . . . . 0.0 111.064 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.34 160.56 49.11 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.662 2.241 . . . . 0.0 112.245 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.51 -26.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.005 1.322 . . . . 0.0 113.713 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.03 6.01 84.02 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.165 1.365 . . . . 0.0 115.569 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.6 t-105 -63.54 153.26 36.23 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.482 1.641 . . . . 0.0 112.617 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.7 m -72.27 87.69 1.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.823 1.649 . . . . 0.0 112.086 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.87 157.27 35.08 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 125.991 1.716 . . . . 0.0 112.505 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.11 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.549 2.833 . . . . 0.0 113.945 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.92 136.3 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.125 1.37 . . . . 0.0 111.492 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.19 147.6 49.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.641 1.176 . . . . 0.0 110.732 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.17 -14.3 66.92 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.8 mp 46.51 50.54 12.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.906 2.082 . . . . 0.0 113.417 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 25.0 m -96.73 173.71 7.18 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.612 1.165 . . . . 0.0 112.467 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -69.07 -34.89 75.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.981 1.312 . . . . 0.0 112.79 173.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.93 165.19 13.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.762 1.625 . . . . 0.0 112.995 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -131.36 92.41 3.18 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.21 1.804 . . . . 0.0 111.252 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -68.48 175.66 3.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.64 1.176 . . . . 0.0 112.099 172.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -125.19 113.0 17.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.097 1.359 . . . . 0.0 110.456 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -115.44 169.29 9.27 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.963 1.705 . . . . 0.0 110.867 173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -135.38 129.5 33.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.214 1.406 . . . . 0.0 109.677 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.82 129.12 41.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.692 1.197 . . . . 0.0 110.775 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.05 134.26 38.84 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.992 0.425 . . . . 0.0 111.497 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.3 mtp -122.5 56.92 1.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.289 1.836 . . . . 0.0 109.97 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.33 -79.7 0.3 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.018 1.77 . . . . 0.0 112.576 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -124.54 1.02 8.26 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 m -136.2 147.08 47.47 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.395 1.878 . . . . 0.0 110.249 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.25 132.85 51.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 111.185 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -126.28 141.7 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.346 1.859 . . . . 0.0 110.544 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.56 148.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.039 0.935 . . . . 0.0 111.776 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -136.1 133.18 37.03 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.792 2.037 . . . . 0.0 110.438 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.91 119.08 18.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.158 1.383 . . . . 0.0 110.956 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.54 51.98 0.02 OUTLIER Glycine 0 N--CA 1.476 1.333 0 N-CA-C 114.592 0.597 . . . . 0.0 114.592 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.36 32.68 20.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.314 1.446 . . . . 0.0 114.233 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.91 121.41 19.01 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.673 1.189 . . . . 0.0 110.602 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -108.36 -7.51 15.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.268 1.427 . . . . 0.0 113.678 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.11 -168.96 40.7 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.958 1.742 . . . . 0.0 113.122 172.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 -162.03 41.74 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.004 0.811 . . . . 0.0 113.989 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.43 138.12 31.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.795 0.838 . . . . 0.0 110.863 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.9 p -77.9 -16.8 57.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 -139.38 155.76 47.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.997 2.119 . . . . 0.0 111.913 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 52.6 tpp -61.77 -39.66 92.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.012 0.925 . . . . 0.0 111.853 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.97 -37.53 94.56 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.146 -0.972 . . . . 0.0 113.436 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -68.49 -29.95 68.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.1 p -81.13 -45.55 16.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.679 1.127 . . . . 0.0 112.499 166.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 -18.94 65.07 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -68.41 -24.69 64.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.928 -1.108 . . . . 0.0 113.156 169.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -106.28 -56.05 2.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.173 1.789 . . . . 0.0 111.481 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m -74.62 157.73 85.72 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.139 0.976 . . . . 0.0 112.814 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.54 -12.57 15.25 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.389 2.726 . . . . 0.0 114.939 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 C-N-CA 126.184 1.85 . . . . 0.0 112.871 -178.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.59 81.58 0.83 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.226 1.41 . . . . 0.0 112.528 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -68.52 174.14 4.41 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.974 1.71 . . . . 0.0 113.477 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.89 159.72 33.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.633 1.573 . . . . 0.0 111.261 171.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -149.72 175.26 11.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.922 1.689 . . . . 0.0 111.758 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.7 t -132.01 100.3 5.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.756 1.222 . . . . 0.0 111.472 -176.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.2 p -136.75 163.67 30.06 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.814 1.645 . . . . 0.0 112.202 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 m -141.77 160.27 56.69 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 126.796 2.038 . . . . 0.0 111.471 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.85 168.67 20.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.955 2.437 . . . . 0.0 112.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 tp -60.47 147.27 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.196 0.998 . . . . 0.0 111.532 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.77 9.72 86.49 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -61.62 157.1 18.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.918 1.359 . . . . 0.0 112.401 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -77.34 62.63 2.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.68 1.592 . . . . 0.0 112.485 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.76 157.85 85.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.368 1.467 . . . . 0.0 112.716 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.31 178.24 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.683 2.922 . . . . 0.0 113.87 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.11 137.45 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.752 1.621 . . . . 0.0 111.248 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -82.7 144.48 30.2 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.306 1.443 . . . . 0.0 111.059 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.54 -8.3 83.31 Favored Glycine 0 CA--C 1.542 1.736 0 C-N-CA 124.761 1.172 . . . . 0.0 115.93 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 mp 55.4 22.35 4.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.208 2.203 . . . . 0.0 114.694 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -67.7 168.83 10.55 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.171 1.789 . . . . 0.0 113.204 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -66.18 -28.93 69.14 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.76 166.72 12.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.567 1.547 . . . . 0.0 113.15 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -132.76 107.22 8.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.154 1.781 . . . . 0.0 111.203 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.3 178.0 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.466 1.506 . . . . 0.0 110.971 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 m -128.97 110.49 12.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 110.015 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -114.49 168.12 10.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.312 1.445 . . . . 0.0 110.856 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -133.69 139.71 46.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.738 1.215 . . . . 0.0 110.29 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.37 131.06 29.34 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.668 1.187 . . . . 0.0 110.492 -176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.7 m -73.45 94.38 2.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.724 0.81 . . . . 0.0 111.574 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.7 mmm -80.46 54.33 2.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.789 1.636 . . . . 0.0 109.944 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.56 -88.77 1.13 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.398 1.951 . . . . 0.0 112.19 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -86.83 -14.04 43.28 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.3 p -145.44 143.52 30.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.8 m -75.06 92.28 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.935 1.294 . . . . 0.0 110.761 169.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -75.53 126.08 30.29 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.89 147.06 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.136 0.574 . . . . 0.0 110.869 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -128.75 108.39 10.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.746 2.018 . . . . 0.0 109.756 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -98.78 110.37 22.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.134 1.774 . . . . 0.0 110.461 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.01 -169.34 33.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.453 1.025 . . . . 0.0 112.647 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.06 87.14 2.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.561 -0.964 . . . . 0.0 111.215 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.36 122.49 27.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.027 1.731 . . . . 0.0 110.644 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.3 p -115.03 -8.06 12.48 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.534 1.534 . . . . 0.0 113.789 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.96 -173.18 49.76 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.776 1.655 . . . . 0.0 113.625 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.94 -159.97 42.73 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.102 0.858 . . . . 0.0 114.61 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -82.53 128.85 34.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.131 0.973 . . . . 0.0 110.65 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.5 p -70.04 -26.9 64.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.645 1.178 . . . . 0.0 113.352 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -139.59 160.04 40.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.891 2.077 . . . . 0.0 111.048 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 50.2 ttm -63.11 -31.61 72.79 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.68 73.68 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 114.036 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -80.98 -29.05 35.37 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.055 0.927 . . . . 0.0 113.265 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.83 -34.35 39.52 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.103 -0.998 . . . . 0.0 112.432 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.88 -22.33 66.63 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -78.54 -5.18 51.98 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.166 1.386 . . . . 0.0 114.566 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -118.92 -43.81 2.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.171 1.788 . . . . 0.0 112.411 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.5 m -63.83 158.74 59.35 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 111.814 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.42 -16.31 17.23 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 122.663 2.242 . . . . 0.0 113.805 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 C-N-CA 126.464 1.983 . . . . 0.0 113.207 177.651 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -58.24 117.02 3.96 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.443 1.897 . . . . 0.0 113.427 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -138.1 161.71 36.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.625 1.97 . . . . 0.0 111.652 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -93.04 68.36 4.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.257 1.423 . . . . 0.0 111.627 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.39 118.24 12.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.496 1.118 . . . . 0.0 112.217 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 p -73.81 148.64 42.26 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.812 0.845 . . . . 0.0 112.416 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.4 p -146.94 169.2 19.67 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.773 1.629 . . . . 0.0 112.144 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.58 157.4 72.21 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 126.626 1.97 . . . . 0.0 111.319 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.26 159.99 48.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.867 2.378 . . . . 0.0 112.675 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -58.82 -27.72 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.192 1.397 . . . . 0.0 113.635 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.88 -3.62 89.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.513 1.054 . . . . 0.0 115.23 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -68.76 141.4 55.23 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.42 1.61 . . . . 0.0 111.739 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -71.63 92.43 1.16 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.92 159.32 63.28 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.194 1.398 . . . . 0.0 112.532 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.03 161.39 38.75 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.748 2.299 . . . . 0.0 113.235 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.77 133.34 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.742 1.217 . . . . 0.0 111.886 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -72.16 144.71 48.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.314 1.046 . . . . 0.0 110.593 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.2 -6.9 80.91 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 57.01 20.02 5.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.974 2.11 . . . . 0.0 114.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 m -74.43 169.49 17.6 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.958 -1.089 . . . . 0.0 112.426 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.74 -39.96 80.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.938 0.895 . . . . 0.0 112.68 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 159.66 29.37 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.806 1.243 . . . . 0.0 113.115 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -131.39 90.18 2.83 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.938 1.695 . . . . 0.0 111.706 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -61.44 174.32 0.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 111.943 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -123.14 107.99 12.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.465 1.106 . . . . 0.0 110.341 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? -111.33 157.55 20.06 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.034 1.334 . . . . 0.0 111.039 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -120.99 138.96 53.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.95 120.71 18.46 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.843 1.257 . . . . 0.0 109.881 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.36 96.44 0.87 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.685 0.755 . . . . 0.0 110.581 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.6 mmm -78.95 81.88 5.19 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 0.0 108.734 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.96 -67.45 2.38 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.47 1.985 . . . . 0.0 114.536 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -132.64 -4.83 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.585 1.554 . . . . 0.0 114.068 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t -134.29 134.43 41.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.447 1.099 . . . . 0.0 112.007 -174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 52.5 m -81.87 95.41 7.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 111.321 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.44 156.44 24.12 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.787 0.835 . . . . 0.0 110.981 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.38 145.11 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.655 1.182 . . . . 0.0 110.46 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.36 131.14 33.85 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.88 1.672 . . . . 0.0 110.388 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.41 122.42 24.96 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 111.187 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.27 52.15 0.02 OUTLIER Glycine 0 N--CA 1.474 1.184 0 C-N-CA 123.753 0.692 . . . . 0.0 113.709 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.6 t 61.22 23.59 13.79 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 0.0 114.459 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -67.73 136.44 54.27 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.389 . . . . 0.0 111.599 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -130.02 -7.38 4.41 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.48 -10.24 59.45 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.411 1.005 . . . . 0.0 115.375 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.82 174.07 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.831 1.205 . . . . 0.0 114.089 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -71.5 149.56 45.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.903 1.281 . . . . 0.0 111.863 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m -70.6 -31.21 68.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.034 1.334 . . . . 0.0 113.752 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -140.23 160.25 40.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.534 1.934 . . . . 0.0 111.063 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.8 ttm -62.57 -36.95 84.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.624 0.77 . . . . 0.0 112.413 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.83 91.69 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.359 -0.838 . . . . 0.0 113.645 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.03 -38.52 82.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.143 0.977 . . . . 0.0 112.65 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.0 p -75.52 -40.76 56.56 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.806 0.73 . . . . 0.0 111.985 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.38 87.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -68.48 -27.21 65.94 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.36 -48.43 10.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.795 1.238 . . . . 0.0 112.165 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -71.51 165.98 43.76 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.3 -24.83 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.143 2.562 . . . . 0.0 114.487 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.317 0 C-N-CA 125.816 1.674 . . . . 0.0 114.159 -175.809 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.499 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -66.95 167.29 11.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.734 1.214 . . . . 0.0 113.861 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.31 9.14 5.59 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.184 1.793 . . . . 0.0 114.039 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -62.2 133.73 55.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.403 1.081 . . . . 0.0 111.617 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -67.26 -51.69 49.89 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.564 1.145 . . . . 0.0 112.865 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.6 t 46.45 37.83 4.73 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.256 1.822 . . . . 0.0 113.457 -173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -60.38 144.98 49.57 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.209 1.404 . . . . 0.0 111.829 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.23 81.43 52.15 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.241 1.416 . . . . 0.0 109.96 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.93 163.71 34.89 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.108 2.539 . . . . 0.0 111.53 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.9 tp -56.79 -26.74 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.544 1.138 . . . . 0.0 113.422 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.83 -5.42 88.63 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.609 1.1 . . . . 0.0 115.274 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -71.51 160.22 33.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.605 1.703 . . . . 0.0 111.357 172.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 m -77.56 55.22 1.28 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.978 1.311 . . . . 0.0 112.233 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.39 156.29 88.82 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.032 1.333 . . . . 0.0 113.575 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.84 171.42 16.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.037 2.491 . . . . 0.0 112.776 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.84 132.74 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.159 1.384 . . . . 0.0 111.904 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -84.38 139.83 31.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.153 1.381 . . . . 0.0 110.53 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.14 -2.85 89.27 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.254 1.407 . . . . 0.0 116.156 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 54.11 27.3 7.46 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.89 2.076 . . . . 0.0 114.342 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 m -65.53 171.09 4.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.654 1.581 . . . . 0.0 112.96 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -75.0 -0.06 17.53 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.449 1.5 . . . . 0.0 114.841 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.28 163.35 19.82 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.156 1.782 . . . . 0.0 112.785 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -132.15 85.26 2.22 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.432 1.893 . . . . 0.0 111.934 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -72.63 172.61 10.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.022 0.929 . . . . 0.0 111.589 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 m -121.82 113.15 19.25 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.855 1.262 . . . . 0.0 109.256 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.49 164.63 14.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.212 1.405 . . . . 0.0 110.801 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.75 140.33 50.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.655 1.582 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -142.01 137.5 31.18 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.217 . . . . 0.0 111.001 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.67 97.16 8.95 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.648 -0.658 . . . . 0.0 111.455 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 88.8 mmm -81.67 71.48 8.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.165 1.386 . . . . 0.0 110.584 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.88 -79.59 1.67 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.505 1.526 . . . . 0.0 112.989 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.11 -10.3 9.04 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -133.07 136.64 46.03 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 110.386 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.56 144.39 47.94 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.362 -0.836 . . . . 0.0 110.884 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -132.68 132.55 42.52 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.019 1.727 . . . . 0.0 110.266 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.77 142.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.669 0.788 . . . . 0.0 110.65 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -129.56 103.35 6.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.694 1.998 . . . . 0.0 109.567 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -86.47 114.75 23.49 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.1 1.36 . . . . 0.0 110.453 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.69 -176.44 33.22 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.542 1.067 . . . . 0.0 113.547 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 9.2 t -79.22 59.71 2.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.724 1.21 . . . . 0.0 111.89 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -85.72 -36.64 20.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.952 0.901 . . . . 0.0 113.358 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p 54.2 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 130.993 3.717 . . . . 0.0 118.187 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.45 -160.29 35.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.91 2.195 . . . . 0.0 113.85 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.17 -136.57 48.1 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.967 1.27 . . . . 0.0 113.518 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -108.33 136.91 47.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.327 1.451 . . . . 0.0 110.599 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t -75.64 -22.83 56.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.228 1.011 . . . . 0.0 112.255 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 154.86 49.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.169 1.788 . . . . 0.0 112.776 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -58.97 -33.07 70.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.081 0.952 . . . . 0.0 112.516 173.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.56 -40.94 94.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.055 0.836 . . . . 0.0 113.652 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.56 -31.8 73.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 0.0 112.249 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -71.04 -51.13 27.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.294 1.038 . . . . 0.0 111.797 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.47 76.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.902 1.681 . . . . 0.0 114.17 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.57 -21.3 65.49 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -105.72 -34.61 7.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.061 1.344 . . . . 0.0 113.464 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.4 m -61.35 159.15 32.88 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.096 0.959 . . . . 0.0 112.81 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.99 -14.62 26.29 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.983 2.455 . . . . 0.0 114.502 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.238 0 C-N-CA 126.324 1.916 . . . . 0.0 113.07 176.559 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -62.88 112.2 2.46 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.298 1.439 . . . . 0.0 112.564 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -134.55 171.91 13.66 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.963 2.105 . . . . 0.0 111.472 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.24 153.13 27.07 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.465 1.106 . . . . 0.0 111.729 171.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.89 157.32 39.7 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.092 1.357 . . . . 0.0 112.847 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.2 m -136.61 106.0 6.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.087 1.755 . . . . 0.0 109.671 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 p -76.38 92.6 3.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.798 0.839 . . . . 0.0 112.401 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -128.95 82.39 68.85 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.652 1.981 . . . . 0.0 110.832 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.99 168.14 25.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.922 2.415 . . . . 0.0 112.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.56 -27.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.545 1.138 . . . . 0.0 113.418 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.21 90.1 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.803 1.192 . . . . 0.0 115.375 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -65.48 152.65 43.48 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.405 1.603 . . . . 0.0 111.984 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 p -75.54 72.17 2.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.375 1.47 . . . . 0.0 112.064 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.8 151.35 85.09 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.682 1.193 . . . . 0.0 112.542 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.6 171.11 17.86 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.018 2.479 . . . . 0.0 112.536 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.72 126.45 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.759 1.224 . . . . 0.0 112.179 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -69.69 141.84 53.47 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.394 1.078 . . . . 0.0 110.246 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.11 -6.67 89.07 Favored Glycine 0 CA--C 1.541 1.681 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.76 20.08 4.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.78 2.032 . . . . 0.0 113.985 -175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 m -77.18 172.03 13.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.643 1.177 . . . . 0.0 113.328 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -84.43 5.33 27.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.756 2.022 . . . . 0.0 115.305 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.01 165.07 20.14 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.302 1.841 . . . . 0.0 113.225 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -128.78 95.16 4.02 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.671 1.988 . . . . 0.0 112.571 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -83.19 177.34 8.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.762 0.825 . . . . 0.0 111.297 166.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -134.43 114.48 12.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.044 1.337 . . . . 0.0 111.227 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.4 mmp_? -116.05 166.14 12.34 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.965 1.706 . . . . 0.0 111.266 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.81 99.25 4.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.412 1.485 . . . . 0.0 110.496 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -97.13 137.15 36.62 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.48 0.712 . . . . 0.0 110.748 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -77.89 107.04 10.13 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.246 -0.909 . . . . 0.0 110.906 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.8 mmm -93.29 17.1 11.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.835 1.654 . . . . 0.0 113.529 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.44 90.04 2.14 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.473 1.511 . . . . 0.0 111.348 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 t30 59.23 14.05 3.39 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.34 1.856 . . . . 0.0 114.803 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.4 m -142.99 116.47 9.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.2 m -61.6 115.0 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.175 0.59 . . . . 0.0 110.55 157.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -113.49 132.18 55.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.63 1.572 . . . . 0.0 110.184 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.62 144.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.265 0.626 . . . . 0.0 111.608 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -133.73 137.93 45.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.881 1.672 . . . . 0.0 110.869 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -135.33 117.92 15.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.503 1.521 . . . . 0.0 110.776 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.41 59.22 0.01 OUTLIER Glycine 0 N--CA 1.475 1.273 0 C-N-CA 123.532 0.587 . . . . 0.0 114.292 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 59.0 25.18 13.52 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.03 113.16 6.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.985 1.314 . . . . 0.0 110.968 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -102.77 -8.26 20.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.944 1.298 . . . . 0.0 113.678 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.96 -174.14 42.46 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.523 1.535 . . . . 0.0 113.011 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 -171.53 26.76 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.206 0.908 . . . . 0.0 114.239 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.64 139.06 38.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.787 0.835 . . . . 0.0 110.746 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.6 p -84.76 -10.98 56.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -135.01 150.55 50.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.248 1.819 . . . . 0.0 112.037 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.3 tpp -59.37 -40.59 86.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.956 1.302 . . . . 0.0 111.575 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.55 93.44 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.558 -0.714 . . . . 0.0 113.471 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.18 -38.02 75.27 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.5 p -70.97 -41.75 70.63 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.602 1.092 . . . . 0.0 111.77 169.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.97 -29.5 68.55 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -69.54 -22.47 63.56 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -102.25 -50.79 3.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.988 1.315 . . . . 0.0 112.87 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.28 160.2 83.16 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 118.697 0.68 . . . . 0.0 112.707 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -75.41 -9.76 20.32 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.388 2.725 . . . . 0.0 114.4 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.522 0 C-N-CA 126.874 2.178 . . . . 0.0 112.572 178.706 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -145.63 164.4 31.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.756 1.623 . . . . 0.0 110.474 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -133.82 -12.04 2.62 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.563 2.345 . . . . 0.0 113.576 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -135.49 76.72 1.63 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.554 1.142 . . . . 0.0 111.823 -172.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.96 166.0 15.79 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.315 1.846 . . . . 0.0 112.565 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.7 t -74.88 131.43 40.72 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.426 -0.796 . . . . 0.0 111.455 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.7 p -139.15 160.3 40.12 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.303 1.441 . . . . 0.0 111.76 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.57 157.5 70.11 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 127.037 2.135 . . . . 0.0 109.949 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.72 161.75 44.7 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.042 . . . . 0.0 112.15 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -62.86 146.19 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.393 0.677 . . . . 0.0 110.653 170.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 15.81 81.27 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.031 0.772 . . . . 0.0 115.031 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -61.52 165.29 4.99 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.87 1.335 . . . . 0.0 111.74 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 t -72.2 93.94 1.51 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.094 -1.003 . . . . 0.0 111.538 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.61 156.73 34.92 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.514 1.525 . . . . 0.0 112.856 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.33 152.6 55.52 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.916 2.411 . . . . 0.0 112.461 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.91 128.62 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.871 0.868 . . . . 0.0 111.936 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -71.53 140.6 49.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.057 0.943 . . . . 0.0 110.664 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.08 -8.94 87.29 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.2 mt 61.67 16.55 7.88 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.222 2.209 . . . . 0.0 115.058 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.0 m -74.94 170.99 14.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.116 1.367 . . . . 0.0 113.551 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.57 -20.55 65.4 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.73 164.36 14.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.427 1.891 . . . . 0.0 112.361 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.55 99.78 4.76 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 112.184 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.34 176.63 1.02 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.349 1.06 . . . . 0.0 110.944 165.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.0 m -124.08 112.41 17.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -119.68 166.59 13.0 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.022 1.729 . . . . 0.0 110.856 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.49 137.75 44.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.356 1.063 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -141.99 126.75 18.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.859 1.264 . . . . 0.0 110.401 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -78.12 128.38 33.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.984 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtp -102.87 5.54 38.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.701 1.2 . . . . 0.0 113.371 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.89 -74.77 0.27 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.527 1.537 . . . . 0.0 111.978 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -120.35 13.69 11.93 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.711 1.605 . . . . 0.0 113.15 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.8 p -147.89 169.37 19.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.21 1.404 . . . . 0.0 111.597 169.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -117.01 111.93 20.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.27 1.828 . . . . 0.0 110.719 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -97.82 137.21 37.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.699 1.599 . . . . 0.0 110.899 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.52 146.79 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.831 0.852 . . . . 0.0 111.456 171.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.37 124.95 25.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.586 1.954 . . . . 0.0 110.555 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -127.44 110.7 13.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.234 1.414 . . . . 0.0 111.388 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.44 52.31 0.01 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 -168.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.0 t 60.51 22.32 12.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.679 1.592 . . . . 0.0 114.476 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.43 128.76 37.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.659 1.584 . . . . 0.0 111.082 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.0 p -105.36 -20.6 13.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.461 1.104 . . . . 0.0 113.769 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.24 -161.06 34.97 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.899 1.714 . . . . 0.0 114.052 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.54 -172.1 48.73 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.861 1.22 . . . . 0.0 114.427 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -73.29 138.12 45.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.525 0.73 . . . . 0.0 109.951 167.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.2 m -70.08 -32.2 70.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.614 0.766 . . . . 0.0 113.054 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -140.49 165.46 27.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.264 1.826 . . . . 0.0 112.17 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.4 ttt -68.91 -24.54 64.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.33 -35.78 69.64 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.259 -0.9 . . . . 0.0 112.809 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -44.07 69.71 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.326 1.45 . . . . 0.0 112.523 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -62.92 -42.56 99.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.777 0.717 . . . . 0.0 112.334 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -3.82 9.98 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.2 mtp-105 -67.22 -42.49 83.97 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.743 -1.223 . . . . 0.0 111.889 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -93.6 -53.08 4.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.248 1.819 . . . . 0.0 111.433 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.3 m -77.05 158.18 80.36 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 111.432 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.6 -11.5 22.27 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.493 2.129 . . . . 0.0 114.943 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.242 0 C-N-CA 125.8 1.667 . . . . 0.0 113.386 179.539 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.453 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.8 162.82 15.36 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.693 1.197 . . . . 0.0 113.768 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -139.71 164.01 31.07 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.393 1.877 . . . . 0.0 111.654 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -68.74 158.97 33.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.766 1.227 . . . . 0.0 111.694 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -130.14 156.92 43.77 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.793 1.237 . . . . 0.0 113.044 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.6 t -97.78 45.48 1.03 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.613 1.965 . . . . 0.0 111.43 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.4 p -67.77 152.79 45.02 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.832 -1.168 . . . . 0.0 112.469 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.5 89.68 18.33 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.281 1.432 . . . . 0.0 109.941 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.27 166.0 29.78 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.015 175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.75 148.14 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.89 0.876 . . . . 0.0 111.229 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.72 6.64 89.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -65.66 159.69 24.33 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 119.029 1.414 . . . . 0.0 112.151 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.1 m -76.39 53.5 0.85 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.047 1.739 . . . . 0.0 112.781 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.43 156.11 86.53 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.029 1.332 . . . . 0.0 112.647 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.49 166.19 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.463 2.776 . . . . 0.0 113.604 176.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -97.34 132.52 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.974 1.31 . . . . 0.0 111.639 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -77.27 142.66 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 111.16 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.05 -9.16 77.61 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.478 1.513 . . . . 0.0 115.209 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mp 55.13 18.07 2.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.365 2.266 . . . . 0.0 114.687 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 p -70.9 173.05 7.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -75.65 2.52 11.71 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.204 1.801 . . . . 0.0 114.206 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.52 169.82 13.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.26 2.224 . . . . 0.0 111.431 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -136.55 105.1 5.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.401 1.48 . . . . 0.0 111.126 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -93.87 155.11 17.36 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.55 1.14 . . . . 0.0 111.667 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -102.95 105.11 15.39 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.712 1.205 . . . . 0.0 110.658 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.26 157.85 32.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.02 1.328 . . . . 0.0 110.814 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.43 92.43 3.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.276 1.83 . . . . 0.0 111.146 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.08 139.47 30.6 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.495 -0.753 . . . . 0.0 111.506 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.7 m -74.43 109.11 7.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.87 0.868 . . . . 0.0 112.151 172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.6 mtp -91.75 69.44 5.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.669 1.188 . . . . 0.0 109.804 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.06 -100.51 1.25 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.266 1.413 . . . . 0.0 112.733 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.33 -8.67 56.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.24 161.0 38.5 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.978 1.711 . . . . 0.0 111.49 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.9 m -90.24 152.49 21.05 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.658 -0.651 . . . . 0.0 111.602 165.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -133.34 132.65 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.253 1.821 . . . . 0.0 109.903 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -77.01 146.54 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.985 0.514 . . . . 0.0 111.126 171.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -109.44 -68.76 0.9 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 67.83 78.57 0.23 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.573 1.949 . . . . 0.0 112.91 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.92 14.84 0.03 OUTLIER Glycine 0 N--CA 1.474 1.181 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.6 t 77.07 91.98 0.07 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.436 2.294 . . . . 0.0 112.104 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.3 -56.94 0.8 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 0.0 113.664 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.9 p 54.84 -2.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 129.693 3.197 . . . . 0.0 118.473 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.53 -19.66 53.89 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 119.848 1.204 . . . . 0.0 115.375 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.87 179.04 27.46 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 126.002 1.763 . . . . 0.0 113.356 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -58.88 142.76 49.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.679 1.191 . . . . 0.0 112.871 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.0 p -83.4 -16.28 46.54 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.219 1.408 . . . . 0.0 114.458 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -137.79 154.71 49.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.324 1.85 . . . . 0.0 111.511 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 46.7 ttm -65.67 -29.42 69.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.508 0.723 . . . . 0.0 112.562 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.33 -37.59 94.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.992 -1.068 . . . . 0.0 113.452 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -71.46 -33.8 69.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.106 0.962 . . . . 0.0 113.098 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.2 p -74.9 -49.46 20.23 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.785 -0.572 . . . . 0.0 111.735 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.24 -16.92 62.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.75 -25.78 65.8 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.052 1.296 . . . . 0.0 113.438 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -100.55 -48.9 4.38 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.103 1.361 . . . . 0.0 111.555 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m -75.25 164.1 63.37 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.443 2.297 . . . . 0.0 111.568 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.78 -6.46 15.22 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.108 1.872 . . . . 0.0 113.683 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 C-N-CA 128.067 2.746 . . . . 0.0 112.527 177.238 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -137.25 44.43 2.28 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.679 1.192 . . . . 0.0 111.245 -159.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -51.02 -31.38 18.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.922 2.489 . . . . 0.0 115.653 -168.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.8 24.59 5.35 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.865 1.666 . . . . 0.0 112.824 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.76 154.6 8.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.953 1.301 . . . . 0.0 112.411 169.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.7 p -64.3 141.9 58.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.215 1.006 . . . . 0.0 113.204 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.7 p -140.1 172.4 12.81 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.451 1.901 . . . . 0.0 110.924 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t -126.36 84.2 62.55 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.85 1.26 . . . . 0.0 109.201 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.75 160.15 48.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.87 2.38 . . . . 0.0 111.682 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -61.62 141.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.306 0.574 . . . . 0.0 110.726 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.37 -3.92 85.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.387 0.994 . . . . 0.0 115.163 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.52 156.51 34.7 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.357 1.579 . . . . 0.0 110.956 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 t -77.52 97.81 5.14 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.52 1.128 . . . . 0.0 111.717 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 157.37 34.31 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.902 1.681 . . . . 0.0 113.181 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.4 161.58 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.043 2.495 . . . . 0.0 112.605 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.68 134.56 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.506 1.122 . . . . 0.0 111.85 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -66.84 141.73 57.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.148 0.979 . . . . 0.0 110.485 174.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -10.39 85.82 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.2 mt 62.78 13.24 6.3 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.466 2.306 . . . . 0.0 114.716 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -80.62 171.54 14.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.592 1.157 . . . . 0.0 113.3 -172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -62.55 -43.4 98.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.941 1.296 . . . . 0.0 113.412 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.52 126.53 35.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 113.238 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.33 89.48 5.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.272 1.429 . . . . 0.0 111.174 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -64.1 176.12 1.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.417 1.087 . . . . 0.0 111.625 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -123.0 105.83 10.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.403 1.081 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -112.42 168.14 9.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.197 1.799 . . . . 0.0 110.729 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -135.97 140.1 43.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.37 1.068 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.36 138.85 35.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.181 0.992 . . . . 0.0 112.277 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.38 91.48 1.35 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.929 1.292 . . . . 0.0 112.251 175.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 76.1 mmm -85.61 76.6 9.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.175 0.99 . . . . 0.0 109.331 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.34 -86.44 0.71 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.747 1.641 . . . . 0.0 112.257 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -122.1 3.63 9.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.659 1.583 . . . . 0.0 114.228 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.6 m -130.48 124.95 33.15 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.539 1.536 . . . . 0.0 111.846 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.3 m -73.34 85.98 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.035 1.334 . . . . 0.0 111.632 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -75.42 139.85 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.536 -0.728 . . . . 0.0 110.897 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.38 143.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.692 1.197 . . . . 0.0 111.366 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.98 133.25 45.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.138 1.775 . . . . 0.0 110.734 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -134.3 106.98 7.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.088 1.355 . . . . 0.0 111.293 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.55 0.01 OUTLIER Glycine 0 N--CA 1.475 1.246 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -171.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 t 55.07 29.48 12.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.002 1.321 . . . . 0.0 114.383 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.34 140.8 52.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.756 1.223 . . . . 0.0 110.764 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.8 p -139.06 -3.35 1.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.95 9.76 74.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.349 1.452 . . . . 0.0 116.019 -172.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.03 -172.1 24.78 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 118.861 1.33 . . . . 0.0 114.702 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -61.56 135.93 57.83 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 114.082 -165.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.1 t -72.23 -22.71 61.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 113.363 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -136.07 152.21 50.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.901 1.68 . . . . 0.0 112.518 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.6 tpp -55.04 -44.45 74.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.572 1.549 . . . . 0.0 111.049 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.84 -50.68 62.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.047 1.308 . . . . 0.0 113.306 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -62.15 -37.86 86.8 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.542 1.171 . . . . 0.0 112.991 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.4 t -60.13 -42.24 94.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 171.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.47 -14.69 44.0 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.22 -54.28 39.83 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.082 1.353 . . . . 0.0 111.838 171.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.05 -33.17 44.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 113.265 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m -66.48 160.03 69.36 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.559 0.743 . . . . 0.0 112.306 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.06 -16.69 22.64 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.375 2.717 . . . . 0.0 114.683 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.229 0 C-N-CA 126.029 1.776 . . . . 0.0 112.694 179.154 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.409 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -68.14 168.64 11.73 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.499 1.119 . . . . 0.0 113.101 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt 53.58 33.28 16.0 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.522 1.929 . . . . 0.0 113.762 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -64.81 165.48 10.52 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.541 1.536 . . . . 0.0 113.523 174.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -149.09 166.8 27.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.73 1.612 . . . . 0.0 111.717 172.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.0 t -124.88 -2.08 7.8 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.858 1.263 . . . . 0.0 113.658 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.6 p -70.16 159.85 33.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.448 1.499 . . . . 0.0 112.884 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 m -140.8 158.35 65.56 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 126.675 1.99 . . . . 0.0 111.232 177.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.14 159.05 54.5 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.387 2.058 . . . . 0.0 111.474 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.53 -28.37 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.291 1.037 . . . . 0.0 113.346 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.44 2.44 87.91 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.125 1.345 . . . . 0.0 115.514 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -64.25 158.45 23.24 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.411 1.605 . . . . 0.0 112.085 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -78.87 98.33 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.647 1.179 . . . . 0.0 111.615 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.01 157.23 37.52 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.874 1.67 . . . . 0.0 112.936 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.08 166.22 29.58 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.348 2.699 . . . . 0.0 112.975 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.53 133.35 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.77 1.228 . . . . 0.0 112.194 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -73.32 143.95 46.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.457 1.503 . . . . 0.0 110.705 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.82 -8.67 87.22 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.3 mp 49.72 35.86 9.75 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.63 1.972 . . . . 0.0 113.321 -173.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 m -78.57 168.35 19.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.35 1.46 . . . . 0.0 112.954 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -68.66 -35.06 76.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.253 1.021 . . . . 0.0 113.198 165.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.88 160.53 27.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.138 1.375 . . . . 0.0 112.6 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -132.87 77.51 1.74 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.007 1.723 . . . . 0.0 111.049 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.81 166.24 22.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.543 1.137 . . . . 0.0 111.389 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -128.82 120.93 27.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.635 1.574 . . . . 0.0 110.647 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -124.82 171.85 9.81 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.088 2.555 . . . . 0.0 110.343 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -134.72 137.62 43.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.681 1.192 . . . . 0.0 110.307 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -137.97 132.43 32.3 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.271 1.028 . . . . 0.0 111.544 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.91 121.56 15.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.009 0.923 . . . . 0.0 111.571 170.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.7 mmm -111.87 11.8 20.81 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.672 1.989 . . . . 0.0 113.082 -176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.27 104.04 1.2 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.694 1.14 . . . . 0.0 111.485 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 63.67 -1.27 0.63 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.148 2.179 . . . . 0.0 115.23 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -141.9 156.25 45.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.873 2.069 . . . . 0.0 110.294 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.42 107.93 14.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.949 1.3 . . . . 0.0 110.006 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -90.53 144.48 25.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.434 1.093 . . . . 0.0 110.874 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.28 146.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.691 0.796 . . . . 0.0 111.002 167.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.34 129.21 42.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.319 1.848 . . . . 0.0 109.012 172.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -133.17 149.91 52.03 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.679 0.792 . . . . 0.0 112.27 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.18 12.01 2.16 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 10.1 t 95.87 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 130.05 3.34 . . . . 0.0 110.504 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.05 130.6 33.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.242 1.817 . . . . 0.0 109.114 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -117.41 -4.36 11.32 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.871 1.268 . . . . 0.0 113.941 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.31 -167.97 31.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.198 1.856 . . . . 0.0 113.197 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.85 -164.47 43.0 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.232 0.92 . . . . 0.0 114.526 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -81.89 138.86 34.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.884 0.873 . . . . 0.0 110.392 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -69.14 -30.56 68.83 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -140.6 158.48 43.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.659 1.984 . . . . 0.0 112.087 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.2 ttm -61.75 -34.87 76.62 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.162 0.585 . . . . 0.0 112.084 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.5 -27.93 70.4 Favored Glycine 0 CA--C 1.536 1.377 0 O-C-N 121.471 -0.768 . . . . 0.0 114.059 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.26 -48.27 17.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.266 1.033 . . . . 0.0 112.072 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -65.13 -30.14 71.05 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.462 1.028 . . . . 0.0 113.058 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -6.52 7.23 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -78.32 -12.2 59.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.0 -1.062 . . . . 0.0 113.598 167.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -125.36 -52.77 1.61 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.567 1.947 . . . . 0.0 112.221 -177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.5 m -65.98 158.99 73.47 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.746 0.819 . . . . 0.0 111.513 164.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.91 -14.55 23.91 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.652 2.234 . . . . 0.0 114.535 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.327 1.917 . . . . 0.0 112.576 -178.786 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.491 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -137.44 162.6 33.22 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.524 1.53 . . . . 0.0 111.667 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.69 109.69 9.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.241 1.816 . . . . 0.0 110.987 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.09 67.78 1.35 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.916 1.286 . . . . 0.0 111.185 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -74.34 143.36 44.93 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.833 -1.167 . . . . 0.0 111.394 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.0 p -106.73 45.72 0.97 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.965 1.306 . . . . 0.0 112.525 -177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.5 t -63.19 -24.43 67.88 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.812 1.645 . . . . 0.0 113.862 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t 55.23 81.52 0.26 Allowed Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 128.443 2.697 . . . . 0.0 111.73 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.88 158.88 56.1 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.713 2.275 . . . . 0.0 111.802 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.06 138.33 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.239 0.616 . . . . 0.0 111.092 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.69 -1.58 68.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.539 1.066 . . . . 0.0 115.312 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.2 t-105 -65.3 151.69 45.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.588 1.694 . . . . 0.0 111.187 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -78.08 72.14 4.59 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.108 1.363 . . . . 0.0 112.526 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.58 155.16 89.48 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.864 1.265 . . . . 0.0 114.082 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.4 174.38 12.93 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.908 3.072 . . . . 0.0 112.124 170.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.3 143.12 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.614 1.165 . . . . 0.0 112.62 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.35 146.27 54.7 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.434 1.493 . . . . 0.0 111.033 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.47 -7.07 79.85 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 56.05 22.77 6.18 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.267 2.227 . . . . 0.0 114.346 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 m -75.02 172.22 12.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.772 1.229 . . . . 0.0 112.723 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -76.57 -2.12 30.89 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.471 1.509 . . . . 0.0 114.819 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.88 160.74 28.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.9 1.68 . . . . 0.0 113.059 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -131.11 85.16 2.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.48 1.912 . . . . 0.0 112.407 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -66.24 172.0 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.233 1.013 . . . . 0.0 111.293 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -121.24 114.0 20.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.294 1.038 . . . . 0.0 110.518 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -118.37 168.13 10.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.955 1.702 . . . . 0.0 110.657 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -131.65 142.6 49.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.533 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.36 132.26 29.3 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.207 1.403 . . . . 0.0 109.987 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.5 t -71.47 140.62 50.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.808 166.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.31 24.99 11.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.488 1.515 . . . . 0.0 112.59 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.26 -40.35 1.68 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.188 2.328 . . . . 0.0 112.491 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -152.19 -48.46 0.11 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.687 1.595 . . . . 0.0 112.223 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.2 m -71.02 134.75 47.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.122 0.969 . . . . 0.0 111.841 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 95.9 m -73.58 134.86 43.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.006 0.922 . . . . 0.0 110.749 162.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.14 133.52 54.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.039 1.736 . . . . 0.0 109.679 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.78 146.45 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.401 0.681 . . . . 0.0 110.847 172.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.54 134.82 41.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.992 1.717 . . . . 0.0 110.747 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -136.67 113.42 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.208 1.403 . . . . 0.0 111.001 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.63 60.52 0.02 OUTLIER Glycine 0 N--CA 1.476 1.344 0 N-CA-C 115.166 0.827 . . . . 0.0 115.166 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 t 59.73 30.52 20.11 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -70.44 -45.78 65.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.786 1.234 . . . . 0.0 113.641 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.2 p 50.83 -8.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 131.112 3.765 . . . . 0.0 118.394 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.52 -161.35 37.36 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 127.265 2.364 . . . . 0.0 113.965 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.69 -122.99 31.94 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.541 1.067 . . . . 0.0 113.007 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.36 152.84 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.768 1.627 . . . . 0.0 111.944 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.2 p -82.2 -23.54 35.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.867 1.267 . . . . 0.0 114.219 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -137.34 156.11 48.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.152 1.381 . . . . 0.0 112.417 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 ttt -66.46 -19.8 65.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.849 1.26 . . . . 0.0 113.123 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.88 -38.58 26.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.904 0.764 . . . . 0.0 113.501 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -64.56 -45.62 86.3 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.767 1.284 . . . . 0.0 112.747 -174.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -59.69 -35.11 73.82 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.55 -0.719 . . . . 0.0 112.176 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -14.21 60.43 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -74.47 -21.03 59.78 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.819 -1.176 . . . . 0.0 112.762 166.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -103.66 -55.51 2.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.018 1.727 . . . . 0.0 111.649 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m -75.68 161.44 76.15 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 113.237 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.13 -8.35 16.44 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.888 3.059 . . . . 0.0 115.433 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 C-N-CA 126.195 1.855 . . . . 0.0 114.721 -178.516 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -75.41 66.35 1.82 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.769 1.628 . . . . 0.0 113.444 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -77.74 102.54 7.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.513 1.525 . . . . 0.0 110.483 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.08 24.14 11.94 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.075 1.75 . . . . 0.0 112.78 -175.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -55.93 144.17 29.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.672 1.589 . . . . 0.0 112.985 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.02 83.11 3.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.893 1.277 . . . . 0.0 111.131 171.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 p -66.15 142.82 57.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.099 0.559 . . . . 0.0 110.642 164.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.56 157.98 69.23 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 125.992 1.717 . . . . 0.0 110.813 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.74 155.69 67.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.238 1.959 . . . . 0.0 112.316 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.62 -26.26 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.213 1.405 . . . . 0.0 113.587 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.98 2.43 86.82 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.996 1.284 . . . . 0.0 115.724 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -65.58 155.41 35.87 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.99 1.895 . . . . 0.0 111.555 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -73.53 75.24 1.46 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.906 1.283 . . . . 0.0 111.763 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -78.15 157.19 78.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.654 1.582 . . . . 0.0 113.287 176.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.0 174.81 11.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.21 2.607 . . . . 0.0 112.595 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.62 135.04 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.475 1.51 . . . . 0.0 111.006 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -86.41 138.75 31.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.51 1.124 . . . . 0.0 110.809 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.59 -2.21 88.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.215 1.388 . . . . 0.0 115.659 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 53.85 19.35 1.89 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.341 2.256 . . . . 0.0 114.866 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.4 p -71.85 170.05 14.49 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.014 -1.054 . . . . 0.0 113.472 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.97 3.15 7.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.85 1.66 . . . . 0.0 114.947 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.16 154.37 31.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.843 1.657 . . . . 0.0 112.257 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -124.47 90.42 3.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.308 1.843 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -75.92 171.77 13.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 111.544 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.9 m -125.59 113.71 17.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.186 1.394 . . . . 0.0 108.889 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -121.33 159.94 25.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.897 1.679 . . . . 0.0 110.723 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -119.52 142.64 48.13 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.069 0.948 . . . . 0.0 110.396 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.06 170.75 15.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.111 1.364 . . . . 0.0 110.195 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -136.95 144.92 43.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.539 1.136 . . . . 0.0 110.777 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.9 mtt -137.04 71.83 1.41 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.468 1.107 . . . . 0.0 110.231 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.87 -109.37 2.68 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.883 1.706 . . . . 0.0 112.73 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -113.12 34.01 4.72 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.868 1.667 . . . . 0.0 111.381 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.0 104.92 1.74 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.266 1.427 . . . . 0.0 112.742 -175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.04 157.13 31.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.605 1.162 . . . . 0.0 112.2 164.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -161.83 -178.98 6.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.125 2.17 . . . . 0.0 111.474 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.04 146.58 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.306 2.242 . . . . 0.0 110.767 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.93 138.12 49.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.004 2.122 . . . . 0.0 109.774 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.41 111.86 14.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.595 1.558 . . . . 0.0 110.377 -168.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.08 -170.95 33.3 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.984 0.802 . . . . 0.0 113.28 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.58 77.15 1.08 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 111.227 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.46 141.91 51.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.069 1.747 . . . . 0.0 111.803 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.3 p -134.51 -7.09 2.53 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -173.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.6 -2.4 65.32 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -172.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.62 174.45 25.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.826 1.203 . . . . 0.0 115.06 -170.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.32 156.86 38.1 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.842 1.657 . . . . 0.0 111.953 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -78.75 -29.83 45.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.707 1.203 . . . . 0.0 114.144 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mtm105 -141.34 159.47 42.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.67 1.988 . . . . 0.0 111.347 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 33.4 ttm -62.86 -32.0 73.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.7 0.8 . . . . 0.0 112.356 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.8 -28.8 72.34 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.834 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.59 -46.53 38.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.019 1.409 . . . . 0.0 112.878 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.4 p -62.3 -31.91 72.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.073 -1.017 . . . . 0.0 112.379 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 -10.47 49.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.177 1.391 . . . . 0.0 114.739 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -79.71 -36.22 37.82 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.281 0.946 . . . . 0.0 112.571 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -84.43 -50.85 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 111.928 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.4 m -70.33 160.36 81.35 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 171.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.88 -16.41 45.62 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.418 2.745 . . . . 0.0 115.136 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 C-N-CA 125.779 1.656 . . . . 0.0 114.523 168.421 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 CA-C-O 121.576 0.542 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -68.64 158.14 34.7 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.593 1.157 . . . . 0.0 112.669 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.88 -6.32 2.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.095 1.758 . . . . 0.0 114.445 177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.44 105.36 4.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.874 1.269 . . . . 0.0 110.106 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -144.31 168.18 20.7 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.726 1.61 . . . . 0.0 110.936 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.4 p -137.47 156.78 47.75 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.978 0.911 . . . . 0.0 112.295 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.6 p -132.45 -20.88 2.32 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.032 1.333 . . . . 0.0 114.121 -169.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t 47.7 75.47 0.66 Allowed Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 128.438 2.695 . . . . 0.0 111.754 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.82 159.33 53.76 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.359 2.706 . . . . 0.0 112.503 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 tt -61.4 143.06 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.009 0.924 . . . . 0.0 111.314 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.77 -0.83 83.0 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.604 1.097 . . . . 0.0 115.291 -178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -65.09 160.06 21.92 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.19 1.495 . . . . 0.0 111.204 167.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.7 m -74.88 64.96 1.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.694 1.598 . . . . 0.0 112.91 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 154.2 91.61 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.672 1.189 . . . . 0.0 113.805 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.91 153.39 42.23 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.092 2.528 . . . . 0.0 112.183 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.95 135.03 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.84 0.856 . . . . 0.0 111.93 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.6 144.06 54.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.311 1.045 . . . . 0.0 110.726 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 -10.61 86.13 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 115.219 0.847 . . . . 0.0 115.219 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.6 mt 61.84 14.37 6.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.495 2.318 . . . . 0.0 115.134 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 m -75.76 171.75 13.82 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.599 1.16 . . . . 0.0 113.617 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.76 -46.7 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 112.14 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.82 159.51 28.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.063 1.345 . . . . 0.0 113.195 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -131.1 90.68 2.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.471 1.909 . . . . 0.0 111.527 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -68.6 174.23 4.4 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.968 1.307 . . . . 0.0 111.763 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -126.48 112.07 15.15 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 110.172 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -117.53 168.89 9.99 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.24 1.816 . . . . 0.0 110.459 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -133.18 135.33 45.03 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.603 1.161 . . . . 0.0 109.953 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -132.93 147.59 52.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 0.0 111.205 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.0 t -85.93 127.43 34.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.152 0.581 . . . . 0.0 110.475 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.1 mmm -116.19 25.14 10.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.494 1.917 . . . . 0.0 112.933 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.42 93.43 1.82 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.124 1.345 . . . . 0.0 111.228 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.257 13.2 p30 47.09 28.05 0.87 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.755 2.022 . . . . 0.0 115.116 -173.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -151.24 154.12 36.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.776 2.03 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.74 138.23 54.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.612 1.165 . . . . 0.0 110.819 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -142.48 148.46 37.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.649 1.18 . . . . 0.0 112.011 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.97 150.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.58 1.152 . . . . 0.0 111.804 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -134.73 132.77 39.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.795 2.038 . . . . 0.0 110.467 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -132.74 115.46 15.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.576 1.55 . . . . 0.0 111.022 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.73 55.23 0.01 OUTLIER Glycine 0 N--CA 1.475 1.295 0 O-C-N 121.823 -0.548 . . . . 0.0 114.454 -170.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.2 t 57.07 28.26 14.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.167 1.387 . . . . 0.0 114.401 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.81 139.67 53.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.651 1.18 . . . . 0.0 110.538 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.2 p -125.89 -5.29 6.87 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.89 1.276 . . . . 0.0 113.915 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.13 -167.67 33.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.813 1.673 . . . . 0.0 112.637 173.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.6 49.49 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 122.245 0.914 . . . . 0.0 113.808 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -79.82 148.77 31.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 0.0 111.198 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -78.14 -19.87 53.18 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.38 159.19 42.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.727 2.011 . . . . 0.0 111.95 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.7 tpp -62.45 -40.59 97.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.0 0.92 . . . . 0.0 112.199 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.82 -38.77 93.24 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.721 0.676 . . . . 0.0 112.902 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -39.24 90.96 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.038 1.335 . . . . 0.0 111.676 173.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.03 -56.62 15.41 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.769 -0.582 . . . . 0.0 111.676 167.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.76 70.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -79.18 -18.94 52.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -98.04 -47.07 5.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.876 1.27 . . . . 0.0 112.535 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 168.48 17.14 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.012 0.525 . . . . 0.0 111.604 167.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.93 -10.97 25.3 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.608 2.205 . . . . 0.0 115.5 -167.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 126.126 1.822 . . . . 0.0 113.186 175.136 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.522 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.14 96.41 6.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.903 1.281 . . . . 0.0 112.579 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.6 168.28 20.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.658 1.583 . . . . 0.0 112.288 168.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -73.16 139.28 46.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.105 0.962 . . . . 0.0 111.322 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -151.45 167.36 28.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.803 1.641 . . . . 0.0 111.353 172.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.8 t -73.88 121.92 21.69 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.445 -0.784 . . . . 0.0 111.391 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.5 p -125.29 166.46 16.47 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.782 1.633 . . . . 0.0 112.038 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.41 126.42 19.24 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.76 1.624 . . . . 0.0 109.371 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.74 146.45 54.14 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.37 2.047 . . . . 0.0 111.614 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.41 -27.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.64 1.176 . . . . 0.0 113.615 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.01 1.56 88.64 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.889 1.233 . . . . 0.0 115.491 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -65.02 155.63 34.04 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.567 1.683 . . . . 0.0 112.015 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 t -78.65 80.3 5.02 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.554 1.142 . . . . 0.0 111.725 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.81 153.84 89.16 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.851 1.26 . . . . 0.0 113.131 172.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.96 168.68 23.02 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.472 2.782 . . . . 0.0 112.897 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.12 134.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.13 1.372 . . . . 0.0 111.769 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -78.16 141.78 38.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.213 1.405 . . . . 0.0 110.93 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.21 -6.8 83.98 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.884 1.113 . . . . 0.0 115.884 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mp 57.5 17.92 4.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.266 2.226 . . . . 0.0 114.765 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.14 167.98 9.2 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.195 1.798 . . . . 0.0 113.706 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -66.34 -23.16 66.31 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.34 162.68 12.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.542 1.537 . . . . 0.0 112.894 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -131.61 95.85 3.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.012 1.725 . . . . 0.0 110.804 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -80.14 175.22 10.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 111.637 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -124.83 123.17 39.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.03 1.332 . . . . 0.0 109.887 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -126.71 162.72 25.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.426 1.89 . . . . 0.0 110.916 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -129.33 123.94 33.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.617 1.167 . . . . 0.0 110.327 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -130.26 126.01 36.23 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.521 1.128 . . . . 0.0 111.394 -172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.36 122.04 18.13 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.293 -0.879 . . . . 0.0 111.659 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mmm -102.72 11.34 37.78 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.812 1.245 . . . . 0.0 113.371 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.08 -76.0 0.31 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.623 2.059 . . . . 0.0 111.863 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -126.14 6.39 7.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.062 1.745 . . . . 0.0 113.379 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.7 m -136.79 117.96 14.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.982 2.113 . . . . 0.0 109.448 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 t -78.25 122.19 25.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.443 0.697 . . . . 0.0 110.764 172.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -111.01 136.44 50.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.569 1.947 . . . . 0.0 110.74 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.84 144.31 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.619 0.768 . . . . 0.0 111.378 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -123.2 133.56 54.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.219 1.807 . . . . 0.0 109.655 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -126.56 109.88 12.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.932 1.693 . . . . 0.0 110.358 -170.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 -168.79 30.84 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.463 1.03 . . . . 0.0 112.121 -171.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.06 84.74 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.47 -1.017 . . . . 0.0 111.201 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -129.43 138.97 51.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.565 1.946 . . . . 0.0 110.268 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -127.94 -9.5 5.45 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.01 1.324 . . . . 0.0 114.43 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 -169.77 43.8 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.577 1.56 . . . . 0.0 113.067 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.47 -171.08 51.93 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 121.921 0.734 . . . . 0.0 114.001 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -83.49 149.81 26.39 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.434 1.494 . . . . 0.0 111.64 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.9 m -84.6 -14.32 49.08 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -141.5 153.9 45.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.453 1.501 . . . . 0.0 111.944 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 45.5 tpp -61.73 -24.51 66.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.383 1.473 . . . . 0.0 113.359 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.11 -22.74 58.64 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.197 -0.94 . . . . 0.0 114.572 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -78.59 -39.11 38.41 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.882 1.341 . . . . 0.0 112.623 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 p -58.87 -39.34 81.07 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.38 -0.825 . . . . 0.0 112.277 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.51 53.39 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -67.7 -40.84 84.32 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.923 -1.111 . . . . 0.0 111.705 169.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.5 -52.92 4.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.761 1.624 . . . . 0.0 111.938 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.7 m -76.04 159.75 79.89 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.983 0.913 . . . . 0.0 113.297 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.73 -9.27 21.06 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.652 2.901 . . . . 0.0 114.244 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 127.408 2.433 . . . . 0.0 113.001 178.522 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.81 166.99 27.17 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.525 2.817 . . . . 0.0 112.235 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.92 -28.15 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.427 1.091 . . . . 0.0 113.4 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.39 2.01 86.06 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.158 1.361 . . . . 0.0 115.393 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.15 156.43 31.72 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.404 1.602 . . . . 0.0 112.217 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -77.15 99.83 5.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.971 1.309 . . . . 0.0 111.483 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.0 155.72 36.23 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.406 1.482 . . . . 0.0 113.263 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.78 165.54 29.95 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.234 2.623 . . . . 0.0 112.475 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.23 138.05 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.803 1.241 . . . . 0.0 111.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -68.61 146.36 53.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.367 1.067 . . . . 0.0 110.604 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.42 -11.07 69.66 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mp 47.33 34.27 3.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.102 2.161 . . . . 0.0 114.737 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -97.37 178.68 5.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 1.75 14.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.544 1.938 . . . . 0.0 114.506 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.76 158.4 31.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.111 1.764 . . . . 0.0 112.778 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -134.7 83.75 2.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.932 1.693 . . . . 0.0 112.354 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.03 171.8 12.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.737 1.215 . . . . 0.0 111.663 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.6 m -122.05 112.75 18.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.355 1.462 . . . . 0.0 109.726 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -119.8 167.38 12.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.788 1.635 . . . . 0.0 110.849 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -133.41 140.14 47.16 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.182 0.993 . . . . 0.0 110.239 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -133.37 165.95 23.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 109.548 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.3 t -112.65 138.8 48.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.55 -0.719 . . . . 0.0 111.293 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.4 mtp -125.67 86.25 2.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.912 1.685 . . . . 0.0 109.255 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.37 -77.3 0.89 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.025 1.774 . . . . 0.0 112.68 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -131.57 -4.41 3.73 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.015 1.326 . . . . 0.0 114.135 -174.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.3 m -123.83 139.37 54.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.179 1.392 . . . . 0.0 111.536 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.09 147.52 32.74 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.942 0.897 . . . . 0.0 111.824 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -147.02 127.02 13.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.554 1.942 . . . . 0.0 110.565 -171.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.44 145.17 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.421 1.089 . . . . 0.0 112.372 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -131.72 137.06 48.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.344 1.857 . . . . 0.0 110.595 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.54 117.46 12.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.381 1.472 . . . . 0.0 110.666 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.62 65.69 0.04 OUTLIER Glycine 0 N--CA 1.477 1.409 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.88 28.74 15.02 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -72.45 -46.43 54.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.152 . . . . 0.0 113.588 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.3 p 50.75 -10.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 131.224 3.81 . . . . 0.0 118.405 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.61 -171.39 47.71 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.656 2.074 . . . . 0.0 113.168 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.06 -168.76 23.82 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.751 -0.852 . . . . 0.0 113.759 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -67.31 146.83 53.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.429 1.492 . . . . 0.0 111.932 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.8 p -75.43 -32.82 60.82 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -136.76 163.05 31.51 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.144 1.777 . . . . 0.0 112.071 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.3 tpp -56.53 -38.53 71.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.749 0.82 . . . . 0.0 111.725 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.06 -17.39 75.61 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.19 0.9 . . . . 0.0 115.07 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -82.85 -33.63 27.03 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.908 1.354 . . . . 0.0 111.798 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.2 t -69.33 -53.4 19.77 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.474 -0.766 . . . . 0.0 112.016 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.31 -17.87 64.94 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -78.94 -18.36 53.93 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -106.91 -51.69 2.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.196 1.398 . . . . 0.0 112.352 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.551 0.987 0 CA-C-N 118.713 0.688 . . . . 0.0 112.251 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.98 161.59 43.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.81 2.34 . . . . 0.0 112.5 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 tp -58.27 -28.12 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.833 1.253 . . . . 0.0 113.262 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.13 4.46 83.26 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.179 1.371 . . . . 0.0 115.506 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -63.6 157.34 24.09 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.479 1.639 . . . . 0.0 112.379 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -76.36 70.35 2.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.368 1.467 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.19 157.05 88.85 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.399 1.479 . . . . 0.0 112.901 171.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.76 176.72 9.01 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.848 3.032 . . . . 0.0 113.263 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.47 135.48 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.728 1.611 . . . . 0.0 111.52 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -77.28 141.95 39.71 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.969 1.308 . . . . 0.0 110.752 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.4 -4.42 90.0 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 56.15 21.16 4.96 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.822 2.049 . . . . 0.0 114.255 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.0 m -70.16 168.84 14.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.167 1.387 . . . . 0.0 113.29 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.17 -0.44 14.23 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.96 164.44 22.32 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.933 1.693 . . . . 0.0 112.766 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -129.47 93.09 3.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.247 1.819 . . . . 0.0 110.905 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.15 174.04 11.97 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.472 1.109 . . . . 0.0 111.455 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.1 m -128.01 110.84 12.9 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.001 1.32 . . . . 0.0 109.744 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -116.42 165.91 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.871 1.668 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.07 85.05 2.18 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.263 1.025 . . . . 0.0 111.135 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -82.35 156.19 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.844 0.858 . . . . 0.0 111.091 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 t -90.48 140.38 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 111.442 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.2 mtp -133.77 111.17 10.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.604 1.962 . . . . 0.0 109.663 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.69 -95.57 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.94 1.257 . . . . 0.0 112.186 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -116.0 -8.98 11.81 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.342 1.457 . . . . 0.0 113.932 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.3 p -120.51 156.58 31.23 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.733 1.151 . . . . 0.0 113.14 -171.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.24 124.53 35.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.687 1.195 . . . . 0.0 110.378 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -121.43 135.16 55.08 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.454 1.902 . . . . 0.0 110.704 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -67.22 145.99 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.318 0.647 . . . . 0.0 112.006 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -127.14 135.79 51.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.732 2.013 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.07 107.97 11.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.519 . . . . 0.0 110.423 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.01 -169.01 31.34 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.911 0.767 . . . . 0.0 113.095 -172.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.45 86.51 3.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.949 -0.736 . . . . 0.0 110.675 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.55 133.62 48.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.845 1.658 . . . . 0.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.2 p -136.79 -3.42 2.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.197 1.399 . . . . 0.0 114.389 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.1 0.83 58.98 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.189 1.376 . . . . 0.0 115.842 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.79 176.58 17.64 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.02 1.771 . . . . 0.0 113.606 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -60.01 136.37 57.99 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.204 1.002 . . . . 0.0 112.522 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.5 m -76.41 -17.16 59.49 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -131.92 146.99 52.44 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.081 1.753 . . . . 0.0 110.951 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 tpp -55.82 -37.84 69.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.241 1.016 . . . . 0.0 111.504 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.02 -47.8 85.68 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.225 0.917 . . . . 0.0 112.646 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.23 -37.9 81.75 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.091 0.946 . . . . 0.0 112.688 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.931 0.492 . . . . 0.0 111.887 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -19.01 65.65 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -66.46 -25.04 66.53 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.676 -1.265 . . . . 0.0 113.116 169.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -109.49 -55.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.807 1.643 . . . . 0.0 112.231 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 0.987 0 C-N-CA 123.709 0.804 . . . . 0.0 112.911 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.385 -0.341 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 160.12 50.44 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.848 2.366 . . . . 0.0 112.346 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 tt -58.85 -26.71 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.94 1.296 . . . . 0.0 113.712 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.83 2.02 88.0 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.886 1.232 . . . . 0.0 115.497 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -66.91 157.39 33.32 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.286 1.543 . . . . 0.0 112.617 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.3 m -75.37 57.7 0.93 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.974 . . . . 0.0 113.425 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.22 155.98 89.24 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.131 1.373 . . . . 0.0 113.912 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -75.39 178.46 7.3 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 124.003 3.135 . . . . 0.0 112.734 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.08 139.68 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.342 1.457 . . . . 0.0 112.213 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -68.18 142.44 55.7 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.026 1.33 . . . . 0.0 110.879 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.09 -11.63 75.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 46.17 69.82 0.44 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.313 2.245 . . . . 0.0 112.671 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.6 m -120.55 175.12 6.15 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.652 1.581 . . . . 0.0 111.874 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -84.64 4.5 32.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.156 1.382 . . . . 0.0 114.475 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.13 163.53 24.44 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.338 1.855 . . . . 0.0 112.808 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -130.33 87.12 2.47 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.156 1.783 . . . . 0.0 111.677 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.06 175.46 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.508 1.123 . . . . 0.0 112.152 171.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -128.04 115.36 18.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.221 1.408 . . . . 0.0 110.256 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -119.98 165.71 14.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.11 1.764 . . . . 0.0 111.037 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -129.04 134.44 48.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 109.945 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.62 139.6 47.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.708 1.203 . . . . 0.0 110.436 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.6 t -81.3 111.19 17.46 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.604 -0.685 . . . . 0.0 111.589 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.8 mmm -92.68 71.61 4.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.109 0.963 . . . . 0.0 109.33 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.25 -75.0 2.39 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.99 1.757 . . . . 0.0 113.804 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -133.65 5.96 3.72 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.843 1.657 . . . . 0.0 113.745 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 93.4 m -135.65 117.18 14.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.188 1.795 . . . . 0.0 110.399 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.61 133.29 49.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.896 0.878 . . . . 0.0 111.165 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -131.21 141.45 50.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.119 1.768 . . . . 0.0 110.983 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.64 145.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 112.19 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -134.39 141.57 46.88 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.113 2.165 . . . . 0.0 110.552 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.97 117.67 10.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.426 1.49 . . . . 0.0 110.759 -172.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.02 58.85 0.02 OUTLIER Glycine 0 N--CA 1.478 1.456 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 56.52 30.92 18.05 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -71.23 -53.24 15.05 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.658 1.183 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.5 p 50.74 3.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 129.618 3.167 . . . . 0.0 118.23 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.97 -6.31 52.21 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.342 1.449 . . . . 0.0 116.082 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.12 -177.97 39.0 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.165 1.364 . . . . 0.0 114.112 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.4 146.76 47.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.167 1.387 . . . . 0.0 111.535 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.8 t -69.39 -36.39 76.73 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -136.26 162.58 32.58 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.259 1.824 . . . . 0.0 111.123 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 35.7 tpp -58.03 -37.56 74.57 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 112.014 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.8 -44.15 98.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.64 1.114 . . . . 0.0 113.792 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.26 -40.25 96.87 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.451 1.126 . . . . 0.0 112.22 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.8 t -57.8 -47.76 81.67 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.378 1.071 . . . . 0.0 111.348 170.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.18 62.71 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -73.08 -40.76 64.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.069 1.304 . . . . 0.0 112.06 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -84.4 -51.5 6.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.45 1.5 . . . . 0.0 112.006 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.549 0.935 0 C-N-CA 123.802 0.841 . . . . 0.0 112.995 174.335 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.81 162.57 41.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.71 2.273 . . . . 0.0 112.67 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.11 -27.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.96 1.304 . . . . 0.0 113.509 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.44 3.98 86.36 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.068 1.318 . . . . 0.0 115.298 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -64.46 157.81 25.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.438 1.619 . . . . 0.0 112.317 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 m -72.92 58.23 0.46 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.926 2.09 . . . . 0.0 113.376 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.55 155.54 80.91 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.873 1.269 . . . . 0.0 113.25 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.12 176.43 9.55 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.478 2.785 . . . . 0.0 113.382 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.46 140.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.651 1.58 . . . . 0.0 111.206 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -81.91 145.73 30.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.047 1.339 . . . . 0.0 111.107 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.08 -7.3 80.65 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 124.99 1.281 . . . . 0.0 115.823 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mp 53.98 26.61 6.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.01 2.124 . . . . 0.0 114.435 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -68.12 171.1 7.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.116 1.766 . . . . 0.0 113.233 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -76.0 -1.82 27.59 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.562 1.545 . . . . 0.0 114.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.85 167.48 18.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.212 1.805 . . . . 0.0 112.859 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -127.57 102.72 6.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.388 1.875 . . . . 0.0 110.988 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.21 175.77 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.803 1.241 . . . . 0.0 111.271 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.7 m -128.75 117.1 20.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.141 1.377 . . . . 0.0 109.518 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -123.91 167.06 14.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.491 1.516 . . . . 0.0 110.463 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.32 105.18 5.87 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.353 1.461 . . . . 0.0 109.993 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -103.57 132.03 50.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 111.117 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.05 91.99 2.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.291 0.567 . . . . 0.0 111.7 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -86.76 83.76 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.54 1.136 . . . . 0.0 109.936 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.67 -73.47 2.26 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.602 1.572 . . . . 0.0 112.837 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -136.1 0.69 2.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 114.058 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -136.22 151.96 50.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.008 0.923 . . . . 0.0 112.992 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.8 m -89.05 81.16 6.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.491 1.516 . . . . 0.0 111.42 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -64.84 124.2 21.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.245 0.618 . . . . 0.0 110.142 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.77 142.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.082 0.553 . . . . 0.0 111.347 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -125.91 125.7 43.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.456 1.902 . . . . 0.0 109.717 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.21 106.18 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.876 1.67 . . . . 0.0 110.237 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.94 -169.55 32.5 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.809 1.195 . . . . 0.0 112.078 -170.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.4 t -77.14 88.6 3.62 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.471 -1.017 . . . . 0.0 111.177 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -129.48 134.68 47.93 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.005 1.722 . . . . 0.0 110.321 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.0 p -138.77 -7.98 1.42 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.983 1.313 . . . . 0.0 114.519 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.91 -2.99 88.24 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.932 1.254 . . . . 0.0 115.982 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.82 178.03 22.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.819 1.676 . . . . 0.0 112.993 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -55.21 134.0 49.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.763 1.625 . . . . 0.0 114.033 -165.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 t -81.04 -10.87 59.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -132.7 146.92 52.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.566 1.546 . . . . 0.0 111.643 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.5 tpp -52.96 -39.1 62.71 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.03 1.332 . . . . 0.0 111.849 168.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.03 -45.16 63.62 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.897 0.761 . . . . 0.0 113.325 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.66 -34.51 77.23 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.123 0.969 . . . . 0.0 112.36 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 t -66.17 -53.58 35.74 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.791 -0.568 . . . . 0.0 112.249 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.23 75.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -63.36 -22.49 66.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -104.53 -23.63 13.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.558 1.543 . . . . 0.0 114.1 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.8 m . . . . . 0 CA--C 1.551 0.988 0 CA-C-N 118.847 0.749 . . . . 0.0 112.697 164.822 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.06 148.81 63.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.451 2.101 . . . . 0.0 111.772 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.8 -21.98 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.416 1.087 . . . . 0.0 113.342 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.31 83.86 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 114.957 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -68.51 139.37 55.65 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.408 1.604 . . . . 0.0 110.829 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 t -72.43 94.18 1.62 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.41 159.07 50.97 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.379 1.471 . . . . 0.0 112.647 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.71 175.59 11.09 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.08 2.52 . . . . 0.0 113.711 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.76 138.28 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.696 1.598 . . . . 0.0 111.632 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HG2' ' H ' ' A' ' 37' ' ' LEU . 2.6 ttpm? -82.9 138.95 33.68 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.0 1.32 . . . . 0.0 111.191 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.68 2.62 82.34 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.544 2.021 . . . . 0.0 115.756 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.445 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 44.9 mt 57.19 17.89 3.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.015 2.526 . . . . 0.0 115.776 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.9 p -78.62 173.63 12.22 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 2.43 6.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.732 2.013 . . . . 0.0 115.252 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.61 162.43 17.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.572 1.549 . . . . 0.0 112.889 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -130.93 87.15 2.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.575 1.95 . . . . 0.0 111.545 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.39 174.88 11.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.976 1.311 . . . . 0.0 111.482 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -128.47 131.89 48.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.289 1.436 . . . . 0.0 109.377 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -130.42 158.29 40.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.833 1.253 . . . . 0.0 111.12 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -123.61 81.36 1.89 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.531 1.158 . . . . 0.0 111.374 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -77.37 170.91 15.72 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -126.45 136.4 52.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.552 1.141 . . . . 0.0 110.549 169.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.4 mmm -121.35 10.59 10.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.694 1.198 . . . . 0.0 112.814 -172.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.87 -91.07 0.12 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.656 1.598 . . . . 0.0 111.914 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.09 8.75 18.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.849 1.66 . . . . 0.0 113.411 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -146.2 132.75 19.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.302 1.841 . . . . 0.0 110.815 -172.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.2 m -81.01 86.68 6.08 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.604 0.761 . . . . 0.0 111.958 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -62.61 114.07 3.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.65 144.09 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.117 0.967 . . . . 0.0 111.165 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -124.93 148.23 48.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.276 1.43 . . . . 0.0 110.528 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -131.36 127.69 38.11 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.044 1.738 . . . . 0.0 110.575 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.62 -168.02 25.68 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.096 0.855 . . . . 0.0 112.652 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.73 71.19 0.34 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.602 -0.94 . . . . 0.0 111.861 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.5 136.15 53.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.699 1.6 . . . . 0.0 110.651 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.5 p -129.75 -8.39 4.52 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.301 1.441 . . . . 0.0 114.117 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.6 -174.06 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.325 1.44 . . . . 0.0 113.444 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.09 -172.95 8.47 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.123 0.868 . . . . 0.0 114.216 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -69.73 137.15 51.77 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.783 0.802 . . . . 0.0 112.05 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -80.82 -13.0 59.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -130.1 144.72 51.5 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.658 1.983 . . . . 0.0 110.875 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.2 ttt -65.3 -15.49 62.57 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.112 1.365 . . . . 0.0 113.895 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.11 -32.15 15.12 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.591 1.091 . . . . 0.0 114.275 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.27 -28.42 67.19 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.537 1.135 . . . . 0.0 113.049 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.7 p -73.98 -44.16 55.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.357 0.663 . . . . 0.0 112.171 168.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.87 -24.3 61.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.264 1.426 . . . . 0.0 114.564 -171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -65.89 -30.1 70.64 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 167.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.68 -49.15 5.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.665 1.186 . . . . 0.0 112.006 -171.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.552 1.033 0 C-N-CA 124.419 1.088 . . . . 0.0 112.431 169.155 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.06 155.23 57.27 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.64 2.226 . . . . 0.0 112.473 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.91 -27.34 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.943 1.297 . . . . 0.0 113.484 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.09 83.05 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.221 1.391 . . . . 0.0 115.51 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -63.7 153.8 35.12 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.527 1.663 . . . . 0.0 112.414 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -78.06 74.87 4.6 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.805 1.242 . . . . 0.0 111.5 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.18 154.25 94.27 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.511 1.125 . . . . 0.0 111.584 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.88 162.53 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 113.203 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.28 132.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.882 1.273 . . . . 0.0 111.437 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.58 136.62 47.5 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.203 1.001 . . . . 0.0 110.733 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.13 -4.22 86.06 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.361 0.982 . . . . 0.0 115.259 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.4 mt 59.35 9.07 1.3 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.747 2.419 . . . . 0.0 115.697 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 p -89.72 173.21 8.41 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -171.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -0.31 15.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.768 2.027 . . . . 0.0 115.92 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.86 152.12 25.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.293 1.437 . . . . 0.0 112.849 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -121.49 78.77 1.47 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.275 1.83 . . . . 0.0 110.624 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -72.14 171.95 11.06 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.194 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -128.29 116.01 19.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.882 1.273 . . . . 0.0 109.573 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -120.46 159.14 25.74 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.848 1.659 . . . . 0.0 110.905 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -126.93 120.0 28.07 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.729 1.212 . . . . 0.0 109.958 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -120.5 124.66 45.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.149 0.979 . . . . 0.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.7 t -73.61 116.02 13.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.096 0.474 . . . . 0.0 110.488 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 mtp -93.83 67.32 3.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.705 1.602 . . . . 0.0 109.439 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.31 -64.92 3.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.605 1.574 . . . . 0.0 114.126 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -140.0 9.6 2.35 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.68 148.08 29.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.789 1.636 . . . . 0.0 109.988 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -102.76 129.66 49.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 112.597 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -119.27 136.96 53.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.858 1.663 . . . . 0.0 110.889 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.12 141.23 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.351 1.06 . . . . 0.0 111.106 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.43 128.45 48.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.351 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.48 97.98 3.83 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.588 1.555 . . . . 0.0 111.894 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.47 63.41 0.01 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.22 -0.925 . . . . 0.0 114.491 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.4 t 52.93 53.7 11.65 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.715 1.206 . . . . 0.0 112.917 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.43 140.8 41.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.5 p -130.2 -12.41 4.07 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.843 1.257 . . . . 0.0 114.341 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.83 -174.4 48.47 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.238 1.399 . . . . 0.0 113.106 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.06 -166.9 52.08 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.808 -0.819 . . . . 0.0 113.313 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -87.02 146.75 26.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 111.977 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.6 m -78.08 -13.2 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -137.73 148.2 45.41 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 112.072 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.01 -27.23 68.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 112.508 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.91 -28.56 45.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.42 -0.8 . . . . 0.0 114.155 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -72.16 -34.02 68.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.432 1.116 . . . . 0.0 112.579 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 p -68.78 -45.47 71.23 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.351 -0.843 . . . . 0.0 111.453 168.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -38.38 88.68 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.906 1.282 . . . . 0.0 114.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -84.77 -46.27 11.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.0 112.118 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 176.512 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.91 161.9 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.881 2.387 . . . . 0.0 112.205 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.4 tt -63.18 146.97 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.718 0.807 . . . . 0.0 111.068 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.49 0.84 89.38 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.527 1.06 . . . . 0.0 115.384 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -62.67 154.7 28.5 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.152 1.476 . . . . 0.0 111.523 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -77.05 68.69 3.23 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.945 1.298 . . . . 0.0 111.922 176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.01 155.65 91.43 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.298 1.439 . . . . 0.0 112.7 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.6 175.06 11.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.223 2.615 . . . . 0.0 112.935 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.55 139.64 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.33 1.452 . . . . 0.0 111.428 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -67.17 146.17 54.49 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.91 82.65 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.84 17.18 4.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.182 2.193 . . . . 0.0 114.662 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.21 168.49 19.03 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.442 1.097 . . . . 0.0 112.937 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -68.6 -42.78 77.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.353 1.061 . . . . 0.0 112.321 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.13 157.44 37.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.913 1.285 . . . . 0.0 113.078 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.09 90.95 2.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.067 1.747 . . . . 0.0 111.213 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.8 173.98 3.21 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.371 1.068 . . . . 0.0 111.656 170.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -125.14 115.02 19.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.877 1.271 . . . . 0.0 109.744 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -118.83 165.63 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.348 1.459 . . . . 0.0 110.929 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.29 136.44 50.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.337 1.455 . . . . 0.0 109.318 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -130.17 137.48 50.12 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.386 1.075 . . . . 0.0 109.457 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.9 t -72.88 131.19 41.93 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.98 -0.45 . . . . 0.0 110.695 169.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 97.2 mmm -123.14 6.42 9.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.625 1.57 . . . . 0.0 113.906 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.23 91.35 0.81 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.582 1.563 . . . . 0.0 111.99 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 58.44 9.32 1.03 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.829 2.052 . . . . 0.0 114.933 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 t -155.74 165.29 36.98 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.054 2.542 . . . . 0.0 108.961 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.5 m -117.29 159.99 21.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 112.792 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.39 142.1 49.98 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.767 2.027 . . . . 0.0 110.095 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.38 143.44 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.0 0.92 . . . . 0.0 111.004 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -132.16 126.82 34.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.312 1.845 . . . . 0.0 110.605 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.99 108.7 9.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.823 1.649 . . . . 0.0 110.562 -171.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.79 55.18 0.01 OUTLIER Glycine 0 N--CA 1.476 1.337 0 C-N-CA 123.599 0.618 . . . . 0.0 114.238 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.1 t 60.5 22.94 12.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.506 1.523 . . . . 0.0 114.887 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.55 135.24 53.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.197 1.399 . . . . 0.0 111.228 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.7 p -132.33 -13.74 3.02 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.37 -9.31 79.64 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.32 170.67 21.6 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.308 1.432 . . . . 0.0 114.198 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.33 144.48 57.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.8 1.64 . . . . 0.0 111.821 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -72.22 -22.69 61.21 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -140.48 152.58 45.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.705 1.602 . . . . 0.0 111.385 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.86 -30.56 71.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.25 70.11 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.316 -0.865 . . . . 0.0 114.208 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.87 -44.3 17.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.915 1.358 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.47 -35.92 78.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.831 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.91 -7.23 49.99 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.976 1.71 . . . . 0.0 115.264 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -76.51 -42.05 44.71 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.658 1.117 . . . . 0.0 111.948 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -81.57 -54.67 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.926 1.691 . . . . 0.0 111.945 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 124.047 0.939 . . . . 0.0 112.22 169.617 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.34 160.56 49.11 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.662 2.241 . . . . 0.0 112.245 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.51 -26.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.005 1.322 . . . . 0.0 113.713 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.03 6.01 84.02 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.165 1.365 . . . . 0.0 115.569 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.6 t-105 -63.54 153.26 36.23 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.482 1.641 . . . . 0.0 112.617 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.7 m -72.27 87.69 1.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.823 1.649 . . . . 0.0 112.086 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.87 157.27 35.08 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 125.991 1.716 . . . . 0.0 112.505 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.11 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.549 2.833 . . . . 0.0 113.945 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.92 136.3 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.125 1.37 . . . . 0.0 111.492 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.19 147.6 49.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.641 1.176 . . . . 0.0 110.732 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.17 -14.3 66.92 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.8 mp 46.51 50.54 12.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.906 2.082 . . . . 0.0 113.417 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 25.0 m -96.73 173.71 7.18 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.612 1.165 . . . . 0.0 112.467 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -69.07 -34.89 75.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.981 1.312 . . . . 0.0 112.79 173.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.93 165.19 13.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.762 1.625 . . . . 0.0 112.995 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -131.36 92.41 3.18 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.21 1.804 . . . . 0.0 111.252 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -68.48 175.66 3.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.64 1.176 . . . . 0.0 112.099 172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -125.19 113.0 17.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.097 1.359 . . . . 0.0 110.456 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -115.44 169.29 9.27 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.963 1.705 . . . . 0.0 110.867 173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -135.38 129.5 33.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.214 1.406 . . . . 0.0 109.677 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.82 129.12 41.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.692 1.197 . . . . 0.0 110.775 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.05 134.26 38.84 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.992 0.425 . . . . 0.0 111.497 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.3 mtp -122.5 56.92 1.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.289 1.836 . . . . 0.0 109.97 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.33 -79.7 0.3 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.018 1.77 . . . . 0.0 112.576 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -124.54 1.02 8.26 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 m -136.2 147.08 47.47 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.395 1.878 . . . . 0.0 110.249 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.25 132.85 51.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 111.185 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -126.28 141.7 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.346 1.859 . . . . 0.0 110.544 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.56 148.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.039 0.935 . . . . 0.0 111.776 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -136.1 133.18 37.03 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.792 2.037 . . . . 0.0 110.438 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.91 119.08 18.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.158 1.383 . . . . 0.0 110.956 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.54 51.98 0.02 OUTLIER Glycine 0 N--CA 1.476 1.333 0 N-CA-C 114.592 0.597 . . . . 0.0 114.592 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.36 32.68 20.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.314 1.446 . . . . 0.0 114.233 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.91 121.41 19.01 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.673 1.189 . . . . 0.0 110.602 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -108.36 -7.51 15.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.268 1.427 . . . . 0.0 113.678 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.11 -168.96 40.7 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.958 1.742 . . . . 0.0 113.122 172.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 -162.03 41.74 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.004 0.811 . . . . 0.0 113.989 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.43 138.12 31.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.795 0.838 . . . . 0.0 110.863 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.9 p -77.9 -16.8 57.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 -139.38 155.76 47.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.997 2.119 . . . . 0.0 111.913 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 52.6 tpp -61.77 -39.66 92.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.012 0.925 . . . . 0.0 111.853 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.97 -37.53 94.56 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.146 -0.972 . . . . 0.0 113.436 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -68.49 -29.95 68.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.1 p -81.13 -45.55 16.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.679 1.127 . . . . 0.0 112.499 166.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 -18.94 65.07 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -68.41 -24.69 64.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.928 -1.108 . . . . 0.0 113.156 169.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -106.28 -56.05 2.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.173 1.789 . . . . 0.0 111.481 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 124.139 0.976 . . . . 0.0 112.814 173.744 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.85 168.67 20.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.955 2.437 . . . . 0.0 112.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 tp -60.47 147.27 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.196 0.998 . . . . 0.0 111.532 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.77 9.72 86.49 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -61.62 157.1 18.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.918 1.359 . . . . 0.0 112.401 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -77.34 62.63 2.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.68 1.592 . . . . 0.0 112.485 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.76 157.85 85.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.368 1.467 . . . . 0.0 112.716 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.31 178.24 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.683 2.922 . . . . 0.0 113.87 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.11 137.45 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.752 1.621 . . . . 0.0 111.248 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -82.7 144.48 30.2 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.306 1.443 . . . . 0.0 111.059 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.54 -8.3 83.31 Favored Glycine 0 CA--C 1.542 1.736 0 C-N-CA 124.761 1.172 . . . . 0.0 115.93 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 mp 55.4 22.35 4.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.208 2.203 . . . . 0.0 114.694 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -67.7 168.83 10.55 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.171 1.789 . . . . 0.0 113.204 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -66.18 -28.93 69.14 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.76 166.72 12.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.567 1.547 . . . . 0.0 113.15 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -132.76 107.22 8.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.154 1.781 . . . . 0.0 111.203 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.3 178.0 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.466 1.506 . . . . 0.0 110.971 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 m -128.97 110.49 12.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 110.015 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -114.49 168.12 10.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.312 1.445 . . . . 0.0 110.856 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -133.69 139.71 46.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.738 1.215 . . . . 0.0 110.29 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.37 131.06 29.34 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.668 1.187 . . . . 0.0 110.492 -176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.7 m -73.45 94.38 2.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.724 0.81 . . . . 0.0 111.574 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.7 mmm -80.46 54.33 2.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.789 1.636 . . . . 0.0 109.944 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.56 -88.77 1.13 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.398 1.951 . . . . 0.0 112.19 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -86.83 -14.04 43.28 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.3 p -145.44 143.52 30.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.8 m -75.06 92.28 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.935 1.294 . . . . 0.0 110.761 169.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -75.53 126.08 30.29 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.89 147.06 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.136 0.574 . . . . 0.0 110.869 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -128.75 108.39 10.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.746 2.018 . . . . 0.0 109.756 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -98.78 110.37 22.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.134 1.774 . . . . 0.0 110.461 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.01 -169.34 33.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.453 1.025 . . . . 0.0 112.647 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.06 87.14 2.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.561 -0.964 . . . . 0.0 111.215 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.36 122.49 27.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.027 1.731 . . . . 0.0 110.644 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.3 p -115.03 -8.06 12.48 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.534 1.534 . . . . 0.0 113.789 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.96 -173.18 49.76 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.776 1.655 . . . . 0.0 113.625 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.94 -159.97 42.73 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.102 0.858 . . . . 0.0 114.61 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -82.53 128.85 34.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.131 0.973 . . . . 0.0 110.65 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.5 p -70.04 -26.9 64.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.645 1.178 . . . . 0.0 113.352 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -139.59 160.04 40.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.891 2.077 . . . . 0.0 111.048 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 50.2 ttm -63.11 -31.61 72.79 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.68 73.68 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 114.036 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -80.98 -29.05 35.37 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.055 0.927 . . . . 0.0 113.265 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.83 -34.35 39.52 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.103 -0.998 . . . . 0.0 112.432 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.88 -22.33 66.63 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -78.54 -5.18 51.98 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.166 1.386 . . . . 0.0 114.566 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -118.92 -43.81 2.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.171 1.788 . . . . 0.0 112.411 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 111.814 167.977 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.26 159.99 48.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.867 2.378 . . . . 0.0 112.675 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -58.82 -27.72 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.192 1.397 . . . . 0.0 113.635 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.88 -3.62 89.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.513 1.054 . . . . 0.0 115.23 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -68.76 141.4 55.23 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.42 1.61 . . . . 0.0 111.739 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -71.63 92.43 1.16 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.92 159.32 63.28 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.194 1.398 . . . . 0.0 112.532 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.03 161.39 38.75 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.748 2.299 . . . . 0.0 113.235 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.77 133.34 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.742 1.217 . . . . 0.0 111.886 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -72.16 144.71 48.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.314 1.046 . . . . 0.0 110.593 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.2 -6.9 80.91 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 57.01 20.02 5.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.974 2.11 . . . . 0.0 114.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 m -74.43 169.49 17.6 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.958 -1.089 . . . . 0.0 112.426 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.74 -39.96 80.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.938 0.895 . . . . 0.0 112.68 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 159.66 29.37 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.806 1.243 . . . . 0.0 113.115 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -131.39 90.18 2.83 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.938 1.695 . . . . 0.0 111.706 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -61.44 174.32 0.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 111.943 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -123.14 107.99 12.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.465 1.106 . . . . 0.0 110.341 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? -111.33 157.55 20.06 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.034 1.334 . . . . 0.0 111.039 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -120.99 138.96 53.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.95 120.71 18.46 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.843 1.257 . . . . 0.0 109.881 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.36 96.44 0.87 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.685 0.755 . . . . 0.0 110.581 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.6 mmm -78.95 81.88 5.19 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 0.0 108.734 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.96 -67.45 2.38 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.47 1.985 . . . . 0.0 114.536 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -132.64 -4.83 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.585 1.554 . . . . 0.0 114.068 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t -134.29 134.43 41.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.447 1.099 . . . . 0.0 112.007 -174.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 52.5 m -81.87 95.41 7.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 111.321 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.44 156.44 24.12 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.787 0.835 . . . . 0.0 110.981 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.38 145.11 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.655 1.182 . . . . 0.0 110.46 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.36 131.14 33.85 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.88 1.672 . . . . 0.0 110.388 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.41 122.42 24.96 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 111.187 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.27 52.15 0.02 OUTLIER Glycine 0 N--CA 1.474 1.184 0 C-N-CA 123.753 0.692 . . . . 0.0 113.709 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.6 t 61.22 23.59 13.79 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 0.0 114.459 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -67.73 136.44 54.27 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.389 . . . . 0.0 111.599 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -130.02 -7.38 4.41 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.48 -10.24 59.45 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.411 1.005 . . . . 0.0 115.375 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.82 174.07 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.831 1.205 . . . . 0.0 114.089 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -71.5 149.56 45.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.903 1.281 . . . . 0.0 111.863 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m -70.6 -31.21 68.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.034 1.334 . . . . 0.0 113.752 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -140.23 160.25 40.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.534 1.934 . . . . 0.0 111.063 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.8 ttm -62.57 -36.95 84.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.624 0.77 . . . . 0.0 112.413 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.83 91.69 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.359 -0.838 . . . . 0.0 113.645 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.03 -38.52 82.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.143 0.977 . . . . 0.0 112.65 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.0 p -75.52 -40.76 56.56 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.806 0.73 . . . . 0.0 111.985 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.38 87.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -68.48 -27.21 65.94 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.36 -48.43 10.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.795 1.238 . . . . 0.0 112.165 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.93 163.71 34.89 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.108 2.539 . . . . 0.0 111.53 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.9 tp -56.79 -26.74 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.544 1.138 . . . . 0.0 113.422 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.83 -5.42 88.63 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.609 1.1 . . . . 0.0 115.274 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -71.51 160.22 33.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.605 1.703 . . . . 0.0 111.357 172.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 m -77.56 55.22 1.28 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.978 1.311 . . . . 0.0 112.233 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.39 156.29 88.82 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.032 1.333 . . . . 0.0 113.575 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.84 171.42 16.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.037 2.491 . . . . 0.0 112.776 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.84 132.74 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.159 1.384 . . . . 0.0 111.904 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -84.38 139.83 31.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.153 1.381 . . . . 0.0 110.53 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.14 -2.85 89.27 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.254 1.407 . . . . 0.0 116.156 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 54.11 27.3 7.46 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.89 2.076 . . . . 0.0 114.342 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 m -65.53 171.09 4.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.654 1.581 . . . . 0.0 112.96 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -75.0 -0.06 17.53 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.449 1.5 . . . . 0.0 114.841 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.28 163.35 19.82 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.156 1.782 . . . . 0.0 112.785 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -132.15 85.26 2.22 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.432 1.893 . . . . 0.0 111.934 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -72.63 172.61 10.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.022 0.929 . . . . 0.0 111.589 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 m -121.82 113.15 19.25 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.855 1.262 . . . . 0.0 109.256 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.49 164.63 14.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.212 1.405 . . . . 0.0 110.801 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.75 140.33 50.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.655 1.582 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -142.01 137.5 31.18 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.217 . . . . 0.0 111.001 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.67 97.16 8.95 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.648 -0.658 . . . . 0.0 111.455 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 88.8 mmm -81.67 71.48 8.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.165 1.386 . . . . 0.0 110.584 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.88 -79.59 1.67 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.505 1.526 . . . . 0.0 112.989 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.11 -10.3 9.04 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -133.07 136.64 46.03 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 110.386 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.56 144.39 47.94 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.362 -0.836 . . . . 0.0 110.884 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -132.68 132.55 42.52 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.019 1.727 . . . . 0.0 110.266 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.77 142.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.669 0.788 . . . . 0.0 110.65 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -129.56 103.35 6.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.694 1.998 . . . . 0.0 109.567 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -86.47 114.75 23.49 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.1 1.36 . . . . 0.0 110.453 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.69 -176.44 33.22 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.542 1.067 . . . . 0.0 113.547 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 9.2 t -79.22 59.71 2.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.724 1.21 . . . . 0.0 111.89 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -85.72 -36.64 20.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.952 0.901 . . . . 0.0 113.358 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p 54.2 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 130.993 3.717 . . . . 0.0 118.187 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.45 -160.29 35.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.91 2.195 . . . . 0.0 113.85 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.17 -136.57 48.1 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.967 1.27 . . . . 0.0 113.518 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -108.33 136.91 47.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.327 1.451 . . . . 0.0 110.599 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t -75.64 -22.83 56.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.228 1.011 . . . . 0.0 112.255 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 154.86 49.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.169 1.788 . . . . 0.0 112.776 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -58.97 -33.07 70.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.081 0.952 . . . . 0.0 112.516 173.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.56 -40.94 94.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.055 0.836 . . . . 0.0 113.652 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.56 -31.8 73.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 0.0 112.249 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -71.04 -51.13 27.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.294 1.038 . . . . 0.0 111.797 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.47 76.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.902 1.681 . . . . 0.0 114.17 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.57 -21.3 65.49 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -105.72 -34.61 7.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.061 1.344 . . . . 0.0 113.464 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.4 m . . . . . 0 CA--C 1.552 1.034 0 C-N-CA 124.096 0.959 . . . . 0.0 112.81 171.178 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 120.71 0.291 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.99 168.14 25.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.922 2.415 . . . . 0.0 112.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.56 -27.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.545 1.138 . . . . 0.0 113.418 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.21 90.1 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.803 1.192 . . . . 0.0 115.375 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -65.48 152.65 43.48 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.405 1.603 . . . . 0.0 111.984 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 p -75.54 72.17 2.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.375 1.47 . . . . 0.0 112.064 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.8 151.35 85.09 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.682 1.193 . . . . 0.0 112.542 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.6 171.11 17.86 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.018 2.479 . . . . 0.0 112.536 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.72 126.45 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.759 1.224 . . . . 0.0 112.179 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -69.69 141.84 53.47 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.394 1.078 . . . . 0.0 110.246 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.11 -6.67 89.07 Favored Glycine 0 CA--C 1.541 1.681 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.76 20.08 4.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.78 2.032 . . . . 0.0 113.985 -175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 m -77.18 172.03 13.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.643 1.177 . . . . 0.0 113.328 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -84.43 5.33 27.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.756 2.022 . . . . 0.0 115.305 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.01 165.07 20.14 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.302 1.841 . . . . 0.0 113.225 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -128.78 95.16 4.02 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.671 1.988 . . . . 0.0 112.571 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -83.19 177.34 8.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.762 0.825 . . . . 0.0 111.297 166.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -134.43 114.48 12.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.044 1.337 . . . . 0.0 111.227 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.4 mmp_? -116.05 166.14 12.34 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.965 1.706 . . . . 0.0 111.266 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.81 99.25 4.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.412 1.485 . . . . 0.0 110.496 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -97.13 137.15 36.62 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.48 0.712 . . . . 0.0 110.748 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -77.89 107.04 10.13 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.246 -0.909 . . . . 0.0 110.906 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.8 mmm -93.29 17.1 11.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.835 1.654 . . . . 0.0 113.529 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.44 90.04 2.14 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.473 1.511 . . . . 0.0 111.348 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 t30 59.23 14.05 3.39 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.34 1.856 . . . . 0.0 114.803 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.4 m -142.99 116.47 9.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.2 m -61.6 115.0 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.175 0.59 . . . . 0.0 110.55 157.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -113.49 132.18 55.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.63 1.572 . . . . 0.0 110.184 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.62 144.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.265 0.626 . . . . 0.0 111.608 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -133.73 137.93 45.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.881 1.672 . . . . 0.0 110.869 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -135.33 117.92 15.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.503 1.521 . . . . 0.0 110.776 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.41 59.22 0.01 OUTLIER Glycine 0 N--CA 1.475 1.273 0 C-N-CA 123.532 0.587 . . . . 0.0 114.292 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 59.0 25.18 13.52 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.03 113.16 6.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.985 1.314 . . . . 0.0 110.968 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -102.77 -8.26 20.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.944 1.298 . . . . 0.0 113.678 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.96 -174.14 42.46 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.523 1.535 . . . . 0.0 113.011 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 -171.53 26.76 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.206 0.908 . . . . 0.0 114.239 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.64 139.06 38.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.787 0.835 . . . . 0.0 110.746 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.6 p -84.76 -10.98 56.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -135.01 150.55 50.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.248 1.819 . . . . 0.0 112.037 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.3 tpp -59.37 -40.59 86.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.956 1.302 . . . . 0.0 111.575 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.55 93.44 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.558 -0.714 . . . . 0.0 113.471 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.18 -38.02 75.27 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.5 p -70.97 -41.75 70.63 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.602 1.092 . . . . 0.0 111.77 169.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.97 -29.5 68.55 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -69.54 -22.47 63.56 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -102.25 -50.79 3.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.988 1.315 . . . . 0.0 112.87 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.551 1.015 0 CA-C-N 118.697 0.68 . . . . 0.0 112.707 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 119.018 -0.515 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.72 161.75 44.7 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.042 . . . . 0.0 112.15 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -62.86 146.19 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.393 0.677 . . . . 0.0 110.653 170.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 15.81 81.27 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.031 0.772 . . . . 0.0 115.031 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -61.52 165.29 4.99 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.87 1.335 . . . . 0.0 111.74 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 t -72.2 93.94 1.51 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.094 -1.003 . . . . 0.0 111.538 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.61 156.73 34.92 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.514 1.525 . . . . 0.0 112.856 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.33 152.6 55.52 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.916 2.411 . . . . 0.0 112.461 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.91 128.62 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.871 0.868 . . . . 0.0 111.936 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -71.53 140.6 49.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.057 0.943 . . . . 0.0 110.664 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.08 -8.94 87.29 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.2 mt 61.67 16.55 7.88 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.222 2.209 . . . . 0.0 115.058 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.0 m -74.94 170.99 14.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.116 1.367 . . . . 0.0 113.551 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.57 -20.55 65.4 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.73 164.36 14.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.427 1.891 . . . . 0.0 112.361 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.55 99.78 4.76 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 112.184 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.34 176.63 1.02 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.349 1.06 . . . . 0.0 110.944 165.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.0 m -124.08 112.41 17.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -119.68 166.59 13.0 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.022 1.729 . . . . 0.0 110.856 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.49 137.75 44.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.356 1.063 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -141.99 126.75 18.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.859 1.264 . . . . 0.0 110.401 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -78.12 128.38 33.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.984 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtp -102.87 5.54 38.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.701 1.2 . . . . 0.0 113.371 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.89 -74.77 0.27 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.527 1.537 . . . . 0.0 111.978 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -120.35 13.69 11.93 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.711 1.605 . . . . 0.0 113.15 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.8 p -147.89 169.37 19.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.21 1.404 . . . . 0.0 111.597 169.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -117.01 111.93 20.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.27 1.828 . . . . 0.0 110.719 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -97.82 137.21 37.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.699 1.599 . . . . 0.0 110.899 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.52 146.79 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.831 0.852 . . . . 0.0 111.456 171.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.37 124.95 25.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.586 1.954 . . . . 0.0 110.555 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -127.44 110.7 13.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.234 1.414 . . . . 0.0 111.388 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.44 52.31 0.01 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 -168.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.0 t 60.51 22.32 12.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.679 1.592 . . . . 0.0 114.476 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.43 128.76 37.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.659 1.584 . . . . 0.0 111.082 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.0 p -105.36 -20.6 13.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.461 1.104 . . . . 0.0 113.769 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.24 -161.06 34.97 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.899 1.714 . . . . 0.0 114.052 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.54 -172.1 48.73 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.861 1.22 . . . . 0.0 114.427 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -73.29 138.12 45.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.525 0.73 . . . . 0.0 109.951 167.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.2 m -70.08 -32.2 70.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.614 0.766 . . . . 0.0 113.054 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -140.49 165.46 27.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.264 1.826 . . . . 0.0 112.17 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.4 ttt -68.91 -24.54 64.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.33 -35.78 69.64 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.259 -0.9 . . . . 0.0 112.809 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -44.07 69.71 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.326 1.45 . . . . 0.0 112.523 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -62.92 -42.56 99.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.777 0.717 . . . . 0.0 112.334 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -3.82 9.98 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.2 mtp-105 -67.22 -42.49 83.97 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.743 -1.223 . . . . 0.0 111.889 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -93.6 -53.08 4.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.248 1.819 . . . . 0.0 111.433 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.3 m . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 111.432 -177.212 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.27 166.0 29.78 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.015 175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.75 148.14 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.89 0.876 . . . . 0.0 111.229 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.72 6.64 89.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -65.66 159.69 24.33 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 119.029 1.414 . . . . 0.0 112.151 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.1 m -76.39 53.5 0.85 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.047 1.739 . . . . 0.0 112.781 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.43 156.11 86.53 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.029 1.332 . . . . 0.0 112.647 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.49 166.19 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.463 2.776 . . . . 0.0 113.604 176.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -97.34 132.52 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.974 1.31 . . . . 0.0 111.639 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -77.27 142.66 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 111.16 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.05 -9.16 77.61 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.478 1.513 . . . . 0.0 115.209 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mp 55.13 18.07 2.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.365 2.266 . . . . 0.0 114.687 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 p -70.9 173.05 7.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -75.65 2.52 11.71 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.204 1.801 . . . . 0.0 114.206 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.52 169.82 13.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.26 2.224 . . . . 0.0 111.431 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -136.55 105.1 5.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.401 1.48 . . . . 0.0 111.126 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -93.87 155.11 17.36 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.55 1.14 . . . . 0.0 111.667 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -102.95 105.11 15.39 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.712 1.205 . . . . 0.0 110.658 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.26 157.85 32.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.02 1.328 . . . . 0.0 110.814 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.43 92.43 3.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.276 1.83 . . . . 0.0 111.146 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.08 139.47 30.6 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.495 -0.753 . . . . 0.0 111.506 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.7 m -74.43 109.11 7.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.87 0.868 . . . . 0.0 112.151 172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.6 mtp -91.75 69.44 5.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.669 1.188 . . . . 0.0 109.804 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.06 -100.51 1.25 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.266 1.413 . . . . 0.0 112.733 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.33 -8.67 56.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.24 161.0 38.5 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.978 1.711 . . . . 0.0 111.49 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.9 m -90.24 152.49 21.05 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.658 -0.651 . . . . 0.0 111.602 165.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -133.34 132.65 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.253 1.821 . . . . 0.0 109.903 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -77.01 146.54 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.985 0.514 . . . . 0.0 111.126 171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -109.44 -68.76 0.9 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 67.83 78.57 0.23 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.573 1.949 . . . . 0.0 112.91 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.92 14.84 0.03 OUTLIER Glycine 0 N--CA 1.474 1.181 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.6 t 77.07 91.98 0.07 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.436 2.294 . . . . 0.0 112.104 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.3 -56.94 0.8 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 0.0 113.664 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.9 p 54.84 -2.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 129.693 3.197 . . . . 0.0 118.473 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.53 -19.66 53.89 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 119.848 1.204 . . . . 0.0 115.375 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.87 179.04 27.46 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 126.002 1.763 . . . . 0.0 113.356 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -58.88 142.76 49.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.679 1.191 . . . . 0.0 112.871 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.0 p -83.4 -16.28 46.54 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.219 1.408 . . . . 0.0 114.458 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -137.79 154.71 49.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.324 1.85 . . . . 0.0 111.511 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 46.7 ttm -65.67 -29.42 69.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.508 0.723 . . . . 0.0 112.562 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.33 -37.59 94.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.992 -1.068 . . . . 0.0 113.452 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -71.46 -33.8 69.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.106 0.962 . . . . 0.0 113.098 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.2 p -74.9 -49.46 20.23 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.785 -0.572 . . . . 0.0 111.735 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.24 -16.92 62.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.75 -25.78 65.8 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.052 1.296 . . . . 0.0 113.438 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -100.55 -48.9 4.38 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.103 1.361 . . . . 0.0 111.555 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 127.443 2.297 . . . . 0.0 111.568 175.655 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.75 160.15 48.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.87 2.38 . . . . 0.0 111.682 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -61.62 141.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.306 0.574 . . . . 0.0 110.726 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.37 -3.92 85.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.387 0.994 . . . . 0.0 115.163 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.52 156.51 34.7 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.357 1.579 . . . . 0.0 110.956 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 t -77.52 97.81 5.14 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.52 1.128 . . . . 0.0 111.717 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 157.37 34.31 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.902 1.681 . . . . 0.0 113.181 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.4 161.58 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.043 2.495 . . . . 0.0 112.605 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.68 134.56 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.506 1.122 . . . . 0.0 111.85 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -66.84 141.73 57.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.148 0.979 . . . . 0.0 110.485 174.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -10.39 85.82 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.2 mt 62.78 13.24 6.3 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.466 2.306 . . . . 0.0 114.716 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -80.62 171.54 14.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.592 1.157 . . . . 0.0 113.3 -172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -62.55 -43.4 98.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.941 1.296 . . . . 0.0 113.412 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.52 126.53 35.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 113.238 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.33 89.48 5.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.272 1.429 . . . . 0.0 111.174 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -64.1 176.12 1.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.417 1.087 . . . . 0.0 111.625 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -123.0 105.83 10.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.403 1.081 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -112.42 168.14 9.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.197 1.799 . . . . 0.0 110.729 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -135.97 140.1 43.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.37 1.068 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.36 138.85 35.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.181 0.992 . . . . 0.0 112.277 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.38 91.48 1.35 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.929 1.292 . . . . 0.0 112.251 175.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 76.1 mmm -85.61 76.6 9.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.175 0.99 . . . . 0.0 109.331 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.34 -86.44 0.71 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.747 1.641 . . . . 0.0 112.257 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -122.1 3.63 9.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.659 1.583 . . . . 0.0 114.228 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.6 m -130.48 124.95 33.15 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.539 1.536 . . . . 0.0 111.846 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.3 m -73.34 85.98 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.035 1.334 . . . . 0.0 111.632 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -75.42 139.85 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.536 -0.728 . . . . 0.0 110.897 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.38 143.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.692 1.197 . . . . 0.0 111.366 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.98 133.25 45.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.138 1.775 . . . . 0.0 110.734 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -134.3 106.98 7.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.088 1.355 . . . . 0.0 111.293 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.55 0.01 OUTLIER Glycine 0 N--CA 1.475 1.246 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -171.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 t 55.07 29.48 12.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.002 1.321 . . . . 0.0 114.383 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.34 140.8 52.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.756 1.223 . . . . 0.0 110.764 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.8 p -139.06 -3.35 1.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.95 9.76 74.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.349 1.452 . . . . 0.0 116.019 -172.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.03 -172.1 24.78 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 118.861 1.33 . . . . 0.0 114.702 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -61.56 135.93 57.83 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 114.082 -165.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.1 t -72.23 -22.71 61.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 113.363 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -136.07 152.21 50.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.901 1.68 . . . . 0.0 112.518 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.6 tpp -55.04 -44.45 74.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.572 1.549 . . . . 0.0 111.049 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.84 -50.68 62.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.047 1.308 . . . . 0.0 113.306 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -62.15 -37.86 86.8 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.542 1.171 . . . . 0.0 112.991 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.4 t -60.13 -42.24 94.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 171.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.47 -14.69 44.0 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.22 -54.28 39.83 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.082 1.353 . . . . 0.0 111.838 171.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.05 -33.17 44.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 113.265 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.559 0.743 . . . . 0.0 112.306 172.572 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.14 159.05 54.5 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.387 2.058 . . . . 0.0 111.474 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.53 -28.37 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.291 1.037 . . . . 0.0 113.346 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.44 2.44 87.91 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.125 1.345 . . . . 0.0 115.514 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -64.25 158.45 23.24 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.411 1.605 . . . . 0.0 112.085 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -78.87 98.33 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.647 1.179 . . . . 0.0 111.615 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.01 157.23 37.52 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.874 1.67 . . . . 0.0 112.936 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.08 166.22 29.58 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.348 2.699 . . . . 0.0 112.975 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.53 133.35 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.77 1.228 . . . . 0.0 112.194 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -73.32 143.95 46.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.457 1.503 . . . . 0.0 110.705 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.82 -8.67 87.22 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.3 mp 49.72 35.86 9.75 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.63 1.972 . . . . 0.0 113.321 -173.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 m -78.57 168.35 19.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.35 1.46 . . . . 0.0 112.954 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -68.66 -35.06 76.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.253 1.021 . . . . 0.0 113.198 165.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.88 160.53 27.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.138 1.375 . . . . 0.0 112.6 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -132.87 77.51 1.74 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.007 1.723 . . . . 0.0 111.049 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.81 166.24 22.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.543 1.137 . . . . 0.0 111.389 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -128.82 120.93 27.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.635 1.574 . . . . 0.0 110.647 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -124.82 171.85 9.81 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.088 2.555 . . . . 0.0 110.343 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -134.72 137.62 43.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.681 1.192 . . . . 0.0 110.307 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -137.97 132.43 32.3 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.271 1.028 . . . . 0.0 111.544 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.91 121.56 15.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.009 0.923 . . . . 0.0 111.571 170.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.7 mmm -111.87 11.8 20.81 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.672 1.989 . . . . 0.0 113.082 -176.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.27 104.04 1.2 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.694 1.14 . . . . 0.0 111.485 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 63.67 -1.27 0.63 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.148 2.179 . . . . 0.0 115.23 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -141.9 156.25 45.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.873 2.069 . . . . 0.0 110.294 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.42 107.93 14.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.949 1.3 . . . . 0.0 110.006 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -90.53 144.48 25.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.434 1.093 . . . . 0.0 110.874 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.28 146.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.691 0.796 . . . . 0.0 111.002 167.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.34 129.21 42.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.319 1.848 . . . . 0.0 109.012 172.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -133.17 149.91 52.03 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.679 0.792 . . . . 0.0 112.27 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.18 12.01 2.16 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 10.1 t 95.87 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 130.05 3.34 . . . . 0.0 110.504 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.05 130.6 33.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.242 1.817 . . . . 0.0 109.114 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -117.41 -4.36 11.32 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.871 1.268 . . . . 0.0 113.941 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.31 -167.97 31.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.198 1.856 . . . . 0.0 113.197 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.85 -164.47 43.0 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.232 0.92 . . . . 0.0 114.526 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -81.89 138.86 34.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.884 0.873 . . . . 0.0 110.392 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -69.14 -30.56 68.83 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -140.6 158.48 43.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.659 1.984 . . . . 0.0 112.087 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.2 ttm -61.75 -34.87 76.62 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.162 0.585 . . . . 0.0 112.084 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.5 -27.93 70.4 Favored Glycine 0 CA--C 1.536 1.377 0 O-C-N 121.471 -0.768 . . . . 0.0 114.059 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.26 -48.27 17.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.266 1.033 . . . . 0.0 112.072 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -65.13 -30.14 71.05 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.462 1.028 . . . . 0.0 113.058 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -6.52 7.23 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -78.32 -12.2 59.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.0 -1.062 . . . . 0.0 113.598 167.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -125.36 -52.77 1.61 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.567 1.947 . . . . 0.0 112.221 -177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 123.746 0.819 . . . . 0.0 111.513 164.512 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.88 158.88 56.1 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.713 2.275 . . . . 0.0 111.802 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.06 138.33 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.239 0.616 . . . . 0.0 111.092 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.69 -1.58 68.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.539 1.066 . . . . 0.0 115.312 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.2 t-105 -65.3 151.69 45.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.588 1.694 . . . . 0.0 111.187 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -78.08 72.14 4.59 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.108 1.363 . . . . 0.0 112.526 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.58 155.16 89.48 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.864 1.265 . . . . 0.0 114.082 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.4 174.38 12.93 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.908 3.072 . . . . 0.0 112.124 170.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.3 143.12 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.614 1.165 . . . . 0.0 112.62 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.35 146.27 54.7 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.434 1.493 . . . . 0.0 111.033 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.47 -7.07 79.85 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 56.05 22.77 6.18 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.267 2.227 . . . . 0.0 114.346 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 m -75.02 172.22 12.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.772 1.229 . . . . 0.0 112.723 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -76.57 -2.12 30.89 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.471 1.509 . . . . 0.0 114.819 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.88 160.74 28.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.9 1.68 . . . . 0.0 113.059 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -131.11 85.16 2.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.48 1.912 . . . . 0.0 112.407 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -66.24 172.0 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.233 1.013 . . . . 0.0 111.293 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -121.24 114.0 20.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.294 1.038 . . . . 0.0 110.518 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -118.37 168.13 10.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.955 1.702 . . . . 0.0 110.657 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -131.65 142.6 49.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.533 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.36 132.26 29.3 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.207 1.403 . . . . 0.0 109.987 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.5 t -71.47 140.62 50.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.808 166.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.31 24.99 11.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.488 1.515 . . . . 0.0 112.59 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.26 -40.35 1.68 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.188 2.328 . . . . 0.0 112.491 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -152.19 -48.46 0.11 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.687 1.595 . . . . 0.0 112.223 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.2 m -71.02 134.75 47.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.122 0.969 . . . . 0.0 111.841 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 95.9 m -73.58 134.86 43.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.006 0.922 . . . . 0.0 110.749 162.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.14 133.52 54.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.039 1.736 . . . . 0.0 109.679 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.78 146.45 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.401 0.681 . . . . 0.0 110.847 172.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.54 134.82 41.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.992 1.717 . . . . 0.0 110.747 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -136.67 113.42 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.208 1.403 . . . . 0.0 111.001 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.63 60.52 0.02 OUTLIER Glycine 0 N--CA 1.476 1.344 0 N-CA-C 115.166 0.827 . . . . 0.0 115.166 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 t 59.73 30.52 20.11 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -70.44 -45.78 65.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.786 1.234 . . . . 0.0 113.641 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.2 p 50.83 -8.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 131.112 3.765 . . . . 0.0 118.394 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.52 -161.35 37.36 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 127.265 2.364 . . . . 0.0 113.965 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.69 -122.99 31.94 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.541 1.067 . . . . 0.0 113.007 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.36 152.84 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.768 1.627 . . . . 0.0 111.944 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.2 p -82.2 -23.54 35.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.867 1.267 . . . . 0.0 114.219 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -137.34 156.11 48.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.152 1.381 . . . . 0.0 112.417 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 ttt -66.46 -19.8 65.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.849 1.26 . . . . 0.0 113.123 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.88 -38.58 26.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.904 0.764 . . . . 0.0 113.501 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -64.56 -45.62 86.3 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.767 1.284 . . . . 0.0 112.747 -174.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -59.69 -35.11 73.82 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.55 -0.719 . . . . 0.0 112.176 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -14.21 60.43 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -74.47 -21.03 59.78 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.819 -1.176 . . . . 0.0 112.762 166.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -103.66 -55.51 2.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.018 1.727 . . . . 0.0 111.649 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 113.237 173.271 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 119.146 -0.455 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.74 155.69 67.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.238 1.959 . . . . 0.0 112.316 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.62 -26.26 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.213 1.405 . . . . 0.0 113.587 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.98 2.43 86.82 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.996 1.284 . . . . 0.0 115.724 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -65.58 155.41 35.87 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.99 1.895 . . . . 0.0 111.555 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -73.53 75.24 1.46 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.906 1.283 . . . . 0.0 111.763 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -78.15 157.19 78.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.654 1.582 . . . . 0.0 113.287 176.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.0 174.81 11.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.21 2.607 . . . . 0.0 112.595 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.62 135.04 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.475 1.51 . . . . 0.0 111.006 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -86.41 138.75 31.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.51 1.124 . . . . 0.0 110.809 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.59 -2.21 88.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.215 1.388 . . . . 0.0 115.659 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 53.85 19.35 1.89 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.341 2.256 . . . . 0.0 114.866 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.4 p -71.85 170.05 14.49 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.014 -1.054 . . . . 0.0 113.472 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.97 3.15 7.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.85 1.66 . . . . 0.0 114.947 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.16 154.37 31.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.843 1.657 . . . . 0.0 112.257 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -124.47 90.42 3.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.308 1.843 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -75.92 171.77 13.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 111.544 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.9 m -125.59 113.71 17.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.186 1.394 . . . . 0.0 108.889 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -121.33 159.94 25.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.897 1.679 . . . . 0.0 110.723 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -119.52 142.64 48.13 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.069 0.948 . . . . 0.0 110.396 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.06 170.75 15.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.111 1.364 . . . . 0.0 110.195 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -136.95 144.92 43.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.539 1.136 . . . . 0.0 110.777 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.9 mtt -137.04 71.83 1.41 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.468 1.107 . . . . 0.0 110.231 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.87 -109.37 2.68 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.883 1.706 . . . . 0.0 112.73 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -113.12 34.01 4.72 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.868 1.667 . . . . 0.0 111.381 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.0 104.92 1.74 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.266 1.427 . . . . 0.0 112.742 -175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.04 157.13 31.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.605 1.162 . . . . 0.0 112.2 164.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -161.83 -178.98 6.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.125 2.17 . . . . 0.0 111.474 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.04 146.58 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.306 2.242 . . . . 0.0 110.767 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.93 138.12 49.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.004 2.122 . . . . 0.0 109.774 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.41 111.86 14.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.595 1.558 . . . . 0.0 110.377 -168.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.08 -170.95 33.3 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.984 0.802 . . . . 0.0 113.28 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.58 77.15 1.08 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 111.227 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.46 141.91 51.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.069 1.747 . . . . 0.0 111.803 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.3 p -134.51 -7.09 2.53 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -173.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.6 -2.4 65.32 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -172.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.62 174.45 25.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.826 1.203 . . . . 0.0 115.06 -170.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.32 156.86 38.1 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.842 1.657 . . . . 0.0 111.953 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -78.75 -29.83 45.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.707 1.203 . . . . 0.0 114.144 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mtm105 -141.34 159.47 42.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.67 1.988 . . . . 0.0 111.347 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 33.4 ttm -62.86 -32.0 73.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.7 0.8 . . . . 0.0 112.356 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.8 -28.8 72.34 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.834 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.59 -46.53 38.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.019 1.409 . . . . 0.0 112.878 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.4 p -62.3 -31.91 72.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.073 -1.017 . . . . 0.0 112.379 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 -10.47 49.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.177 1.391 . . . . 0.0 114.739 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -79.71 -36.22 37.82 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.281 0.946 . . . . 0.0 112.571 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -84.43 -50.85 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 111.928 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 171.537 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.82 159.33 53.76 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.359 2.706 . . . . 0.0 112.503 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 tt -61.4 143.06 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.009 0.924 . . . . 0.0 111.314 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.77 -0.83 83.0 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.604 1.097 . . . . 0.0 115.291 -178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -65.09 160.06 21.92 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.19 1.495 . . . . 0.0 111.204 167.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.7 m -74.88 64.96 1.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.694 1.598 . . . . 0.0 112.91 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 154.2 91.61 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.672 1.189 . . . . 0.0 113.805 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.91 153.39 42.23 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.092 2.528 . . . . 0.0 112.183 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.95 135.03 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.84 0.856 . . . . 0.0 111.93 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.6 144.06 54.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.311 1.045 . . . . 0.0 110.726 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 -10.61 86.13 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 115.219 0.847 . . . . 0.0 115.219 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.6 mt 61.84 14.37 6.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.495 2.318 . . . . 0.0 115.134 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 m -75.76 171.75 13.82 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.599 1.16 . . . . 0.0 113.617 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.76 -46.7 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 112.14 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.82 159.51 28.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.063 1.345 . . . . 0.0 113.195 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -131.1 90.68 2.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.471 1.909 . . . . 0.0 111.527 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -68.6 174.23 4.4 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.968 1.307 . . . . 0.0 111.763 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -126.48 112.07 15.15 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 110.172 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -117.53 168.89 9.99 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.24 1.816 . . . . 0.0 110.459 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -133.18 135.33 45.03 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.603 1.161 . . . . 0.0 109.953 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -132.93 147.59 52.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 0.0 111.205 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.0 t -85.93 127.43 34.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.152 0.581 . . . . 0.0 110.475 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.1 mmm -116.19 25.14 10.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.494 1.917 . . . . 0.0 112.933 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.42 93.43 1.82 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.124 1.345 . . . . 0.0 111.228 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.257 13.2 p30 47.09 28.05 0.87 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.755 2.022 . . . . 0.0 115.116 -173.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -151.24 154.12 36.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.776 2.03 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.74 138.23 54.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.612 1.165 . . . . 0.0 110.819 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -142.48 148.46 37.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.649 1.18 . . . . 0.0 112.011 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.97 150.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.58 1.152 . . . . 0.0 111.804 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -134.73 132.77 39.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.795 2.038 . . . . 0.0 110.467 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -132.74 115.46 15.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.576 1.55 . . . . 0.0 111.022 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.73 55.23 0.01 OUTLIER Glycine 0 N--CA 1.475 1.295 0 O-C-N 121.823 -0.548 . . . . 0.0 114.454 -170.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.2 t 57.07 28.26 14.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.167 1.387 . . . . 0.0 114.401 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.81 139.67 53.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.651 1.18 . . . . 0.0 110.538 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.2 p -125.89 -5.29 6.87 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.89 1.276 . . . . 0.0 113.915 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.13 -167.67 33.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.813 1.673 . . . . 0.0 112.637 173.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.6 49.49 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 122.245 0.914 . . . . 0.0 113.808 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -79.82 148.77 31.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 0.0 111.198 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -78.14 -19.87 53.18 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.38 159.19 42.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.727 2.011 . . . . 0.0 111.95 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.7 tpp -62.45 -40.59 97.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.0 0.92 . . . . 0.0 112.199 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.82 -38.77 93.24 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.721 0.676 . . . . 0.0 112.902 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -39.24 90.96 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.038 1.335 . . . . 0.0 111.676 173.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.03 -56.62 15.41 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.769 -0.582 . . . . 0.0 111.676 167.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.76 70.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -79.18 -18.94 52.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -98.04 -47.07 5.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.876 1.27 . . . . 0.0 112.535 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.557 1.212 0 C-N-CA 123.012 0.525 . . . . 0.0 111.604 167.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.74 146.45 54.14 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.37 2.047 . . . . 0.0 111.614 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.41 -27.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.64 1.176 . . . . 0.0 113.615 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.01 1.56 88.64 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.889 1.233 . . . . 0.0 115.491 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -65.02 155.63 34.04 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.567 1.683 . . . . 0.0 112.015 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 t -78.65 80.3 5.02 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.554 1.142 . . . . 0.0 111.725 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.81 153.84 89.16 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.851 1.26 . . . . 0.0 113.131 172.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.96 168.68 23.02 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.472 2.782 . . . . 0.0 112.897 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.12 134.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.13 1.372 . . . . 0.0 111.769 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -78.16 141.78 38.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.213 1.405 . . . . 0.0 110.93 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.21 -6.8 83.98 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.884 1.113 . . . . 0.0 115.884 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mp 57.5 17.92 4.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.266 2.226 . . . . 0.0 114.765 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.14 167.98 9.2 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.195 1.798 . . . . 0.0 113.706 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -66.34 -23.16 66.31 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.34 162.68 12.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.542 1.537 . . . . 0.0 112.894 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -131.61 95.85 3.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.012 1.725 . . . . 0.0 110.804 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -80.14 175.22 10.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 111.637 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -124.83 123.17 39.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.03 1.332 . . . . 0.0 109.887 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -126.71 162.72 25.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.426 1.89 . . . . 0.0 110.916 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -129.33 123.94 33.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.617 1.167 . . . . 0.0 110.327 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -130.26 126.01 36.23 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.521 1.128 . . . . 0.0 111.394 -172.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.36 122.04 18.13 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.293 -0.879 . . . . 0.0 111.659 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mmm -102.72 11.34 37.78 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.812 1.245 . . . . 0.0 113.371 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.08 -76.0 0.31 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.623 2.059 . . . . 0.0 111.863 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -126.14 6.39 7.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.062 1.745 . . . . 0.0 113.379 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.7 m -136.79 117.96 14.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.982 2.113 . . . . 0.0 109.448 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 t -78.25 122.19 25.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.443 0.697 . . . . 0.0 110.764 172.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -111.01 136.44 50.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.569 1.947 . . . . 0.0 110.74 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.84 144.31 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.619 0.768 . . . . 0.0 111.378 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -123.2 133.56 54.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.219 1.807 . . . . 0.0 109.655 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -126.56 109.88 12.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.932 1.693 . . . . 0.0 110.358 -170.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 -168.79 30.84 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.463 1.03 . . . . 0.0 112.121 -171.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.06 84.74 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.47 -1.017 . . . . 0.0 111.201 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -129.43 138.97 51.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.565 1.946 . . . . 0.0 110.268 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -127.94 -9.5 5.45 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.01 1.324 . . . . 0.0 114.43 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 -169.77 43.8 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.577 1.56 . . . . 0.0 113.067 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.47 -171.08 51.93 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 121.921 0.734 . . . . 0.0 114.001 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -83.49 149.81 26.39 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.434 1.494 . . . . 0.0 111.64 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.9 m -84.6 -14.32 49.08 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -141.5 153.9 45.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.453 1.501 . . . . 0.0 111.944 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 45.5 tpp -61.73 -24.51 66.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.383 1.473 . . . . 0.0 113.359 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.11 -22.74 58.64 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.197 -0.94 . . . . 0.0 114.572 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -78.59 -39.11 38.41 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.882 1.341 . . . . 0.0 112.623 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 p -58.87 -39.34 81.07 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.38 -0.825 . . . . 0.0 112.277 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.51 53.39 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -67.7 -40.84 84.32 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.923 -1.111 . . . . 0.0 111.705 169.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.5 -52.92 4.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.761 1.624 . . . . 0.0 111.938 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.7 m . . . . . 0 CA--C 1.548 0.871 0 C-N-CA 123.983 0.913 . . . . 0.0 113.297 179.142 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.558 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.26 117.88 15.96 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.469 1.508 . . . . 0.0 111.559 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -137.77 171.74 13.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.982 2.113 . . . . 0.0 111.55 173.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -109.86 162.67 14.26 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.894 1.678 . . . . 0.0 111.48 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -75.06 164.69 26.27 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.372 1.069 . . . . 0.0 112.18 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.4 m -127.88 81.23 2.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.923 1.689 . . . . 0.0 110.495 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 p -71.06 109.46 5.16 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.924 1.69 . . . . 0.0 111.734 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.0 t -125.67 83.68 61.76 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.31 1.444 . . . . 0.0 110.041 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.81 166.99 27.17 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.525 2.817 . . . . 0.0 112.235 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.92 -28.15 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.427 1.091 . . . . 0.0 113.4 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.39 2.01 86.06 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.158 1.361 . . . . 0.0 115.393 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.15 156.43 31.72 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.404 1.602 . . . . 0.0 112.217 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -77.15 99.83 5.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.971 1.309 . . . . 0.0 111.483 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.0 155.72 36.23 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.406 1.482 . . . . 0.0 113.263 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.78 165.54 29.95 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.234 2.623 . . . . 0.0 112.475 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.23 138.05 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.803 1.241 . . . . 0.0 111.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -68.61 146.36 53.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.367 1.067 . . . . 0.0 110.604 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.42 -11.07 69.66 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mp 47.33 34.27 3.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.102 2.161 . . . . 0.0 114.737 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -97.37 178.68 5.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 1.75 14.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.544 1.938 . . . . 0.0 114.506 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.76 158.4 31.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.111 1.764 . . . . 0.0 112.778 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -134.7 83.75 2.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.932 1.693 . . . . 0.0 112.354 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.03 171.8 12.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.737 1.215 . . . . 0.0 111.663 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.6 m -122.05 112.75 18.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.355 1.462 . . . . 0.0 109.726 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -119.8 167.38 12.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.788 1.635 . . . . 0.0 110.849 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -133.41 140.14 47.16 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.182 0.993 . . . . 0.0 110.239 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -133.37 165.95 23.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 109.548 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.3 t -112.65 138.8 48.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.55 -0.719 . . . . 0.0 111.293 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.4 mtp -125.67 86.25 2.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.912 1.685 . . . . 0.0 109.255 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.37 -77.3 0.89 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.025 1.774 . . . . 0.0 112.68 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -131.57 -4.41 3.73 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.015 1.326 . . . . 0.0 114.135 -174.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.3 m -123.83 139.37 54.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.179 1.392 . . . . 0.0 111.536 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.09 147.52 32.74 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.942 0.897 . . . . 0.0 111.824 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -147.02 127.02 13.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.554 1.942 . . . . 0.0 110.565 -171.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.44 145.17 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.421 1.089 . . . . 0.0 112.372 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -131.72 137.06 48.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.344 1.857 . . . . 0.0 110.595 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.54 117.46 12.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.381 1.472 . . . . 0.0 110.666 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.62 65.69 0.04 OUTLIER Glycine 0 N--CA 1.477 1.409 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.88 28.74 15.02 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -72.45 -46.43 54.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.152 . . . . 0.0 113.588 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.3 p 50.75 -10.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 131.224 3.81 . . . . 0.0 118.405 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.61 -171.39 47.71 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.656 2.074 . . . . 0.0 113.168 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.06 -168.76 23.82 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.751 -0.852 . . . . 0.0 113.759 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -67.31 146.83 53.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.429 1.492 . . . . 0.0 111.932 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.8 p -75.43 -32.82 60.82 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -136.76 163.05 31.51 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.144 1.777 . . . . 0.0 112.071 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.3 tpp -56.53 -38.53 71.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.749 0.82 . . . . 0.0 111.725 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.06 -17.39 75.61 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.19 0.9 . . . . 0.0 115.07 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -82.85 -33.63 27.03 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.908 1.354 . . . . 0.0 111.798 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.2 t -69.33 -53.4 19.77 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.474 -0.766 . . . . 0.0 112.016 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.31 -17.87 64.94 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -78.94 -18.36 53.93 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -106.91 -51.69 2.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.196 1.398 . . . . 0.0 112.352 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.8 159.0 85.34 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 118.713 0.688 . . . . 0.0 112.251 171.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.36 -12.94 15.39 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.178 2.585 . . . . 0.0 115.197 -170.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.207 0 C-N-CA 126.229 1.871 . . . . 0.0 112.972 -179.009 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.457 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -134.75 78.08 1.72 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.913 1.285 . . . . 0.0 110.698 -166.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -108.3 -52.64 2.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.09 1.356 . . . . 0.0 112.7 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -80.59 -19.56 45.27 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.556 1.143 . . . . 0.0 113.515 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -73.63 165.49 25.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.245 1.018 . . . . 0.0 113.118 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.7 p -84.72 155.75 21.75 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.027 0.931 . . . . 0.0 112.396 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.6 p -143.82 158.79 43.44 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.283 1.833 . . . . 0.0 110.842 171.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 m -140.89 155.84 68.85 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 126.15 1.78 . . . . 0.0 110.97 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.98 161.59 43.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.81 2.34 . . . . 0.0 112.5 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 tp -58.27 -28.12 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.833 1.253 . . . . 0.0 113.262 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.13 4.46 83.26 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.179 1.371 . . . . 0.0 115.506 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -63.6 157.34 24.09 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.479 1.639 . . . . 0.0 112.379 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -76.36 70.35 2.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.368 1.467 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.19 157.05 88.85 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.399 1.479 . . . . 0.0 112.901 171.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.76 176.72 9.01 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.848 3.032 . . . . 0.0 113.263 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.47 135.48 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.728 1.611 . . . . 0.0 111.52 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -77.28 141.95 39.71 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.969 1.308 . . . . 0.0 110.752 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.4 -4.42 90.0 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 56.15 21.16 4.96 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.822 2.049 . . . . 0.0 114.255 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.0 m -70.16 168.84 14.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.167 1.387 . . . . 0.0 113.29 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.17 -0.44 14.23 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.96 164.44 22.32 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.933 1.693 . . . . 0.0 112.766 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -129.47 93.09 3.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.247 1.819 . . . . 0.0 110.905 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.15 174.04 11.97 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.472 1.109 . . . . 0.0 111.455 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.1 m -128.01 110.84 12.9 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.001 1.32 . . . . 0.0 109.744 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -116.42 165.91 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.871 1.668 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.07 85.05 2.18 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.263 1.025 . . . . 0.0 111.135 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -82.35 156.19 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.844 0.858 . . . . 0.0 111.091 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 t -90.48 140.38 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 111.442 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.2 mtp -133.77 111.17 10.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.604 1.962 . . . . 0.0 109.663 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.69 -95.57 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.94 1.257 . . . . 0.0 112.186 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -116.0 -8.98 11.81 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.342 1.457 . . . . 0.0 113.932 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.3 p -120.51 156.58 31.23 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.733 1.151 . . . . 0.0 113.14 -171.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.24 124.53 35.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.687 1.195 . . . . 0.0 110.378 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -121.43 135.16 55.08 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.454 1.902 . . . . 0.0 110.704 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -67.22 145.99 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.318 0.647 . . . . 0.0 112.006 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -127.14 135.79 51.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.732 2.013 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.07 107.97 11.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.519 . . . . 0.0 110.423 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.01 -169.01 31.34 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.911 0.767 . . . . 0.0 113.095 -172.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.45 86.51 3.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.949 -0.736 . . . . 0.0 110.675 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.55 133.62 48.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.845 1.658 . . . . 0.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.2 p -136.79 -3.42 2.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.197 1.399 . . . . 0.0 114.389 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.1 0.83 58.98 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.189 1.376 . . . . 0.0 115.842 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.79 176.58 17.64 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.02 1.771 . . . . 0.0 113.606 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -60.01 136.37 57.99 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.204 1.002 . . . . 0.0 112.522 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.5 m -76.41 -17.16 59.49 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -131.92 146.99 52.44 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.081 1.753 . . . . 0.0 110.951 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 tpp -55.82 -37.84 69.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.241 1.016 . . . . 0.0 111.504 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.02 -47.8 85.68 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.225 0.917 . . . . 0.0 112.646 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.23 -37.9 81.75 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.091 0.946 . . . . 0.0 112.688 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.931 0.492 . . . . 0.0 111.887 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -19.01 65.65 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -66.46 -25.04 66.53 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.676 -1.265 . . . . 0.0 113.116 169.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -109.49 -55.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.807 1.643 . . . . 0.0 112.231 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.99 159.72 75.34 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.709 0.804 . . . . 0.0 112.911 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.62 -17.64 12.49 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.054 2.502 . . . . 0.0 115.125 -170.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.253 0 C-N-CA 125.916 1.722 . . . . 0.0 113.893 -179.391 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.441 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -64.98 133.58 52.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.111 0.964 . . . . 0.0 112.074 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -138.63 129.32 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.209 1.804 . . . . 0.0 110.215 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -144.05 165.5 27.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.092 1.357 . . . . 0.0 112.015 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.74 111.52 19.89 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.119 1.367 . . . . 0.0 111.13 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -89.63 99.0 12.09 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.478 0.711 . . . . 0.0 111.426 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.7 p -129.7 172.55 11.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.084 1.753 . . . . 0.0 111.342 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.05 156.04 79.78 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 125.904 1.682 . . . . 0.0 111.489 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 160.12 50.44 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.848 2.366 . . . . 0.0 112.346 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 tt -58.85 -26.71 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.94 1.296 . . . . 0.0 113.712 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.83 2.02 88.0 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.886 1.232 . . . . 0.0 115.497 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -66.91 157.39 33.32 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.286 1.543 . . . . 0.0 112.617 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.3 m -75.37 57.7 0.93 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.974 . . . . 0.0 113.425 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.22 155.98 89.24 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.131 1.373 . . . . 0.0 113.912 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -75.39 178.46 7.3 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 124.003 3.135 . . . . 0.0 112.734 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.08 139.68 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.342 1.457 . . . . 0.0 112.213 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -68.18 142.44 55.7 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.026 1.33 . . . . 0.0 110.879 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.09 -11.63 75.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 46.17 69.82 0.44 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.313 2.245 . . . . 0.0 112.671 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.6 m -120.55 175.12 6.15 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.652 1.581 . . . . 0.0 111.874 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -84.64 4.5 32.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.156 1.382 . . . . 0.0 114.475 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.13 163.53 24.44 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.338 1.855 . . . . 0.0 112.808 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -130.33 87.12 2.47 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.156 1.783 . . . . 0.0 111.677 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.06 175.46 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.508 1.123 . . . . 0.0 112.152 171.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -128.04 115.36 18.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.221 1.408 . . . . 0.0 110.256 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -119.98 165.71 14.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.11 1.764 . . . . 0.0 111.037 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -129.04 134.44 48.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 109.945 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.62 139.6 47.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.708 1.203 . . . . 0.0 110.436 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.6 t -81.3 111.19 17.46 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.604 -0.685 . . . . 0.0 111.589 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.8 mmm -92.68 71.61 4.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.109 0.963 . . . . 0.0 109.33 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.25 -75.0 2.39 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.99 1.757 . . . . 0.0 113.804 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -133.65 5.96 3.72 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.843 1.657 . . . . 0.0 113.745 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 93.4 m -135.65 117.18 14.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.188 1.795 . . . . 0.0 110.399 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.61 133.29 49.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.896 0.878 . . . . 0.0 111.165 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -131.21 141.45 50.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.119 1.768 . . . . 0.0 110.983 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.64 145.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 112.19 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -134.39 141.57 46.88 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.113 2.165 . . . . 0.0 110.552 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.97 117.67 10.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.426 1.49 . . . . 0.0 110.759 -172.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.02 58.85 0.02 OUTLIER Glycine 0 N--CA 1.478 1.456 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 56.52 30.92 18.05 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -71.23 -53.24 15.05 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.658 1.183 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.5 p 50.74 3.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 129.618 3.167 . . . . 0.0 118.23 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.97 -6.31 52.21 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.342 1.449 . . . . 0.0 116.082 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.12 -177.97 39.0 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.165 1.364 . . . . 0.0 114.112 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.4 146.76 47.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.167 1.387 . . . . 0.0 111.535 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.8 t -69.39 -36.39 76.73 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -136.26 162.58 32.58 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.259 1.824 . . . . 0.0 111.123 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 35.7 tpp -58.03 -37.56 74.57 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 112.014 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.8 -44.15 98.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.64 1.114 . . . . 0.0 113.792 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.26 -40.25 96.87 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.451 1.126 . . . . 0.0 112.22 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.8 t -57.8 -47.76 81.67 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.378 1.071 . . . . 0.0 111.348 170.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.18 62.71 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -73.08 -40.76 64.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.069 1.304 . . . . 0.0 112.06 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -84.4 -51.5 6.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.45 1.5 . . . . 0.0 112.006 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.2 163.93 61.8 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.802 0.841 . . . . 0.0 112.995 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.11 -9.35 20.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.418 2.745 . . . . 0.0 114.483 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 C-N-CA 127.197 2.332 . . . . 0.0 112.775 178.342 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.499 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -143.26 168.18 20.38 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.724 1.61 . . . . 0.0 112.546 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -148.62 169.13 21.04 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.981 1.712 . . . . 0.0 112.443 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.09 15.51 2.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.538 1.535 . . . . 0.0 113.991 -174.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -61.71 155.86 21.67 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -67.16 123.14 19.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.213 1.405 . . . . 0.0 111.723 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -139.98 164.15 30.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.311 1.444 . . . . 0.0 111.941 173.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 m -139.14 157.37 71.28 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 126.892 2.077 . . . . 0.0 110.527 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.81 162.57 41.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.71 2.273 . . . . 0.0 112.67 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.11 -27.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.96 1.304 . . . . 0.0 113.509 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.44 3.98 86.36 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.068 1.318 . . . . 0.0 115.298 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -64.46 157.81 25.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.438 1.619 . . . . 0.0 112.317 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 m -72.92 58.23 0.46 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.926 2.09 . . . . 0.0 113.376 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.55 155.54 80.91 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.873 1.269 . . . . 0.0 113.25 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.12 176.43 9.55 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.478 2.785 . . . . 0.0 113.382 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.46 140.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.651 1.58 . . . . 0.0 111.206 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -81.91 145.73 30.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.047 1.339 . . . . 0.0 111.107 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.08 -7.3 80.65 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 124.99 1.281 . . . . 0.0 115.823 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mp 53.98 26.61 6.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.01 2.124 . . . . 0.0 114.435 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -68.12 171.1 7.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.116 1.766 . . . . 0.0 113.233 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -76.0 -1.82 27.59 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.562 1.545 . . . . 0.0 114.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.85 167.48 18.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.212 1.805 . . . . 0.0 112.859 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -127.57 102.72 6.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.388 1.875 . . . . 0.0 110.988 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.21 175.77 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.803 1.241 . . . . 0.0 111.271 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.7 m -128.75 117.1 20.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.141 1.377 . . . . 0.0 109.518 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -123.91 167.06 14.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.491 1.516 . . . . 0.0 110.463 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.32 105.18 5.87 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.353 1.461 . . . . 0.0 109.993 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -103.57 132.03 50.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 111.117 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.05 91.99 2.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.291 0.567 . . . . 0.0 111.7 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -86.76 83.76 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.54 1.136 . . . . 0.0 109.936 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.67 -73.47 2.26 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.602 1.572 . . . . 0.0 112.837 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -136.1 0.69 2.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 114.058 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -136.22 151.96 50.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.008 0.923 . . . . 0.0 112.992 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.8 m -89.05 81.16 6.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.491 1.516 . . . . 0.0 111.42 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -64.84 124.2 21.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.245 0.618 . . . . 0.0 110.142 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.77 142.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.082 0.553 . . . . 0.0 111.347 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -125.91 125.7 43.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.456 1.902 . . . . 0.0 109.717 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.21 106.18 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.876 1.67 . . . . 0.0 110.237 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.94 -169.55 32.5 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.809 1.195 . . . . 0.0 112.078 -170.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.4 t -77.14 88.6 3.62 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.471 -1.017 . . . . 0.0 111.177 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -129.48 134.68 47.93 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.005 1.722 . . . . 0.0 110.321 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.0 p -138.77 -7.98 1.42 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.983 1.313 . . . . 0.0 114.519 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.91 -2.99 88.24 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.932 1.254 . . . . 0.0 115.982 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.82 178.03 22.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.819 1.676 . . . . 0.0 112.993 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -55.21 134.0 49.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.763 1.625 . . . . 0.0 114.033 -165.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 t -81.04 -10.87 59.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -132.7 146.92 52.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.566 1.546 . . . . 0.0 111.643 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.5 tpp -52.96 -39.1 62.71 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.03 1.332 . . . . 0.0 111.849 168.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.03 -45.16 63.62 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.897 0.761 . . . . 0.0 113.325 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.66 -34.51 77.23 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.123 0.969 . . . . 0.0 112.36 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 t -66.17 -53.58 35.74 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.791 -0.568 . . . . 0.0 112.249 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.23 75.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -63.36 -22.49 66.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -104.53 -23.63 13.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.558 1.543 . . . . 0.0 114.1 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.8 m -58.1 155.79 23.44 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 118.847 0.749 . . . . 0.0 112.697 164.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.61 -8.43 18.19 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 123.522 2.815 . . . . 0.0 114.336 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 126.99 2.233 . . . . 0.0 113.016 179.544 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -138.42 111.96 8.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.901 1.28 . . . . 0.0 111.67 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -122.82 -13.08 7.95 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.39 1.476 . . . . 0.0 114.372 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.35 75.53 4.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.863 1.265 . . . . 0.0 110.568 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -142.92 166.69 23.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.962 1.305 . . . . 0.0 112.898 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.6 m -119.09 59.38 0.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.701 1.6 . . . . 0.0 110.995 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 p -67.87 149.32 49.99 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.8 0.84 . . . . 0.0 110.99 163.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.44 156.1 63.9 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.589 1.556 . . . . 0.0 111.357 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.06 148.81 63.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.451 2.101 . . . . 0.0 111.772 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.8 -21.98 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.416 1.087 . . . . 0.0 113.342 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.31 83.86 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 114.957 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -68.51 139.37 55.65 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.408 1.604 . . . . 0.0 110.829 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 t -72.43 94.18 1.62 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.41 159.07 50.97 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.379 1.471 . . . . 0.0 112.647 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.71 175.59 11.09 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.08 2.52 . . . . 0.0 113.711 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.76 138.28 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.696 1.598 . . . . 0.0 111.632 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HG2' ' H ' ' A' ' 37' ' ' LEU . 2.6 ttpm? -82.9 138.95 33.68 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.0 1.32 . . . . 0.0 111.191 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.68 2.62 82.34 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.544 2.021 . . . . 0.0 115.756 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.445 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 44.9 mt 57.19 17.89 3.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.015 2.526 . . . . 0.0 115.776 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.9 p -78.62 173.63 12.22 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 2.43 6.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.732 2.013 . . . . 0.0 115.252 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.61 162.43 17.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.572 1.549 . . . . 0.0 112.889 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -130.93 87.15 2.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.575 1.95 . . . . 0.0 111.545 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.39 174.88 11.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.976 1.311 . . . . 0.0 111.482 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -128.47 131.89 48.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.289 1.436 . . . . 0.0 109.377 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -130.42 158.29 40.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.833 1.253 . . . . 0.0 111.12 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -123.61 81.36 1.89 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.531 1.158 . . . . 0.0 111.374 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -77.37 170.91 15.72 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -126.45 136.4 52.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.552 1.141 . . . . 0.0 110.549 169.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.4 mmm -121.35 10.59 10.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.694 1.198 . . . . 0.0 112.814 -172.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.87 -91.07 0.12 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.656 1.598 . . . . 0.0 111.914 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.09 8.75 18.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.849 1.66 . . . . 0.0 113.411 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -146.2 132.75 19.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.302 1.841 . . . . 0.0 110.815 -172.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.2 m -81.01 86.68 6.08 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.604 0.761 . . . . 0.0 111.958 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -62.61 114.07 3.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.65 144.09 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.117 0.967 . . . . 0.0 111.165 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -124.93 148.23 48.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.276 1.43 . . . . 0.0 110.528 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -131.36 127.69 38.11 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.044 1.738 . . . . 0.0 110.575 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.62 -168.02 25.68 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.096 0.855 . . . . 0.0 112.652 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.73 71.19 0.34 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.602 -0.94 . . . . 0.0 111.861 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.5 136.15 53.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.699 1.6 . . . . 0.0 110.651 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.5 p -129.75 -8.39 4.52 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.301 1.441 . . . . 0.0 114.117 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.6 -174.06 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.325 1.44 . . . . 0.0 113.444 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.09 -172.95 8.47 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.123 0.868 . . . . 0.0 114.216 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -69.73 137.15 51.77 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.783 0.802 . . . . 0.0 112.05 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -80.82 -13.0 59.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -130.1 144.72 51.5 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.658 1.983 . . . . 0.0 110.875 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.2 ttt -65.3 -15.49 62.57 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.112 1.365 . . . . 0.0 113.895 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.11 -32.15 15.12 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.591 1.091 . . . . 0.0 114.275 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.27 -28.42 67.19 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.537 1.135 . . . . 0.0 113.049 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.7 p -73.98 -44.16 55.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.357 0.663 . . . . 0.0 112.171 168.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.87 -24.3 61.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.264 1.426 . . . . 0.0 114.564 -171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -65.89 -30.1 70.64 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 167.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.68 -49.15 5.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.665 1.186 . . . . 0.0 112.006 -171.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.5 m -68.39 160.42 75.95 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.419 1.088 . . . . 0.0 112.431 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.42 -23.75 20.03 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.321 2.681 . . . . 0.0 114.275 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.279 0 C-N-CA 125.978 1.751 . . . . 0.0 114.55 -177.573 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.439 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -134.96 137.68 43.31 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.438 1.495 . . . . 0.0 111.006 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.74 154.63 36.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.487 1.115 . . . . 0.0 110.71 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -138.64 92.22 2.6 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.971 1.308 . . . . 0.0 111.04 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.84 164.88 12.59 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.011 1.725 . . . . 0.0 112.931 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.5 m -125.72 85.88 2.46 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.512 1.525 . . . . 0.0 111.248 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.3 p -71.09 122.49 20.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.573 1.149 . . . . 0.0 111.761 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.53 157.03 66.41 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 126.257 1.823 . . . . 0.0 111.701 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.06 155.23 57.27 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.64 2.226 . . . . 0.0 112.473 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.91 -27.34 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.943 1.297 . . . . 0.0 113.484 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.09 83.05 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.221 1.391 . . . . 0.0 115.51 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -63.7 153.8 35.12 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.527 1.663 . . . . 0.0 112.414 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -78.06 74.87 4.6 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.805 1.242 . . . . 0.0 111.5 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.18 154.25 94.27 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.511 1.125 . . . . 0.0 111.584 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.88 162.53 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 113.203 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.28 132.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.882 1.273 . . . . 0.0 111.437 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.58 136.62 47.5 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.203 1.001 . . . . 0.0 110.733 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.13 -4.22 86.06 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.361 0.982 . . . . 0.0 115.259 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.4 mt 59.35 9.07 1.3 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.747 2.419 . . . . 0.0 115.697 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 p -89.72 173.21 8.41 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -171.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -0.31 15.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.768 2.027 . . . . 0.0 115.92 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.86 152.12 25.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.293 1.437 . . . . 0.0 112.849 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -121.49 78.77 1.47 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.275 1.83 . . . . 0.0 110.624 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -72.14 171.95 11.06 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.194 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -128.29 116.01 19.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.882 1.273 . . . . 0.0 109.573 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -120.46 159.14 25.74 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.848 1.659 . . . . 0.0 110.905 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -126.93 120.0 28.07 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.729 1.212 . . . . 0.0 109.958 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -120.5 124.66 45.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.149 0.979 . . . . 0.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.7 t -73.61 116.02 13.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.096 0.474 . . . . 0.0 110.488 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 mtp -93.83 67.32 3.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.705 1.602 . . . . 0.0 109.439 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.31 -64.92 3.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.605 1.574 . . . . 0.0 114.126 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -140.0 9.6 2.35 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.68 148.08 29.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.789 1.636 . . . . 0.0 109.988 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -102.76 129.66 49.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 112.597 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -119.27 136.96 53.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.858 1.663 . . . . 0.0 110.889 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.12 141.23 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.351 1.06 . . . . 0.0 111.106 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.43 128.45 48.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.351 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.48 97.98 3.83 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.588 1.555 . . . . 0.0 111.894 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.47 63.41 0.01 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.22 -0.925 . . . . 0.0 114.491 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.4 t 52.93 53.7 11.65 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.715 1.206 . . . . 0.0 112.917 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.43 140.8 41.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.5 p -130.2 -12.41 4.07 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.843 1.257 . . . . 0.0 114.341 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.83 -174.4 48.47 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.238 1.399 . . . . 0.0 113.106 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.06 -166.9 52.08 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.808 -0.819 . . . . 0.0 113.313 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -87.02 146.75 26.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 111.977 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.6 m -78.08 -13.2 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -137.73 148.2 45.41 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 112.072 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.01 -27.23 68.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 112.508 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.91 -28.56 45.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.42 -0.8 . . . . 0.0 114.155 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -72.16 -34.02 68.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.432 1.116 . . . . 0.0 112.579 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 p -68.78 -45.47 71.23 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.351 -0.843 . . . . 0.0 111.453 168.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -38.38 88.68 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.906 1.282 . . . . 0.0 114.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -84.77 -46.27 11.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.0 112.118 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.05 166.15 43.55 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.01 -8.21 18.74 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.514 2.809 . . . . 0.0 114.347 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 127.322 2.391 . . . . 0.0 112.706 179.019 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.482 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.91 98.64 3.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.341 1.456 . . . . 0.0 110.178 -167.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -131.27 4.94 4.4 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.28 1.832 . . . . 0.0 114.028 -172.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -67.62 14.6 0.05 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.787 2.435 . . . . 0.0 115.27 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.89 152.56 31.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.837 1.655 . . . . 0.0 112.826 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.07 103.01 4.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.148 0.979 . . . . 0.0 111.714 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -143.22 155.33 44.49 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.013 1.325 . . . . 0.0 111.723 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t -141.17 91.13 8.93 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.968 1.707 . . . . 0.0 109.837 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.91 161.9 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.881 2.387 . . . . 0.0 112.205 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.4 tt -63.18 146.97 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.718 0.807 . . . . 0.0 111.068 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.49 0.84 89.38 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.527 1.06 . . . . 0.0 115.384 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -62.67 154.7 28.5 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.152 1.476 . . . . 0.0 111.523 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -77.05 68.69 3.23 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.945 1.298 . . . . 0.0 111.922 176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.01 155.65 91.43 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.298 1.439 . . . . 0.0 112.7 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.6 175.06 11.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.223 2.615 . . . . 0.0 112.935 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.55 139.64 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.33 1.452 . . . . 0.0 111.428 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -67.17 146.17 54.49 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.91 82.65 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.84 17.18 4.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.182 2.193 . . . . 0.0 114.662 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.21 168.49 19.03 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.442 1.097 . . . . 0.0 112.937 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -68.6 -42.78 77.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.353 1.061 . . . . 0.0 112.321 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.13 157.44 37.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.913 1.285 . . . . 0.0 113.078 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.09 90.95 2.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.067 1.747 . . . . 0.0 111.213 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.8 173.98 3.21 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.371 1.068 . . . . 0.0 111.656 170.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -125.14 115.02 19.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.877 1.271 . . . . 0.0 109.744 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -118.83 165.63 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.348 1.459 . . . . 0.0 110.929 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.29 136.44 50.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.337 1.455 . . . . 0.0 109.318 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -130.17 137.48 50.12 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.386 1.075 . . . . 0.0 109.457 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.9 t -72.88 131.19 41.93 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.98 -0.45 . . . . 0.0 110.695 169.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 97.2 mmm -123.14 6.42 9.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.625 1.57 . . . . 0.0 113.906 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.23 91.35 0.81 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.582 1.563 . . . . 0.0 111.99 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 58.44 9.32 1.03 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.829 2.052 . . . . 0.0 114.933 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 t -155.74 165.29 36.98 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.054 2.542 . . . . 0.0 108.961 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.5 m -117.29 159.99 21.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 112.792 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.39 142.1 49.98 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.767 2.027 . . . . 0.0 110.095 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.38 143.44 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.0 0.92 . . . . 0.0 111.004 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -132.16 126.82 34.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.312 1.845 . . . . 0.0 110.605 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.99 108.7 9.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.823 1.649 . . . . 0.0 110.562 -171.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.79 55.18 0.01 OUTLIER Glycine 0 N--CA 1.476 1.337 0 C-N-CA 123.599 0.618 . . . . 0.0 114.238 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.1 t 60.5 22.94 12.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.506 1.523 . . . . 0.0 114.887 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.55 135.24 53.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.197 1.399 . . . . 0.0 111.228 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.7 p -132.33 -13.74 3.02 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.37 -9.31 79.64 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.32 170.67 21.6 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.308 1.432 . . . . 0.0 114.198 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.33 144.48 57.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.8 1.64 . . . . 0.0 111.821 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -72.22 -22.69 61.21 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -140.48 152.58 45.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.705 1.602 . . . . 0.0 111.385 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.86 -30.56 71.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.25 70.11 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.316 -0.865 . . . . 0.0 114.208 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.87 -44.3 17.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.915 1.358 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.47 -35.92 78.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.831 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.91 -7.23 49.99 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.976 1.71 . . . . 0.0 115.264 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -76.51 -42.05 44.71 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.658 1.117 . . . . 0.0 111.948 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -81.57 -54.67 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.926 1.691 . . . . 0.0 111.945 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.28 160.87 74.65 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.047 0.939 . . . . 0.0 112.22 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.45 -7.76 18.01 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.304 2.669 . . . . 0.0 114.24 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 C-N-CA 127.714 2.578 . . . . 0.0 112.487 177.88 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.431 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -140.16 166.31 25.02 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.461 1.505 . . . . 0.0 110.982 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -79.5 -26.03 41.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.64 1.576 . . . . 0.0 113.118 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -135.82 111.0 8.95 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.045 1.738 . . . . 0.0 110.508 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.2 164.64 25.89 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.973 1.309 . . . . 0.0 113.488 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.92 94.02 4.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.851 1.66 . . . . 0.0 111.555 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.4 p -110.85 164.57 12.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.597 1.959 . . . . 0.0 112.183 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.55 159.07 58.87 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 126.741 2.017 . . . . 0.0 111.064 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.34 160.56 49.11 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.662 2.241 . . . . 0.0 112.245 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.51 -26.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.005 1.322 . . . . 0.0 113.713 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.03 6.01 84.02 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.165 1.365 . . . . 0.0 115.569 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.6 t-105 -63.54 153.26 36.23 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.482 1.641 . . . . 0.0 112.617 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.7 m -72.27 87.69 1.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.823 1.649 . . . . 0.0 112.086 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.87 157.27 35.08 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 125.991 1.716 . . . . 0.0 112.505 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.11 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.549 2.833 . . . . 0.0 113.945 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.92 136.3 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.125 1.37 . . . . 0.0 111.492 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.19 147.6 49.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.641 1.176 . . . . 0.0 110.732 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.17 -14.3 66.92 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.8 mp 46.51 50.54 12.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.906 2.082 . . . . 0.0 113.417 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 25.0 m -96.73 173.71 7.18 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.612 1.165 . . . . 0.0 112.467 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -69.07 -34.89 75.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.981 1.312 . . . . 0.0 112.79 173.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.93 165.19 13.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.762 1.625 . . . . 0.0 112.995 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -131.36 92.41 3.18 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.21 1.804 . . . . 0.0 111.252 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -68.48 175.66 3.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.64 1.176 . . . . 0.0 112.099 172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -125.19 113.0 17.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.097 1.359 . . . . 0.0 110.456 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -115.44 169.29 9.27 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.963 1.705 . . . . 0.0 110.867 173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -135.38 129.5 33.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.214 1.406 . . . . 0.0 109.677 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.82 129.12 41.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.692 1.197 . . . . 0.0 110.775 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.05 134.26 38.84 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.992 0.425 . . . . 0.0 111.497 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.3 mtp -122.5 56.92 1.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.289 1.836 . . . . 0.0 109.97 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.33 -79.7 0.3 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.018 1.77 . . . . 0.0 112.576 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -124.54 1.02 8.26 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 m -136.2 147.08 47.47 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.395 1.878 . . . . 0.0 110.249 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.25 132.85 51.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 111.185 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -126.28 141.7 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.346 1.859 . . . . 0.0 110.544 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.56 148.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.039 0.935 . . . . 0.0 111.776 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -136.1 133.18 37.03 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.792 2.037 . . . . 0.0 110.438 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.91 119.08 18.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.158 1.383 . . . . 0.0 110.956 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.54 51.98 0.02 OUTLIER Glycine 0 N--CA 1.476 1.333 0 N-CA-C 114.592 0.597 . . . . 0.0 114.592 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.36 32.68 20.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.314 1.446 . . . . 0.0 114.233 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.91 121.41 19.01 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.673 1.189 . . . . 0.0 110.602 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -108.36 -7.51 15.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.268 1.427 . . . . 0.0 113.678 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.11 -168.96 40.7 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.958 1.742 . . . . 0.0 113.122 172.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 -162.03 41.74 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.004 0.811 . . . . 0.0 113.989 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.43 138.12 31.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.795 0.838 . . . . 0.0 110.863 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.9 p -77.9 -16.8 57.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 -139.38 155.76 47.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.997 2.119 . . . . 0.0 111.913 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 52.6 tpp -61.77 -39.66 92.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.012 0.925 . . . . 0.0 111.853 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.97 -37.53 94.56 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.146 -0.972 . . . . 0.0 113.436 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -68.49 -29.95 68.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.1 p -81.13 -45.55 16.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.679 1.127 . . . . 0.0 112.499 166.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 -18.94 65.07 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -68.41 -24.69 64.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.928 -1.108 . . . . 0.0 113.156 169.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -106.28 -56.05 2.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.173 1.789 . . . . 0.0 111.481 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m -74.62 157.73 85.72 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.139 0.976 . . . . 0.0 112.814 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.54 -12.57 15.25 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.389 2.726 . . . . 0.0 114.939 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 C-N-CA 126.184 1.85 . . . . 0.0 112.871 -178.993 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.59 81.58 0.83 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.226 1.41 . . . . 0.0 112.528 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -68.52 174.14 4.41 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.974 1.71 . . . . 0.0 113.477 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.89 159.72 33.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.633 1.573 . . . . 0.0 111.261 171.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -149.72 175.26 11.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.922 1.689 . . . . 0.0 111.758 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.7 t -132.01 100.3 5.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.756 1.222 . . . . 0.0 111.472 -176.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.2 p -136.75 163.67 30.06 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.814 1.645 . . . . 0.0 112.202 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 m -141.77 160.27 56.69 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 126.796 2.038 . . . . 0.0 111.471 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.85 168.67 20.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.955 2.437 . . . . 0.0 112.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 tp -60.47 147.27 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.196 0.998 . . . . 0.0 111.532 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.77 9.72 86.49 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -61.62 157.1 18.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.918 1.359 . . . . 0.0 112.401 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -77.34 62.63 2.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.68 1.592 . . . . 0.0 112.485 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.76 157.85 85.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.368 1.467 . . . . 0.0 112.716 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.31 178.24 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.683 2.922 . . . . 0.0 113.87 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.11 137.45 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.752 1.621 . . . . 0.0 111.248 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -82.7 144.48 30.2 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.306 1.443 . . . . 0.0 111.059 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.54 -8.3 83.31 Favored Glycine 0 CA--C 1.542 1.736 0 C-N-CA 124.761 1.172 . . . . 0.0 115.93 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 mp 55.4 22.35 4.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.208 2.203 . . . . 0.0 114.694 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -67.7 168.83 10.55 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.171 1.789 . . . . 0.0 113.204 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -66.18 -28.93 69.14 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.76 166.72 12.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.567 1.547 . . . . 0.0 113.15 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -132.76 107.22 8.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.154 1.781 . . . . 0.0 111.203 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.3 178.0 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.466 1.506 . . . . 0.0 110.971 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 m -128.97 110.49 12.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 110.015 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -114.49 168.12 10.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.312 1.445 . . . . 0.0 110.856 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -133.69 139.71 46.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.738 1.215 . . . . 0.0 110.29 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.37 131.06 29.34 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.668 1.187 . . . . 0.0 110.492 -176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.7 m -73.45 94.38 2.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.724 0.81 . . . . 0.0 111.574 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.7 mmm -80.46 54.33 2.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.789 1.636 . . . . 0.0 109.944 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.56 -88.77 1.13 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.398 1.951 . . . . 0.0 112.19 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -86.83 -14.04 43.28 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.3 p -145.44 143.52 30.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.8 m -75.06 92.28 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.935 1.294 . . . . 0.0 110.761 169.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -75.53 126.08 30.29 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.89 147.06 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.136 0.574 . . . . 0.0 110.869 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -128.75 108.39 10.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.746 2.018 . . . . 0.0 109.756 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -98.78 110.37 22.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.134 1.774 . . . . 0.0 110.461 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.01 -169.34 33.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.453 1.025 . . . . 0.0 112.647 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.06 87.14 2.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.561 -0.964 . . . . 0.0 111.215 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.36 122.49 27.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.027 1.731 . . . . 0.0 110.644 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.3 p -115.03 -8.06 12.48 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.534 1.534 . . . . 0.0 113.789 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.96 -173.18 49.76 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.776 1.655 . . . . 0.0 113.625 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.94 -159.97 42.73 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.102 0.858 . . . . 0.0 114.61 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -82.53 128.85 34.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.131 0.973 . . . . 0.0 110.65 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.5 p -70.04 -26.9 64.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.645 1.178 . . . . 0.0 113.352 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -139.59 160.04 40.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.891 2.077 . . . . 0.0 111.048 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 50.2 ttm -63.11 -31.61 72.79 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.68 73.68 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 114.036 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -80.98 -29.05 35.37 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.055 0.927 . . . . 0.0 113.265 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.83 -34.35 39.52 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.103 -0.998 . . . . 0.0 112.432 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.88 -22.33 66.63 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -78.54 -5.18 51.98 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.166 1.386 . . . . 0.0 114.566 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -118.92 -43.81 2.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.171 1.788 . . . . 0.0 112.411 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.5 m -63.83 158.74 59.35 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 111.814 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.42 -16.31 17.23 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 122.663 2.242 . . . . 0.0 113.805 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 C-N-CA 126.464 1.983 . . . . 0.0 113.207 177.651 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -58.24 117.02 3.96 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.443 1.897 . . . . 0.0 113.427 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -138.1 161.71 36.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.625 1.97 . . . . 0.0 111.652 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -93.04 68.36 4.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.257 1.423 . . . . 0.0 111.627 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.39 118.24 12.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.496 1.118 . . . . 0.0 112.217 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 p -73.81 148.64 42.26 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.812 0.845 . . . . 0.0 112.416 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.4 p -146.94 169.2 19.67 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.773 1.629 . . . . 0.0 112.144 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.58 157.4 72.21 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 126.626 1.97 . . . . 0.0 111.319 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.26 159.99 48.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.867 2.378 . . . . 0.0 112.675 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -58.82 -27.72 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.192 1.397 . . . . 0.0 113.635 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.88 -3.62 89.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.513 1.054 . . . . 0.0 115.23 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -68.76 141.4 55.23 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.42 1.61 . . . . 0.0 111.739 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -71.63 92.43 1.16 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.92 159.32 63.28 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.194 1.398 . . . . 0.0 112.532 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.03 161.39 38.75 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.748 2.299 . . . . 0.0 113.235 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.77 133.34 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.742 1.217 . . . . 0.0 111.886 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -72.16 144.71 48.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.314 1.046 . . . . 0.0 110.593 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.2 -6.9 80.91 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 57.01 20.02 5.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.974 2.11 . . . . 0.0 114.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 m -74.43 169.49 17.6 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.958 -1.089 . . . . 0.0 112.426 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.74 -39.96 80.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.938 0.895 . . . . 0.0 112.68 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 159.66 29.37 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.806 1.243 . . . . 0.0 113.115 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -131.39 90.18 2.83 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.938 1.695 . . . . 0.0 111.706 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -61.44 174.32 0.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 111.943 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -123.14 107.99 12.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.465 1.106 . . . . 0.0 110.341 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? -111.33 157.55 20.06 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.034 1.334 . . . . 0.0 111.039 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -120.99 138.96 53.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.95 120.71 18.46 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.843 1.257 . . . . 0.0 109.881 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.36 96.44 0.87 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.685 0.755 . . . . 0.0 110.581 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.6 mmm -78.95 81.88 5.19 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 0.0 108.734 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.96 -67.45 2.38 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.47 1.985 . . . . 0.0 114.536 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -132.64 -4.83 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.585 1.554 . . . . 0.0 114.068 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t -134.29 134.43 41.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.447 1.099 . . . . 0.0 112.007 -174.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 52.5 m -81.87 95.41 7.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 111.321 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.44 156.44 24.12 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.787 0.835 . . . . 0.0 110.981 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.38 145.11 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.655 1.182 . . . . 0.0 110.46 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.36 131.14 33.85 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.88 1.672 . . . . 0.0 110.388 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.41 122.42 24.96 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 111.187 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.27 52.15 0.02 OUTLIER Glycine 0 N--CA 1.474 1.184 0 C-N-CA 123.753 0.692 . . . . 0.0 113.709 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.6 t 61.22 23.59 13.79 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 0.0 114.459 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -67.73 136.44 54.27 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.389 . . . . 0.0 111.599 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -130.02 -7.38 4.41 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.48 -10.24 59.45 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.411 1.005 . . . . 0.0 115.375 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.82 174.07 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.831 1.205 . . . . 0.0 114.089 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -71.5 149.56 45.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.903 1.281 . . . . 0.0 111.863 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m -70.6 -31.21 68.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.034 1.334 . . . . 0.0 113.752 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -140.23 160.25 40.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.534 1.934 . . . . 0.0 111.063 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.8 ttm -62.57 -36.95 84.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.624 0.77 . . . . 0.0 112.413 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.83 91.69 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.359 -0.838 . . . . 0.0 113.645 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.03 -38.52 82.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.143 0.977 . . . . 0.0 112.65 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.0 p -75.52 -40.76 56.56 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.806 0.73 . . . . 0.0 111.985 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.38 87.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -68.48 -27.21 65.94 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.36 -48.43 10.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.795 1.238 . . . . 0.0 112.165 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -71.51 165.98 43.76 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.3 -24.83 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.143 2.562 . . . . 0.0 114.487 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.317 0 C-N-CA 125.816 1.674 . . . . 0.0 114.159 -175.809 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.499 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -66.95 167.29 11.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.734 1.214 . . . . 0.0 113.861 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.31 9.14 5.59 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.184 1.793 . . . . 0.0 114.039 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -62.2 133.73 55.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.403 1.081 . . . . 0.0 111.617 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -67.26 -51.69 49.89 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.564 1.145 . . . . 0.0 112.865 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.6 t 46.45 37.83 4.73 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.256 1.822 . . . . 0.0 113.457 -173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -60.38 144.98 49.57 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.209 1.404 . . . . 0.0 111.829 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.23 81.43 52.15 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.241 1.416 . . . . 0.0 109.96 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.93 163.71 34.89 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.108 2.539 . . . . 0.0 111.53 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.9 tp -56.79 -26.74 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.544 1.138 . . . . 0.0 113.422 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.83 -5.42 88.63 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.609 1.1 . . . . 0.0 115.274 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -71.51 160.22 33.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.605 1.703 . . . . 0.0 111.357 172.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 m -77.56 55.22 1.28 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.978 1.311 . . . . 0.0 112.233 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.39 156.29 88.82 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.032 1.333 . . . . 0.0 113.575 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.84 171.42 16.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.037 2.491 . . . . 0.0 112.776 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.84 132.74 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.159 1.384 . . . . 0.0 111.904 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -84.38 139.83 31.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.153 1.381 . . . . 0.0 110.53 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.14 -2.85 89.27 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.254 1.407 . . . . 0.0 116.156 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 54.11 27.3 7.46 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.89 2.076 . . . . 0.0 114.342 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 m -65.53 171.09 4.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.654 1.581 . . . . 0.0 112.96 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -75.0 -0.06 17.53 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.449 1.5 . . . . 0.0 114.841 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.28 163.35 19.82 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.156 1.782 . . . . 0.0 112.785 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -132.15 85.26 2.22 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.432 1.893 . . . . 0.0 111.934 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -72.63 172.61 10.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.022 0.929 . . . . 0.0 111.589 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 m -121.82 113.15 19.25 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.855 1.262 . . . . 0.0 109.256 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.49 164.63 14.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.212 1.405 . . . . 0.0 110.801 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.75 140.33 50.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.655 1.582 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -142.01 137.5 31.18 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.217 . . . . 0.0 111.001 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.67 97.16 8.95 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.648 -0.658 . . . . 0.0 111.455 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 88.8 mmm -81.67 71.48 8.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.165 1.386 . . . . 0.0 110.584 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.88 -79.59 1.67 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.505 1.526 . . . . 0.0 112.989 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.11 -10.3 9.04 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -133.07 136.64 46.03 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 110.386 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.56 144.39 47.94 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.362 -0.836 . . . . 0.0 110.884 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -132.68 132.55 42.52 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.019 1.727 . . . . 0.0 110.266 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.77 142.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.669 0.788 . . . . 0.0 110.65 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -129.56 103.35 6.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.694 1.998 . . . . 0.0 109.567 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -86.47 114.75 23.49 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.1 1.36 . . . . 0.0 110.453 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.69 -176.44 33.22 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.542 1.067 . . . . 0.0 113.547 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 9.2 t -79.22 59.71 2.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.724 1.21 . . . . 0.0 111.89 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -85.72 -36.64 20.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.952 0.901 . . . . 0.0 113.358 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p 54.2 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 130.993 3.717 . . . . 0.0 118.187 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.45 -160.29 35.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.91 2.195 . . . . 0.0 113.85 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.17 -136.57 48.1 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.967 1.27 . . . . 0.0 113.518 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -108.33 136.91 47.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.327 1.451 . . . . 0.0 110.599 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t -75.64 -22.83 56.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.228 1.011 . . . . 0.0 112.255 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 154.86 49.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.169 1.788 . . . . 0.0 112.776 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -58.97 -33.07 70.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.081 0.952 . . . . 0.0 112.516 173.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.56 -40.94 94.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.055 0.836 . . . . 0.0 113.652 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.56 -31.8 73.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 0.0 112.249 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -71.04 -51.13 27.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.294 1.038 . . . . 0.0 111.797 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.47 76.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.902 1.681 . . . . 0.0 114.17 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.57 -21.3 65.49 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -105.72 -34.61 7.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.061 1.344 . . . . 0.0 113.464 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.4 m -61.35 159.15 32.88 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.096 0.959 . . . . 0.0 112.81 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.99 -14.62 26.29 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.983 2.455 . . . . 0.0 114.502 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.238 0 C-N-CA 126.324 1.916 . . . . 0.0 113.07 176.559 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -62.88 112.2 2.46 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.298 1.439 . . . . 0.0 112.564 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -134.55 171.91 13.66 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.963 2.105 . . . . 0.0 111.472 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.24 153.13 27.07 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.465 1.106 . . . . 0.0 111.729 171.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.89 157.32 39.7 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.092 1.357 . . . . 0.0 112.847 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.2 m -136.61 106.0 6.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.087 1.755 . . . . 0.0 109.671 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 p -76.38 92.6 3.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.798 0.839 . . . . 0.0 112.401 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -128.95 82.39 68.85 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.652 1.981 . . . . 0.0 110.832 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.99 168.14 25.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.922 2.415 . . . . 0.0 112.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.56 -27.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.545 1.138 . . . . 0.0 113.418 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.21 90.1 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.803 1.192 . . . . 0.0 115.375 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -65.48 152.65 43.48 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.405 1.603 . . . . 0.0 111.984 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 p -75.54 72.17 2.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.375 1.47 . . . . 0.0 112.064 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.8 151.35 85.09 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.682 1.193 . . . . 0.0 112.542 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.6 171.11 17.86 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.018 2.479 . . . . 0.0 112.536 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.72 126.45 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.759 1.224 . . . . 0.0 112.179 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -69.69 141.84 53.47 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.394 1.078 . . . . 0.0 110.246 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.11 -6.67 89.07 Favored Glycine 0 CA--C 1.541 1.681 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.76 20.08 4.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.78 2.032 . . . . 0.0 113.985 -175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 m -77.18 172.03 13.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.643 1.177 . . . . 0.0 113.328 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -84.43 5.33 27.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.756 2.022 . . . . 0.0 115.305 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.01 165.07 20.14 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.302 1.841 . . . . 0.0 113.225 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -128.78 95.16 4.02 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.671 1.988 . . . . 0.0 112.571 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -83.19 177.34 8.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.762 0.825 . . . . 0.0 111.297 166.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -134.43 114.48 12.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.044 1.337 . . . . 0.0 111.227 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.4 mmp_? -116.05 166.14 12.34 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.965 1.706 . . . . 0.0 111.266 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.81 99.25 4.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.412 1.485 . . . . 0.0 110.496 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -97.13 137.15 36.62 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.48 0.712 . . . . 0.0 110.748 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -77.89 107.04 10.13 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.246 -0.909 . . . . 0.0 110.906 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.8 mmm -93.29 17.1 11.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.835 1.654 . . . . 0.0 113.529 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.44 90.04 2.14 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.473 1.511 . . . . 0.0 111.348 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 t30 59.23 14.05 3.39 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.34 1.856 . . . . 0.0 114.803 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.4 m -142.99 116.47 9.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.2 m -61.6 115.0 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.175 0.59 . . . . 0.0 110.55 157.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -113.49 132.18 55.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.63 1.572 . . . . 0.0 110.184 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.62 144.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.265 0.626 . . . . 0.0 111.608 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -133.73 137.93 45.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.881 1.672 . . . . 0.0 110.869 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -135.33 117.92 15.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.503 1.521 . . . . 0.0 110.776 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.41 59.22 0.01 OUTLIER Glycine 0 N--CA 1.475 1.273 0 C-N-CA 123.532 0.587 . . . . 0.0 114.292 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 59.0 25.18 13.52 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.03 113.16 6.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.985 1.314 . . . . 0.0 110.968 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -102.77 -8.26 20.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.944 1.298 . . . . 0.0 113.678 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.96 -174.14 42.46 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.523 1.535 . . . . 0.0 113.011 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 -171.53 26.76 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.206 0.908 . . . . 0.0 114.239 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.64 139.06 38.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.787 0.835 . . . . 0.0 110.746 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.6 p -84.76 -10.98 56.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -135.01 150.55 50.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.248 1.819 . . . . 0.0 112.037 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.3 tpp -59.37 -40.59 86.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.956 1.302 . . . . 0.0 111.575 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.55 93.44 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.558 -0.714 . . . . 0.0 113.471 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.18 -38.02 75.27 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.5 p -70.97 -41.75 70.63 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.602 1.092 . . . . 0.0 111.77 169.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.97 -29.5 68.55 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -69.54 -22.47 63.56 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -102.25 -50.79 3.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.988 1.315 . . . . 0.0 112.87 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.28 160.2 83.16 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 118.697 0.68 . . . . 0.0 112.707 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -75.41 -9.76 20.32 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.388 2.725 . . . . 0.0 114.4 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.522 0 C-N-CA 126.874 2.178 . . . . 0.0 112.572 178.706 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -145.63 164.4 31.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.756 1.623 . . . . 0.0 110.474 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -133.82 -12.04 2.62 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.563 2.345 . . . . 0.0 113.576 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -135.49 76.72 1.63 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.554 1.142 . . . . 0.0 111.823 -172.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.96 166.0 15.79 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.315 1.846 . . . . 0.0 112.565 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.7 t -74.88 131.43 40.72 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.426 -0.796 . . . . 0.0 111.455 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.7 p -139.15 160.3 40.12 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.303 1.441 . . . . 0.0 111.76 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.57 157.5 70.11 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 127.037 2.135 . . . . 0.0 109.949 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.72 161.75 44.7 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.042 . . . . 0.0 112.15 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -62.86 146.19 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.393 0.677 . . . . 0.0 110.653 170.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 15.81 81.27 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.031 0.772 . . . . 0.0 115.031 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -61.52 165.29 4.99 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.87 1.335 . . . . 0.0 111.74 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 t -72.2 93.94 1.51 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.094 -1.003 . . . . 0.0 111.538 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.61 156.73 34.92 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.514 1.525 . . . . 0.0 112.856 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.33 152.6 55.52 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.916 2.411 . . . . 0.0 112.461 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.91 128.62 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.871 0.868 . . . . 0.0 111.936 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -71.53 140.6 49.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.057 0.943 . . . . 0.0 110.664 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.08 -8.94 87.29 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.2 mt 61.67 16.55 7.88 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.222 2.209 . . . . 0.0 115.058 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.0 m -74.94 170.99 14.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.116 1.367 . . . . 0.0 113.551 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.57 -20.55 65.4 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.73 164.36 14.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.427 1.891 . . . . 0.0 112.361 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.55 99.78 4.76 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 112.184 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.34 176.63 1.02 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.349 1.06 . . . . 0.0 110.944 165.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.0 m -124.08 112.41 17.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -119.68 166.59 13.0 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.022 1.729 . . . . 0.0 110.856 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.49 137.75 44.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.356 1.063 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -141.99 126.75 18.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.859 1.264 . . . . 0.0 110.401 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -78.12 128.38 33.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.984 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtp -102.87 5.54 38.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.701 1.2 . . . . 0.0 113.371 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.89 -74.77 0.27 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.527 1.537 . . . . 0.0 111.978 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -120.35 13.69 11.93 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.711 1.605 . . . . 0.0 113.15 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.8 p -147.89 169.37 19.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.21 1.404 . . . . 0.0 111.597 169.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -117.01 111.93 20.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.27 1.828 . . . . 0.0 110.719 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -97.82 137.21 37.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.699 1.599 . . . . 0.0 110.899 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.52 146.79 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.831 0.852 . . . . 0.0 111.456 171.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.37 124.95 25.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.586 1.954 . . . . 0.0 110.555 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -127.44 110.7 13.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.234 1.414 . . . . 0.0 111.388 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.44 52.31 0.01 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 -168.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.0 t 60.51 22.32 12.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.679 1.592 . . . . 0.0 114.476 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.43 128.76 37.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.659 1.584 . . . . 0.0 111.082 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.0 p -105.36 -20.6 13.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.461 1.104 . . . . 0.0 113.769 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.24 -161.06 34.97 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.899 1.714 . . . . 0.0 114.052 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.54 -172.1 48.73 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.861 1.22 . . . . 0.0 114.427 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -73.29 138.12 45.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.525 0.73 . . . . 0.0 109.951 167.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.2 m -70.08 -32.2 70.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.614 0.766 . . . . 0.0 113.054 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -140.49 165.46 27.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.264 1.826 . . . . 0.0 112.17 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.4 ttt -68.91 -24.54 64.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.33 -35.78 69.64 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.259 -0.9 . . . . 0.0 112.809 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -44.07 69.71 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.326 1.45 . . . . 0.0 112.523 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -62.92 -42.56 99.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.777 0.717 . . . . 0.0 112.334 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -3.82 9.98 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.2 mtp-105 -67.22 -42.49 83.97 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.743 -1.223 . . . . 0.0 111.889 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -93.6 -53.08 4.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.248 1.819 . . . . 0.0 111.433 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.3 m -77.05 158.18 80.36 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 111.432 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.6 -11.5 22.27 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.493 2.129 . . . . 0.0 114.943 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.242 0 C-N-CA 125.8 1.667 . . . . 0.0 113.386 179.539 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.453 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.8 162.82 15.36 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.693 1.197 . . . . 0.0 113.768 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -139.71 164.01 31.07 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.393 1.877 . . . . 0.0 111.654 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -68.74 158.97 33.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.766 1.227 . . . . 0.0 111.694 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -130.14 156.92 43.77 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.793 1.237 . . . . 0.0 113.044 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.6 t -97.78 45.48 1.03 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.613 1.965 . . . . 0.0 111.43 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.4 p -67.77 152.79 45.02 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.832 -1.168 . . . . 0.0 112.469 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.5 89.68 18.33 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.281 1.432 . . . . 0.0 109.941 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.27 166.0 29.78 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.015 175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.75 148.14 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.89 0.876 . . . . 0.0 111.229 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.72 6.64 89.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -65.66 159.69 24.33 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 119.029 1.414 . . . . 0.0 112.151 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.1 m -76.39 53.5 0.85 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.047 1.739 . . . . 0.0 112.781 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.43 156.11 86.53 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.029 1.332 . . . . 0.0 112.647 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.49 166.19 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.463 2.776 . . . . 0.0 113.604 176.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -97.34 132.52 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.974 1.31 . . . . 0.0 111.639 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -77.27 142.66 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 111.16 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.05 -9.16 77.61 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.478 1.513 . . . . 0.0 115.209 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mp 55.13 18.07 2.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.365 2.266 . . . . 0.0 114.687 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 p -70.9 173.05 7.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -75.65 2.52 11.71 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.204 1.801 . . . . 0.0 114.206 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.52 169.82 13.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.26 2.224 . . . . 0.0 111.431 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -136.55 105.1 5.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.401 1.48 . . . . 0.0 111.126 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -93.87 155.11 17.36 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.55 1.14 . . . . 0.0 111.667 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -102.95 105.11 15.39 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.712 1.205 . . . . 0.0 110.658 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.26 157.85 32.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.02 1.328 . . . . 0.0 110.814 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.43 92.43 3.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.276 1.83 . . . . 0.0 111.146 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.08 139.47 30.6 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.495 -0.753 . . . . 0.0 111.506 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.7 m -74.43 109.11 7.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.87 0.868 . . . . 0.0 112.151 172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.6 mtp -91.75 69.44 5.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.669 1.188 . . . . 0.0 109.804 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.06 -100.51 1.25 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.266 1.413 . . . . 0.0 112.733 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.33 -8.67 56.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.24 161.0 38.5 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.978 1.711 . . . . 0.0 111.49 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.9 m -90.24 152.49 21.05 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.658 -0.651 . . . . 0.0 111.602 165.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -133.34 132.65 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.253 1.821 . . . . 0.0 109.903 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -77.01 146.54 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.985 0.514 . . . . 0.0 111.126 171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -109.44 -68.76 0.9 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 67.83 78.57 0.23 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.573 1.949 . . . . 0.0 112.91 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.92 14.84 0.03 OUTLIER Glycine 0 N--CA 1.474 1.181 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.6 t 77.07 91.98 0.07 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.436 2.294 . . . . 0.0 112.104 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.3 -56.94 0.8 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 0.0 113.664 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.9 p 54.84 -2.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 129.693 3.197 . . . . 0.0 118.473 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.53 -19.66 53.89 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 119.848 1.204 . . . . 0.0 115.375 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.87 179.04 27.46 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 126.002 1.763 . . . . 0.0 113.356 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -58.88 142.76 49.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.679 1.191 . . . . 0.0 112.871 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.0 p -83.4 -16.28 46.54 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.219 1.408 . . . . 0.0 114.458 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -137.79 154.71 49.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.324 1.85 . . . . 0.0 111.511 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 46.7 ttm -65.67 -29.42 69.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.508 0.723 . . . . 0.0 112.562 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.33 -37.59 94.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.992 -1.068 . . . . 0.0 113.452 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -71.46 -33.8 69.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.106 0.962 . . . . 0.0 113.098 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.2 p -74.9 -49.46 20.23 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.785 -0.572 . . . . 0.0 111.735 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.24 -16.92 62.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.75 -25.78 65.8 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.052 1.296 . . . . 0.0 113.438 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -100.55 -48.9 4.38 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.103 1.361 . . . . 0.0 111.555 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m -75.25 164.1 63.37 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.443 2.297 . . . . 0.0 111.568 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.78 -6.46 15.22 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.108 1.872 . . . . 0.0 113.683 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 C-N-CA 128.067 2.746 . . . . 0.0 112.527 177.238 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -137.25 44.43 2.28 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.679 1.192 . . . . 0.0 111.245 -159.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -51.02 -31.38 18.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.922 2.489 . . . . 0.0 115.653 -168.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.8 24.59 5.35 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.865 1.666 . . . . 0.0 112.824 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.76 154.6 8.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.953 1.301 . . . . 0.0 112.411 169.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.7 p -64.3 141.9 58.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.215 1.006 . . . . 0.0 113.204 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.7 p -140.1 172.4 12.81 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.451 1.901 . . . . 0.0 110.924 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t -126.36 84.2 62.55 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.85 1.26 . . . . 0.0 109.201 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.75 160.15 48.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.87 2.38 . . . . 0.0 111.682 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -61.62 141.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.306 0.574 . . . . 0.0 110.726 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.37 -3.92 85.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.387 0.994 . . . . 0.0 115.163 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.52 156.51 34.7 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.357 1.579 . . . . 0.0 110.956 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 t -77.52 97.81 5.14 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.52 1.128 . . . . 0.0 111.717 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 157.37 34.31 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.902 1.681 . . . . 0.0 113.181 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.4 161.58 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.043 2.495 . . . . 0.0 112.605 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.68 134.56 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.506 1.122 . . . . 0.0 111.85 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -66.84 141.73 57.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.148 0.979 . . . . 0.0 110.485 174.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -10.39 85.82 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.2 mt 62.78 13.24 6.3 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.466 2.306 . . . . 0.0 114.716 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -80.62 171.54 14.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.592 1.157 . . . . 0.0 113.3 -172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -62.55 -43.4 98.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.941 1.296 . . . . 0.0 113.412 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.52 126.53 35.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 113.238 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.33 89.48 5.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.272 1.429 . . . . 0.0 111.174 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -64.1 176.12 1.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.417 1.087 . . . . 0.0 111.625 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -123.0 105.83 10.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.403 1.081 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -112.42 168.14 9.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.197 1.799 . . . . 0.0 110.729 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -135.97 140.1 43.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.37 1.068 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.36 138.85 35.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.181 0.992 . . . . 0.0 112.277 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.38 91.48 1.35 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.929 1.292 . . . . 0.0 112.251 175.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 76.1 mmm -85.61 76.6 9.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.175 0.99 . . . . 0.0 109.331 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.34 -86.44 0.71 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.747 1.641 . . . . 0.0 112.257 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -122.1 3.63 9.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.659 1.583 . . . . 0.0 114.228 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.6 m -130.48 124.95 33.15 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.539 1.536 . . . . 0.0 111.846 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.3 m -73.34 85.98 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.035 1.334 . . . . 0.0 111.632 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -75.42 139.85 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.536 -0.728 . . . . 0.0 110.897 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.38 143.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.692 1.197 . . . . 0.0 111.366 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.98 133.25 45.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.138 1.775 . . . . 0.0 110.734 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -134.3 106.98 7.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.088 1.355 . . . . 0.0 111.293 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.55 0.01 OUTLIER Glycine 0 N--CA 1.475 1.246 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -171.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 t 55.07 29.48 12.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.002 1.321 . . . . 0.0 114.383 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.34 140.8 52.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.756 1.223 . . . . 0.0 110.764 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.8 p -139.06 -3.35 1.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.95 9.76 74.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.349 1.452 . . . . 0.0 116.019 -172.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.03 -172.1 24.78 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 118.861 1.33 . . . . 0.0 114.702 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -61.56 135.93 57.83 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 114.082 -165.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.1 t -72.23 -22.71 61.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 113.363 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -136.07 152.21 50.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.901 1.68 . . . . 0.0 112.518 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.6 tpp -55.04 -44.45 74.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.572 1.549 . . . . 0.0 111.049 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.84 -50.68 62.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.047 1.308 . . . . 0.0 113.306 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -62.15 -37.86 86.8 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.542 1.171 . . . . 0.0 112.991 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.4 t -60.13 -42.24 94.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 171.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.47 -14.69 44.0 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.22 -54.28 39.83 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.082 1.353 . . . . 0.0 111.838 171.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.05 -33.17 44.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 113.265 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m -66.48 160.03 69.36 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.559 0.743 . . . . 0.0 112.306 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.06 -16.69 22.64 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.375 2.717 . . . . 0.0 114.683 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.229 0 C-N-CA 126.029 1.776 . . . . 0.0 112.694 179.154 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.409 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -68.14 168.64 11.73 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.499 1.119 . . . . 0.0 113.101 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt 53.58 33.28 16.0 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.522 1.929 . . . . 0.0 113.762 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -64.81 165.48 10.52 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.541 1.536 . . . . 0.0 113.523 174.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -149.09 166.8 27.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.73 1.612 . . . . 0.0 111.717 172.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.0 t -124.88 -2.08 7.8 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.858 1.263 . . . . 0.0 113.658 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.6 p -70.16 159.85 33.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.448 1.499 . . . . 0.0 112.884 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 m -140.8 158.35 65.56 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 126.675 1.99 . . . . 0.0 111.232 177.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.14 159.05 54.5 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.387 2.058 . . . . 0.0 111.474 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.53 -28.37 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.291 1.037 . . . . 0.0 113.346 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.44 2.44 87.91 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.125 1.345 . . . . 0.0 115.514 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -64.25 158.45 23.24 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.411 1.605 . . . . 0.0 112.085 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -78.87 98.33 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.647 1.179 . . . . 0.0 111.615 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.01 157.23 37.52 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.874 1.67 . . . . 0.0 112.936 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.08 166.22 29.58 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.348 2.699 . . . . 0.0 112.975 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.53 133.35 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.77 1.228 . . . . 0.0 112.194 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -73.32 143.95 46.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.457 1.503 . . . . 0.0 110.705 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.82 -8.67 87.22 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.3 mp 49.72 35.86 9.75 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.63 1.972 . . . . 0.0 113.321 -173.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 m -78.57 168.35 19.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.35 1.46 . . . . 0.0 112.954 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -68.66 -35.06 76.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.253 1.021 . . . . 0.0 113.198 165.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.88 160.53 27.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.138 1.375 . . . . 0.0 112.6 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -132.87 77.51 1.74 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.007 1.723 . . . . 0.0 111.049 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.81 166.24 22.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.543 1.137 . . . . 0.0 111.389 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -128.82 120.93 27.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.635 1.574 . . . . 0.0 110.647 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -124.82 171.85 9.81 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.088 2.555 . . . . 0.0 110.343 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -134.72 137.62 43.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.681 1.192 . . . . 0.0 110.307 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -137.97 132.43 32.3 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.271 1.028 . . . . 0.0 111.544 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.91 121.56 15.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.009 0.923 . . . . 0.0 111.571 170.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.7 mmm -111.87 11.8 20.81 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.672 1.989 . . . . 0.0 113.082 -176.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.27 104.04 1.2 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.694 1.14 . . . . 0.0 111.485 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 63.67 -1.27 0.63 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.148 2.179 . . . . 0.0 115.23 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -141.9 156.25 45.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.873 2.069 . . . . 0.0 110.294 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.42 107.93 14.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.949 1.3 . . . . 0.0 110.006 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -90.53 144.48 25.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.434 1.093 . . . . 0.0 110.874 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.28 146.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.691 0.796 . . . . 0.0 111.002 167.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.34 129.21 42.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.319 1.848 . . . . 0.0 109.012 172.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -133.17 149.91 52.03 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.679 0.792 . . . . 0.0 112.27 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.18 12.01 2.16 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 10.1 t 95.87 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 130.05 3.34 . . . . 0.0 110.504 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.05 130.6 33.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.242 1.817 . . . . 0.0 109.114 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -117.41 -4.36 11.32 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.871 1.268 . . . . 0.0 113.941 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.31 -167.97 31.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.198 1.856 . . . . 0.0 113.197 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.85 -164.47 43.0 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.232 0.92 . . . . 0.0 114.526 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -81.89 138.86 34.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.884 0.873 . . . . 0.0 110.392 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -69.14 -30.56 68.83 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -140.6 158.48 43.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.659 1.984 . . . . 0.0 112.087 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.2 ttm -61.75 -34.87 76.62 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.162 0.585 . . . . 0.0 112.084 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.5 -27.93 70.4 Favored Glycine 0 CA--C 1.536 1.377 0 O-C-N 121.471 -0.768 . . . . 0.0 114.059 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.26 -48.27 17.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.266 1.033 . . . . 0.0 112.072 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -65.13 -30.14 71.05 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.462 1.028 . . . . 0.0 113.058 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -6.52 7.23 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -78.32 -12.2 59.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.0 -1.062 . . . . 0.0 113.598 167.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -125.36 -52.77 1.61 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.567 1.947 . . . . 0.0 112.221 -177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.5 m -65.98 158.99 73.47 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.746 0.819 . . . . 0.0 111.513 164.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.91 -14.55 23.91 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.652 2.234 . . . . 0.0 114.535 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.327 1.917 . . . . 0.0 112.576 -178.786 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.491 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -137.44 162.6 33.22 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.524 1.53 . . . . 0.0 111.667 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.69 109.69 9.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.241 1.816 . . . . 0.0 110.987 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.09 67.78 1.35 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.916 1.286 . . . . 0.0 111.185 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -74.34 143.36 44.93 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.833 -1.167 . . . . 0.0 111.394 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.0 p -106.73 45.72 0.97 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.965 1.306 . . . . 0.0 112.525 -177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.5 t -63.19 -24.43 67.88 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.812 1.645 . . . . 0.0 113.862 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t 55.23 81.52 0.26 Allowed Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 128.443 2.697 . . . . 0.0 111.73 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.88 158.88 56.1 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.713 2.275 . . . . 0.0 111.802 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.06 138.33 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.239 0.616 . . . . 0.0 111.092 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.69 -1.58 68.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.539 1.066 . . . . 0.0 115.312 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.2 t-105 -65.3 151.69 45.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.588 1.694 . . . . 0.0 111.187 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -78.08 72.14 4.59 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.108 1.363 . . . . 0.0 112.526 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.58 155.16 89.48 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.864 1.265 . . . . 0.0 114.082 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.4 174.38 12.93 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.908 3.072 . . . . 0.0 112.124 170.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.3 143.12 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.614 1.165 . . . . 0.0 112.62 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.35 146.27 54.7 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.434 1.493 . . . . 0.0 111.033 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.47 -7.07 79.85 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 56.05 22.77 6.18 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.267 2.227 . . . . 0.0 114.346 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 m -75.02 172.22 12.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.772 1.229 . . . . 0.0 112.723 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -76.57 -2.12 30.89 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.471 1.509 . . . . 0.0 114.819 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.88 160.74 28.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.9 1.68 . . . . 0.0 113.059 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -131.11 85.16 2.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.48 1.912 . . . . 0.0 112.407 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -66.24 172.0 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.233 1.013 . . . . 0.0 111.293 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -121.24 114.0 20.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.294 1.038 . . . . 0.0 110.518 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -118.37 168.13 10.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.955 1.702 . . . . 0.0 110.657 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -131.65 142.6 49.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.533 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.36 132.26 29.3 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.207 1.403 . . . . 0.0 109.987 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.5 t -71.47 140.62 50.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.808 166.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.31 24.99 11.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.488 1.515 . . . . 0.0 112.59 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.26 -40.35 1.68 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.188 2.328 . . . . 0.0 112.491 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -152.19 -48.46 0.11 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.687 1.595 . . . . 0.0 112.223 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.2 m -71.02 134.75 47.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.122 0.969 . . . . 0.0 111.841 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 95.9 m -73.58 134.86 43.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.006 0.922 . . . . 0.0 110.749 162.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.14 133.52 54.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.039 1.736 . . . . 0.0 109.679 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.78 146.45 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.401 0.681 . . . . 0.0 110.847 172.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.54 134.82 41.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.992 1.717 . . . . 0.0 110.747 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -136.67 113.42 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.208 1.403 . . . . 0.0 111.001 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.63 60.52 0.02 OUTLIER Glycine 0 N--CA 1.476 1.344 0 N-CA-C 115.166 0.827 . . . . 0.0 115.166 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 t 59.73 30.52 20.11 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -70.44 -45.78 65.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.786 1.234 . . . . 0.0 113.641 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.2 p 50.83 -8.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 131.112 3.765 . . . . 0.0 118.394 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.52 -161.35 37.36 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 127.265 2.364 . . . . 0.0 113.965 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.69 -122.99 31.94 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.541 1.067 . . . . 0.0 113.007 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.36 152.84 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.768 1.627 . . . . 0.0 111.944 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.2 p -82.2 -23.54 35.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.867 1.267 . . . . 0.0 114.219 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -137.34 156.11 48.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.152 1.381 . . . . 0.0 112.417 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 ttt -66.46 -19.8 65.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.849 1.26 . . . . 0.0 113.123 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.88 -38.58 26.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.904 0.764 . . . . 0.0 113.501 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -64.56 -45.62 86.3 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.767 1.284 . . . . 0.0 112.747 -174.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -59.69 -35.11 73.82 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.55 -0.719 . . . . 0.0 112.176 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -14.21 60.43 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -74.47 -21.03 59.78 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.819 -1.176 . . . . 0.0 112.762 166.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -103.66 -55.51 2.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.018 1.727 . . . . 0.0 111.649 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m -75.68 161.44 76.15 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 113.237 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.13 -8.35 16.44 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.888 3.059 . . . . 0.0 115.433 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 C-N-CA 126.195 1.855 . . . . 0.0 114.721 -178.516 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -75.41 66.35 1.82 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.769 1.628 . . . . 0.0 113.444 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -77.74 102.54 7.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.513 1.525 . . . . 0.0 110.483 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.08 24.14 11.94 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.075 1.75 . . . . 0.0 112.78 -175.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -55.93 144.17 29.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.672 1.589 . . . . 0.0 112.985 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.02 83.11 3.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.893 1.277 . . . . 0.0 111.131 171.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 p -66.15 142.82 57.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.099 0.559 . . . . 0.0 110.642 164.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.56 157.98 69.23 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 125.992 1.717 . . . . 0.0 110.813 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.74 155.69 67.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.238 1.959 . . . . 0.0 112.316 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.62 -26.26 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.213 1.405 . . . . 0.0 113.587 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.98 2.43 86.82 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.996 1.284 . . . . 0.0 115.724 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -65.58 155.41 35.87 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.99 1.895 . . . . 0.0 111.555 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -73.53 75.24 1.46 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.906 1.283 . . . . 0.0 111.763 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -78.15 157.19 78.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.654 1.582 . . . . 0.0 113.287 176.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.0 174.81 11.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.21 2.607 . . . . 0.0 112.595 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.62 135.04 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.475 1.51 . . . . 0.0 111.006 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -86.41 138.75 31.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.51 1.124 . . . . 0.0 110.809 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.59 -2.21 88.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.215 1.388 . . . . 0.0 115.659 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 53.85 19.35 1.89 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.341 2.256 . . . . 0.0 114.866 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.4 p -71.85 170.05 14.49 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.014 -1.054 . . . . 0.0 113.472 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.97 3.15 7.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.85 1.66 . . . . 0.0 114.947 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.16 154.37 31.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.843 1.657 . . . . 0.0 112.257 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -124.47 90.42 3.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.308 1.843 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -75.92 171.77 13.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 111.544 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.9 m -125.59 113.71 17.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.186 1.394 . . . . 0.0 108.889 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -121.33 159.94 25.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.897 1.679 . . . . 0.0 110.723 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -119.52 142.64 48.13 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.069 0.948 . . . . 0.0 110.396 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.06 170.75 15.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.111 1.364 . . . . 0.0 110.195 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -136.95 144.92 43.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.539 1.136 . . . . 0.0 110.777 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.9 mtt -137.04 71.83 1.41 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.468 1.107 . . . . 0.0 110.231 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.87 -109.37 2.68 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.883 1.706 . . . . 0.0 112.73 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -113.12 34.01 4.72 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.868 1.667 . . . . 0.0 111.381 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.0 104.92 1.74 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.266 1.427 . . . . 0.0 112.742 -175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.04 157.13 31.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.605 1.162 . . . . 0.0 112.2 164.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -161.83 -178.98 6.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.125 2.17 . . . . 0.0 111.474 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.04 146.58 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.306 2.242 . . . . 0.0 110.767 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.93 138.12 49.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.004 2.122 . . . . 0.0 109.774 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.41 111.86 14.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.595 1.558 . . . . 0.0 110.377 -168.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.08 -170.95 33.3 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.984 0.802 . . . . 0.0 113.28 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.58 77.15 1.08 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 111.227 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.46 141.91 51.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.069 1.747 . . . . 0.0 111.803 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.3 p -134.51 -7.09 2.53 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -173.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.6 -2.4 65.32 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -172.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.62 174.45 25.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.826 1.203 . . . . 0.0 115.06 -170.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.32 156.86 38.1 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.842 1.657 . . . . 0.0 111.953 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -78.75 -29.83 45.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.707 1.203 . . . . 0.0 114.144 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mtm105 -141.34 159.47 42.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.67 1.988 . . . . 0.0 111.347 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 33.4 ttm -62.86 -32.0 73.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.7 0.8 . . . . 0.0 112.356 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.8 -28.8 72.34 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.834 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.59 -46.53 38.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.019 1.409 . . . . 0.0 112.878 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.4 p -62.3 -31.91 72.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.073 -1.017 . . . . 0.0 112.379 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 -10.47 49.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.177 1.391 . . . . 0.0 114.739 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -79.71 -36.22 37.82 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.281 0.946 . . . . 0.0 112.571 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -84.43 -50.85 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 111.928 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.4 m -70.33 160.36 81.35 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 171.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.88 -16.41 45.62 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.418 2.745 . . . . 0.0 115.136 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 C-N-CA 125.779 1.656 . . . . 0.0 114.523 168.421 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 CA-C-O 121.576 0.542 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -68.64 158.14 34.7 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.593 1.157 . . . . 0.0 112.669 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.88 -6.32 2.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.095 1.758 . . . . 0.0 114.445 177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.44 105.36 4.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.874 1.269 . . . . 0.0 110.106 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -144.31 168.18 20.7 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.726 1.61 . . . . 0.0 110.936 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.4 p -137.47 156.78 47.75 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.978 0.911 . . . . 0.0 112.295 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.6 p -132.45 -20.88 2.32 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.032 1.333 . . . . 0.0 114.121 -169.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t 47.7 75.47 0.66 Allowed Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 128.438 2.695 . . . . 0.0 111.754 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.82 159.33 53.76 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.359 2.706 . . . . 0.0 112.503 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 tt -61.4 143.06 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.009 0.924 . . . . 0.0 111.314 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.77 -0.83 83.0 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.604 1.097 . . . . 0.0 115.291 -178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -65.09 160.06 21.92 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.19 1.495 . . . . 0.0 111.204 167.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.7 m -74.88 64.96 1.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.694 1.598 . . . . 0.0 112.91 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 154.2 91.61 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.672 1.189 . . . . 0.0 113.805 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.91 153.39 42.23 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.092 2.528 . . . . 0.0 112.183 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.95 135.03 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.84 0.856 . . . . 0.0 111.93 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.6 144.06 54.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.311 1.045 . . . . 0.0 110.726 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 -10.61 86.13 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 115.219 0.847 . . . . 0.0 115.219 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.6 mt 61.84 14.37 6.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.495 2.318 . . . . 0.0 115.134 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 m -75.76 171.75 13.82 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.599 1.16 . . . . 0.0 113.617 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.76 -46.7 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 112.14 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.82 159.51 28.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.063 1.345 . . . . 0.0 113.195 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -131.1 90.68 2.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.471 1.909 . . . . 0.0 111.527 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -68.6 174.23 4.4 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.968 1.307 . . . . 0.0 111.763 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -126.48 112.07 15.15 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 110.172 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -117.53 168.89 9.99 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.24 1.816 . . . . 0.0 110.459 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -133.18 135.33 45.03 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.603 1.161 . . . . 0.0 109.953 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -132.93 147.59 52.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 0.0 111.205 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.0 t -85.93 127.43 34.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.152 0.581 . . . . 0.0 110.475 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.1 mmm -116.19 25.14 10.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.494 1.917 . . . . 0.0 112.933 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.42 93.43 1.82 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.124 1.345 . . . . 0.0 111.228 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.257 13.2 p30 47.09 28.05 0.87 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.755 2.022 . . . . 0.0 115.116 -173.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -151.24 154.12 36.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.776 2.03 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.74 138.23 54.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.612 1.165 . . . . 0.0 110.819 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -142.48 148.46 37.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.649 1.18 . . . . 0.0 112.011 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.97 150.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.58 1.152 . . . . 0.0 111.804 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -134.73 132.77 39.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.795 2.038 . . . . 0.0 110.467 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -132.74 115.46 15.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.576 1.55 . . . . 0.0 111.022 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.73 55.23 0.01 OUTLIER Glycine 0 N--CA 1.475 1.295 0 O-C-N 121.823 -0.548 . . . . 0.0 114.454 -170.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.2 t 57.07 28.26 14.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.167 1.387 . . . . 0.0 114.401 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.81 139.67 53.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.651 1.18 . . . . 0.0 110.538 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.2 p -125.89 -5.29 6.87 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.89 1.276 . . . . 0.0 113.915 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.13 -167.67 33.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.813 1.673 . . . . 0.0 112.637 173.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.6 49.49 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 122.245 0.914 . . . . 0.0 113.808 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -79.82 148.77 31.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 0.0 111.198 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -78.14 -19.87 53.18 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.38 159.19 42.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.727 2.011 . . . . 0.0 111.95 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.7 tpp -62.45 -40.59 97.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.0 0.92 . . . . 0.0 112.199 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.82 -38.77 93.24 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.721 0.676 . . . . 0.0 112.902 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -39.24 90.96 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.038 1.335 . . . . 0.0 111.676 173.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.03 -56.62 15.41 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.769 -0.582 . . . . 0.0 111.676 167.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.76 70.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -79.18 -18.94 52.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -98.04 -47.07 5.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.876 1.27 . . . . 0.0 112.535 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 168.48 17.14 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.012 0.525 . . . . 0.0 111.604 167.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.93 -10.97 25.3 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.608 2.205 . . . . 0.0 115.5 -167.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 126.126 1.822 . . . . 0.0 113.186 175.136 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.522 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.14 96.41 6.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.903 1.281 . . . . 0.0 112.579 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.6 168.28 20.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.658 1.583 . . . . 0.0 112.288 168.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -73.16 139.28 46.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.105 0.962 . . . . 0.0 111.322 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -151.45 167.36 28.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.803 1.641 . . . . 0.0 111.353 172.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.8 t -73.88 121.92 21.69 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.445 -0.784 . . . . 0.0 111.391 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.5 p -125.29 166.46 16.47 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.782 1.633 . . . . 0.0 112.038 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.41 126.42 19.24 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.76 1.624 . . . . 0.0 109.371 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.74 146.45 54.14 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.37 2.047 . . . . 0.0 111.614 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.41 -27.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.64 1.176 . . . . 0.0 113.615 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.01 1.56 88.64 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.889 1.233 . . . . 0.0 115.491 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -65.02 155.63 34.04 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.567 1.683 . . . . 0.0 112.015 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 t -78.65 80.3 5.02 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.554 1.142 . . . . 0.0 111.725 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.81 153.84 89.16 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.851 1.26 . . . . 0.0 113.131 172.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.96 168.68 23.02 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.472 2.782 . . . . 0.0 112.897 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.12 134.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.13 1.372 . . . . 0.0 111.769 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -78.16 141.78 38.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.213 1.405 . . . . 0.0 110.93 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.21 -6.8 83.98 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.884 1.113 . . . . 0.0 115.884 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mp 57.5 17.92 4.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.266 2.226 . . . . 0.0 114.765 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.14 167.98 9.2 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.195 1.798 . . . . 0.0 113.706 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -66.34 -23.16 66.31 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.34 162.68 12.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.542 1.537 . . . . 0.0 112.894 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -131.61 95.85 3.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.012 1.725 . . . . 0.0 110.804 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -80.14 175.22 10.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 111.637 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -124.83 123.17 39.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.03 1.332 . . . . 0.0 109.887 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -126.71 162.72 25.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.426 1.89 . . . . 0.0 110.916 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -129.33 123.94 33.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.617 1.167 . . . . 0.0 110.327 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -130.26 126.01 36.23 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.521 1.128 . . . . 0.0 111.394 -172.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.36 122.04 18.13 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.293 -0.879 . . . . 0.0 111.659 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mmm -102.72 11.34 37.78 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.812 1.245 . . . . 0.0 113.371 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.08 -76.0 0.31 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.623 2.059 . . . . 0.0 111.863 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -126.14 6.39 7.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.062 1.745 . . . . 0.0 113.379 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.7 m -136.79 117.96 14.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.982 2.113 . . . . 0.0 109.448 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 t -78.25 122.19 25.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.443 0.697 . . . . 0.0 110.764 172.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -111.01 136.44 50.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.569 1.947 . . . . 0.0 110.74 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.84 144.31 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.619 0.768 . . . . 0.0 111.378 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -123.2 133.56 54.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.219 1.807 . . . . 0.0 109.655 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -126.56 109.88 12.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.932 1.693 . . . . 0.0 110.358 -170.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 -168.79 30.84 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.463 1.03 . . . . 0.0 112.121 -171.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.06 84.74 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.47 -1.017 . . . . 0.0 111.201 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -129.43 138.97 51.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.565 1.946 . . . . 0.0 110.268 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -127.94 -9.5 5.45 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.01 1.324 . . . . 0.0 114.43 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 -169.77 43.8 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.577 1.56 . . . . 0.0 113.067 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.47 -171.08 51.93 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 121.921 0.734 . . . . 0.0 114.001 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -83.49 149.81 26.39 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.434 1.494 . . . . 0.0 111.64 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.9 m -84.6 -14.32 49.08 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -141.5 153.9 45.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.453 1.501 . . . . 0.0 111.944 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 45.5 tpp -61.73 -24.51 66.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.383 1.473 . . . . 0.0 113.359 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.11 -22.74 58.64 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.197 -0.94 . . . . 0.0 114.572 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -78.59 -39.11 38.41 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.882 1.341 . . . . 0.0 112.623 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 p -58.87 -39.34 81.07 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.38 -0.825 . . . . 0.0 112.277 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.51 53.39 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -67.7 -40.84 84.32 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.923 -1.111 . . . . 0.0 111.705 169.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.5 -52.92 4.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.761 1.624 . . . . 0.0 111.938 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.7 m -76.04 159.75 79.89 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.983 0.913 . . . . 0.0 113.297 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.73 -9.27 21.06 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.652 2.901 . . . . 0.0 114.244 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 127.408 2.433 . . . . 0.0 113.001 178.522 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.81 166.99 27.17 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.525 2.817 . . . . 0.0 112.235 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.92 -28.15 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.427 1.091 . . . . 0.0 113.4 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.39 2.01 86.06 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.158 1.361 . . . . 0.0 115.393 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.15 156.43 31.72 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.404 1.602 . . . . 0.0 112.217 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -77.15 99.83 5.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.971 1.309 . . . . 0.0 111.483 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.0 155.72 36.23 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.406 1.482 . . . . 0.0 113.263 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.78 165.54 29.95 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.234 2.623 . . . . 0.0 112.475 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.23 138.05 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.803 1.241 . . . . 0.0 111.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -68.61 146.36 53.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.367 1.067 . . . . 0.0 110.604 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.42 -11.07 69.66 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mp 47.33 34.27 3.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.102 2.161 . . . . 0.0 114.737 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -97.37 178.68 5.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 1.75 14.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.544 1.938 . . . . 0.0 114.506 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.76 158.4 31.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.111 1.764 . . . . 0.0 112.778 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -134.7 83.75 2.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.932 1.693 . . . . 0.0 112.354 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.03 171.8 12.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.737 1.215 . . . . 0.0 111.663 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.6 m -122.05 112.75 18.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.355 1.462 . . . . 0.0 109.726 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -119.8 167.38 12.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.788 1.635 . . . . 0.0 110.849 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -133.41 140.14 47.16 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.182 0.993 . . . . 0.0 110.239 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -133.37 165.95 23.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 109.548 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.3 t -112.65 138.8 48.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.55 -0.719 . . . . 0.0 111.293 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.4 mtp -125.67 86.25 2.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.912 1.685 . . . . 0.0 109.255 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.37 -77.3 0.89 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.025 1.774 . . . . 0.0 112.68 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -131.57 -4.41 3.73 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.015 1.326 . . . . 0.0 114.135 -174.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.3 m -123.83 139.37 54.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.179 1.392 . . . . 0.0 111.536 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.09 147.52 32.74 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.942 0.897 . . . . 0.0 111.824 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -147.02 127.02 13.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.554 1.942 . . . . 0.0 110.565 -171.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.44 145.17 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.421 1.089 . . . . 0.0 112.372 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -131.72 137.06 48.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.344 1.857 . . . . 0.0 110.595 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.54 117.46 12.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.381 1.472 . . . . 0.0 110.666 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.62 65.69 0.04 OUTLIER Glycine 0 N--CA 1.477 1.409 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.88 28.74 15.02 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -72.45 -46.43 54.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.152 . . . . 0.0 113.588 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.3 p 50.75 -10.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 131.224 3.81 . . . . 0.0 118.405 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.61 -171.39 47.71 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.656 2.074 . . . . 0.0 113.168 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.06 -168.76 23.82 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.751 -0.852 . . . . 0.0 113.759 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -67.31 146.83 53.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.429 1.492 . . . . 0.0 111.932 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.8 p -75.43 -32.82 60.82 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -136.76 163.05 31.51 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.144 1.777 . . . . 0.0 112.071 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.3 tpp -56.53 -38.53 71.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.749 0.82 . . . . 0.0 111.725 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.06 -17.39 75.61 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.19 0.9 . . . . 0.0 115.07 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -82.85 -33.63 27.03 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.908 1.354 . . . . 0.0 111.798 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.2 t -69.33 -53.4 19.77 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.474 -0.766 . . . . 0.0 112.016 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.31 -17.87 64.94 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -78.94 -18.36 53.93 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -106.91 -51.69 2.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.196 1.398 . . . . 0.0 112.352 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.551 0.987 0 CA-C-N 118.713 0.688 . . . . 0.0 112.251 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.98 161.59 43.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.81 2.34 . . . . 0.0 112.5 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 tp -58.27 -28.12 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.833 1.253 . . . . 0.0 113.262 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.13 4.46 83.26 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.179 1.371 . . . . 0.0 115.506 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -63.6 157.34 24.09 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.479 1.639 . . . . 0.0 112.379 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -76.36 70.35 2.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.368 1.467 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.19 157.05 88.85 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.399 1.479 . . . . 0.0 112.901 171.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.76 176.72 9.01 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.848 3.032 . . . . 0.0 113.263 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.47 135.48 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.728 1.611 . . . . 0.0 111.52 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -77.28 141.95 39.71 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.969 1.308 . . . . 0.0 110.752 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.4 -4.42 90.0 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 56.15 21.16 4.96 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.822 2.049 . . . . 0.0 114.255 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.0 m -70.16 168.84 14.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.167 1.387 . . . . 0.0 113.29 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.17 -0.44 14.23 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.96 164.44 22.32 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.933 1.693 . . . . 0.0 112.766 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -129.47 93.09 3.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.247 1.819 . . . . 0.0 110.905 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.15 174.04 11.97 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.472 1.109 . . . . 0.0 111.455 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.1 m -128.01 110.84 12.9 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.001 1.32 . . . . 0.0 109.744 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -116.42 165.91 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.871 1.668 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.07 85.05 2.18 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.263 1.025 . . . . 0.0 111.135 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -82.35 156.19 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.844 0.858 . . . . 0.0 111.091 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 t -90.48 140.38 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 111.442 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.2 mtp -133.77 111.17 10.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.604 1.962 . . . . 0.0 109.663 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.69 -95.57 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.94 1.257 . . . . 0.0 112.186 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -116.0 -8.98 11.81 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.342 1.457 . . . . 0.0 113.932 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.3 p -120.51 156.58 31.23 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.733 1.151 . . . . 0.0 113.14 -171.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.24 124.53 35.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.687 1.195 . . . . 0.0 110.378 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -121.43 135.16 55.08 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.454 1.902 . . . . 0.0 110.704 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -67.22 145.99 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.318 0.647 . . . . 0.0 112.006 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -127.14 135.79 51.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.732 2.013 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.07 107.97 11.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.519 . . . . 0.0 110.423 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.01 -169.01 31.34 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.911 0.767 . . . . 0.0 113.095 -172.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.45 86.51 3.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.949 -0.736 . . . . 0.0 110.675 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.55 133.62 48.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.845 1.658 . . . . 0.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.2 p -136.79 -3.42 2.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.197 1.399 . . . . 0.0 114.389 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.1 0.83 58.98 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.189 1.376 . . . . 0.0 115.842 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.79 176.58 17.64 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.02 1.771 . . . . 0.0 113.606 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -60.01 136.37 57.99 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.204 1.002 . . . . 0.0 112.522 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.5 m -76.41 -17.16 59.49 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -131.92 146.99 52.44 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.081 1.753 . . . . 0.0 110.951 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 tpp -55.82 -37.84 69.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.241 1.016 . . . . 0.0 111.504 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.02 -47.8 85.68 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.225 0.917 . . . . 0.0 112.646 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.23 -37.9 81.75 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.091 0.946 . . . . 0.0 112.688 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.931 0.492 . . . . 0.0 111.887 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -19.01 65.65 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -66.46 -25.04 66.53 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.676 -1.265 . . . . 0.0 113.116 169.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -109.49 -55.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.807 1.643 . . . . 0.0 112.231 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.551 0.987 0 C-N-CA 123.709 0.804 . . . . 0.0 112.911 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.385 -0.341 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 160.12 50.44 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.848 2.366 . . . . 0.0 112.346 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 tt -58.85 -26.71 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.94 1.296 . . . . 0.0 113.712 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.83 2.02 88.0 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.886 1.232 . . . . 0.0 115.497 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -66.91 157.39 33.32 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.286 1.543 . . . . 0.0 112.617 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.3 m -75.37 57.7 0.93 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.974 . . . . 0.0 113.425 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.22 155.98 89.24 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.131 1.373 . . . . 0.0 113.912 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -75.39 178.46 7.3 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 124.003 3.135 . . . . 0.0 112.734 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.08 139.68 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.342 1.457 . . . . 0.0 112.213 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -68.18 142.44 55.7 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.026 1.33 . . . . 0.0 110.879 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.09 -11.63 75.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 46.17 69.82 0.44 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.313 2.245 . . . . 0.0 112.671 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.6 m -120.55 175.12 6.15 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.652 1.581 . . . . 0.0 111.874 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -84.64 4.5 32.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.156 1.382 . . . . 0.0 114.475 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.13 163.53 24.44 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.338 1.855 . . . . 0.0 112.808 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -130.33 87.12 2.47 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.156 1.783 . . . . 0.0 111.677 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.06 175.46 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.508 1.123 . . . . 0.0 112.152 171.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -128.04 115.36 18.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.221 1.408 . . . . 0.0 110.256 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -119.98 165.71 14.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.11 1.764 . . . . 0.0 111.037 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -129.04 134.44 48.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 109.945 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.62 139.6 47.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.708 1.203 . . . . 0.0 110.436 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.6 t -81.3 111.19 17.46 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.604 -0.685 . . . . 0.0 111.589 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.8 mmm -92.68 71.61 4.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.109 0.963 . . . . 0.0 109.33 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.25 -75.0 2.39 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.99 1.757 . . . . 0.0 113.804 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -133.65 5.96 3.72 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.843 1.657 . . . . 0.0 113.745 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 93.4 m -135.65 117.18 14.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.188 1.795 . . . . 0.0 110.399 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.61 133.29 49.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.896 0.878 . . . . 0.0 111.165 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -131.21 141.45 50.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.119 1.768 . . . . 0.0 110.983 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.64 145.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 112.19 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -134.39 141.57 46.88 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.113 2.165 . . . . 0.0 110.552 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.97 117.67 10.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.426 1.49 . . . . 0.0 110.759 -172.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.02 58.85 0.02 OUTLIER Glycine 0 N--CA 1.478 1.456 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 56.52 30.92 18.05 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -71.23 -53.24 15.05 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.658 1.183 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.5 p 50.74 3.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 129.618 3.167 . . . . 0.0 118.23 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.97 -6.31 52.21 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.342 1.449 . . . . 0.0 116.082 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.12 -177.97 39.0 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.165 1.364 . . . . 0.0 114.112 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.4 146.76 47.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.167 1.387 . . . . 0.0 111.535 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.8 t -69.39 -36.39 76.73 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -136.26 162.58 32.58 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.259 1.824 . . . . 0.0 111.123 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 35.7 tpp -58.03 -37.56 74.57 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 112.014 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.8 -44.15 98.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.64 1.114 . . . . 0.0 113.792 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.26 -40.25 96.87 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.451 1.126 . . . . 0.0 112.22 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.8 t -57.8 -47.76 81.67 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.378 1.071 . . . . 0.0 111.348 170.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.18 62.71 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -73.08 -40.76 64.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.069 1.304 . . . . 0.0 112.06 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -84.4 -51.5 6.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.45 1.5 . . . . 0.0 112.006 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.549 0.935 0 C-N-CA 123.802 0.841 . . . . 0.0 112.995 174.335 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.81 162.57 41.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.71 2.273 . . . . 0.0 112.67 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.11 -27.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.96 1.304 . . . . 0.0 113.509 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.44 3.98 86.36 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.068 1.318 . . . . 0.0 115.298 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -64.46 157.81 25.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.438 1.619 . . . . 0.0 112.317 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 m -72.92 58.23 0.46 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.926 2.09 . . . . 0.0 113.376 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.55 155.54 80.91 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.873 1.269 . . . . 0.0 113.25 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.12 176.43 9.55 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.478 2.785 . . . . 0.0 113.382 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.46 140.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.651 1.58 . . . . 0.0 111.206 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -81.91 145.73 30.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.047 1.339 . . . . 0.0 111.107 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.08 -7.3 80.65 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 124.99 1.281 . . . . 0.0 115.823 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mp 53.98 26.61 6.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.01 2.124 . . . . 0.0 114.435 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -68.12 171.1 7.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.116 1.766 . . . . 0.0 113.233 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -76.0 -1.82 27.59 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.562 1.545 . . . . 0.0 114.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.85 167.48 18.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.212 1.805 . . . . 0.0 112.859 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -127.57 102.72 6.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.388 1.875 . . . . 0.0 110.988 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.21 175.77 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.803 1.241 . . . . 0.0 111.271 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.7 m -128.75 117.1 20.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.141 1.377 . . . . 0.0 109.518 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -123.91 167.06 14.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.491 1.516 . . . . 0.0 110.463 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.32 105.18 5.87 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.353 1.461 . . . . 0.0 109.993 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -103.57 132.03 50.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 111.117 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.05 91.99 2.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.291 0.567 . . . . 0.0 111.7 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -86.76 83.76 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.54 1.136 . . . . 0.0 109.936 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.67 -73.47 2.26 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.602 1.572 . . . . 0.0 112.837 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -136.1 0.69 2.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 114.058 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -136.22 151.96 50.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.008 0.923 . . . . 0.0 112.992 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.8 m -89.05 81.16 6.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.491 1.516 . . . . 0.0 111.42 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -64.84 124.2 21.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.245 0.618 . . . . 0.0 110.142 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.77 142.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.082 0.553 . . . . 0.0 111.347 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -125.91 125.7 43.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.456 1.902 . . . . 0.0 109.717 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.21 106.18 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.876 1.67 . . . . 0.0 110.237 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.94 -169.55 32.5 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.809 1.195 . . . . 0.0 112.078 -170.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.4 t -77.14 88.6 3.62 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.471 -1.017 . . . . 0.0 111.177 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -129.48 134.68 47.93 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.005 1.722 . . . . 0.0 110.321 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.0 p -138.77 -7.98 1.42 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.983 1.313 . . . . 0.0 114.519 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.91 -2.99 88.24 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.932 1.254 . . . . 0.0 115.982 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.82 178.03 22.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.819 1.676 . . . . 0.0 112.993 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -55.21 134.0 49.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.763 1.625 . . . . 0.0 114.033 -165.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 t -81.04 -10.87 59.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -132.7 146.92 52.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.566 1.546 . . . . 0.0 111.643 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.5 tpp -52.96 -39.1 62.71 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.03 1.332 . . . . 0.0 111.849 168.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.03 -45.16 63.62 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.897 0.761 . . . . 0.0 113.325 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.66 -34.51 77.23 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.123 0.969 . . . . 0.0 112.36 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 t -66.17 -53.58 35.74 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.791 -0.568 . . . . 0.0 112.249 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.23 75.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -63.36 -22.49 66.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -104.53 -23.63 13.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.558 1.543 . . . . 0.0 114.1 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.8 m . . . . . 0 CA--C 1.551 0.988 0 CA-C-N 118.847 0.749 . . . . 0.0 112.697 164.822 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.06 148.81 63.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.451 2.101 . . . . 0.0 111.772 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.8 -21.98 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.416 1.087 . . . . 0.0 113.342 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.31 83.86 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 114.957 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -68.51 139.37 55.65 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.408 1.604 . . . . 0.0 110.829 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 t -72.43 94.18 1.62 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.41 159.07 50.97 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.379 1.471 . . . . 0.0 112.647 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.71 175.59 11.09 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.08 2.52 . . . . 0.0 113.711 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.76 138.28 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.696 1.598 . . . . 0.0 111.632 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HG2' ' H ' ' A' ' 37' ' ' LEU . 2.6 ttpm? -82.9 138.95 33.68 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.0 1.32 . . . . 0.0 111.191 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.68 2.62 82.34 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.544 2.021 . . . . 0.0 115.756 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.445 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 44.9 mt 57.19 17.89 3.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.015 2.526 . . . . 0.0 115.776 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.9 p -78.62 173.63 12.22 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 2.43 6.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.732 2.013 . . . . 0.0 115.252 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.61 162.43 17.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.572 1.549 . . . . 0.0 112.889 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -130.93 87.15 2.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.575 1.95 . . . . 0.0 111.545 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.39 174.88 11.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.976 1.311 . . . . 0.0 111.482 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -128.47 131.89 48.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.289 1.436 . . . . 0.0 109.377 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -130.42 158.29 40.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.833 1.253 . . . . 0.0 111.12 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -123.61 81.36 1.89 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.531 1.158 . . . . 0.0 111.374 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -77.37 170.91 15.72 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -126.45 136.4 52.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.552 1.141 . . . . 0.0 110.549 169.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.4 mmm -121.35 10.59 10.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.694 1.198 . . . . 0.0 112.814 -172.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.87 -91.07 0.12 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.656 1.598 . . . . 0.0 111.914 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.09 8.75 18.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.849 1.66 . . . . 0.0 113.411 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -146.2 132.75 19.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.302 1.841 . . . . 0.0 110.815 -172.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.2 m -81.01 86.68 6.08 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.604 0.761 . . . . 0.0 111.958 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -62.61 114.07 3.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.65 144.09 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.117 0.967 . . . . 0.0 111.165 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -124.93 148.23 48.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.276 1.43 . . . . 0.0 110.528 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -131.36 127.69 38.11 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.044 1.738 . . . . 0.0 110.575 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.62 -168.02 25.68 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.096 0.855 . . . . 0.0 112.652 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.73 71.19 0.34 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.602 -0.94 . . . . 0.0 111.861 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.5 136.15 53.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.699 1.6 . . . . 0.0 110.651 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.5 p -129.75 -8.39 4.52 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.301 1.441 . . . . 0.0 114.117 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.6 -174.06 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.325 1.44 . . . . 0.0 113.444 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.09 -172.95 8.47 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.123 0.868 . . . . 0.0 114.216 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -69.73 137.15 51.77 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.783 0.802 . . . . 0.0 112.05 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -80.82 -13.0 59.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -130.1 144.72 51.5 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.658 1.983 . . . . 0.0 110.875 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.2 ttt -65.3 -15.49 62.57 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.112 1.365 . . . . 0.0 113.895 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.11 -32.15 15.12 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.591 1.091 . . . . 0.0 114.275 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.27 -28.42 67.19 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.537 1.135 . . . . 0.0 113.049 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.7 p -73.98 -44.16 55.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.357 0.663 . . . . 0.0 112.171 168.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.87 -24.3 61.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.264 1.426 . . . . 0.0 114.564 -171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -65.89 -30.1 70.64 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 167.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.68 -49.15 5.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.665 1.186 . . . . 0.0 112.006 -171.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.552 1.033 0 C-N-CA 124.419 1.088 . . . . 0.0 112.431 169.155 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.06 155.23 57.27 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.64 2.226 . . . . 0.0 112.473 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.91 -27.34 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.943 1.297 . . . . 0.0 113.484 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.09 83.05 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.221 1.391 . . . . 0.0 115.51 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -63.7 153.8 35.12 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.527 1.663 . . . . 0.0 112.414 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -78.06 74.87 4.6 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.805 1.242 . . . . 0.0 111.5 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.18 154.25 94.27 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.511 1.125 . . . . 0.0 111.584 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.88 162.53 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 113.203 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.28 132.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.882 1.273 . . . . 0.0 111.437 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.58 136.62 47.5 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.203 1.001 . . . . 0.0 110.733 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.13 -4.22 86.06 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.361 0.982 . . . . 0.0 115.259 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.4 mt 59.35 9.07 1.3 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.747 2.419 . . . . 0.0 115.697 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 p -89.72 173.21 8.41 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -171.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -0.31 15.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.768 2.027 . . . . 0.0 115.92 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.86 152.12 25.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.293 1.437 . . . . 0.0 112.849 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -121.49 78.77 1.47 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.275 1.83 . . . . 0.0 110.624 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -72.14 171.95 11.06 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.194 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -128.29 116.01 19.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.882 1.273 . . . . 0.0 109.573 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -120.46 159.14 25.74 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.848 1.659 . . . . 0.0 110.905 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -126.93 120.0 28.07 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.729 1.212 . . . . 0.0 109.958 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -120.5 124.66 45.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.149 0.979 . . . . 0.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.7 t -73.61 116.02 13.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.096 0.474 . . . . 0.0 110.488 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 mtp -93.83 67.32 3.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.705 1.602 . . . . 0.0 109.439 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.31 -64.92 3.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.605 1.574 . . . . 0.0 114.126 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -140.0 9.6 2.35 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.68 148.08 29.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.789 1.636 . . . . 0.0 109.988 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -102.76 129.66 49.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 112.597 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -119.27 136.96 53.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.858 1.663 . . . . 0.0 110.889 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.12 141.23 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.351 1.06 . . . . 0.0 111.106 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.43 128.45 48.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.351 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.48 97.98 3.83 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.588 1.555 . . . . 0.0 111.894 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.47 63.41 0.01 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.22 -0.925 . . . . 0.0 114.491 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.4 t 52.93 53.7 11.65 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.715 1.206 . . . . 0.0 112.917 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.43 140.8 41.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.5 p -130.2 -12.41 4.07 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.843 1.257 . . . . 0.0 114.341 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.83 -174.4 48.47 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.238 1.399 . . . . 0.0 113.106 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.06 -166.9 52.08 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.808 -0.819 . . . . 0.0 113.313 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -87.02 146.75 26.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 111.977 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.6 m -78.08 -13.2 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -137.73 148.2 45.41 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 112.072 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.01 -27.23 68.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 112.508 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.91 -28.56 45.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.42 -0.8 . . . . 0.0 114.155 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -72.16 -34.02 68.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.432 1.116 . . . . 0.0 112.579 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 p -68.78 -45.47 71.23 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.351 -0.843 . . . . 0.0 111.453 168.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -38.38 88.68 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.906 1.282 . . . . 0.0 114.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -84.77 -46.27 11.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.0 112.118 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 176.512 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.91 161.9 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.881 2.387 . . . . 0.0 112.205 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.4 tt -63.18 146.97 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.718 0.807 . . . . 0.0 111.068 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.49 0.84 89.38 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.527 1.06 . . . . 0.0 115.384 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -62.67 154.7 28.5 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.152 1.476 . . . . 0.0 111.523 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -77.05 68.69 3.23 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.945 1.298 . . . . 0.0 111.922 176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.01 155.65 91.43 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.298 1.439 . . . . 0.0 112.7 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.6 175.06 11.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.223 2.615 . . . . 0.0 112.935 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.55 139.64 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.33 1.452 . . . . 0.0 111.428 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -67.17 146.17 54.49 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.91 82.65 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.84 17.18 4.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.182 2.193 . . . . 0.0 114.662 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.21 168.49 19.03 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.442 1.097 . . . . 0.0 112.937 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -68.6 -42.78 77.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.353 1.061 . . . . 0.0 112.321 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.13 157.44 37.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.913 1.285 . . . . 0.0 113.078 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.09 90.95 2.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.067 1.747 . . . . 0.0 111.213 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.8 173.98 3.21 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.371 1.068 . . . . 0.0 111.656 170.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -125.14 115.02 19.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.877 1.271 . . . . 0.0 109.744 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -118.83 165.63 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.348 1.459 . . . . 0.0 110.929 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.29 136.44 50.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.337 1.455 . . . . 0.0 109.318 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -130.17 137.48 50.12 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.386 1.075 . . . . 0.0 109.457 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.9 t -72.88 131.19 41.93 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.98 -0.45 . . . . 0.0 110.695 169.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 97.2 mmm -123.14 6.42 9.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.625 1.57 . . . . 0.0 113.906 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.23 91.35 0.81 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.582 1.563 . . . . 0.0 111.99 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 58.44 9.32 1.03 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.829 2.052 . . . . 0.0 114.933 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 t -155.74 165.29 36.98 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.054 2.542 . . . . 0.0 108.961 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.5 m -117.29 159.99 21.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 112.792 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.39 142.1 49.98 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.767 2.027 . . . . 0.0 110.095 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.38 143.44 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.0 0.92 . . . . 0.0 111.004 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -132.16 126.82 34.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.312 1.845 . . . . 0.0 110.605 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.99 108.7 9.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.823 1.649 . . . . 0.0 110.562 -171.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.79 55.18 0.01 OUTLIER Glycine 0 N--CA 1.476 1.337 0 C-N-CA 123.599 0.618 . . . . 0.0 114.238 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.1 t 60.5 22.94 12.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.506 1.523 . . . . 0.0 114.887 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.55 135.24 53.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.197 1.399 . . . . 0.0 111.228 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.7 p -132.33 -13.74 3.02 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.37 -9.31 79.64 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.32 170.67 21.6 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.308 1.432 . . . . 0.0 114.198 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.33 144.48 57.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.8 1.64 . . . . 0.0 111.821 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -72.22 -22.69 61.21 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -140.48 152.58 45.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.705 1.602 . . . . 0.0 111.385 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.86 -30.56 71.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.25 70.11 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.316 -0.865 . . . . 0.0 114.208 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.87 -44.3 17.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.915 1.358 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.47 -35.92 78.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.831 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.91 -7.23 49.99 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.976 1.71 . . . . 0.0 115.264 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -76.51 -42.05 44.71 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.658 1.117 . . . . 0.0 111.948 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -81.57 -54.67 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.926 1.691 . . . . 0.0 111.945 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 124.047 0.939 . . . . 0.0 112.22 169.617 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.34 160.56 49.11 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.662 2.241 . . . . 0.0 112.245 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.51 -26.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.005 1.322 . . . . 0.0 113.713 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.03 6.01 84.02 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.165 1.365 . . . . 0.0 115.569 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.6 t-105 -63.54 153.26 36.23 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.482 1.641 . . . . 0.0 112.617 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.7 m -72.27 87.69 1.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.823 1.649 . . . . 0.0 112.086 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.87 157.27 35.08 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 125.991 1.716 . . . . 0.0 112.505 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.11 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.549 2.833 . . . . 0.0 113.945 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.92 136.3 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.125 1.37 . . . . 0.0 111.492 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.19 147.6 49.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.641 1.176 . . . . 0.0 110.732 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.17 -14.3 66.92 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.8 mp 46.51 50.54 12.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.906 2.082 . . . . 0.0 113.417 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 25.0 m -96.73 173.71 7.18 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.612 1.165 . . . . 0.0 112.467 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -69.07 -34.89 75.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.981 1.312 . . . . 0.0 112.79 173.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.93 165.19 13.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.762 1.625 . . . . 0.0 112.995 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -131.36 92.41 3.18 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.21 1.804 . . . . 0.0 111.252 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -68.48 175.66 3.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.64 1.176 . . . . 0.0 112.099 172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -125.19 113.0 17.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.097 1.359 . . . . 0.0 110.456 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -115.44 169.29 9.27 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.963 1.705 . . . . 0.0 110.867 173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -135.38 129.5 33.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.214 1.406 . . . . 0.0 109.677 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.82 129.12 41.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.692 1.197 . . . . 0.0 110.775 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.05 134.26 38.84 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.992 0.425 . . . . 0.0 111.497 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.3 mtp -122.5 56.92 1.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.289 1.836 . . . . 0.0 109.97 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.33 -79.7 0.3 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.018 1.77 . . . . 0.0 112.576 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -124.54 1.02 8.26 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 m -136.2 147.08 47.47 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.395 1.878 . . . . 0.0 110.249 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.25 132.85 51.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 111.185 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -126.28 141.7 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.346 1.859 . . . . 0.0 110.544 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.56 148.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.039 0.935 . . . . 0.0 111.776 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -136.1 133.18 37.03 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.792 2.037 . . . . 0.0 110.438 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.91 119.08 18.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.158 1.383 . . . . 0.0 110.956 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.54 51.98 0.02 OUTLIER Glycine 0 N--CA 1.476 1.333 0 N-CA-C 114.592 0.597 . . . . 0.0 114.592 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.36 32.68 20.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.314 1.446 . . . . 0.0 114.233 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.91 121.41 19.01 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.673 1.189 . . . . 0.0 110.602 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -108.36 -7.51 15.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.268 1.427 . . . . 0.0 113.678 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.11 -168.96 40.7 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.958 1.742 . . . . 0.0 113.122 172.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 -162.03 41.74 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.004 0.811 . . . . 0.0 113.989 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.43 138.12 31.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.795 0.838 . . . . 0.0 110.863 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.9 p -77.9 -16.8 57.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 -139.38 155.76 47.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.997 2.119 . . . . 0.0 111.913 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 52.6 tpp -61.77 -39.66 92.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.012 0.925 . . . . 0.0 111.853 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.97 -37.53 94.56 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.146 -0.972 . . . . 0.0 113.436 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -68.49 -29.95 68.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.1 p -81.13 -45.55 16.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.679 1.127 . . . . 0.0 112.499 166.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 -18.94 65.07 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -68.41 -24.69 64.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.928 -1.108 . . . . 0.0 113.156 169.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -106.28 -56.05 2.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.173 1.789 . . . . 0.0 111.481 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 124.139 0.976 . . . . 0.0 112.814 173.744 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.85 168.67 20.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.955 2.437 . . . . 0.0 112.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 tp -60.47 147.27 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.196 0.998 . . . . 0.0 111.532 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.77 9.72 86.49 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -61.62 157.1 18.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.918 1.359 . . . . 0.0 112.401 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -77.34 62.63 2.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.68 1.592 . . . . 0.0 112.485 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.76 157.85 85.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.368 1.467 . . . . 0.0 112.716 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.31 178.24 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.683 2.922 . . . . 0.0 113.87 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.11 137.45 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.752 1.621 . . . . 0.0 111.248 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -82.7 144.48 30.2 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.306 1.443 . . . . 0.0 111.059 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.54 -8.3 83.31 Favored Glycine 0 CA--C 1.542 1.736 0 C-N-CA 124.761 1.172 . . . . 0.0 115.93 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 mp 55.4 22.35 4.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.208 2.203 . . . . 0.0 114.694 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -67.7 168.83 10.55 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.171 1.789 . . . . 0.0 113.204 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -66.18 -28.93 69.14 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.76 166.72 12.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.567 1.547 . . . . 0.0 113.15 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -132.76 107.22 8.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.154 1.781 . . . . 0.0 111.203 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.3 178.0 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.466 1.506 . . . . 0.0 110.971 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 m -128.97 110.49 12.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 110.015 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -114.49 168.12 10.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.312 1.445 . . . . 0.0 110.856 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -133.69 139.71 46.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.738 1.215 . . . . 0.0 110.29 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.37 131.06 29.34 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.668 1.187 . . . . 0.0 110.492 -176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.7 m -73.45 94.38 2.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.724 0.81 . . . . 0.0 111.574 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.7 mmm -80.46 54.33 2.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.789 1.636 . . . . 0.0 109.944 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.56 -88.77 1.13 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.398 1.951 . . . . 0.0 112.19 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -86.83 -14.04 43.28 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.3 p -145.44 143.52 30.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.8 m -75.06 92.28 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.935 1.294 . . . . 0.0 110.761 169.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -75.53 126.08 30.29 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.89 147.06 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.136 0.574 . . . . 0.0 110.869 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -128.75 108.39 10.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.746 2.018 . . . . 0.0 109.756 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -98.78 110.37 22.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.134 1.774 . . . . 0.0 110.461 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.01 -169.34 33.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.453 1.025 . . . . 0.0 112.647 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.06 87.14 2.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.561 -0.964 . . . . 0.0 111.215 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.36 122.49 27.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.027 1.731 . . . . 0.0 110.644 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.3 p -115.03 -8.06 12.48 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.534 1.534 . . . . 0.0 113.789 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.96 -173.18 49.76 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.776 1.655 . . . . 0.0 113.625 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.94 -159.97 42.73 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.102 0.858 . . . . 0.0 114.61 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -82.53 128.85 34.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.131 0.973 . . . . 0.0 110.65 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.5 p -70.04 -26.9 64.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.645 1.178 . . . . 0.0 113.352 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -139.59 160.04 40.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.891 2.077 . . . . 0.0 111.048 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 50.2 ttm -63.11 -31.61 72.79 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.68 73.68 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 114.036 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -80.98 -29.05 35.37 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.055 0.927 . . . . 0.0 113.265 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.83 -34.35 39.52 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.103 -0.998 . . . . 0.0 112.432 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.88 -22.33 66.63 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -78.54 -5.18 51.98 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.166 1.386 . . . . 0.0 114.566 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -118.92 -43.81 2.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.171 1.788 . . . . 0.0 112.411 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 111.814 167.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.26 159.99 48.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.867 2.378 . . . . 0.0 112.675 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -58.82 -27.72 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.192 1.397 . . . . 0.0 113.635 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.88 -3.62 89.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.513 1.054 . . . . 0.0 115.23 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -68.76 141.4 55.23 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.42 1.61 . . . . 0.0 111.739 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -71.63 92.43 1.16 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.92 159.32 63.28 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.194 1.398 . . . . 0.0 112.532 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.03 161.39 38.75 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.748 2.299 . . . . 0.0 113.235 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.77 133.34 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.742 1.217 . . . . 0.0 111.886 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -72.16 144.71 48.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.314 1.046 . . . . 0.0 110.593 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.2 -6.9 80.91 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 57.01 20.02 5.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.974 2.11 . . . . 0.0 114.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 m -74.43 169.49 17.6 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.958 -1.089 . . . . 0.0 112.426 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.74 -39.96 80.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.938 0.895 . . . . 0.0 112.68 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 159.66 29.37 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.806 1.243 . . . . 0.0 113.115 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -131.39 90.18 2.83 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.938 1.695 . . . . 0.0 111.706 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -61.44 174.32 0.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 111.943 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -123.14 107.99 12.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.465 1.106 . . . . 0.0 110.341 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? -111.33 157.55 20.06 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.034 1.334 . . . . 0.0 111.039 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -120.99 138.96 53.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.95 120.71 18.46 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.843 1.257 . . . . 0.0 109.881 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.36 96.44 0.87 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.685 0.755 . . . . 0.0 110.581 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.6 mmm -78.95 81.88 5.19 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 0.0 108.734 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.96 -67.45 2.38 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.47 1.985 . . . . 0.0 114.536 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -132.64 -4.83 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.585 1.554 . . . . 0.0 114.068 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t -134.29 134.43 41.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.447 1.099 . . . . 0.0 112.007 -174.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 52.5 m -81.87 95.41 7.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 111.321 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.44 156.44 24.12 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.787 0.835 . . . . 0.0 110.981 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.38 145.11 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.655 1.182 . . . . 0.0 110.46 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.36 131.14 33.85 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.88 1.672 . . . . 0.0 110.388 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.41 122.42 24.96 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 111.187 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.27 52.15 0.02 OUTLIER Glycine 0 N--CA 1.474 1.184 0 C-N-CA 123.753 0.692 . . . . 0.0 113.709 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.6 t 61.22 23.59 13.79 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 0.0 114.459 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -67.73 136.44 54.27 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.389 . . . . 0.0 111.599 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -130.02 -7.38 4.41 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.48 -10.24 59.45 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.411 1.005 . . . . 0.0 115.375 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.82 174.07 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.831 1.205 . . . . 0.0 114.089 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -71.5 149.56 45.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.903 1.281 . . . . 0.0 111.863 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m -70.6 -31.21 68.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.034 1.334 . . . . 0.0 113.752 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -140.23 160.25 40.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.534 1.934 . . . . 0.0 111.063 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.8 ttm -62.57 -36.95 84.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.624 0.77 . . . . 0.0 112.413 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.83 91.69 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.359 -0.838 . . . . 0.0 113.645 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.03 -38.52 82.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.143 0.977 . . . . 0.0 112.65 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.0 p -75.52 -40.76 56.56 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.806 0.73 . . . . 0.0 111.985 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.38 87.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -68.48 -27.21 65.94 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.36 -48.43 10.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.795 1.238 . . . . 0.0 112.165 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.93 163.71 34.89 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.108 2.539 . . . . 0.0 111.53 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.9 tp -56.79 -26.74 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.544 1.138 . . . . 0.0 113.422 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.83 -5.42 88.63 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.609 1.1 . . . . 0.0 115.274 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -71.51 160.22 33.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.605 1.703 . . . . 0.0 111.357 172.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 m -77.56 55.22 1.28 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.978 1.311 . . . . 0.0 112.233 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.39 156.29 88.82 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.032 1.333 . . . . 0.0 113.575 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.84 171.42 16.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.037 2.491 . . . . 0.0 112.776 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.84 132.74 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.159 1.384 . . . . 0.0 111.904 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -84.38 139.83 31.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.153 1.381 . . . . 0.0 110.53 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.14 -2.85 89.27 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.254 1.407 . . . . 0.0 116.156 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 54.11 27.3 7.46 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.89 2.076 . . . . 0.0 114.342 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 m -65.53 171.09 4.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.654 1.581 . . . . 0.0 112.96 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -75.0 -0.06 17.53 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.449 1.5 . . . . 0.0 114.841 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.28 163.35 19.82 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.156 1.782 . . . . 0.0 112.785 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -132.15 85.26 2.22 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.432 1.893 . . . . 0.0 111.934 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -72.63 172.61 10.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.022 0.929 . . . . 0.0 111.589 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 m -121.82 113.15 19.25 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.855 1.262 . . . . 0.0 109.256 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.49 164.63 14.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.212 1.405 . . . . 0.0 110.801 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.75 140.33 50.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.655 1.582 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -142.01 137.5 31.18 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.217 . . . . 0.0 111.001 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.67 97.16 8.95 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.648 -0.658 . . . . 0.0 111.455 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 88.8 mmm -81.67 71.48 8.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.165 1.386 . . . . 0.0 110.584 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.88 -79.59 1.67 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.505 1.526 . . . . 0.0 112.989 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.11 -10.3 9.04 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -133.07 136.64 46.03 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 110.386 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.56 144.39 47.94 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.362 -0.836 . . . . 0.0 110.884 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -132.68 132.55 42.52 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.019 1.727 . . . . 0.0 110.266 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.77 142.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.669 0.788 . . . . 0.0 110.65 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -129.56 103.35 6.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.694 1.998 . . . . 0.0 109.567 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -86.47 114.75 23.49 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.1 1.36 . . . . 0.0 110.453 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.69 -176.44 33.22 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.542 1.067 . . . . 0.0 113.547 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 9.2 t -79.22 59.71 2.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.724 1.21 . . . . 0.0 111.89 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -85.72 -36.64 20.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.952 0.901 . . . . 0.0 113.358 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p 54.2 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 130.993 3.717 . . . . 0.0 118.187 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.45 -160.29 35.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.91 2.195 . . . . 0.0 113.85 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.17 -136.57 48.1 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.967 1.27 . . . . 0.0 113.518 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -108.33 136.91 47.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.327 1.451 . . . . 0.0 110.599 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t -75.64 -22.83 56.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.228 1.011 . . . . 0.0 112.255 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 154.86 49.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.169 1.788 . . . . 0.0 112.776 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -58.97 -33.07 70.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.081 0.952 . . . . 0.0 112.516 173.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.56 -40.94 94.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.055 0.836 . . . . 0.0 113.652 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.56 -31.8 73.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 0.0 112.249 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -71.04 -51.13 27.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.294 1.038 . . . . 0.0 111.797 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.47 76.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.902 1.681 . . . . 0.0 114.17 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.57 -21.3 65.49 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -105.72 -34.61 7.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.061 1.344 . . . . 0.0 113.464 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.4 m . . . . . 0 CA--C 1.552 1.034 0 C-N-CA 124.096 0.959 . . . . 0.0 112.81 171.178 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 120.71 0.291 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.99 168.14 25.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.922 2.415 . . . . 0.0 112.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.56 -27.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.545 1.138 . . . . 0.0 113.418 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.21 90.1 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.803 1.192 . . . . 0.0 115.375 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -65.48 152.65 43.48 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.405 1.603 . . . . 0.0 111.984 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 p -75.54 72.17 2.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.375 1.47 . . . . 0.0 112.064 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.8 151.35 85.09 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.682 1.193 . . . . 0.0 112.542 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.6 171.11 17.86 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.018 2.479 . . . . 0.0 112.536 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.72 126.45 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.759 1.224 . . . . 0.0 112.179 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -69.69 141.84 53.47 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.394 1.078 . . . . 0.0 110.246 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.11 -6.67 89.07 Favored Glycine 0 CA--C 1.541 1.681 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.76 20.08 4.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.78 2.032 . . . . 0.0 113.985 -175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 m -77.18 172.03 13.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.643 1.177 . . . . 0.0 113.328 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -84.43 5.33 27.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.756 2.022 . . . . 0.0 115.305 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.01 165.07 20.14 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.302 1.841 . . . . 0.0 113.225 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -128.78 95.16 4.02 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.671 1.988 . . . . 0.0 112.571 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -83.19 177.34 8.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.762 0.825 . . . . 0.0 111.297 166.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -134.43 114.48 12.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.044 1.337 . . . . 0.0 111.227 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.4 mmp_? -116.05 166.14 12.34 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.965 1.706 . . . . 0.0 111.266 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.81 99.25 4.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.412 1.485 . . . . 0.0 110.496 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -97.13 137.15 36.62 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.48 0.712 . . . . 0.0 110.748 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -77.89 107.04 10.13 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.246 -0.909 . . . . 0.0 110.906 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.8 mmm -93.29 17.1 11.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.835 1.654 . . . . 0.0 113.529 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.44 90.04 2.14 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.473 1.511 . . . . 0.0 111.348 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 t30 59.23 14.05 3.39 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.34 1.856 . . . . 0.0 114.803 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.4 m -142.99 116.47 9.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.2 m -61.6 115.0 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.175 0.59 . . . . 0.0 110.55 157.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -113.49 132.18 55.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.63 1.572 . . . . 0.0 110.184 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.62 144.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.265 0.626 . . . . 0.0 111.608 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -133.73 137.93 45.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.881 1.672 . . . . 0.0 110.869 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -135.33 117.92 15.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.503 1.521 . . . . 0.0 110.776 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.41 59.22 0.01 OUTLIER Glycine 0 N--CA 1.475 1.273 0 C-N-CA 123.532 0.587 . . . . 0.0 114.292 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 59.0 25.18 13.52 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.03 113.16 6.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.985 1.314 . . . . 0.0 110.968 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -102.77 -8.26 20.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.944 1.298 . . . . 0.0 113.678 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.96 -174.14 42.46 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.523 1.535 . . . . 0.0 113.011 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 -171.53 26.76 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.206 0.908 . . . . 0.0 114.239 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.64 139.06 38.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.787 0.835 . . . . 0.0 110.746 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.6 p -84.76 -10.98 56.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -135.01 150.55 50.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.248 1.819 . . . . 0.0 112.037 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.3 tpp -59.37 -40.59 86.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.956 1.302 . . . . 0.0 111.575 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.55 93.44 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.558 -0.714 . . . . 0.0 113.471 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.18 -38.02 75.27 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.5 p -70.97 -41.75 70.63 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.602 1.092 . . . . 0.0 111.77 169.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.97 -29.5 68.55 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -69.54 -22.47 63.56 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -102.25 -50.79 3.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.988 1.315 . . . . 0.0 112.87 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.551 1.015 0 CA-C-N 118.697 0.68 . . . . 0.0 112.707 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 119.018 -0.515 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.72 161.75 44.7 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.042 . . . . 0.0 112.15 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -62.86 146.19 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.393 0.677 . . . . 0.0 110.653 170.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 15.81 81.27 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.031 0.772 . . . . 0.0 115.031 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -61.52 165.29 4.99 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.87 1.335 . . . . 0.0 111.74 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 t -72.2 93.94 1.51 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.094 -1.003 . . . . 0.0 111.538 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.61 156.73 34.92 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.514 1.525 . . . . 0.0 112.856 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.33 152.6 55.52 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.916 2.411 . . . . 0.0 112.461 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.91 128.62 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.871 0.868 . . . . 0.0 111.936 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -71.53 140.6 49.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.057 0.943 . . . . 0.0 110.664 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.08 -8.94 87.29 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.2 mt 61.67 16.55 7.88 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.222 2.209 . . . . 0.0 115.058 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.0 m -74.94 170.99 14.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.116 1.367 . . . . 0.0 113.551 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.57 -20.55 65.4 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.73 164.36 14.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.427 1.891 . . . . 0.0 112.361 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.55 99.78 4.76 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 112.184 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.34 176.63 1.02 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.349 1.06 . . . . 0.0 110.944 165.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.0 m -124.08 112.41 17.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -119.68 166.59 13.0 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.022 1.729 . . . . 0.0 110.856 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.49 137.75 44.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.356 1.063 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -141.99 126.75 18.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.859 1.264 . . . . 0.0 110.401 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -78.12 128.38 33.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.984 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtp -102.87 5.54 38.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.701 1.2 . . . . 0.0 113.371 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.89 -74.77 0.27 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.527 1.537 . . . . 0.0 111.978 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -120.35 13.69 11.93 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.711 1.605 . . . . 0.0 113.15 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.8 p -147.89 169.37 19.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.21 1.404 . . . . 0.0 111.597 169.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -117.01 111.93 20.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.27 1.828 . . . . 0.0 110.719 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -97.82 137.21 37.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.699 1.599 . . . . 0.0 110.899 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.52 146.79 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.831 0.852 . . . . 0.0 111.456 171.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.37 124.95 25.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.586 1.954 . . . . 0.0 110.555 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -127.44 110.7 13.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.234 1.414 . . . . 0.0 111.388 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.44 52.31 0.01 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 -168.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.0 t 60.51 22.32 12.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.679 1.592 . . . . 0.0 114.476 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.43 128.76 37.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.659 1.584 . . . . 0.0 111.082 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.0 p -105.36 -20.6 13.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.461 1.104 . . . . 0.0 113.769 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.24 -161.06 34.97 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.899 1.714 . . . . 0.0 114.052 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.54 -172.1 48.73 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.861 1.22 . . . . 0.0 114.427 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -73.29 138.12 45.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.525 0.73 . . . . 0.0 109.951 167.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.2 m -70.08 -32.2 70.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.614 0.766 . . . . 0.0 113.054 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -140.49 165.46 27.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.264 1.826 . . . . 0.0 112.17 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.4 ttt -68.91 -24.54 64.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.33 -35.78 69.64 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.259 -0.9 . . . . 0.0 112.809 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -44.07 69.71 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.326 1.45 . . . . 0.0 112.523 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -62.92 -42.56 99.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.777 0.717 . . . . 0.0 112.334 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -3.82 9.98 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.2 mtp-105 -67.22 -42.49 83.97 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.743 -1.223 . . . . 0.0 111.889 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -93.6 -53.08 4.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.248 1.819 . . . . 0.0 111.433 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.3 m . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 111.432 -177.212 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.27 166.0 29.78 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.015 175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.75 148.14 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.89 0.876 . . . . 0.0 111.229 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.72 6.64 89.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -65.66 159.69 24.33 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 119.029 1.414 . . . . 0.0 112.151 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.1 m -76.39 53.5 0.85 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.047 1.739 . . . . 0.0 112.781 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.43 156.11 86.53 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.029 1.332 . . . . 0.0 112.647 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.49 166.19 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.463 2.776 . . . . 0.0 113.604 176.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -97.34 132.52 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.974 1.31 . . . . 0.0 111.639 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -77.27 142.66 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 111.16 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.05 -9.16 77.61 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.478 1.513 . . . . 0.0 115.209 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mp 55.13 18.07 2.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.365 2.266 . . . . 0.0 114.687 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 p -70.9 173.05 7.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -75.65 2.52 11.71 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.204 1.801 . . . . 0.0 114.206 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.52 169.82 13.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.26 2.224 . . . . 0.0 111.431 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -136.55 105.1 5.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.401 1.48 . . . . 0.0 111.126 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -93.87 155.11 17.36 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.55 1.14 . . . . 0.0 111.667 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -102.95 105.11 15.39 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.712 1.205 . . . . 0.0 110.658 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.26 157.85 32.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.02 1.328 . . . . 0.0 110.814 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.43 92.43 3.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.276 1.83 . . . . 0.0 111.146 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.08 139.47 30.6 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.495 -0.753 . . . . 0.0 111.506 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.7 m -74.43 109.11 7.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.87 0.868 . . . . 0.0 112.151 172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.6 mtp -91.75 69.44 5.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.669 1.188 . . . . 0.0 109.804 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.06 -100.51 1.25 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.266 1.413 . . . . 0.0 112.733 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.33 -8.67 56.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.24 161.0 38.5 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.978 1.711 . . . . 0.0 111.49 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.9 m -90.24 152.49 21.05 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.658 -0.651 . . . . 0.0 111.602 165.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -133.34 132.65 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.253 1.821 . . . . 0.0 109.903 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -77.01 146.54 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.985 0.514 . . . . 0.0 111.126 171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -109.44 -68.76 0.9 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 67.83 78.57 0.23 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.573 1.949 . . . . 0.0 112.91 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.92 14.84 0.03 OUTLIER Glycine 0 N--CA 1.474 1.181 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.6 t 77.07 91.98 0.07 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.436 2.294 . . . . 0.0 112.104 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.3 -56.94 0.8 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 0.0 113.664 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.9 p 54.84 -2.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 129.693 3.197 . . . . 0.0 118.473 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.53 -19.66 53.89 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 119.848 1.204 . . . . 0.0 115.375 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.87 179.04 27.46 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 126.002 1.763 . . . . 0.0 113.356 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -58.88 142.76 49.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.679 1.191 . . . . 0.0 112.871 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.0 p -83.4 -16.28 46.54 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.219 1.408 . . . . 0.0 114.458 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -137.79 154.71 49.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.324 1.85 . . . . 0.0 111.511 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 46.7 ttm -65.67 -29.42 69.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.508 0.723 . . . . 0.0 112.562 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.33 -37.59 94.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.992 -1.068 . . . . 0.0 113.452 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -71.46 -33.8 69.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.106 0.962 . . . . 0.0 113.098 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.2 p -74.9 -49.46 20.23 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.785 -0.572 . . . . 0.0 111.735 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.24 -16.92 62.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.75 -25.78 65.8 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.052 1.296 . . . . 0.0 113.438 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -100.55 -48.9 4.38 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.103 1.361 . . . . 0.0 111.555 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 127.443 2.297 . . . . 0.0 111.568 175.655 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.75 160.15 48.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.87 2.38 . . . . 0.0 111.682 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -61.62 141.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.306 0.574 . . . . 0.0 110.726 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.37 -3.92 85.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.387 0.994 . . . . 0.0 115.163 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.52 156.51 34.7 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.357 1.579 . . . . 0.0 110.956 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 t -77.52 97.81 5.14 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.52 1.128 . . . . 0.0 111.717 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 157.37 34.31 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.902 1.681 . . . . 0.0 113.181 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.4 161.58 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.043 2.495 . . . . 0.0 112.605 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.68 134.56 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.506 1.122 . . . . 0.0 111.85 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -66.84 141.73 57.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.148 0.979 . . . . 0.0 110.485 174.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -10.39 85.82 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.2 mt 62.78 13.24 6.3 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.466 2.306 . . . . 0.0 114.716 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -80.62 171.54 14.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.592 1.157 . . . . 0.0 113.3 -172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -62.55 -43.4 98.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.941 1.296 . . . . 0.0 113.412 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.52 126.53 35.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 113.238 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.33 89.48 5.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.272 1.429 . . . . 0.0 111.174 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -64.1 176.12 1.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.417 1.087 . . . . 0.0 111.625 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -123.0 105.83 10.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.403 1.081 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -112.42 168.14 9.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.197 1.799 . . . . 0.0 110.729 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -135.97 140.1 43.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.37 1.068 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.36 138.85 35.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.181 0.992 . . . . 0.0 112.277 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.38 91.48 1.35 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.929 1.292 . . . . 0.0 112.251 175.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 76.1 mmm -85.61 76.6 9.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.175 0.99 . . . . 0.0 109.331 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.34 -86.44 0.71 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.747 1.641 . . . . 0.0 112.257 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -122.1 3.63 9.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.659 1.583 . . . . 0.0 114.228 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.6 m -130.48 124.95 33.15 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.539 1.536 . . . . 0.0 111.846 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.3 m -73.34 85.98 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.035 1.334 . . . . 0.0 111.632 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -75.42 139.85 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.536 -0.728 . . . . 0.0 110.897 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.38 143.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.692 1.197 . . . . 0.0 111.366 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.98 133.25 45.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.138 1.775 . . . . 0.0 110.734 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -134.3 106.98 7.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.088 1.355 . . . . 0.0 111.293 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.55 0.01 OUTLIER Glycine 0 N--CA 1.475 1.246 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -171.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 t 55.07 29.48 12.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.002 1.321 . . . . 0.0 114.383 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.34 140.8 52.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.756 1.223 . . . . 0.0 110.764 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.8 p -139.06 -3.35 1.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.95 9.76 74.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.349 1.452 . . . . 0.0 116.019 -172.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.03 -172.1 24.78 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 118.861 1.33 . . . . 0.0 114.702 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -61.56 135.93 57.83 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 114.082 -165.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.1 t -72.23 -22.71 61.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 113.363 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -136.07 152.21 50.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.901 1.68 . . . . 0.0 112.518 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.6 tpp -55.04 -44.45 74.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.572 1.549 . . . . 0.0 111.049 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.84 -50.68 62.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.047 1.308 . . . . 0.0 113.306 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -62.15 -37.86 86.8 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.542 1.171 . . . . 0.0 112.991 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.4 t -60.13 -42.24 94.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 171.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.47 -14.69 44.0 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.22 -54.28 39.83 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.082 1.353 . . . . 0.0 111.838 171.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.05 -33.17 44.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 113.265 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.559 0.743 . . . . 0.0 112.306 172.572 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.14 159.05 54.5 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.387 2.058 . . . . 0.0 111.474 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.53 -28.37 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.291 1.037 . . . . 0.0 113.346 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.44 2.44 87.91 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.125 1.345 . . . . 0.0 115.514 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -64.25 158.45 23.24 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.411 1.605 . . . . 0.0 112.085 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -78.87 98.33 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.647 1.179 . . . . 0.0 111.615 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.01 157.23 37.52 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.874 1.67 . . . . 0.0 112.936 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.08 166.22 29.58 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.348 2.699 . . . . 0.0 112.975 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.53 133.35 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.77 1.228 . . . . 0.0 112.194 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -73.32 143.95 46.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.457 1.503 . . . . 0.0 110.705 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.82 -8.67 87.22 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.3 mp 49.72 35.86 9.75 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.63 1.972 . . . . 0.0 113.321 -173.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 m -78.57 168.35 19.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.35 1.46 . . . . 0.0 112.954 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -68.66 -35.06 76.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.253 1.021 . . . . 0.0 113.198 165.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.88 160.53 27.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.138 1.375 . . . . 0.0 112.6 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -132.87 77.51 1.74 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.007 1.723 . . . . 0.0 111.049 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.81 166.24 22.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.543 1.137 . . . . 0.0 111.389 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -128.82 120.93 27.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.635 1.574 . . . . 0.0 110.647 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -124.82 171.85 9.81 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.088 2.555 . . . . 0.0 110.343 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -134.72 137.62 43.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.681 1.192 . . . . 0.0 110.307 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -137.97 132.43 32.3 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.271 1.028 . . . . 0.0 111.544 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.91 121.56 15.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.009 0.923 . . . . 0.0 111.571 170.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.7 mmm -111.87 11.8 20.81 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.672 1.989 . . . . 0.0 113.082 -176.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.27 104.04 1.2 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.694 1.14 . . . . 0.0 111.485 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 63.67 -1.27 0.63 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.148 2.179 . . . . 0.0 115.23 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -141.9 156.25 45.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.873 2.069 . . . . 0.0 110.294 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.42 107.93 14.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.949 1.3 . . . . 0.0 110.006 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -90.53 144.48 25.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.434 1.093 . . . . 0.0 110.874 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.28 146.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.691 0.796 . . . . 0.0 111.002 167.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.34 129.21 42.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.319 1.848 . . . . 0.0 109.012 172.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -133.17 149.91 52.03 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.679 0.792 . . . . 0.0 112.27 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.18 12.01 2.16 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 10.1 t 95.87 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 130.05 3.34 . . . . 0.0 110.504 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.05 130.6 33.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.242 1.817 . . . . 0.0 109.114 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -117.41 -4.36 11.32 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.871 1.268 . . . . 0.0 113.941 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.31 -167.97 31.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.198 1.856 . . . . 0.0 113.197 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.85 -164.47 43.0 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.232 0.92 . . . . 0.0 114.526 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -81.89 138.86 34.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.884 0.873 . . . . 0.0 110.392 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -69.14 -30.56 68.83 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -140.6 158.48 43.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.659 1.984 . . . . 0.0 112.087 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.2 ttm -61.75 -34.87 76.62 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.162 0.585 . . . . 0.0 112.084 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.5 -27.93 70.4 Favored Glycine 0 CA--C 1.536 1.377 0 O-C-N 121.471 -0.768 . . . . 0.0 114.059 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.26 -48.27 17.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.266 1.033 . . . . 0.0 112.072 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -65.13 -30.14 71.05 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.462 1.028 . . . . 0.0 113.058 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -6.52 7.23 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -78.32 -12.2 59.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.0 -1.062 . . . . 0.0 113.598 167.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -125.36 -52.77 1.61 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.567 1.947 . . . . 0.0 112.221 -177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 123.746 0.819 . . . . 0.0 111.513 164.512 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.88 158.88 56.1 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.713 2.275 . . . . 0.0 111.802 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.06 138.33 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.239 0.616 . . . . 0.0 111.092 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.69 -1.58 68.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.539 1.066 . . . . 0.0 115.312 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.2 t-105 -65.3 151.69 45.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.588 1.694 . . . . 0.0 111.187 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -78.08 72.14 4.59 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.108 1.363 . . . . 0.0 112.526 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.58 155.16 89.48 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.864 1.265 . . . . 0.0 114.082 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.4 174.38 12.93 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.908 3.072 . . . . 0.0 112.124 170.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.3 143.12 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.614 1.165 . . . . 0.0 112.62 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.35 146.27 54.7 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.434 1.493 . . . . 0.0 111.033 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.47 -7.07 79.85 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 56.05 22.77 6.18 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.267 2.227 . . . . 0.0 114.346 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 m -75.02 172.22 12.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.772 1.229 . . . . 0.0 112.723 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -76.57 -2.12 30.89 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.471 1.509 . . . . 0.0 114.819 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.88 160.74 28.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.9 1.68 . . . . 0.0 113.059 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -131.11 85.16 2.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.48 1.912 . . . . 0.0 112.407 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -66.24 172.0 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.233 1.013 . . . . 0.0 111.293 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -121.24 114.0 20.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.294 1.038 . . . . 0.0 110.518 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -118.37 168.13 10.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.955 1.702 . . . . 0.0 110.657 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -131.65 142.6 49.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.533 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.36 132.26 29.3 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.207 1.403 . . . . 0.0 109.987 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.5 t -71.47 140.62 50.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.808 166.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.31 24.99 11.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.488 1.515 . . . . 0.0 112.59 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.26 -40.35 1.68 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.188 2.328 . . . . 0.0 112.491 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -152.19 -48.46 0.11 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.687 1.595 . . . . 0.0 112.223 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.2 m -71.02 134.75 47.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.122 0.969 . . . . 0.0 111.841 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 95.9 m -73.58 134.86 43.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.006 0.922 . . . . 0.0 110.749 162.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.14 133.52 54.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.039 1.736 . . . . 0.0 109.679 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.78 146.45 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.401 0.681 . . . . 0.0 110.847 172.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.54 134.82 41.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.992 1.717 . . . . 0.0 110.747 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -136.67 113.42 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.208 1.403 . . . . 0.0 111.001 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.63 60.52 0.02 OUTLIER Glycine 0 N--CA 1.476 1.344 0 N-CA-C 115.166 0.827 . . . . 0.0 115.166 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 t 59.73 30.52 20.11 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -70.44 -45.78 65.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.786 1.234 . . . . 0.0 113.641 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.2 p 50.83 -8.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 131.112 3.765 . . . . 0.0 118.394 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.52 -161.35 37.36 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 127.265 2.364 . . . . 0.0 113.965 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.69 -122.99 31.94 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.541 1.067 . . . . 0.0 113.007 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.36 152.84 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.768 1.627 . . . . 0.0 111.944 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.2 p -82.2 -23.54 35.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.867 1.267 . . . . 0.0 114.219 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -137.34 156.11 48.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.152 1.381 . . . . 0.0 112.417 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 ttt -66.46 -19.8 65.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.849 1.26 . . . . 0.0 113.123 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.88 -38.58 26.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.904 0.764 . . . . 0.0 113.501 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -64.56 -45.62 86.3 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.767 1.284 . . . . 0.0 112.747 -174.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -59.69 -35.11 73.82 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.55 -0.719 . . . . 0.0 112.176 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -14.21 60.43 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -74.47 -21.03 59.78 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.819 -1.176 . . . . 0.0 112.762 166.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -103.66 -55.51 2.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.018 1.727 . . . . 0.0 111.649 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 113.237 173.271 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 119.146 -0.455 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.74 155.69 67.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.238 1.959 . . . . 0.0 112.316 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.62 -26.26 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.213 1.405 . . . . 0.0 113.587 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.98 2.43 86.82 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.996 1.284 . . . . 0.0 115.724 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -65.58 155.41 35.87 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.99 1.895 . . . . 0.0 111.555 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -73.53 75.24 1.46 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.906 1.283 . . . . 0.0 111.763 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -78.15 157.19 78.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.654 1.582 . . . . 0.0 113.287 176.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.0 174.81 11.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.21 2.607 . . . . 0.0 112.595 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.62 135.04 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.475 1.51 . . . . 0.0 111.006 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -86.41 138.75 31.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.51 1.124 . . . . 0.0 110.809 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.59 -2.21 88.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.215 1.388 . . . . 0.0 115.659 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 53.85 19.35 1.89 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.341 2.256 . . . . 0.0 114.866 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.4 p -71.85 170.05 14.49 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.014 -1.054 . . . . 0.0 113.472 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.97 3.15 7.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.85 1.66 . . . . 0.0 114.947 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.16 154.37 31.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.843 1.657 . . . . 0.0 112.257 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -124.47 90.42 3.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.308 1.843 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -75.92 171.77 13.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 111.544 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.9 m -125.59 113.71 17.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.186 1.394 . . . . 0.0 108.889 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -121.33 159.94 25.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.897 1.679 . . . . 0.0 110.723 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -119.52 142.64 48.13 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.069 0.948 . . . . 0.0 110.396 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.06 170.75 15.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.111 1.364 . . . . 0.0 110.195 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -136.95 144.92 43.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.539 1.136 . . . . 0.0 110.777 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.9 mtt -137.04 71.83 1.41 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.468 1.107 . . . . 0.0 110.231 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.87 -109.37 2.68 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.883 1.706 . . . . 0.0 112.73 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -113.12 34.01 4.72 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.868 1.667 . . . . 0.0 111.381 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.0 104.92 1.74 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.266 1.427 . . . . 0.0 112.742 -175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.04 157.13 31.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.605 1.162 . . . . 0.0 112.2 164.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -161.83 -178.98 6.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.125 2.17 . . . . 0.0 111.474 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.04 146.58 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.306 2.242 . . . . 0.0 110.767 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.93 138.12 49.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.004 2.122 . . . . 0.0 109.774 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.41 111.86 14.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.595 1.558 . . . . 0.0 110.377 -168.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.08 -170.95 33.3 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.984 0.802 . . . . 0.0 113.28 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.58 77.15 1.08 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 111.227 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.46 141.91 51.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.069 1.747 . . . . 0.0 111.803 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.3 p -134.51 -7.09 2.53 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -173.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.6 -2.4 65.32 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -172.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.62 174.45 25.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.826 1.203 . . . . 0.0 115.06 -170.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.32 156.86 38.1 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.842 1.657 . . . . 0.0 111.953 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -78.75 -29.83 45.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.707 1.203 . . . . 0.0 114.144 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mtm105 -141.34 159.47 42.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.67 1.988 . . . . 0.0 111.347 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 33.4 ttm -62.86 -32.0 73.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.7 0.8 . . . . 0.0 112.356 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.8 -28.8 72.34 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.834 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.59 -46.53 38.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.019 1.409 . . . . 0.0 112.878 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.4 p -62.3 -31.91 72.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.073 -1.017 . . . . 0.0 112.379 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 -10.47 49.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.177 1.391 . . . . 0.0 114.739 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -79.71 -36.22 37.82 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.281 0.946 . . . . 0.0 112.571 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -84.43 -50.85 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 111.928 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 171.537 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.82 159.33 53.76 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.359 2.706 . . . . 0.0 112.503 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 tt -61.4 143.06 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.009 0.924 . . . . 0.0 111.314 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.77 -0.83 83.0 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.604 1.097 . . . . 0.0 115.291 -178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -65.09 160.06 21.92 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.19 1.495 . . . . 0.0 111.204 167.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.7 m -74.88 64.96 1.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.694 1.598 . . . . 0.0 112.91 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 154.2 91.61 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.672 1.189 . . . . 0.0 113.805 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.91 153.39 42.23 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.092 2.528 . . . . 0.0 112.183 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.95 135.03 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.84 0.856 . . . . 0.0 111.93 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.6 144.06 54.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.311 1.045 . . . . 0.0 110.726 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 -10.61 86.13 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 115.219 0.847 . . . . 0.0 115.219 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.6 mt 61.84 14.37 6.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.495 2.318 . . . . 0.0 115.134 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 m -75.76 171.75 13.82 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.599 1.16 . . . . 0.0 113.617 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.76 -46.7 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 112.14 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.82 159.51 28.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.063 1.345 . . . . 0.0 113.195 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -131.1 90.68 2.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.471 1.909 . . . . 0.0 111.527 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -68.6 174.23 4.4 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.968 1.307 . . . . 0.0 111.763 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -126.48 112.07 15.15 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 110.172 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -117.53 168.89 9.99 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.24 1.816 . . . . 0.0 110.459 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -133.18 135.33 45.03 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.603 1.161 . . . . 0.0 109.953 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -132.93 147.59 52.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 0.0 111.205 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.0 t -85.93 127.43 34.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.152 0.581 . . . . 0.0 110.475 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.1 mmm -116.19 25.14 10.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.494 1.917 . . . . 0.0 112.933 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.42 93.43 1.82 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.124 1.345 . . . . 0.0 111.228 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.257 13.2 p30 47.09 28.05 0.87 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.755 2.022 . . . . 0.0 115.116 -173.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -151.24 154.12 36.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.776 2.03 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.74 138.23 54.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.612 1.165 . . . . 0.0 110.819 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -142.48 148.46 37.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.649 1.18 . . . . 0.0 112.011 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.97 150.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.58 1.152 . . . . 0.0 111.804 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -134.73 132.77 39.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.795 2.038 . . . . 0.0 110.467 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -132.74 115.46 15.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.576 1.55 . . . . 0.0 111.022 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.73 55.23 0.01 OUTLIER Glycine 0 N--CA 1.475 1.295 0 O-C-N 121.823 -0.548 . . . . 0.0 114.454 -170.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.2 t 57.07 28.26 14.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.167 1.387 . . . . 0.0 114.401 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.81 139.67 53.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.651 1.18 . . . . 0.0 110.538 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.2 p -125.89 -5.29 6.87 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.89 1.276 . . . . 0.0 113.915 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.13 -167.67 33.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.813 1.673 . . . . 0.0 112.637 173.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.6 49.49 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 122.245 0.914 . . . . 0.0 113.808 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -79.82 148.77 31.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 0.0 111.198 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -78.14 -19.87 53.18 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.38 159.19 42.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.727 2.011 . . . . 0.0 111.95 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.7 tpp -62.45 -40.59 97.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.0 0.92 . . . . 0.0 112.199 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.82 -38.77 93.24 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.721 0.676 . . . . 0.0 112.902 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -39.24 90.96 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.038 1.335 . . . . 0.0 111.676 173.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.03 -56.62 15.41 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.769 -0.582 . . . . 0.0 111.676 167.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.76 70.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -79.18 -18.94 52.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -98.04 -47.07 5.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.876 1.27 . . . . 0.0 112.535 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.557 1.212 0 C-N-CA 123.012 0.525 . . . . 0.0 111.604 167.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.74 146.45 54.14 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.37 2.047 . . . . 0.0 111.614 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.41 -27.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.64 1.176 . . . . 0.0 113.615 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.01 1.56 88.64 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.889 1.233 . . . . 0.0 115.491 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -65.02 155.63 34.04 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.567 1.683 . . . . 0.0 112.015 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 t -78.65 80.3 5.02 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.554 1.142 . . . . 0.0 111.725 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.81 153.84 89.16 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.851 1.26 . . . . 0.0 113.131 172.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.96 168.68 23.02 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.472 2.782 . . . . 0.0 112.897 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.12 134.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.13 1.372 . . . . 0.0 111.769 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -78.16 141.78 38.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.213 1.405 . . . . 0.0 110.93 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.21 -6.8 83.98 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.884 1.113 . . . . 0.0 115.884 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mp 57.5 17.92 4.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.266 2.226 . . . . 0.0 114.765 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.14 167.98 9.2 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.195 1.798 . . . . 0.0 113.706 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -66.34 -23.16 66.31 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.34 162.68 12.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.542 1.537 . . . . 0.0 112.894 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -131.61 95.85 3.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.012 1.725 . . . . 0.0 110.804 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -80.14 175.22 10.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 111.637 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -124.83 123.17 39.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.03 1.332 . . . . 0.0 109.887 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -126.71 162.72 25.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.426 1.89 . . . . 0.0 110.916 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -129.33 123.94 33.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.617 1.167 . . . . 0.0 110.327 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -130.26 126.01 36.23 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.521 1.128 . . . . 0.0 111.394 -172.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.36 122.04 18.13 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.293 -0.879 . . . . 0.0 111.659 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mmm -102.72 11.34 37.78 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.812 1.245 . . . . 0.0 113.371 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.08 -76.0 0.31 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.623 2.059 . . . . 0.0 111.863 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -126.14 6.39 7.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.062 1.745 . . . . 0.0 113.379 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.7 m -136.79 117.96 14.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.982 2.113 . . . . 0.0 109.448 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 t -78.25 122.19 25.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.443 0.697 . . . . 0.0 110.764 172.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -111.01 136.44 50.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.569 1.947 . . . . 0.0 110.74 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.84 144.31 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.619 0.768 . . . . 0.0 111.378 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -123.2 133.56 54.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.219 1.807 . . . . 0.0 109.655 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -126.56 109.88 12.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.932 1.693 . . . . 0.0 110.358 -170.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 -168.79 30.84 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.463 1.03 . . . . 0.0 112.121 -171.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.06 84.74 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.47 -1.017 . . . . 0.0 111.201 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -129.43 138.97 51.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.565 1.946 . . . . 0.0 110.268 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -127.94 -9.5 5.45 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.01 1.324 . . . . 0.0 114.43 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 -169.77 43.8 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.577 1.56 . . . . 0.0 113.067 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.47 -171.08 51.93 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 121.921 0.734 . . . . 0.0 114.001 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -83.49 149.81 26.39 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.434 1.494 . . . . 0.0 111.64 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.9 m -84.6 -14.32 49.08 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -141.5 153.9 45.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.453 1.501 . . . . 0.0 111.944 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 45.5 tpp -61.73 -24.51 66.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.383 1.473 . . . . 0.0 113.359 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.11 -22.74 58.64 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.197 -0.94 . . . . 0.0 114.572 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -78.59 -39.11 38.41 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.882 1.341 . . . . 0.0 112.623 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 p -58.87 -39.34 81.07 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.38 -0.825 . . . . 0.0 112.277 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.51 53.39 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -67.7 -40.84 84.32 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.923 -1.111 . . . . 0.0 111.705 169.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.5 -52.92 4.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.761 1.624 . . . . 0.0 111.938 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.7 m . . . . . 0 CA--C 1.548 0.871 0 C-N-CA 123.983 0.913 . . . . 0.0 113.297 179.142 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.558 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.26 117.88 15.96 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.469 1.508 . . . . 0.0 111.559 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -137.77 171.74 13.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.982 2.113 . . . . 0.0 111.55 173.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -109.86 162.67 14.26 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.894 1.678 . . . . 0.0 111.48 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -75.06 164.69 26.27 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.372 1.069 . . . . 0.0 112.18 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.4 m -127.88 81.23 2.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.923 1.689 . . . . 0.0 110.495 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 p -71.06 109.46 5.16 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.924 1.69 . . . . 0.0 111.734 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.0 t -125.67 83.68 61.76 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.31 1.444 . . . . 0.0 110.041 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.81 166.99 27.17 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.525 2.817 . . . . 0.0 112.235 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -57.92 -28.15 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.427 1.091 . . . . 0.0 113.4 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.39 2.01 86.06 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.158 1.361 . . . . 0.0 115.393 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.15 156.43 31.72 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.404 1.602 . . . . 0.0 112.217 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -77.15 99.83 5.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.971 1.309 . . . . 0.0 111.483 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.0 155.72 36.23 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.406 1.482 . . . . 0.0 113.263 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.78 165.54 29.95 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.234 2.623 . . . . 0.0 112.475 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.23 138.05 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.803 1.241 . . . . 0.0 111.875 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -68.61 146.36 53.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.367 1.067 . . . . 0.0 110.604 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.42 -11.07 69.66 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 mp 47.33 34.27 3.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.102 2.161 . . . . 0.0 114.737 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -97.37 178.68 5.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.84 1.75 14.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.544 1.938 . . . . 0.0 114.506 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.76 158.4 31.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.111 1.764 . . . . 0.0 112.778 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -134.7 83.75 2.05 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.932 1.693 . . . . 0.0 112.354 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -73.03 171.8 12.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.737 1.215 . . . . 0.0 111.663 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.6 m -122.05 112.75 18.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.355 1.462 . . . . 0.0 109.726 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -119.8 167.38 12.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.788 1.635 . . . . 0.0 110.849 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -133.41 140.14 47.16 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.182 0.993 . . . . 0.0 110.239 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -133.37 165.95 23.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.213 1.405 . . . . 0.0 109.548 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.3 t -112.65 138.8 48.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.55 -0.719 . . . . 0.0 111.293 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.4 mtp -125.67 86.25 2.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.912 1.685 . . . . 0.0 109.255 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.37 -77.3 0.89 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.025 1.774 . . . . 0.0 112.68 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -131.57 -4.41 3.73 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.015 1.326 . . . . 0.0 114.135 -174.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.3 m -123.83 139.37 54.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.179 1.392 . . . . 0.0 111.536 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.09 147.52 32.74 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.942 0.897 . . . . 0.0 111.824 168.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -147.02 127.02 13.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.554 1.942 . . . . 0.0 110.565 -171.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.44 145.17 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.421 1.089 . . . . 0.0 112.372 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -131.72 137.06 48.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.344 1.857 . . . . 0.0 110.595 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -138.54 117.46 12.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.381 1.472 . . . . 0.0 110.666 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.62 65.69 0.04 OUTLIER Glycine 0 N--CA 1.477 1.409 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.88 28.74 15.02 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -72.45 -46.43 54.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.152 . . . . 0.0 113.588 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.3 p 50.75 -10.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 131.224 3.81 . . . . 0.0 118.405 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.61 -171.39 47.71 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.656 2.074 . . . . 0.0 113.168 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.06 -168.76 23.82 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.751 -0.852 . . . . 0.0 113.759 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -67.31 146.83 53.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.429 1.492 . . . . 0.0 111.932 175.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.8 p -75.43 -32.82 60.82 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -136.76 163.05 31.51 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.144 1.777 . . . . 0.0 112.071 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.3 tpp -56.53 -38.53 71.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.749 0.82 . . . . 0.0 111.725 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.06 -17.39 75.61 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.19 0.9 . . . . 0.0 115.07 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -82.85 -33.63 27.03 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.908 1.354 . . . . 0.0 111.798 168.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.2 t -69.33 -53.4 19.77 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.474 -0.766 . . . . 0.0 112.016 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.31 -17.87 64.94 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -78.94 -18.36 53.93 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -106.91 -51.69 2.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.196 1.398 . . . . 0.0 112.352 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -73.8 159.0 85.34 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 118.713 0.688 . . . . 0.0 112.251 171.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.36 -12.94 15.39 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.178 2.585 . . . . 0.0 115.197 -170.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.207 0 C-N-CA 126.229 1.871 . . . . 0.0 112.972 -179.009 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.457 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -134.75 78.08 1.72 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.913 1.285 . . . . 0.0 110.698 -166.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -108.3 -52.64 2.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.09 1.356 . . . . 0.0 112.7 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -80.59 -19.56 45.27 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.556 1.143 . . . . 0.0 113.515 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -73.63 165.49 25.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.245 1.018 . . . . 0.0 113.118 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.7 p -84.72 155.75 21.75 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.027 0.931 . . . . 0.0 112.396 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.6 p -143.82 158.79 43.44 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.283 1.833 . . . . 0.0 110.842 171.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 m -140.89 155.84 68.85 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 126.15 1.78 . . . . 0.0 110.97 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.98 161.59 43.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.81 2.34 . . . . 0.0 112.5 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.6 tp -58.27 -28.12 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.833 1.253 . . . . 0.0 113.262 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.13 4.46 83.26 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.179 1.371 . . . . 0.0 115.506 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.9 t-105 -63.6 157.34 24.09 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.479 1.639 . . . . 0.0 112.379 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -76.36 70.35 2.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.368 1.467 . . . . 0.0 112.266 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.19 157.05 88.85 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.399 1.479 . . . . 0.0 112.901 171.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.76 176.72 9.01 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.848 3.032 . . . . 0.0 113.263 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.47 135.48 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.728 1.611 . . . . 0.0 111.52 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -77.28 141.95 39.71 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.969 1.308 . . . . 0.0 110.752 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.4 -4.42 90.0 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.035 1.174 . . . . 0.0 116.035 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 56.15 21.16 4.96 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.822 2.049 . . . . 0.0 114.255 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.0 m -70.16 168.84 14.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.167 1.387 . . . . 0.0 113.29 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -73.17 -0.44 14.23 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.96 164.44 22.32 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.933 1.693 . . . . 0.0 112.766 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -129.47 93.09 3.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.247 1.819 . . . . 0.0 110.905 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.15 174.04 11.97 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.472 1.109 . . . . 0.0 111.455 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.1 m -128.01 110.84 12.9 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.001 1.32 . . . . 0.0 109.744 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -116.42 165.91 12.68 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.871 1.668 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.07 85.05 2.18 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.263 1.025 . . . . 0.0 111.135 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -82.35 156.19 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.844 0.858 . . . . 0.0 111.091 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.0 t -90.48 140.38 29.78 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.388 -0.82 . . . . 0.0 111.442 168.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.2 mtp -133.77 111.17 10.32 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.604 1.962 . . . . 0.0 109.663 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.69 -95.57 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.94 1.257 . . . . 0.0 112.186 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -116.0 -8.98 11.81 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.342 1.457 . . . . 0.0 113.932 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.3 p -120.51 156.58 31.23 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.733 1.151 . . . . 0.0 113.14 -171.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.24 124.53 35.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.687 1.195 . . . . 0.0 110.378 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -121.43 135.16 55.08 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.454 1.902 . . . . 0.0 110.704 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -67.22 145.99 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.318 0.647 . . . . 0.0 112.006 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -127.14 135.79 51.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.732 2.013 . . . . 0.0 109.675 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.07 107.97 11.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.499 1.519 . . . . 0.0 110.423 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.01 -169.01 31.34 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.911 0.767 . . . . 0.0 113.095 -172.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.45 86.51 3.82 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.949 -0.736 . . . . 0.0 110.675 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.55 133.62 48.44 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.845 1.658 . . . . 0.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 57.2 p -136.79 -3.42 2.06 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.197 1.399 . . . . 0.0 114.389 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.1 0.83 58.98 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.189 1.376 . . . . 0.0 115.842 -172.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.79 176.58 17.64 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 126.02 1.771 . . . . 0.0 113.606 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -60.01 136.37 57.99 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.204 1.002 . . . . 0.0 112.522 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.5 m -76.41 -17.16 59.49 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -131.92 146.99 52.44 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 126.081 1.753 . . . . 0.0 110.951 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 tpp -55.82 -37.84 69.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.241 1.016 . . . . 0.0 111.504 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.02 -47.8 85.68 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.225 0.917 . . . . 0.0 112.646 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.23 -37.9 81.75 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.091 0.946 . . . . 0.0 112.688 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.56 -51.27 70.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.931 0.492 . . . . 0.0 111.887 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 -19.01 65.65 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -66.46 -25.04 66.53 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.676 -1.265 . . . . 0.0 113.116 169.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -109.49 -55.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.807 1.643 . . . . 0.0 112.231 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.99 159.72 75.34 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.709 0.804 . . . . 0.0 112.911 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.62 -17.64 12.49 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.054 2.502 . . . . 0.0 115.125 -170.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.253 0 C-N-CA 125.916 1.722 . . . . 0.0 113.893 -179.391 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.441 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -64.98 133.58 52.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.111 0.964 . . . . 0.0 112.074 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -138.63 129.32 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.209 1.804 . . . . 0.0 110.215 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -144.05 165.5 27.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.092 1.357 . . . . 0.0 112.015 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.74 111.52 19.89 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.119 1.367 . . . . 0.0 111.13 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.5 t -89.63 99.0 12.09 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.478 0.711 . . . . 0.0 111.426 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.7 p -129.7 172.55 11.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.084 1.753 . . . . 0.0 111.342 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.05 156.04 79.78 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 125.904 1.682 . . . . 0.0 111.489 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.75 160.12 50.44 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.848 2.366 . . . . 0.0 112.346 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 tt -58.85 -26.71 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.94 1.296 . . . . 0.0 113.712 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.83 2.02 88.0 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.886 1.232 . . . . 0.0 115.497 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -66.91 157.39 33.32 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 119.286 1.543 . . . . 0.0 112.617 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.3 m -75.37 57.7 0.93 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.634 1.974 . . . . 0.0 113.425 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.22 155.98 89.24 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.131 1.373 . . . . 0.0 113.912 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -75.39 178.46 7.3 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 124.003 3.135 . . . . 0.0 112.734 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.08 139.68 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.342 1.457 . . . . 0.0 112.213 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -68.18 142.44 55.7 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.026 1.33 . . . . 0.0 110.879 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.09 -11.63 75.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 46.17 69.82 0.44 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.313 2.245 . . . . 0.0 112.671 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.6 m -120.55 175.12 6.15 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.652 1.581 . . . . 0.0 111.874 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -84.64 4.5 32.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.156 1.382 . . . . 0.0 114.475 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.13 163.53 24.44 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.338 1.855 . . . . 0.0 112.808 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -130.33 87.12 2.47 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.156 1.783 . . . . 0.0 111.677 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.06 175.46 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.508 1.123 . . . . 0.0 112.152 171.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -128.04 115.36 18.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.221 1.408 . . . . 0.0 110.256 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -119.98 165.71 14.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.11 1.764 . . . . 0.0 111.037 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -129.04 134.44 48.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 109.945 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -132.62 139.6 47.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.708 1.203 . . . . 0.0 110.436 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.6 t -81.3 111.19 17.46 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.604 -0.685 . . . . 0.0 111.589 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.8 mmm -92.68 71.61 4.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.109 0.963 . . . . 0.0 109.33 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.25 -75.0 2.39 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.99 1.757 . . . . 0.0 113.804 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -133.65 5.96 3.72 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.843 1.657 . . . . 0.0 113.745 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 93.4 m -135.65 117.18 14.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.188 1.795 . . . . 0.0 110.399 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.7 m -67.61 133.29 49.13 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.896 0.878 . . . . 0.0 111.165 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -131.21 141.45 50.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.119 1.768 . . . . 0.0 110.983 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.64 145.88 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 112.19 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -134.39 141.57 46.88 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.113 2.165 . . . . 0.0 110.552 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.97 117.67 10.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.426 1.49 . . . . 0.0 110.759 -172.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.02 58.85 0.02 OUTLIER Glycine 0 N--CA 1.478 1.456 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 56.52 30.92 18.05 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -71.23 -53.24 15.05 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.658 1.183 . . . . 0.0 113.391 -172.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.5 p 50.74 3.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 129.618 3.167 . . . . 0.0 118.23 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.97 -6.31 52.21 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.342 1.449 . . . . 0.0 116.082 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.12 -177.97 39.0 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.165 1.364 . . . . 0.0 114.112 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.4 146.76 47.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.167 1.387 . . . . 0.0 111.535 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.8 t -69.39 -36.39 76.73 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -136.26 162.58 32.58 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.259 1.824 . . . . 0.0 111.123 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 35.7 tpp -58.03 -37.56 74.57 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 112.014 174.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.8 -44.15 98.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.64 1.114 . . . . 0.0 113.792 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.26 -40.25 96.87 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.451 1.126 . . . . 0.0 112.22 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.8 t -57.8 -47.76 81.67 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.378 1.071 . . . . 0.0 111.348 170.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.18 62.71 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.5 mtp85 -73.08 -40.76 64.76 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 120.069 1.304 . . . . 0.0 112.06 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -84.4 -51.5 6.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.45 1.5 . . . . 0.0 112.006 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.2 163.93 61.8 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.802 0.841 . . . . 0.0 112.995 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.11 -9.35 20.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.418 2.745 . . . . 0.0 114.483 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 C-N-CA 127.197 2.332 . . . . 0.0 112.775 178.342 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.499 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -143.26 168.18 20.38 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.724 1.61 . . . . 0.0 112.546 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -148.62 169.13 21.04 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.981 1.712 . . . . 0.0 112.443 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.09 15.51 2.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.538 1.535 . . . . 0.0 113.991 -174.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -61.71 155.86 21.67 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -67.16 123.14 19.46 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.213 1.405 . . . . 0.0 111.723 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -139.98 164.15 30.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.311 1.444 . . . . 0.0 111.941 173.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 m -139.14 157.37 71.28 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 126.892 2.077 . . . . 0.0 110.527 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.81 162.57 41.6 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.71 2.273 . . . . 0.0 112.67 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.11 -27.53 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.96 1.304 . . . . 0.0 113.509 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.44 3.98 86.36 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.068 1.318 . . . . 0.0 115.298 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -64.46 157.81 25.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.438 1.619 . . . . 0.0 112.317 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 m -72.92 58.23 0.46 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.926 2.09 . . . . 0.0 113.376 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.55 155.54 80.91 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.873 1.269 . . . . 0.0 113.25 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.12 176.43 9.55 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.478 2.785 . . . . 0.0 113.382 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.46 140.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.651 1.58 . . . . 0.0 111.206 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -81.91 145.73 30.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.047 1.339 . . . . 0.0 111.107 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.08 -7.3 80.65 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 124.99 1.281 . . . . 0.0 115.823 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mp 53.98 26.61 6.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.01 2.124 . . . . 0.0 114.435 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -68.12 171.1 7.38 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.116 1.766 . . . . 0.0 113.233 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -76.0 -1.82 27.59 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.562 1.545 . . . . 0.0 114.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.85 167.48 18.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.212 1.805 . . . . 0.0 112.859 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -127.57 102.72 6.97 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.388 1.875 . . . . 0.0 110.988 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.21 175.77 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.803 1.241 . . . . 0.0 111.271 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.7 m -128.75 117.1 20.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.141 1.377 . . . . 0.0 109.518 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -123.91 167.06 14.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.491 1.516 . . . . 0.0 110.463 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.32 105.18 5.87 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.353 1.461 . . . . 0.0 109.993 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -103.57 132.03 50.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 111.117 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.05 91.99 2.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.291 0.567 . . . . 0.0 111.7 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -86.76 83.76 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.54 1.136 . . . . 0.0 109.936 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.67 -73.47 2.26 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.602 1.572 . . . . 0.0 112.837 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -136.1 0.69 2.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 114.058 -174.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 p -136.22 151.96 50.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.008 0.923 . . . . 0.0 112.992 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.8 m -89.05 81.16 6.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.491 1.516 . . . . 0.0 111.42 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -64.84 124.2 21.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.245 0.618 . . . . 0.0 110.142 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.77 142.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.082 0.553 . . . . 0.0 111.347 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -125.91 125.7 43.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.456 1.902 . . . . 0.0 109.717 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.21 106.18 12.55 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.876 1.67 . . . . 0.0 110.237 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.94 -169.55 32.5 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.809 1.195 . . . . 0.0 112.078 -170.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.4 t -77.14 88.6 3.62 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.471 -1.017 . . . . 0.0 111.177 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -129.48 134.68 47.93 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.005 1.722 . . . . 0.0 110.321 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.0 p -138.77 -7.98 1.42 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.983 1.313 . . . . 0.0 114.519 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.91 -2.99 88.24 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.932 1.254 . . . . 0.0 115.982 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.82 178.03 22.92 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.819 1.676 . . . . 0.0 112.993 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -55.21 134.0 49.49 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.763 1.625 . . . . 0.0 114.033 -165.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 t -81.04 -10.87 59.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -132.7 146.92 52.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.566 1.546 . . . . 0.0 111.643 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.5 tpp -52.96 -39.1 62.71 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.03 1.332 . . . . 0.0 111.849 168.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.03 -45.16 63.62 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.897 0.761 . . . . 0.0 113.325 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -62.66 -34.51 77.23 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.123 0.969 . . . . 0.0 112.36 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 t -66.17 -53.58 35.74 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.791 -0.568 . . . . 0.0 112.249 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.23 75.84 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -63.36 -22.49 66.91 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -104.53 -23.63 13.11 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.558 1.543 . . . . 0.0 114.1 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.8 m -58.1 155.79 23.44 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 118.847 0.749 . . . . 0.0 112.697 164.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.61 -8.43 18.19 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 123.522 2.815 . . . . 0.0 114.336 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 126.99 2.233 . . . . 0.0 113.016 179.544 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -138.42 111.96 8.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.901 1.28 . . . . 0.0 111.67 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -122.82 -13.08 7.95 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.39 1.476 . . . . 0.0 114.372 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.35 75.53 4.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.863 1.265 . . . . 0.0 110.568 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -142.92 166.69 23.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.962 1.305 . . . . 0.0 112.898 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.6 m -119.09 59.38 0.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.701 1.6 . . . . 0.0 110.995 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 p -67.87 149.32 49.99 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.8 0.84 . . . . 0.0 110.99 163.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.44 156.1 63.9 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.589 1.556 . . . . 0.0 111.357 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.06 148.81 63.93 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.451 2.101 . . . . 0.0 111.772 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 tt -59.8 -21.98 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.416 1.087 . . . . 0.0 113.342 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.02 -9.31 83.86 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 114.957 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -68.51 139.37 55.65 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.408 1.604 . . . . 0.0 110.829 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 t -72.43 94.18 1.62 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.41 159.07 50.97 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.379 1.471 . . . . 0.0 112.647 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.71 175.59 11.09 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.08 2.52 . . . . 0.0 113.711 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.76 138.28 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.696 1.598 . . . . 0.0 111.632 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HG2' ' H ' ' A' ' 37' ' ' LEU . 2.6 ttpm? -82.9 138.95 33.68 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.0 1.32 . . . . 0.0 111.191 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.68 2.62 82.34 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.544 2.021 . . . . 0.0 115.756 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.445 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 44.9 mt 57.19 17.89 3.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.015 2.526 . . . . 0.0 115.776 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.9 p -78.62 173.63 12.22 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 2.43 6.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.732 2.013 . . . . 0.0 115.252 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.61 162.43 17.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.572 1.549 . . . . 0.0 112.889 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -130.93 87.15 2.44 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.575 1.95 . . . . 0.0 111.545 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.39 174.88 11.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.976 1.311 . . . . 0.0 111.482 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.9 m -128.47 131.89 48.38 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.289 1.436 . . . . 0.0 109.377 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -130.42 158.29 40.28 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.833 1.253 . . . . 0.0 111.12 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -123.61 81.36 1.89 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.531 1.158 . . . . 0.0 111.374 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -77.37 170.91 15.72 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 0.0 110.974 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -126.45 136.4 52.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.552 1.141 . . . . 0.0 110.549 169.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.4 mmm -121.35 10.59 10.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.694 1.198 . . . . 0.0 112.814 -172.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.87 -91.07 0.12 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.656 1.598 . . . . 0.0 111.914 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.09 8.75 18.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.849 1.66 . . . . 0.0 113.411 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -146.2 132.75 19.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.302 1.841 . . . . 0.0 110.815 -172.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.2 m -81.01 86.68 6.08 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.604 0.761 . . . . 0.0 111.958 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -62.61 114.07 3.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.65 144.09 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.117 0.967 . . . . 0.0 111.165 169.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -124.93 148.23 48.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.276 1.43 . . . . 0.0 110.528 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -131.36 127.69 38.11 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.044 1.738 . . . . 0.0 110.575 -174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.62 -168.02 25.68 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.096 0.855 . . . . 0.0 112.652 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.73 71.19 0.34 Allowed 'General case' 0 CA--C 1.552 1.054 0 O-C-N 121.602 -0.94 . . . . 0.0 111.861 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.5 136.15 53.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.699 1.6 . . . . 0.0 110.651 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.5 p -129.75 -8.39 4.52 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.301 1.441 . . . . 0.0 114.117 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.6 -174.06 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.325 1.44 . . . . 0.0 113.444 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.09 -172.95 8.47 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.123 0.868 . . . . 0.0 114.216 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -69.73 137.15 51.77 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.783 0.802 . . . . 0.0 112.05 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 t -80.82 -13.0 59.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -130.1 144.72 51.5 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.658 1.983 . . . . 0.0 110.875 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.2 ttt -65.3 -15.49 62.57 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.112 1.365 . . . . 0.0 113.895 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.11 -32.15 15.12 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.591 1.091 . . . . 0.0 114.275 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.27 -28.42 67.19 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.537 1.135 . . . . 0.0 113.049 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.7 p -73.98 -44.16 55.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.357 0.663 . . . . 0.0 112.171 168.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.87 -24.3 61.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.264 1.426 . . . . 0.0 114.564 -171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -65.89 -30.1 70.64 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 167.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.68 -49.15 5.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.665 1.186 . . . . 0.0 112.006 -171.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.5 m -68.39 160.42 75.95 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.419 1.088 . . . . 0.0 112.431 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.42 -23.75 20.03 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.321 2.681 . . . . 0.0 114.275 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.279 0 C-N-CA 125.978 1.751 . . . . 0.0 114.55 -177.573 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.439 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -134.96 137.68 43.31 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.438 1.495 . . . . 0.0 111.006 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.74 154.63 36.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.487 1.115 . . . . 0.0 110.71 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -138.64 92.22 2.6 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.971 1.308 . . . . 0.0 111.04 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.84 164.88 12.59 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.011 1.725 . . . . 0.0 112.931 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.5 m -125.72 85.88 2.46 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.512 1.525 . . . . 0.0 111.248 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.3 p -71.09 122.49 20.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.573 1.149 . . . . 0.0 111.761 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.53 157.03 66.41 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 126.257 1.823 . . . . 0.0 111.701 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.06 155.23 57.27 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.64 2.226 . . . . 0.0 112.473 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.91 -27.34 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.943 1.297 . . . . 0.0 113.484 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.09 83.05 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.221 1.391 . . . . 0.0 115.51 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -63.7 153.8 35.12 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.527 1.663 . . . . 0.0 112.414 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -78.06 74.87 4.6 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.805 1.242 . . . . 0.0 111.5 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.18 154.25 94.27 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.511 1.125 . . . . 0.0 111.584 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.88 162.53 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 113.203 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.28 132.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.882 1.273 . . . . 0.0 111.437 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -71.58 136.62 47.5 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.203 1.001 . . . . 0.0 110.733 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.13 -4.22 86.06 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.361 0.982 . . . . 0.0 115.259 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.4 mt 59.35 9.07 1.3 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.747 2.419 . . . . 0.0 115.697 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 p -89.72 173.21 8.41 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -171.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -0.31 15.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.768 2.027 . . . . 0.0 115.92 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.86 152.12 25.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.293 1.437 . . . . 0.0 112.849 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -121.49 78.77 1.47 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.275 1.83 . . . . 0.0 110.624 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -72.14 171.95 11.06 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.194 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -128.29 116.01 19.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.882 1.273 . . . . 0.0 109.573 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -120.46 159.14 25.74 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.848 1.659 . . . . 0.0 110.905 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -126.93 120.0 28.07 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.729 1.212 . . . . 0.0 109.958 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -120.5 124.66 45.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.149 0.979 . . . . 0.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.7 t -73.61 116.02 13.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.096 0.474 . . . . 0.0 110.488 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.9 mtp -93.83 67.32 3.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.705 1.602 . . . . 0.0 109.439 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.31 -64.92 3.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.605 1.574 . . . . 0.0 114.126 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -140.0 9.6 2.35 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 16.0 t -148.68 148.08 29.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.789 1.636 . . . . 0.0 109.988 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -102.76 129.66 49.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 112.597 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -119.27 136.96 53.98 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.858 1.663 . . . . 0.0 110.889 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.12 141.23 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.351 1.06 . . . . 0.0 111.106 172.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.43 128.45 48.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.351 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.48 97.98 3.83 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.588 1.555 . . . . 0.0 111.894 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.47 63.41 0.01 OUTLIER Glycine 0 N--CA 1.472 1.048 0 O-C-N 121.22 -0.925 . . . . 0.0 114.491 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.4 t 52.93 53.7 11.65 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.715 1.206 . . . . 0.0 112.917 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.43 140.8 41.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.5 p -130.2 -12.41 4.07 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.843 1.257 . . . . 0.0 114.341 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.83 -174.4 48.47 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.238 1.399 . . . . 0.0 113.106 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.06 -166.9 52.08 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.808 -0.819 . . . . 0.0 113.313 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -87.02 146.75 26.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 111.977 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.6 m -78.08 -13.2 59.96 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -137.73 148.2 45.41 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 112.072 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.01 -27.23 68.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 112.508 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.91 -28.56 45.56 Favored Glycine 0 CA--C 1.535 1.307 0 O-C-N 121.42 -0.8 . . . . 0.0 114.155 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -72.16 -34.02 68.17 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.432 1.116 . . . . 0.0 112.579 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 p -68.78 -45.47 71.23 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.351 -0.843 . . . . 0.0 111.453 168.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -38.38 88.68 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.906 1.282 . . . . 0.0 114.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -66.19 -29.6 69.91 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -84.77 -46.27 11.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.0 112.118 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.05 166.15 43.55 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.01 -8.21 18.74 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.514 2.809 . . . . 0.0 114.347 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 127.322 2.391 . . . . 0.0 112.706 179.019 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.482 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.91 98.64 3.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.341 1.456 . . . . 0.0 110.178 -167.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -131.27 4.94 4.4 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.28 1.832 . . . . 0.0 114.028 -172.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -67.62 14.6 0.05 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.787 2.435 . . . . 0.0 115.27 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.89 152.56 31.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.837 1.655 . . . . 0.0 112.826 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.07 103.01 4.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.148 0.979 . . . . 0.0 111.714 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.9 t -143.22 155.33 44.49 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.013 1.325 . . . . 0.0 111.723 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 t -141.17 91.13 8.93 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.968 1.707 . . . . 0.0 109.837 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.91 161.9 40.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.881 2.387 . . . . 0.0 112.205 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.4 tt -63.18 146.97 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.718 0.807 . . . . 0.0 111.068 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.49 0.84 89.38 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.527 1.06 . . . . 0.0 115.384 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -62.67 154.7 28.5 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.152 1.476 . . . . 0.0 111.523 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -77.05 68.69 3.23 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.945 1.298 . . . . 0.0 111.922 176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.01 155.65 91.43 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.298 1.439 . . . . 0.0 112.7 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.6 175.06 11.59 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.223 2.615 . . . . 0.0 112.935 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.55 139.64 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.33 1.452 . . . . 0.0 111.428 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -67.17 146.17 54.49 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.91 82.65 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.718 1.047 . . . . 0.0 115.718 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.84 17.18 4.06 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.182 2.193 . . . . 0.0 114.662 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.3 m -73.21 168.49 19.03 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.442 1.097 . . . . 0.0 112.937 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -68.6 -42.78 77.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.353 1.061 . . . . 0.0 112.321 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.13 157.44 37.76 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.913 1.285 . . . . 0.0 113.078 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -132.09 90.95 2.88 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.067 1.747 . . . . 0.0 111.213 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.8 173.98 3.21 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.371 1.068 . . . . 0.0 111.656 170.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.7 m -125.14 115.02 19.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.877 1.271 . . . . 0.0 109.744 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -118.83 165.63 13.8 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.348 1.459 . . . . 0.0 110.929 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.29 136.44 50.06 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.337 1.455 . . . . 0.0 109.318 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -130.17 137.48 50.12 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.386 1.075 . . . . 0.0 109.457 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.9 t -72.88 131.19 41.93 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.98 -0.45 . . . . 0.0 110.695 169.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 97.2 mmm -123.14 6.42 9.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.625 1.57 . . . . 0.0 113.906 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.23 91.35 0.81 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.582 1.563 . . . . 0.0 111.99 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 58.44 9.32 1.03 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.829 2.052 . . . . 0.0 114.933 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 t -155.74 165.29 36.98 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.054 2.542 . . . . 0.0 108.961 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.5 m -117.29 159.99 21.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.675 0.79 . . . . 0.0 112.792 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.39 142.1 49.98 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.767 2.027 . . . . 0.0 110.095 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.38 143.44 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.0 0.92 . . . . 0.0 111.004 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -132.16 126.82 34.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.312 1.845 . . . . 0.0 110.605 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.99 108.7 9.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.823 1.649 . . . . 0.0 110.562 -171.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.79 55.18 0.01 OUTLIER Glycine 0 N--CA 1.476 1.337 0 C-N-CA 123.599 0.618 . . . . 0.0 114.238 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.1 t 60.5 22.94 12.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.506 1.523 . . . . 0.0 114.887 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -66.55 135.24 53.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.197 1.399 . . . . 0.0 111.228 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.7 p -132.33 -13.74 3.02 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.37 -9.31 79.64 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 115.333 0.893 . . . . 0.0 115.333 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.32 170.67 21.6 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.308 1.432 . . . . 0.0 114.198 -175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.33 144.48 57.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.8 1.64 . . . . 0.0 111.821 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -72.22 -22.69 61.21 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -140.48 152.58 45.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.705 1.602 . . . . 0.0 111.385 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.2 ttm -62.86 -30.56 71.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.25 70.11 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.316 -0.865 . . . . 0.0 114.208 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.87 -44.3 17.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.915 1.358 . . . . 0.0 112.88 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -61.47 -35.92 78.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.831 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.91 -7.23 49.99 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.976 1.71 . . . . 0.0 115.264 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -76.51 -42.05 44.71 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.658 1.117 . . . . 0.0 111.948 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -81.57 -54.67 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.926 1.691 . . . . 0.0 111.945 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m -77.28 160.87 74.65 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.047 0.939 . . . . 0.0 112.22 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.45 -7.76 18.01 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.304 2.669 . . . . 0.0 114.24 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 C-N-CA 127.714 2.578 . . . . 0.0 112.487 177.88 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.431 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -140.16 166.31 25.02 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.461 1.505 . . . . 0.0 110.982 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -79.5 -26.03 41.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.64 1.576 . . . . 0.0 113.118 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -135.82 111.0 8.95 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.045 1.738 . . . . 0.0 110.508 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.2 164.64 25.89 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.973 1.309 . . . . 0.0 113.488 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.92 94.02 4.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.851 1.66 . . . . 0.0 111.555 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.4 p -110.85 164.57 12.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.597 1.959 . . . . 0.0 112.183 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.55 159.07 58.87 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 126.741 2.017 . . . . 0.0 111.064 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.34 160.56 49.11 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.662 2.241 . . . . 0.0 112.245 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -58.51 -26.37 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.005 1.322 . . . . 0.0 113.713 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.03 6.01 84.02 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.165 1.365 . . . . 0.0 115.569 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.6 t-105 -63.54 153.26 36.23 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.482 1.641 . . . . 0.0 112.617 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.7 m -72.27 87.69 1.13 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.823 1.649 . . . . 0.0 112.086 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -105.87 157.27 35.08 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 125.991 1.716 . . . . 0.0 112.505 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.11 170.9 19.38 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.549 2.833 . . . . 0.0 113.945 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.92 136.3 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.125 1.37 . . . . 0.0 111.492 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -70.19 147.6 49.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.641 1.176 . . . . 0.0 110.732 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.17 -14.3 66.92 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.8 mp 46.51 50.54 12.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.906 2.082 . . . . 0.0 113.417 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 25.0 m -96.73 173.71 7.18 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.612 1.165 . . . . 0.0 112.467 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -69.07 -34.89 75.87 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.981 1.312 . . . . 0.0 112.79 173.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.93 165.19 13.0 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.762 1.625 . . . . 0.0 112.995 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -131.36 92.41 3.18 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.21 1.804 . . . . 0.0 111.252 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -68.48 175.66 3.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.64 1.176 . . . . 0.0 112.099 172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -125.19 113.0 17.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.097 1.359 . . . . 0.0 110.456 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -115.44 169.29 9.27 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.963 1.705 . . . . 0.0 110.867 173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -135.38 129.5 33.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.214 1.406 . . . . 0.0 109.677 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.82 129.12 41.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.692 1.197 . . . . 0.0 110.775 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.05 134.26 38.84 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.992 0.425 . . . . 0.0 111.497 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.3 mtp -122.5 56.92 1.11 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.289 1.836 . . . . 0.0 109.97 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.33 -79.7 0.3 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.018 1.77 . . . . 0.0 112.576 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -124.54 1.02 8.26 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 m -136.2 147.08 47.47 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.395 1.878 . . . . 0.0 110.249 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.9 t -106.25 132.85 51.82 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 111.185 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -126.28 141.7 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.346 1.859 . . . . 0.0 110.544 -173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.56 148.06 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.039 0.935 . . . . 0.0 111.776 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -136.1 133.18 37.03 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.792 2.037 . . . . 0.0 110.438 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -133.91 119.08 18.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.158 1.383 . . . . 0.0 110.956 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.54 51.98 0.02 OUTLIER Glycine 0 N--CA 1.476 1.333 0 N-CA-C 114.592 0.597 . . . . 0.0 114.592 -171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.6 t 56.36 32.68 20.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.314 1.446 . . . . 0.0 114.233 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -71.91 121.41 19.01 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.673 1.189 . . . . 0.0 110.602 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -108.36 -7.51 15.86 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.268 1.427 . . . . 0.0 113.678 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.11 -168.96 40.7 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.958 1.742 . . . . 0.0 113.122 172.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 -162.03 41.74 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.004 0.811 . . . . 0.0 113.989 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.43 138.12 31.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.795 0.838 . . . . 0.0 110.863 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.9 p -77.9 -16.8 57.94 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 -139.38 155.76 47.44 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.997 2.119 . . . . 0.0 111.913 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 52.6 tpp -61.77 -39.66 92.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.012 0.925 . . . . 0.0 111.853 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.97 -37.53 94.56 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.146 -0.972 . . . . 0.0 113.436 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -68.49 -29.95 68.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.1 p -81.13 -45.55 16.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.679 1.127 . . . . 0.0 112.499 166.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 -18.94 65.07 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -68.41 -24.69 64.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.928 -1.108 . . . . 0.0 113.156 169.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -106.28 -56.05 2.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.173 1.789 . . . . 0.0 111.481 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m -74.62 157.73 85.72 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.139 0.976 . . . . 0.0 112.814 173.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.54 -12.57 15.25 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.389 2.726 . . . . 0.0 114.939 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 C-N-CA 126.184 1.85 . . . . 0.0 112.871 -178.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.59 81.58 0.83 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.226 1.41 . . . . 0.0 112.528 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -68.52 174.14 4.41 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.974 1.71 . . . . 0.0 113.477 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -126.89 159.72 33.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.633 1.573 . . . . 0.0 111.261 171.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -149.72 175.26 11.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.922 1.689 . . . . 0.0 111.758 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.7 t -132.01 100.3 5.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.756 1.222 . . . . 0.0 111.472 -176.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.2 p -136.75 163.67 30.06 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.814 1.645 . . . . 0.0 112.202 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 m -141.77 160.27 56.69 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 126.796 2.038 . . . . 0.0 111.471 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.85 168.67 20.99 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.955 2.437 . . . . 0.0 112.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 tp -60.47 147.27 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.196 0.998 . . . . 0.0 111.532 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.77 9.72 86.49 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -61.62 157.1 18.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.918 1.359 . . . . 0.0 112.401 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -77.34 62.63 2.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.68 1.592 . . . . 0.0 112.485 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.76 157.85 85.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.368 1.467 . . . . 0.0 112.716 172.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.31 178.24 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.683 2.922 . . . . 0.0 113.87 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.11 137.45 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.752 1.621 . . . . 0.0 111.248 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -82.7 144.48 30.2 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.306 1.443 . . . . 0.0 111.059 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.54 -8.3 83.31 Favored Glycine 0 CA--C 1.542 1.736 0 C-N-CA 124.761 1.172 . . . . 0.0 115.93 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 mp 55.4 22.35 4.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.208 2.203 . . . . 0.0 114.694 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -67.7 168.83 10.55 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.171 1.789 . . . . 0.0 113.204 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -66.18 -28.93 69.14 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.76 166.72 12.62 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.567 1.547 . . . . 0.0 113.15 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -132.76 107.22 8.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.154 1.781 . . . . 0.0 111.203 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.3 178.0 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.466 1.506 . . . . 0.0 110.971 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 m -128.97 110.49 12.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 110.015 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -114.49 168.12 10.14 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.312 1.445 . . . . 0.0 110.856 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -133.69 139.71 46.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.738 1.215 . . . . 0.0 110.29 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.37 131.06 29.34 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.668 1.187 . . . . 0.0 110.492 -176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 20.7 m -73.45 94.38 2.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.724 0.81 . . . . 0.0 111.574 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 78.7 mmm -80.46 54.33 2.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.789 1.636 . . . . 0.0 109.944 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.56 -88.77 1.13 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.398 1.951 . . . . 0.0 112.19 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -86.83 -14.04 43.28 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -173.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.3 p -145.44 143.52 30.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -167.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.8 m -75.06 92.28 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.935 1.294 . . . . 0.0 110.761 169.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -75.53 126.08 30.29 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.931 170.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.89 147.06 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.136 0.574 . . . . 0.0 110.869 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -128.75 108.39 10.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.746 2.018 . . . . 0.0 109.756 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -98.78 110.37 22.98 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.134 1.774 . . . . 0.0 110.461 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.01 -169.34 33.09 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.453 1.025 . . . . 0.0 112.647 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.06 87.14 2.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.561 -0.964 . . . . 0.0 111.215 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.36 122.49 27.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.027 1.731 . . . . 0.0 110.644 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.3 p -115.03 -8.06 12.48 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.534 1.534 . . . . 0.0 113.789 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.96 -173.18 49.76 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.776 1.655 . . . . 0.0 113.625 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.94 -159.97 42.73 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.102 0.858 . . . . 0.0 114.61 171.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -82.53 128.85 34.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.131 0.973 . . . . 0.0 110.65 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.5 p -70.04 -26.9 64.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.645 1.178 . . . . 0.0 113.352 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -139.59 160.04 40.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.891 2.077 . . . . 0.0 111.048 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 50.2 ttm -63.11 -31.61 72.79 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.68 73.68 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 114.036 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -80.98 -29.05 35.37 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.055 0.927 . . . . 0.0 113.265 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.5 p -79.83 -34.35 39.52 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.103 -0.998 . . . . 0.0 112.432 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.88 -22.33 66.63 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -78.54 -5.18 51.98 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.166 1.386 . . . . 0.0 114.566 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -118.92 -43.81 2.64 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.171 1.788 . . . . 0.0 112.411 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.5 m -63.83 158.74 59.35 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 111.814 167.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.42 -16.31 17.23 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 122.663 2.242 . . . . 0.0 113.805 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 C-N-CA 126.464 1.983 . . . . 0.0 113.207 177.651 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -58.24 117.02 3.96 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.443 1.897 . . . . 0.0 113.427 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -138.1 161.71 36.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.625 1.97 . . . . 0.0 111.652 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -93.04 68.36 4.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.257 1.423 . . . . 0.0 111.627 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.39 118.24 12.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.496 1.118 . . . . 0.0 112.217 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 p -73.81 148.64 42.26 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.812 0.845 . . . . 0.0 112.416 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.4 p -146.94 169.2 19.67 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.773 1.629 . . . . 0.0 112.144 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.58 157.4 72.21 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 126.626 1.97 . . . . 0.0 111.319 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.26 159.99 48.24 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.867 2.378 . . . . 0.0 112.675 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -58.82 -27.72 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.192 1.397 . . . . 0.0 113.635 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.88 -3.62 89.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.513 1.054 . . . . 0.0 115.23 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -68.76 141.4 55.23 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.42 1.61 . . . . 0.0 111.739 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -71.63 92.43 1.16 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.92 159.32 63.28 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.194 1.398 . . . . 0.0 112.532 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.03 161.39 38.75 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.748 2.299 . . . . 0.0 113.235 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.8 p -91.77 133.34 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.742 1.217 . . . . 0.0 111.886 177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -72.16 144.71 48.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.314 1.046 . . . . 0.0 110.593 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.2 -6.9 80.91 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 115.956 1.143 . . . . 0.0 115.956 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 57.01 20.02 5.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.974 2.11 . . . . 0.0 114.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 m -74.43 169.49 17.6 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.958 -1.089 . . . . 0.0 112.426 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.74 -39.96 80.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.938 0.895 . . . . 0.0 112.68 171.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.34 159.66 29.37 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.806 1.243 . . . . 0.0 113.115 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -131.39 90.18 2.83 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.938 1.695 . . . . 0.0 111.706 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -61.44 174.32 0.76 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 111.943 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 m -123.14 107.99 12.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.465 1.106 . . . . 0.0 110.341 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? -111.33 157.55 20.06 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.034 1.334 . . . . 0.0 111.039 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -120.99 138.96 53.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.483 1.113 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -135.95 120.71 18.46 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.843 1.257 . . . . 0.0 109.881 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.7 t -69.36 96.44 0.87 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.685 0.755 . . . . 0.0 110.581 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.6 mmm -78.95 81.88 5.19 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 0.0 108.734 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.96 -67.45 2.38 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.47 1.985 . . . . 0.0 114.536 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -132.64 -4.83 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.585 1.554 . . . . 0.0 114.068 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t -134.29 134.43 41.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.447 1.099 . . . . 0.0 112.007 -174.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 52.5 m -81.87 95.41 7.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 111.321 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.44 156.44 24.12 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.787 0.835 . . . . 0.0 110.981 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.38 145.11 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.655 1.182 . . . . 0.0 110.46 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.36 131.14 33.85 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.88 1.672 . . . . 0.0 110.388 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.41 122.42 24.96 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 111.187 -177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.27 52.15 0.02 OUTLIER Glycine 0 N--CA 1.474 1.184 0 C-N-CA 123.753 0.692 . . . . 0.0 113.709 -169.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 2.6 t 61.22 23.59 13.79 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.515 1.526 . . . . 0.0 114.459 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -67.73 136.44 54.27 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.389 . . . . 0.0 111.599 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -130.02 -7.38 4.41 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.48 -10.24 59.45 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.411 1.005 . . . . 0.0 115.375 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.82 174.07 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.831 1.205 . . . . 0.0 114.089 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -71.5 149.56 45.69 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.903 1.281 . . . . 0.0 111.863 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.6 m -70.6 -31.21 68.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.034 1.334 . . . . 0.0 113.752 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -140.23 160.25 40.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.534 1.934 . . . . 0.0 111.063 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.8 ttm -62.57 -36.95 84.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.624 0.77 . . . . 0.0 112.413 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.83 91.69 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.359 -0.838 . . . . 0.0 113.645 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.03 -38.52 82.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.143 0.977 . . . . 0.0 112.65 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.0 p -75.52 -40.76 56.56 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.806 0.73 . . . . 0.0 111.985 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.98 -37.38 87.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -68.48 -27.21 65.94 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -83.36 -48.43 10.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.795 1.238 . . . . 0.0 112.165 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -71.51 165.98 43.76 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.3 -24.83 16.24 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.143 2.562 . . . . 0.0 114.487 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.317 0 C-N-CA 125.816 1.674 . . . . 0.0 114.159 -175.809 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.499 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -66.95 167.29 11.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.734 1.214 . . . . 0.0 113.861 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -129.31 9.14 5.59 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.184 1.793 . . . . 0.0 114.039 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -62.2 133.73 55.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.403 1.081 . . . . 0.0 111.617 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -67.26 -51.69 49.89 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.564 1.145 . . . . 0.0 112.865 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.6 t 46.45 37.83 4.73 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.256 1.822 . . . . 0.0 113.457 -173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 m -60.38 144.98 49.57 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.209 1.404 . . . . 0.0 111.829 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.23 81.43 52.15 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.241 1.416 . . . . 0.0 109.96 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.93 163.71 34.89 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.108 2.539 . . . . 0.0 111.53 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.9 tp -56.79 -26.74 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.544 1.138 . . . . 0.0 113.422 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.83 -5.42 88.63 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.609 1.1 . . . . 0.0 115.274 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -71.51 160.22 33.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.605 1.703 . . . . 0.0 111.357 172.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 m -77.56 55.22 1.28 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.978 1.311 . . . . 0.0 112.233 175.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.39 156.29 88.82 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.032 1.333 . . . . 0.0 113.575 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.84 171.42 16.58 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.037 2.491 . . . . 0.0 112.776 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.84 132.74 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.159 1.384 . . . . 0.0 111.904 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -84.38 139.83 31.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.153 1.381 . . . . 0.0 110.53 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.14 -2.85 89.27 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.254 1.407 . . . . 0.0 116.156 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 54.11 27.3 7.46 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.89 2.076 . . . . 0.0 114.342 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 m -65.53 171.09 4.32 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.654 1.581 . . . . 0.0 112.96 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -75.0 -0.06 17.53 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.449 1.5 . . . . 0.0 114.841 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.28 163.35 19.82 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.156 1.782 . . . . 0.0 112.785 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -132.15 85.26 2.22 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.432 1.893 . . . . 0.0 111.934 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -72.63 172.61 10.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.022 0.929 . . . . 0.0 111.589 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 m -121.82 113.15 19.25 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.855 1.262 . . . . 0.0 109.256 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.49 164.63 14.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.212 1.405 . . . . 0.0 110.801 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -130.75 140.33 50.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.655 1.582 . . . . 0.0 109.976 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -142.01 137.5 31.18 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.217 . . . . 0.0 111.001 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.67 97.16 8.95 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.648 -0.658 . . . . 0.0 111.455 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 88.8 mmm -81.67 71.48 8.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.165 1.386 . . . . 0.0 110.584 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.88 -79.59 1.67 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.505 1.526 . . . . 0.0 112.989 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.11 -10.3 9.04 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -133.07 136.64 46.03 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 110.386 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.4 t -72.56 144.39 47.94 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.362 -0.836 . . . . 0.0 110.884 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -132.68 132.55 42.52 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.019 1.727 . . . . 0.0 110.266 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.77 142.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.669 0.788 . . . . 0.0 110.65 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -129.56 103.35 6.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.694 1.998 . . . . 0.0 109.567 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -86.47 114.75 23.49 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.1 1.36 . . . . 0.0 110.453 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.69 -176.44 33.22 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.542 1.067 . . . . 0.0 113.547 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 9.2 t -79.22 59.71 2.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.724 1.21 . . . . 0.0 111.89 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -85.72 -36.64 20.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.952 0.901 . . . . 0.0 113.358 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p 54.2 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 130.993 3.717 . . . . 0.0 118.187 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.45 -160.29 35.77 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.91 2.195 . . . . 0.0 113.85 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.17 -136.57 48.1 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.967 1.27 . . . . 0.0 113.518 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -108.33 136.91 47.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.327 1.451 . . . . 0.0 110.599 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.0 t -75.64 -22.83 56.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.228 1.011 . . . . 0.0 112.255 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 154.86 49.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.169 1.788 . . . . 0.0 112.776 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -58.97 -33.07 70.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.081 0.952 . . . . 0.0 112.516 173.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.56 -40.94 94.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.055 0.836 . . . . 0.0 113.652 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.56 -31.8 73.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 0.0 112.249 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -71.04 -51.13 27.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.294 1.038 . . . . 0.0 111.797 170.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.47 76.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.902 1.681 . . . . 0.0 114.17 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.57 -21.3 65.49 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -105.72 -34.61 7.65 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.061 1.344 . . . . 0.0 113.464 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 66.4 m -61.35 159.15 32.88 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.096 0.959 . . . . 0.0 112.81 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.99 -14.62 26.29 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.983 2.455 . . . . 0.0 114.502 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.238 0 C-N-CA 126.324 1.916 . . . . 0.0 113.07 176.559 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -62.88 112.2 2.46 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.298 1.439 . . . . 0.0 112.564 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -134.55 171.91 13.66 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.963 2.105 . . . . 0.0 111.472 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.24 153.13 27.07 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.465 1.106 . . . . 0.0 111.729 171.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.89 157.32 39.7 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.092 1.357 . . . . 0.0 112.847 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.2 m -136.61 106.0 6.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.087 1.755 . . . . 0.0 109.671 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 p -76.38 92.6 3.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.798 0.839 . . . . 0.0 112.401 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -128.95 82.39 68.85 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.652 1.981 . . . . 0.0 110.832 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.99 168.14 25.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.922 2.415 . . . . 0.0 112.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.56 -27.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.545 1.138 . . . . 0.0 113.418 175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.21 90.1 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.803 1.192 . . . . 0.0 115.375 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -65.48 152.65 43.48 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.405 1.603 . . . . 0.0 111.984 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.7 p -75.54 72.17 2.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.375 1.47 . . . . 0.0 112.064 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.8 151.35 85.09 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.682 1.193 . . . . 0.0 112.542 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.6 171.11 17.86 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.018 2.479 . . . . 0.0 112.536 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.72 126.45 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.759 1.224 . . . . 0.0 112.179 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -69.69 141.84 53.47 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.394 1.078 . . . . 0.0 110.246 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.11 -6.67 89.07 Favored Glycine 0 CA--C 1.541 1.681 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 56.76 20.08 4.88 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 126.78 2.032 . . . . 0.0 113.985 -175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 m -77.18 172.03 13.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.643 1.177 . . . . 0.0 113.328 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -84.43 5.33 27.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.756 2.022 . . . . 0.0 115.305 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.01 165.07 20.14 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.302 1.841 . . . . 0.0 113.225 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -128.78 95.16 4.02 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.671 1.988 . . . . 0.0 112.571 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -83.19 177.34 8.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.762 0.825 . . . . 0.0 111.297 166.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.8 m -134.43 114.48 12.95 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.044 1.337 . . . . 0.0 111.227 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.4 mmp_? -116.05 166.14 12.34 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.965 1.706 . . . . 0.0 111.266 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.81 99.25 4.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.412 1.485 . . . . 0.0 110.496 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -97.13 137.15 36.62 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.48 0.712 . . . . 0.0 110.748 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -77.89 107.04 10.13 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.246 -0.909 . . . . 0.0 110.906 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 92.8 mmm -93.29 17.1 11.76 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.835 1.654 . . . . 0.0 113.529 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.44 90.04 2.14 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.473 1.511 . . . . 0.0 111.348 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 t30 59.23 14.05 3.39 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.34 1.856 . . . . 0.0 114.803 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 88.4 m -142.99 116.47 9.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.908 1.683 . . . . 0.0 111.572 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.2 m -61.6 115.0 3.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.175 0.59 . . . . 0.0 110.55 157.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -113.49 132.18 55.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.63 1.572 . . . . 0.0 110.184 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.62 144.02 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.265 0.626 . . . . 0.0 111.608 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -133.73 137.93 45.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.881 1.672 . . . . 0.0 110.869 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -135.33 117.92 15.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.503 1.521 . . . . 0.0 110.776 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.41 59.22 0.01 OUTLIER Glycine 0 N--CA 1.475 1.273 0 C-N-CA 123.532 0.587 . . . . 0.0 114.292 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.2 t 59.0 25.18 13.52 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.03 113.16 6.16 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.985 1.314 . . . . 0.0 110.968 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -102.77 -8.26 20.97 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.944 1.298 . . . . 0.0 113.678 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.96 -174.14 42.46 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.523 1.535 . . . . 0.0 113.011 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 -171.53 26.76 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.206 0.908 . . . . 0.0 114.239 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.64 139.06 38.59 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.787 0.835 . . . . 0.0 110.746 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.6 p -84.76 -10.98 56.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -135.01 150.55 50.34 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.248 1.819 . . . . 0.0 112.037 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 57.3 tpp -59.37 -40.59 86.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.956 1.302 . . . . 0.0 111.575 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.55 93.44 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.558 -0.714 . . . . 0.0 113.471 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.18 -38.02 75.27 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.5 p -70.97 -41.75 70.63 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.602 1.092 . . . . 0.0 111.77 169.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.97 -29.5 68.55 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -69.54 -22.47 63.56 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -102.25 -50.79 3.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.988 1.315 . . . . 0.0 112.87 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.28 160.2 83.16 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-N 118.697 0.68 . . . . 0.0 112.707 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -75.41 -9.76 20.32 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.388 2.725 . . . . 0.0 114.4 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.522 0 C-N-CA 126.874 2.178 . . . . 0.0 112.572 178.706 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -145.63 164.4 31.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.756 1.623 . . . . 0.0 110.474 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -133.82 -12.04 2.62 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.563 2.345 . . . . 0.0 113.576 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -135.49 76.72 1.63 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.554 1.142 . . . . 0.0 111.823 -172.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.96 166.0 15.79 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.315 1.846 . . . . 0.0 112.565 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.7 t -74.88 131.43 40.72 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.426 -0.796 . . . . 0.0 111.455 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.7 p -139.15 160.3 40.12 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.303 1.441 . . . . 0.0 111.76 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.57 157.5 70.11 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 127.037 2.135 . . . . 0.0 109.949 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.72 161.75 44.7 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.042 . . . . 0.0 112.15 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -62.86 146.19 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.393 0.677 . . . . 0.0 110.653 170.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 15.81 81.27 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.031 0.772 . . . . 0.0 115.031 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -61.52 165.29 4.99 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.87 1.335 . . . . 0.0 111.74 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 t -72.2 93.94 1.51 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.094 -1.003 . . . . 0.0 111.538 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.61 156.73 34.92 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 125.514 1.525 . . . . 0.0 112.856 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.33 152.6 55.52 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.916 2.411 . . . . 0.0 112.461 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.91 128.62 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.871 0.868 . . . . 0.0 111.936 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -71.53 140.6 49.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.057 0.943 . . . . 0.0 110.664 175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.08 -8.94 87.29 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.2 mt 61.67 16.55 7.88 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 127.222 2.209 . . . . 0.0 115.058 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.0 m -74.94 170.99 14.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.116 1.367 . . . . 0.0 113.551 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -67.57 -20.55 65.4 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.73 164.36 14.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.427 1.891 . . . . 0.0 112.361 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.55 99.78 4.76 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 112.184 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.34 176.63 1.02 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.349 1.06 . . . . 0.0 110.944 165.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.0 m -124.08 112.41 17.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -119.68 166.59 13.0 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.022 1.729 . . . . 0.0 110.856 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.49 137.75 44.16 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.356 1.063 . . . . 0.0 110.801 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -141.99 126.75 18.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.859 1.264 . . . . 0.0 110.401 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -78.12 128.38 33.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.984 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtp -102.87 5.54 38.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.701 1.2 . . . . 0.0 113.371 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.89 -74.77 0.27 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 125.527 1.537 . . . . 0.0 111.978 174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -120.35 13.69 11.93 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.711 1.605 . . . . 0.0 113.15 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.8 p -147.89 169.37 19.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.21 1.404 . . . . 0.0 111.597 169.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -117.01 111.93 20.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.27 1.828 . . . . 0.0 110.719 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -97.82 137.21 37.02 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.699 1.599 . . . . 0.0 110.899 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.52 146.79 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.831 0.852 . . . . 0.0 111.456 171.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.37 124.95 25.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.586 1.954 . . . . 0.0 110.555 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -127.44 110.7 13.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.234 1.414 . . . . 0.0 111.388 -174.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.44 52.31 0.01 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 -168.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.0 t 60.51 22.32 12.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.679 1.592 . . . . 0.0 114.476 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -65.43 128.76 37.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.659 1.584 . . . . 0.0 111.082 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.0 p -105.36 -20.6 13.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.461 1.104 . . . . 0.0 113.769 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.24 -161.06 34.97 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.899 1.714 . . . . 0.0 114.052 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.54 -172.1 48.73 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.861 1.22 . . . . 0.0 114.427 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -73.29 138.12 45.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.525 0.73 . . . . 0.0 109.951 167.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.2 m -70.08 -32.2 70.16 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.614 0.766 . . . . 0.0 113.054 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -140.49 165.46 27.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.264 1.826 . . . . 0.0 112.17 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.4 ttt -68.91 -24.54 64.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.33 -35.78 69.64 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.259 -0.9 . . . . 0.0 112.809 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -44.07 69.71 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.326 1.45 . . . . 0.0 112.523 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -62.92 -42.56 99.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.777 0.717 . . . . 0.0 112.334 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -3.82 9.98 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.2 mtp-105 -67.22 -42.49 83.97 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.743 -1.223 . . . . 0.0 111.889 167.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -93.6 -53.08 4.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.248 1.819 . . . . 0.0 111.433 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.3 m -77.05 158.18 80.36 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.07 1.748 . . . . 0.0 111.432 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.6 -11.5 22.27 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.493 2.129 . . . . 0.0 114.943 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.242 0 C-N-CA 125.8 1.667 . . . . 0.0 113.386 179.539 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.453 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -64.8 162.82 15.36 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.693 1.197 . . . . 0.0 113.768 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -139.71 164.01 31.07 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.393 1.877 . . . . 0.0 111.654 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -68.74 158.97 33.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.766 1.227 . . . . 0.0 111.694 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -130.14 156.92 43.77 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.793 1.237 . . . . 0.0 113.044 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.6 t -97.78 45.48 1.03 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.613 1.965 . . . . 0.0 111.43 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.4 p -67.77 152.79 45.02 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.832 -1.168 . . . . 0.0 112.469 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.5 89.68 18.33 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.281 1.432 . . . . 0.0 109.941 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.27 166.0 29.78 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.015 175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 tt -62.75 148.14 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.89 0.876 . . . . 0.0 111.229 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.72 6.64 89.25 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 115.654 1.022 . . . . 0.0 115.654 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -65.66 159.69 24.33 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 119.029 1.414 . . . . 0.0 112.151 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.1 m -76.39 53.5 0.85 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.047 1.739 . . . . 0.0 112.781 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.43 156.11 86.53 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.029 1.332 . . . . 0.0 112.647 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.49 166.19 30.13 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.463 2.776 . . . . 0.0 113.604 176.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -97.34 132.52 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.974 1.31 . . . . 0.0 111.639 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -77.27 142.66 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 111.16 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.05 -9.16 77.61 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.478 1.513 . . . . 0.0 115.209 174.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mp 55.13 18.07 2.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.365 2.266 . . . . 0.0 114.687 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 p -70.9 173.05 7.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -172.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -75.65 2.52 11.71 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.204 1.801 . . . . 0.0 114.206 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.52 169.82 13.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.26 2.224 . . . . 0.0 111.431 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -136.55 105.1 5.78 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.401 1.48 . . . . 0.0 111.126 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -93.87 155.11 17.36 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.55 1.14 . . . . 0.0 111.667 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -102.95 105.11 15.39 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.712 1.205 . . . . 0.0 110.658 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -123.26 157.85 32.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.02 1.328 . . . . 0.0 110.814 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.43 92.43 3.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.276 1.83 . . . . 0.0 111.146 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -92.08 139.47 30.6 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.495 -0.753 . . . . 0.0 111.506 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.7 m -74.43 109.11 7.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.87 0.868 . . . . 0.0 112.151 172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.6 mtp -91.75 69.44 5.61 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.669 1.188 . . . . 0.0 109.804 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.06 -100.51 1.25 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.266 1.413 . . . . 0.0 112.733 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -87.33 -8.67 56.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.24 161.0 38.5 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.978 1.711 . . . . 0.0 111.49 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.9 m -90.24 152.49 21.05 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.658 -0.651 . . . . 0.0 111.602 165.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -133.34 132.65 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.253 1.821 . . . . 0.0 109.903 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -77.01 146.54 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.985 0.514 . . . . 0.0 111.126 171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -109.44 -68.76 0.9 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 67.83 78.57 0.23 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.573 1.949 . . . . 0.0 112.91 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.92 14.84 0.03 OUTLIER Glycine 0 N--CA 1.474 1.181 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.6 t 77.07 91.98 0.07 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.436 2.294 . . . . 0.0 112.104 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.3 -56.94 0.8 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.293 1.437 . . . . 0.0 113.664 -171.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.9 p 54.84 -2.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 129.693 3.197 . . . . 0.0 118.473 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.53 -19.66 53.89 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 119.848 1.204 . . . . 0.0 115.375 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.87 179.04 27.46 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 126.002 1.763 . . . . 0.0 113.356 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -58.88 142.76 49.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.679 1.191 . . . . 0.0 112.871 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.0 p -83.4 -16.28 46.54 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.219 1.408 . . . . 0.0 114.458 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -137.79 154.71 49.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.324 1.85 . . . . 0.0 111.511 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 46.7 ttm -65.67 -29.42 69.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.508 0.723 . . . . 0.0 112.562 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.33 -37.59 94.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 120.992 -1.068 . . . . 0.0 113.452 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -71.46 -33.8 69.65 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.106 0.962 . . . . 0.0 113.098 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.2 p -74.9 -49.46 20.23 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.785 -0.572 . . . . 0.0 111.735 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.24 -16.92 62.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.75 -25.78 65.8 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.052 1.296 . . . . 0.0 113.438 167.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -100.55 -48.9 4.38 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.103 1.361 . . . . 0.0 111.555 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m -75.25 164.1 63.37 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.443 2.297 . . . . 0.0 111.568 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.78 -6.46 15.22 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.108 1.872 . . . . 0.0 113.683 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 C-N-CA 128.067 2.746 . . . . 0.0 112.527 177.238 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -137.25 44.43 2.28 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.679 1.192 . . . . 0.0 111.245 -159.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -51.02 -31.38 18.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.922 2.489 . . . . 0.0 115.653 -168.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.8 24.59 5.35 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.865 1.666 . . . . 0.0 112.824 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.76 154.6 8.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.953 1.301 . . . . 0.0 112.411 169.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.7 p -64.3 141.9 58.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.215 1.006 . . . . 0.0 113.204 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.7 p -140.1 172.4 12.81 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.451 1.901 . . . . 0.0 110.924 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 t -126.36 84.2 62.55 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.85 1.26 . . . . 0.0 109.201 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.75 160.15 48.81 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.87 2.38 . . . . 0.0 111.682 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 tp -61.62 141.46 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.306 0.574 . . . . 0.0 110.726 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.37 -3.92 85.32 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.387 0.994 . . . . 0.0 115.163 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.52 156.51 34.7 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.357 1.579 . . . . 0.0 110.956 167.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 t -77.52 97.81 5.14 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.52 1.128 . . . . 0.0 111.717 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 157.37 34.31 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.902 1.681 . . . . 0.0 113.181 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.4 161.58 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.043 2.495 . . . . 0.0 112.605 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.68 134.56 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.506 1.122 . . . . 0.0 111.85 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -66.84 141.73 57.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.148 0.979 . . . . 0.0 110.485 174.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -10.39 85.82 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.2 mt 62.78 13.24 6.3 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.466 2.306 . . . . 0.0 114.716 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.8 m -80.62 171.54 14.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.592 1.157 . . . . 0.0 113.3 -172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -62.55 -43.4 98.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.941 1.296 . . . . 0.0 113.412 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.52 126.53 35.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.685 1.194 . . . . 0.0 113.238 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.33 89.48 5.48 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.272 1.429 . . . . 0.0 111.174 173.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -64.1 176.12 1.08 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.417 1.087 . . . . 0.0 111.625 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 m -123.0 105.83 10.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.403 1.081 . . . . 0.0 110.179 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -112.42 168.14 9.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.197 1.799 . . . . 0.0 110.729 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -135.97 140.1 43.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.37 1.068 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.36 138.85 35.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.181 0.992 . . . . 0.0 112.277 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.5 m -72.38 91.48 1.35 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.929 1.292 . . . . 0.0 112.251 175.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 76.1 mmm -85.61 76.6 9.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.175 0.99 . . . . 0.0 109.331 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.34 -86.44 0.71 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.747 1.641 . . . . 0.0 112.257 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -122.1 3.63 9.86 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.659 1.583 . . . . 0.0 114.228 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.6 m -130.48 124.95 33.15 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.539 1.536 . . . . 0.0 111.846 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.3 m -73.34 85.98 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.035 1.334 . . . . 0.0 111.632 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -75.42 139.85 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.536 -0.728 . . . . 0.0 110.897 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.38 143.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.692 1.197 . . . . 0.0 111.366 172.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -130.98 133.25 45.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.138 1.775 . . . . 0.0 110.734 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -134.3 106.98 7.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.088 1.355 . . . . 0.0 111.293 -171.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.55 0.01 OUTLIER Glycine 0 N--CA 1.475 1.246 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -171.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.4 t 55.07 29.48 12.52 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.002 1.321 . . . . 0.0 114.383 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -70.34 140.8 52.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.756 1.223 . . . . 0.0 110.764 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 47.8 p -139.06 -3.35 1.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.95 9.76 74.88 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.349 1.452 . . . . 0.0 116.019 -172.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.03 -172.1 24.78 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 118.861 1.33 . . . . 0.0 114.702 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -61.56 135.93 57.83 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 114.082 -165.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.1 t -72.23 -22.71 61.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.182 0.993 . . . . 0.0 113.363 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -136.07 152.21 50.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.901 1.68 . . . . 0.0 112.518 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.6 tpp -55.04 -44.45 74.7 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.572 1.549 . . . . 0.0 111.049 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.84 -50.68 62.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.047 1.308 . . . . 0.0 113.306 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -62.15 -37.86 86.8 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.542 1.171 . . . . 0.0 112.991 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.4 t -60.13 -42.24 94.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 171.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.47 -14.69 44.0 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.22 -54.28 39.83 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.082 1.353 . . . . 0.0 111.838 171.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.05 -33.17 44.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 113.265 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.8 m -66.48 160.03 69.36 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.559 0.743 . . . . 0.0 112.306 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.06 -16.69 22.64 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.375 2.717 . . . . 0.0 114.683 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.229 0 C-N-CA 126.029 1.776 . . . . 0.0 112.694 179.154 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.409 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -68.14 168.64 11.73 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.499 1.119 . . . . 0.0 113.101 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt 53.58 33.28 16.0 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.522 1.929 . . . . 0.0 113.762 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -64.81 165.48 10.52 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.541 1.536 . . . . 0.0 113.523 174.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -149.09 166.8 27.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.73 1.612 . . . . 0.0 111.717 172.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.0 t -124.88 -2.08 7.8 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.858 1.263 . . . . 0.0 113.658 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.6 p -70.16 159.85 33.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.448 1.499 . . . . 0.0 112.884 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 m -140.8 158.35 65.56 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 126.675 1.99 . . . . 0.0 111.232 177.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.14 159.05 54.5 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.387 2.058 . . . . 0.0 111.474 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.53 -28.37 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.291 1.037 . . . . 0.0 113.346 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.44 2.44 87.91 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.125 1.345 . . . . 0.0 115.514 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -64.25 158.45 23.24 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 119.411 1.605 . . . . 0.0 112.085 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 t -78.87 98.33 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.647 1.179 . . . . 0.0 111.615 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.01 157.23 37.52 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 125.874 1.67 . . . . 0.0 112.936 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.08 166.22 29.58 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.348 2.699 . . . . 0.0 112.975 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.53 133.35 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.77 1.228 . . . . 0.0 112.194 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -73.32 143.95 46.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.457 1.503 . . . . 0.0 110.705 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.82 -8.67 87.22 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.3 mp 49.72 35.86 9.75 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.63 1.972 . . . . 0.0 113.321 -173.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.8 m -78.57 168.35 19.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.35 1.46 . . . . 0.0 112.954 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -68.66 -35.06 76.74 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.253 1.021 . . . . 0.0 113.198 165.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.88 160.53 27.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.138 1.375 . . . . 0.0 112.6 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -132.87 77.51 1.74 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.007 1.723 . . . . 0.0 111.049 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.81 166.24 22.45 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.543 1.137 . . . . 0.0 111.389 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -128.82 120.93 27.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.635 1.574 . . . . 0.0 110.647 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -124.82 171.85 9.81 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.088 2.555 . . . . 0.0 110.343 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -134.72 137.62 43.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.681 1.192 . . . . 0.0 110.307 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -137.97 132.43 32.3 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.271 1.028 . . . . 0.0 111.544 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 m -66.91 121.56 15.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.009 0.923 . . . . 0.0 111.571 170.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.7 mmm -111.87 11.8 20.81 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.672 1.989 . . . . 0.0 113.082 -176.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.27 104.04 1.2 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.694 1.14 . . . . 0.0 111.485 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 63.67 -1.27 0.63 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.148 2.179 . . . . 0.0 115.23 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.2 t -141.9 156.25 45.51 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.873 2.069 . . . . 0.0 110.294 170.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.42 107.93 14.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.949 1.3 . . . . 0.0 110.006 169.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -90.53 144.48 25.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.434 1.093 . . . . 0.0 110.874 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.28 146.91 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.691 0.796 . . . . 0.0 111.002 167.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -130.34 129.21 42.88 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.319 1.848 . . . . 0.0 109.012 172.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -133.17 149.91 52.03 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.679 0.792 . . . . 0.0 112.27 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.18 12.01 2.16 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 10.1 t 95.87 90.04 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 130.05 3.34 . . . . 0.0 110.504 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.05 130.6 33.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.242 1.817 . . . . 0.0 109.114 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 p -117.41 -4.36 11.32 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.871 1.268 . . . . 0.0 113.941 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.31 -167.97 31.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.198 1.856 . . . . 0.0 113.197 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.85 -164.47 43.0 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.232 0.92 . . . . 0.0 114.526 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -81.89 138.86 34.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.884 0.873 . . . . 0.0 110.392 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.6 p -69.14 -30.56 68.83 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -140.6 158.48 43.93 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.659 1.984 . . . . 0.0 112.087 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 53.2 ttm -61.75 -34.87 76.62 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.162 0.585 . . . . 0.0 112.084 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.5 -27.93 70.4 Favored Glycine 0 CA--C 1.536 1.377 0 O-C-N 121.471 -0.768 . . . . 0.0 114.059 175.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.26 -48.27 17.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.266 1.033 . . . . 0.0 112.072 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -65.13 -30.14 71.05 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.462 1.028 . . . . 0.0 113.058 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -6.52 7.23 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -78.32 -12.2 59.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 121.0 -1.062 . . . . 0.0 113.598 167.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -125.36 -52.77 1.61 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.567 1.947 . . . . 0.0 112.221 -177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.5 m -65.98 158.99 73.47 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.746 0.819 . . . . 0.0 111.513 164.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.91 -14.55 23.91 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.652 2.234 . . . . 0.0 114.535 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.327 1.917 . . . . 0.0 112.576 -178.786 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.491 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -137.44 162.6 33.22 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.524 1.53 . . . . 0.0 111.667 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.69 109.69 9.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.241 1.816 . . . . 0.0 110.987 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.09 67.78 1.35 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.916 1.286 . . . . 0.0 111.185 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -74.34 143.36 44.93 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.833 -1.167 . . . . 0.0 111.394 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.0 p -106.73 45.72 0.97 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.965 1.306 . . . . 0.0 112.525 -177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.5 t -63.19 -24.43 67.88 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.812 1.645 . . . . 0.0 113.862 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t 55.23 81.52 0.26 Allowed Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 128.443 2.697 . . . . 0.0 111.73 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.88 158.88 56.1 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.713 2.275 . . . . 0.0 111.802 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.06 138.33 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.239 0.616 . . . . 0.0 111.092 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.69 -1.58 68.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.539 1.066 . . . . 0.0 115.312 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.2 t-105 -65.3 151.69 45.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.588 1.694 . . . . 0.0 111.187 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -78.08 72.14 4.59 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.108 1.363 . . . . 0.0 112.526 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.58 155.16 89.48 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.864 1.265 . . . . 0.0 114.082 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.4 174.38 12.93 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.908 3.072 . . . . 0.0 112.124 170.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.3 143.12 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.614 1.165 . . . . 0.0 112.62 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.35 146.27 54.7 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.434 1.493 . . . . 0.0 111.033 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.47 -7.07 79.85 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 56.05 22.77 6.18 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.267 2.227 . . . . 0.0 114.346 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 m -75.02 172.22 12.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.772 1.229 . . . . 0.0 112.723 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -76.57 -2.12 30.89 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.471 1.509 . . . . 0.0 114.819 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.88 160.74 28.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.9 1.68 . . . . 0.0 113.059 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -131.11 85.16 2.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.48 1.912 . . . . 0.0 112.407 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -66.24 172.0 4.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.233 1.013 . . . . 0.0 111.293 168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -121.24 114.0 20.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.294 1.038 . . . . 0.0 110.518 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -118.37 168.13 10.92 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.955 1.702 . . . . 0.0 110.657 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -131.65 142.6 49.89 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.53 1.132 . . . . 0.0 110.533 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.36 132.26 29.3 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.207 1.403 . . . . 0.0 109.987 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.5 t -71.47 140.62 50.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.558 -0.714 . . . . 0.0 110.808 166.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.31 24.99 11.18 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.488 1.515 . . . . 0.0 112.59 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.26 -40.35 1.68 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.188 2.328 . . . . 0.0 112.491 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -152.19 -48.46 0.11 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.687 1.595 . . . . 0.0 112.223 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.2 m -71.02 134.75 47.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.122 0.969 . . . . 0.0 111.841 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 95.9 m -73.58 134.86 43.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.006 0.922 . . . . 0.0 110.749 162.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -122.14 133.52 54.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.039 1.736 . . . . 0.0 109.679 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.78 146.45 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.401 0.681 . . . . 0.0 110.847 172.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -134.54 134.82 41.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.992 1.717 . . . . 0.0 110.747 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -136.67 113.42 10.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.208 1.403 . . . . 0.0 111.001 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.63 60.52 0.02 OUTLIER Glycine 0 N--CA 1.476 1.344 0 N-CA-C 115.166 0.827 . . . . 0.0 115.166 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 3.8 t 59.73 30.52 20.11 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -70.44 -45.78 65.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.786 1.234 . . . . 0.0 113.641 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.2 p 50.83 -8.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 131.112 3.765 . . . . 0.0 118.394 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.52 -161.35 37.36 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 127.265 2.364 . . . . 0.0 113.965 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.69 -122.99 31.94 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.541 1.067 . . . . 0.0 113.007 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.36 152.84 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.768 1.627 . . . . 0.0 111.944 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.2 p -82.2 -23.54 35.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.867 1.267 . . . . 0.0 114.219 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -137.34 156.11 48.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.152 1.381 . . . . 0.0 112.417 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 ttt -66.46 -19.8 65.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.849 1.26 . . . . 0.0 113.123 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.88 -38.58 26.72 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.904 0.764 . . . . 0.0 113.501 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -64.56 -45.62 86.3 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.767 1.284 . . . . 0.0 112.747 -174.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.0 p -59.69 -35.11 73.82 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.55 -0.719 . . . . 0.0 112.176 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.43 -14.21 60.43 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -74.47 -21.03 59.78 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.819 -1.176 . . . . 0.0 112.762 166.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -103.66 -55.51 2.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.018 1.727 . . . . 0.0 111.649 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.4 m -75.68 161.44 76.15 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.568 1.147 . . . . 0.0 113.237 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.13 -8.35 16.44 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.888 3.059 . . . . 0.0 115.433 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 C-N-CA 126.195 1.855 . . . . 0.0 114.721 -178.516 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -75.41 66.35 1.82 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.769 1.628 . . . . 0.0 113.444 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -77.74 102.54 7.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.513 1.525 . . . . 0.0 110.483 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.08 24.14 11.94 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.075 1.75 . . . . 0.0 112.78 -175.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -55.93 144.17 29.28 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.672 1.589 . . . . 0.0 112.985 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.02 83.11 3.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.893 1.277 . . . . 0.0 111.131 171.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 p -66.15 142.82 57.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.099 0.559 . . . . 0.0 110.642 164.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.56 157.98 69.23 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 125.992 1.717 . . . . 0.0 110.813 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.74 155.69 67.93 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.238 1.959 . . . . 0.0 112.316 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.62 -26.26 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.213 1.405 . . . . 0.0 113.587 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.98 2.43 86.82 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.996 1.284 . . . . 0.0 115.724 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -65.58 155.41 35.87 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.99 1.895 . . . . 0.0 111.555 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -73.53 75.24 1.46 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.906 1.283 . . . . 0.0 111.763 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -78.15 157.19 78.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.654 1.582 . . . . 0.0 113.287 176.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.0 174.81 11.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.21 2.607 . . . . 0.0 112.595 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.62 135.04 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.475 1.51 . . . . 0.0 111.006 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -86.41 138.75 31.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.51 1.124 . . . . 0.0 110.809 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.59 -2.21 88.91 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.215 1.388 . . . . 0.0 115.659 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 53.85 19.35 1.89 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.341 2.256 . . . . 0.0 114.866 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.4 p -71.85 170.05 14.49 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.014 -1.054 . . . . 0.0 113.472 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.97 3.15 7.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.85 1.66 . . . . 0.0 114.947 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.16 154.37 31.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.843 1.657 . . . . 0.0 112.257 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -124.47 90.42 3.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.308 1.843 . . . . 0.0 110.366 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -75.92 171.77 13.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 111.544 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.9 m -125.59 113.71 17.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.186 1.394 . . . . 0.0 108.889 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -121.33 159.94 25.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.897 1.679 . . . . 0.0 110.723 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -119.52 142.64 48.13 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.069 0.948 . . . . 0.0 110.396 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.06 170.75 15.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.111 1.364 . . . . 0.0 110.195 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -136.95 144.92 43.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.539 1.136 . . . . 0.0 110.777 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.9 mtt -137.04 71.83 1.41 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.468 1.107 . . . . 0.0 110.231 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.87 -109.37 2.68 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.883 1.706 . . . . 0.0 112.73 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -113.12 34.01 4.72 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.868 1.667 . . . . 0.0 111.381 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.0 104.92 1.74 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.266 1.427 . . . . 0.0 112.742 -175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.5 m -66.04 157.13 31.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.605 1.162 . . . . 0.0 112.2 164.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -161.83 -178.98 6.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.125 2.17 . . . . 0.0 111.474 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.04 146.58 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.306 2.242 . . . . 0.0 110.767 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.93 138.12 49.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.004 2.122 . . . . 0.0 109.774 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.41 111.86 14.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.595 1.558 . . . . 0.0 110.377 -168.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.08 -170.95 33.3 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.984 0.802 . . . . 0.0 113.28 -173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.7 t -72.58 77.15 1.08 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.068 0.947 . . . . 0.0 111.227 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.46 141.91 51.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.069 1.747 . . . . 0.0 111.803 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 53.3 p -134.51 -7.09 2.53 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -173.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.6 -2.4 65.32 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -172.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.62 174.45 25.78 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.826 1.203 . . . . 0.0 115.06 -170.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -69.32 156.86 38.1 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.842 1.657 . . . . 0.0 111.953 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 p -78.75 -29.83 45.42 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.707 1.203 . . . . 0.0 114.144 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mtm105 -141.34 159.47 42.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.67 1.988 . . . . 0.0 111.347 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 33.4 ttm -62.86 -32.0 73.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.7 0.8 . . . . 0.0 112.356 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.8 -28.8 72.34 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.834 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -74.59 -46.53 38.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.019 1.409 . . . . 0.0 112.878 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.4 p -62.3 -31.91 72.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.073 -1.017 . . . . 0.0 112.379 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.9 -10.47 49.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.177 1.391 . . . . 0.0 114.739 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -79.71 -36.22 37.82 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.281 0.946 . . . . 0.0 112.571 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -84.43 -50.85 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.105 1.362 . . . . 0.0 111.928 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.4 m -70.33 160.36 81.35 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 171.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.88 -16.41 45.62 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.418 2.745 . . . . 0.0 115.136 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 C-N-CA 125.779 1.656 . . . . 0.0 114.523 168.421 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 CA-C-O 121.576 0.542 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -68.64 158.14 34.7 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.593 1.157 . . . . 0.0 112.669 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.88 -6.32 2.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.095 1.758 . . . . 0.0 114.445 177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.44 105.36 4.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.874 1.269 . . . . 0.0 110.106 168.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -144.31 168.18 20.7 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.726 1.61 . . . . 0.0 110.936 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.4 p -137.47 156.78 47.75 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.978 0.911 . . . . 0.0 112.295 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.6 p -132.45 -20.88 2.32 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.032 1.333 . . . . 0.0 114.121 -169.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t 47.7 75.47 0.66 Allowed Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 128.438 2.695 . . . . 0.0 111.754 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.82 159.33 53.76 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.359 2.706 . . . . 0.0 112.503 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 tt -61.4 143.06 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.009 0.924 . . . . 0.0 111.314 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.77 -0.83 83.0 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.604 1.097 . . . . 0.0 115.291 -178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -65.09 160.06 21.92 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.19 1.495 . . . . 0.0 111.204 167.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.7 m -74.88 64.96 1.34 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.694 1.598 . . . . 0.0 112.91 177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 154.2 91.61 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.672 1.189 . . . . 0.0 113.805 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.91 153.39 42.23 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.092 2.528 . . . . 0.0 112.183 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.95 135.03 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.84 0.856 . . . . 0.0 111.93 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -68.6 144.06 54.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.311 1.045 . . . . 0.0 110.726 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 -10.61 86.13 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 115.219 0.847 . . . . 0.0 115.219 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.6 mt 61.84 14.37 6.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.495 2.318 . . . . 0.0 115.134 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 m -75.76 171.75 13.82 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.599 1.16 . . . . 0.0 113.617 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.76 -46.7 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.44 1.496 . . . . 0.0 112.14 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.82 159.51 28.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.063 1.345 . . . . 0.0 113.195 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.8 mtm105 -131.1 90.68 2.92 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.471 1.909 . . . . 0.0 111.527 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -68.6 174.23 4.4 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.968 1.307 . . . . 0.0 111.763 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -126.48 112.07 15.15 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.36 1.464 . . . . 0.0 110.172 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -117.53 168.89 9.99 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.24 1.816 . . . . 0.0 110.459 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -133.18 135.33 45.03 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.603 1.161 . . . . 0.0 109.953 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -132.93 147.59 52.29 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.042 0.937 . . . . 0.0 111.205 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.0 t -85.93 127.43 34.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.152 0.581 . . . . 0.0 110.475 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 89.1 mmm -116.19 25.14 10.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.494 1.917 . . . . 0.0 112.933 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.42 93.43 1.82 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.124 1.345 . . . . 0.0 111.228 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.257 13.2 p30 47.09 28.05 0.87 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.755 2.022 . . . . 0.0 115.116 -173.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 t -151.24 154.12 36.19 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.776 2.03 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.7 m -122.74 138.23 54.68 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.612 1.165 . . . . 0.0 110.819 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -142.48 148.46 37.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.649 1.18 . . . . 0.0 112.011 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.97 150.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.58 1.152 . . . . 0.0 111.804 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -134.73 132.77 39.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.795 2.038 . . . . 0.0 110.467 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -132.74 115.46 15.37 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.576 1.55 . . . . 0.0 111.022 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.73 55.23 0.01 OUTLIER Glycine 0 N--CA 1.475 1.295 0 O-C-N 121.823 -0.548 . . . . 0.0 114.454 -170.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 5.2 t 57.07 28.26 14.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.167 1.387 . . . . 0.0 114.401 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -69.81 139.67 53.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.651 1.18 . . . . 0.0 110.538 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.2 p -125.89 -5.29 6.87 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.89 1.276 . . . . 0.0 113.915 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.13 -167.67 33.03 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.813 1.673 . . . . 0.0 112.637 173.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.42 -169.6 49.49 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 122.245 0.914 . . . . 0.0 113.808 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -79.82 148.77 31.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 0.0 111.198 175.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 t -78.14 -19.87 53.18 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.38 159.19 42.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.727 2.011 . . . . 0.0 111.95 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.7 tpp -62.45 -40.59 97.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.0 0.92 . . . . 0.0 112.199 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.82 -38.77 93.24 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.721 0.676 . . . . 0.0 112.902 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -39.24 90.96 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.038 1.335 . . . . 0.0 111.676 173.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.03 -56.62 15.41 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.769 -0.582 . . . . 0.0 111.676 167.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.76 70.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -79.18 -18.94 52.11 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -98.04 -47.07 5.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.876 1.27 . . . . 0.0 112.535 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 168.48 17.14 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.012 0.525 . . . . 0.0 111.604 167.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.93 -10.97 25.3 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.608 2.205 . . . . 0.0 115.5 -167.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 126.126 1.822 . . . . 0.0 113.186 175.136 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.522 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.14 96.41 6.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.903 1.281 . . . . 0.0 112.579 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.6 168.28 20.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.658 1.583 . . . . 0.0 112.288 168.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -73.16 139.28 46.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.105 0.962 . . . . 0.0 111.322 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -151.45 167.36 28.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.803 1.641 . . . . 0.0 111.353 172.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.8 t -73.88 121.92 21.69 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.445 -0.784 . . . . 0.0 111.391 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.5 p -125.29 166.46 16.47 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.782 1.633 . . . . 0.0 112.038 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.41 126.42 19.24 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.76 1.624 . . . . 0.0 109.371 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.74 146.45 54.14 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.37 2.047 . . . . 0.0 111.614 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.41 -27.65 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.64 1.176 . . . . 0.0 113.615 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.01 1.56 88.64 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.889 1.233 . . . . 0.0 115.491 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.2 t-105 -65.02 155.63 34.04 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.567 1.683 . . . . 0.0 112.015 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 t -78.65 80.3 5.02 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.554 1.142 . . . . 0.0 111.725 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.81 153.84 89.16 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.851 1.26 . . . . 0.0 113.131 172.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.96 168.68 23.02 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.472 2.782 . . . . 0.0 112.897 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.12 134.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.13 1.372 . . . . 0.0 111.769 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -78.16 141.78 38.46 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.213 1.405 . . . . 0.0 110.93 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.21 -6.8 83.98 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 115.884 1.113 . . . . 0.0 115.884 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mp 57.5 17.92 4.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.266 2.226 . . . . 0.0 114.765 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.14 167.98 9.2 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.195 1.798 . . . . 0.0 113.706 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -66.34 -23.16 66.31 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.34 162.68 12.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.542 1.537 . . . . 0.0 112.894 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.7 mtm-85 -131.61 95.85 3.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.012 1.725 . . . . 0.0 110.804 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -80.14 175.22 10.84 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.162 1.385 . . . . 0.0 111.637 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -124.83 123.17 39.37 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.03 1.332 . . . . 0.0 109.887 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -126.71 162.72 25.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.426 1.89 . . . . 0.0 110.916 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -129.33 123.94 33.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.617 1.167 . . . . 0.0 110.327 -176.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -130.26 126.01 36.23 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.521 1.128 . . . . 0.0 111.394 -172.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.36 122.04 18.13 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.293 -0.879 . . . . 0.0 111.659 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mmm -102.72 11.34 37.78 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.812 1.245 . . . . 0.0 113.371 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.08 -76.0 0.31 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.623 2.059 . . . . 0.0 111.863 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -126.14 6.39 7.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.062 1.745 . . . . 0.0 113.379 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 72.7 m -136.79 117.96 14.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.982 2.113 . . . . 0.0 109.448 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.0 t -78.25 122.19 25.38 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.443 0.697 . . . . 0.0 110.764 172.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -111.01 136.44 50.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.569 1.947 . . . . 0.0 110.74 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.84 144.31 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.619 0.768 . . . . 0.0 111.378 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -123.2 133.56 54.21 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.219 1.807 . . . . 0.0 109.655 172.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -126.56 109.88 12.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.932 1.693 . . . . 0.0 110.358 -170.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.22 -168.79 30.84 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.463 1.03 . . . . 0.0 112.121 -171.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.06 84.74 2.31 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.47 -1.017 . . . . 0.0 111.201 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -129.43 138.97 51.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.565 1.946 . . . . 0.0 110.268 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.0 p -127.94 -9.5 5.45 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.01 1.324 . . . . 0.0 114.43 -174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 -169.77 43.8 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.577 1.56 . . . . 0.0 113.067 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.47 -171.08 51.93 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 121.921 0.734 . . . . 0.0 114.001 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -83.49 149.81 26.39 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.434 1.494 . . . . 0.0 111.64 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.9 m -84.6 -14.32 49.08 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -141.5 153.9 45.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.453 1.501 . . . . 0.0 111.944 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 45.5 tpp -61.73 -24.51 66.84 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.383 1.473 . . . . 0.0 113.359 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.11 -22.74 58.64 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 121.197 -0.94 . . . . 0.0 114.572 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -78.59 -39.11 38.41 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.882 1.341 . . . . 0.0 112.623 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 p -58.87 -39.34 81.07 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.38 -0.825 . . . . 0.0 112.277 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.51 53.39 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -67.7 -40.84 84.32 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 120.923 -1.111 . . . . 0.0 111.705 169.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.5 -52.92 4.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.761 1.624 . . . . 0.0 111.938 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.7 m -76.04 159.75 79.89 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.983 0.913 . . . . 0.0 113.297 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.73 -9.27 21.06 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.652 2.901 . . . . 0.0 114.244 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 C-N-CA 127.408 2.433 . . . . 0.0 113.001 178.522 . . . . . . . . 0 0 . 1 stop_ save_